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ABSTRACT  
 
People with lower limb amputations often face challenges in rehabilitation and 
returning to normal living. Peripheral vascular disease and diabetes are the most 
prevalent precipitating causes of lower limb amputation in economically developed 
countries. Both of these aetiologies are associated with a range of deficits in 
cognitive functioning. Deficits in cognitive functioning have the potential to impact 
rehabilitation engagement, and rehabilitation outcomes.  
The first aim of the present research was to establish a comprehensive profile 
of cognitive functioning in people engaged in lower limb amputation rehabilitation. 
The second aim was to examine relationships between selected cognitive functions, 
rehabilitation engagement, and prosthetic, mobility, and psychosocial rehabilitation 
outcomes. 
Comprehensive neuropsychological data was collected from 87 participants 
with lower limb amputations on admission to comprehensive rehabilitation. 
Prosthetic (use, satisfaction), mobility, and psychosocial (activation, adjustment, 
distress, social support, community participation) outcomes were examined at 
discharge, six months, and 12 months post-discharge. Clinician-rated rehabilitation 
engagement was examined at discharge. 
Impairments in overall cognitive functioning, estimated premorbid cognitive 
functioning, reasoning, psychomotor function, information processing, attention, 
memory, visuospatial functions, language, and executive functions were evident. 
Aetiology was not related to cognitive functioning. Outcomes were generally 
longitudinally stable. Higher rehabilitation engagement was related to favourable 
discharge and six month outcomes, and higher overall cognitive functioning, 
information processing, delayed recall, and visuospatial construction abilities (but 
not cognitive flexibility or planning). Generally, cognitive functions were not 
predictive of rehabilitation outcomes when controlling for rehabilitation engagement.  
Findings support the need for cognitive screening at rehabilitation admission, 
including of persons with non-dysvascular amputations. Administration of 
comprehensive neuropsychological assessment with a battery sensitive to 
cerebrovascular disease sequelae is recommended. Rehabilitation engagement may 
be a potentially modifiable contributor to outcomes. Cognitive functioning is a 
potential intervention point for improvement of rehabilitation engagement. 
Understanding precise relationships between outcomes and executive functioning 
warrants further research.   
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1.1 Lower Limb Amputation 
Major lower limb amputation is the surgical or traumatic removal of a person’s 
lower limb at the transmetatarsal level or more proximally. Amputations arise from a 
number of aetiologies: peripheral vascular disease (PVD), complications related to 
diabetes, trauma (including penetrating and blunt force injuries, as well as burns, 
cold exposure – frostbite, animal bites, and snakebite), cancer, infection 
(osteomyelitis (bone infection), necrotising fasciitis), intravenous drug use, 
neurological conditions, congenital conditions, and elective surgery of healthy limbs 
(i.e. body identity integrity disorder) (Bayne & Levy, 2005; Chalya et al., 2012; 
Espandar & Yousef, 2011; Kurichi, Bates, & Stineman, 2010; Ramdass, 2009). 
Amputations may also result from multiple aetiologies, and more proximal re-
amputation following an initial amputation may occur due to disease progression, 
device infection, or skin breakdown (Kurichi et al., 2010). Lower limb amputation 
(LLA) is distinctly different from upper limb amputation in terms of the frequency of 
their precipitating aetiologies, consequences for mobility, and rehabilitation needs. 
Within economically developed countries the leading causes of upper limb 
amputation are traumatic, whereas peripheral vascular disease and diabetes are the 
leading causes of LLA. An introduction to aetiologies and epidemiology of lower 
limb amputation follows, with emphasis on the most frequent aetiologies in the 
economically developed world.  
The majority of lower limb amputations in economically developed countries 
result from peripheral vascular disease (PVD) (Amputee Coalition of America, 2008; 
National Amputee Statistical Database, 2009). PVD is a disease of insufficient blood 
supply to tissues of the lower limbs because of arteriosclerosis (Scottish 
Intercollegiate Guidelines Network, 2006). Arteriosclerosis is the process of 
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accumulation of fatty deposits on, and thickening and hardening of, arterial walls 
(Mottet, 2014). Vessels affected include the distal aorta, iliac artery, femoral artery, 
and popliteal artery (Rafnsson, Deary, & Fowkes, 2009). There are a number of 
stages of PVD: 
 stage 1: asymptomatic 
 stage 2: intermittent claudication; muscular pain and weakness instigated by 
activity or exercise, which abates with rest 
 stage 3: pain occurring during rest or nocturnally 
 stage 4: necrosis or gangrene  
Stages 3 and 4 are known as critical limb ischaemia. Persons with stage 3 PVD, and 
particularly stage 4 PVD, are at risk of amputation. Amputation is a common 
treatment option for ischaemic peripheral vascular disease (Tunis, Bass, & Steinberg, 
1991). PVD has regularly been associated with cognitive difficulties. In reviewing 
the literature on PVD and cognitive functioning Rafnsson et al. (2009) found that 
people with PVD perform worse than controls on assessments of cognitive 
functioning, and have increased cognitive decline independent of history of 
cerebrovascular disease and presence of cognitive risk factors. Ultimately, persons 
with PVD generally have a profile of cognitive impairments similar to the profile in 
cerebrovascular disease including reasoning, psychomotor speed, attention, memory, 
and executive functions, as well as processing speed and visuospatial cognition.  
Diabetes is an endocrine disorder resulting in hyperglycaemia, and presents 
an increased risk of lower limb amputation (Pernot, Lindeman, & Cluitmans, 1997). 
Complications of diabetes include ulceration of the lower extremities (Boulton, 
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2000; Ohsawa, Inamori, Fukuda, & Hirotuji, 2001). Diabetic neuropathy may result 
from hyperglycaemia, infection, or neglect of the lower extremity. Via peripheral 
vascular disease, this can lead to ischaemia, which may progress to gangrene, and 
ultimately lower limb amputation (Bild et al., 1989). In Ireland, persons with 
diabetes (either type 1 or 2) were reported to be at least 21 times more likely to 
undergo lower limb amputation of non-traumatic aetiology than persons without 
diabetes (Buckley et al., 2012). Additionally, presence of diabetes may pose 
increased risk of post-traumatic amputation rather than limb salvage. Trauma-related 
amputations have been found to be 5% more common in persons with diabetes than 
in those without (Fosse et al., 2009). Diabetes has long been associated with 
cognitive impairment (Strachan, Deary, Ewing, & Frier, 1997). Psychomotor speed, 
information processing speed, attention, immediate and delayed memory, and 
executive functions are among the functions impaired in type 2 diabetes, with 
particular focus on psychomotor, memory, and executive functions (Kodl & 
Seaquist, 2008). A recent meta-analysis found that episodic memory and executive 
functions (especially cognitive flexibility) are particularly impaired functions in 
people with diabetes (Sadanand, Balachandar, & Bharath, 2016). People with 
diabetes are also at higher risk of developing mild cognitive impairment or dementia 
(Cheng, Huang, Deng, & Wang, 2012). 
In economically developed countries, trauma is a less common aetiology for 
lower limb amputation than dysvascularity (Carmona et al., 2005). While risk of 
amputation for all causes increases with age (Dillingham, Pezzin, & MacKenzie, 
2002), generally people with lower limb amputations resulting from trauma or cancer 
are younger than those who have undergone amputation due to dysvascularity 
(Ziegler-Graham, MacKenzie, Ephraim, Travison, & Brookmeyer, 2008). 
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Considering the lack of systemic vascular disease (assuming absence of dysvascular 
comorbidity or comorbid traumatic brain injury), people with traumatic amputations 
are less likely to be susceptible to cognitive impairment. Their younger age also 
means age-related cognitive decline is less likely to be present. 
As of 2005 in the USA, it was estimated that there were 623,000 persons 
living with a major LLA (i.e. transmetatarsal or more proximal)  (Ziegler-Graham et 
al., 2008). 78.5% of these underwent amputation as a result of PVD, about 70% of 
whom had comorbid diabetes mellitus. Prevalence of dysvascular amputation was 
74% to 78% over a six year period from 2006 to 2012 in Germany (Heyer, Debus, 
Mayerhoff, & Augustin, 2015). In terms of incidence, there are no Irish estimates, 
but comparison can be made to rates across Western Europe. For example, the 
percentage of lower limb amputations performed in recent years as a result of 
dysvascularity ranged from 86% (1994 to 1997) and 82% (2004 to 2007) in Norway 
(Witsø, Lium, & Lydersen, 2010) to 95% in France (Fosse et al., 2009). 72% of LLA 
referrals to prosthetic centres in Great Britain in the 2006/7 period related to 
dysvascularity (including PVD and diabetes) (National Amputee Statistical 
Database, 2009). It is useful to note, however, that not all cases of lower limb 
amputation will be referred to prosthetic rehabilitation, as not all people with lower 
limb amputations are considered suitable candidates. This may be due to a variety of 
medical reasons, including greater illness burden (Bates et al., 2009), that are 
deemed likely to impact their ability to benefit from prosthetic rehabilitation and to 
ambulate safely. 
Amputation rates for trauma and cancer are declining (Varma, Stineman, & 
Dillingham, 2014). Incidence of LLA in people with diabetes also appears to be 
falling and/or stable following a fall  (Bruun, Siersma, Guassora, Holstein, & de Fine 
CHAPTER 1: INTRODUCTION 
6 
 
Olivarius, 2013; Buckley et al., 2012; Gregg et al., 2014; Holstein, Ellitsgaard, 
Bornefeldt Olsen, & Ellitsgaard, 2000; Jørgensen, Almdal, & Faerch, 2014; Lopez-
de-Andres et al., 2015; Varma et al., 2014). Decreasing incidence of diabetes-related 
LLA is likely due to utilization of revascularization procedures and improved disease 
management. However, incidence of diabetes itself is rising  in developed countries 
(Geiss et al., 2006; Haines, Wan, Lynn, Barrett, & Shield, 2007; Lipscombe & Hux, 
2007), and high future prevalence is projected (Boyle, Thompson, Gregg, Barker, & 
Williamson, 2010; Narayan, Boyle, Geiss, Saaddine, & Thompson, 2006). The 
profile is similar for peripheral vascular disease. The number of amputations 
resulting from PVD seems to be falling (Jones et al., 2012), yet there is high 
incidence of PVD and rising (Alzamora et al., 2016; Velescu et al., 2016). Countries 
with developing economies are also witnessing rising incidence of cardiovascular 
disease, diabetes, and PVD (e.g. Barceló and Rajpathak (2001), Hall, Thomsen, 
Henriksen, and Lohse (2011), Mbanya, Motala, Sobngwi, Assah, and Enoru (2010), 
and Shaw, Sicree, and Zimmet (2010)). Moreover, populations in almost every 
country are ageing, with the number of persons aged 60+ projected to more than 
double by 2050 (United Nations Department of Economic and Social Affairs 
Population Division, 2013). There are strong links between age and aetiology – older 
persons are more likely to have dysvascular aetiology – and these are outlined 
further below. The result is that despite disease management improvements, many 
persons will continue to present to rehabilitation programmes with dysvascular-
related amputations. Bruun et al. (2013, p. 8) for example has described the rate of 
people undergoing amputation precipitated by diabetes as “unacceptably high”. 
These presentations will also be increasingly common in countries not currently 
considered to have developed economies as such economies develop.  
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Advanced age is often an issue in persons undergoing lower limb amputation. 
Age over 60 years has been reported as a univariate predictor of major lower limb 
amputation (Nather et al., 2008), and indeed the majority of those undergoing a 
lower limb amputation are aged over 60 (Pernot et al., 1997). In the UK, roughly 
three quarters of people with traumatic LLA are aged under 55, whilst 85% of those 
with dysvascular aetiology are over 55 and 32% are over 75 (National Amputee 
Statistical Database, 2009). Overall, 56% of amputations were carried out on patients 
over 65 years of age in the UK between 2006 and 2007 (National Amputee 
Statistical Database, 2009). Mean ages at amputation incidence of 70.5 (Finland) and 
75/74 (The Netherlands; ‘91 – ‘92 and ’03 – ‘04) have been reported (Alaranta, 
Alaranta, Pohjolainen, & Kärkkäinen, 1995; Fortington et al., 2013). With improved 
disease management, the age at which amputations are performed may be rising 
(Carmona et al., 2005). The mean age at which people are being admitted to 
rehabilitation is also rising – likely due to improved disease management and 
revascularization prior to the critical limb ischaemia. With increasing age comes an 
increased risk not just of dysvascular amputation, but of all amputations including 
post-traumatic, peaking amongst those aged 85 or older (Amputee Coalition of 
America, 2008; Dillingham et al., 2002). This may be as a result of the link between 
ageing and peripheral vascular disease, with vascular insufficiency post-trauma also 
contributing to increased rate of amputations due to trauma (Golomb, Dang, & 
Criqui, 2006). Increasing age also carries increased risk of cognitive impairment and 
dementia. 
In sum, the most prevalent causes of lower limb amputations are peripheral 
vascular disease (PVD) and diabetes. Although incidence rates of amputation in 
people with PVD and diabetes are falling, the overall rate remains high, while 
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incidence of both PVD and diabetes is rising. Additionally, amputations are 
associated with older age and most populations across the world are ageing. PVD 
and diabetes are both associated with cognitive impairments. Ageing is also 
associated with increased risk of cognitive impairment and dementia.  
 
1.2 Cognitive Functioning and Lower Limb Amputation 
People with lower limb amputations are at greater risk of having or developing 
impaired cognitive functioning (Coffey, O’Keeffe, Gallagher, Desmond, & 
Lombard-Vance, 2012). The high prevalence of dysvascularity as a precipitating 
factor in LLA underlies this risk. Peripheral vascular disease has been linked to 
vascular cognitive impairment (Rafnsson et al., 2009). PVD is also a marker for 
generalised cardiovascular pathology and therefore cerebrovascular pathology. 
Diabetes too, has been associated with impaired cognitive functioning. Additionally, 
the age at which most lower limb amputations are carried out (>60, and increasing) 
means that age-related cognitive decline may be an issue in this population, while 
older age is also a risk factor in itself for cognitive impairment and dementia 
(Tucker-Drob, 2011). In essence, risk factors for lower limb amputation – 
dysvascularity and advanced age – are shared with cognitive impairment. Cognitive 
functions have thus become of interest as potential contributors to variation in LLA 
rehabilitation outcomes, yet cognitive functioning in LLA has received relatively 
little research attention (Coffey et al., 2012).  
The provision of prosthetic services is a fundamental component of 
rehabilitation programmes, but variation in rates of prosthesis use suggest that 
prosthetic provision interventions may not always be effective (Gallagher, Desmond, 
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& MacLachlan, 2008) and that opportunities to improve provision remain. 
Prostheses are difficult to learn to use and must be appropriately maintained. Intact 
cognitive functioning is likely to be important in learning to don, doff, use, ambulate 
with, and maintain prostheses.
1
 Furthermore, some people with lower limb 
amputation achieve functional independence and adjust well after limb loss, yet 
others do not (Gallagher et al., 2008). Reintegration into community living and 
social roles may also be dependent somewhat on cognitive functions and their 
successful application. An additional burden of planning, organization of activity, 
memory for prosthetic procedures, attention to appropriate gait, and so on exists for 
people with lower limb amputations. Understanding precipitant factors of good and 
poor performance of activities, participation, and overall adjustment to limb loss will 
assist in the further development and optimization of limb loss rehabilitation 
programmes.  
 
1.3 The International Classification of Functioning, Disability and Health 
The International Classification of Functioning, Disability and Health (ICF) is a 
model of health and disability that was developed to focus on components of health 
rather than consequences of disease (World Health Organization, 2001). The ICF 
was designed to be consensus-based, culturally sensitive, and have input from 
multiple stakeholders, including for example, people with impairments/disabilities, 
healthcare professionals, and professionals in the areas of insurance, policy, and 
social welfare/security.  
                                                 
1 Donning and doffing is putting on and taking off a prosthesis.  
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The ICF conceptualizes functioning as being determined by the interaction 
between one’s health condition, environmental factors, and personal factors, and thus 
can be seen as a biopsycho-ecological paradigm (Stineman & Streim, 2010). This 
interaction is mediated by the three major components of the ICF; a person’s body 
structure and functions (including psychological functions), their activities, and the 
areas of life in which they participate. Barriers to optimal functioning have been 
identified in each of these domains, including impairment of body structure and/or 
function, activity limitations, and participation restrictions, as well as environmental 
barriers, and potentially personal factors such as age. Just as there are barriers, there 
are also facilitators. Facilitators include assistive technology, adapted architecture, 
and changes in law. Personal factors such as coping style or age are also potentially 
facilitative. Bruyère and Peterson (2005) argue that ICF allows for diagnostic labels 
to be avoided, in favour of describing health in terms of functioning. This allows for 
greater precision and better understanding of what impacts functioning, while 
assessment of a broad spectrum of functioning and maximization of social inclusion 
are both emphasized.  
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Figure 1: The International Classification of Functioning, Disability and Health 
(ICF) Model 
 
The ICF has been criticised for unclear distinctions between activities and 
participation due to conceptual overlap (Whiteneck & Dijkers, 2009). Nevertheless, 
it is gathering momentum as a conceptual framework for healthcare clinical practice 
and research, particularly in the field of rehabilitation (Cerniauskaite et al., 2011). 
The ICF is a more suitable model to apply to the rehabilitation process than overtly 
biological medical models, as health and ‘real-world’ functioning is determined by 
more than merely impairment and alleviation of same – improvement of capacity 
(Reed et al., 2005). Within the ICF framework, it is also possible to have an 
impairment such as an amputation and be neither unhealthy nor consider oneself 
socially oppressed. This would not be possible within current social model 
frameworks according to Shakespeare (2013). In consideration of the high lifetime 
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incidence of impairment, the ICF model sees health and disability as universal 
human experiences rather than minority issues (World Health Organization, 2001). 
As Llewellyn and Hogan (2000, p.157) stated, “Models of disability are not 
synonymous with theory as their usage does not involve data collection, but they 
may have some usage as generators of hypotheses.” The ICF offers a 
conceptualization of functioning, health, and disability that is useful in a 
rehabilitation context. The ICF, as more explicitly a model of health, is more suitable 
to a study of the effects of cognitive functioning on rehabilitation outcomes in people 
with amputations than the social model of disability, which is primarily a model of 
social exclusion (Shakespeare, 2013). Cognitive functioning and impairments are 
included in the ICF model as impairments. Within the ICF model, impaired 
cognitive functioning could adversely affect a person’s activities, participation, and 
health status. The ICF serves as the overarching theoretical framework for the 
present research.  
 
1.4 Thesis Aims 
The first aim of this thesis was to obtain a comprehensive neuropsychological profile 
of people who attended comprehensive rehabilitation with a lower limb amputation. 
Aspects of cognitive functioning to be assessed include estimated premorbid 
intellectual functioning, overall cognitive functioning, reasoning, psychomotor 
speed, information processing, attention, memory, visuospatial perception and 
construction, language, and executive function. The second aim was to assess the 
relationships between cognitive functions and prosthetic, mobility, and psychosocial 
NEUROPSYCHOLOGICAL FUNCTIONING & LOWER LIMB LOSS 
13 
 
outcomes, and rehabilitation engagement in people with lower limb amputations in a 
rehabilitation programme.   
 
1.5 Thesis Outline 
Chapter two is a review of the literature relating to cognitive functioning in 
lower limb amputation. Chapter three sets out the aims and hypotheses for the 
present research study. Chapter four states the methodology of the present 
research. Chapter five is a presentation and discussion of the results of a 
neuropsychological assessment of people with lower limb amputations during an 
inpatient/day-patient rehabilitation programme. Chapter six is a presentation and 
discussion of the results of a) a prosthetic, mobility, and psychosocial outcomes 
questionnaire follow-up and b) the relationship between these prosthetic, 
mobility, and psychosocial outcomes and cognitive functioning. Finally, chapter 
seven presents a discussion and conclusion for the present thesis as a whole. 
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This chapter reviews the literature on cognitive functioning and lower limb 
amputation. A review of the association between dysvascularity and cognitive 
functioning is provided in the first instance to contextualise the literature on 
cognitive functioning and lower limb amputation. This is followed by the review of 
cognitive functioning and lower limb amputation proper. This review comprises two 
sections. In the first section, studies which have attempted to contribute to profiling 
cognitive functioning in lower limb amputation are reviewed. In the second section, 
studies which have examined relationships between cognitive functioning and 
various aspects of rehabilitation or its outcomes are reviewed. A summary of the 
literature on cognitive functioning and lower limb amputation in totality is then 
provided. At the end of this chapter, there is a determination of research needs before 
the following chapter sets out objectives and hypotheses for the current research.  
 
2.1 Dysvascularity and Cognitive Functioning 
The majority of lower limb amputations are necessitated by dysvascularity, an 
umbrella term for amputations resulting from peripheral vascular disease and 
diabetes. Both peripheral vascular disease and diabetes have been associated with a 
range of cognitive impairments or deficits in cognitive functioning.  
 
2.1.1 Vascular Cognitive Impairment 
Cerebrovascular disease is “any pathological process involving blood vessels in the 
brain. Vascular pathology may include lesions of the vessel wall, occlusion of the 
vessel, rupture of the vessel, or malformation” (Weinstein & Swenson, 2006, p. 
294). Vascular cognitive impairment (VCI) is cognitive decline or impairment 
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related to cerebrovascular disease. There is a relationship between peripheral 
vascular disease and vascular cognitive impairment (Rafnsson et al., 2009). Systemic 
vascular disease is associated with presence of brain infarcts, white matter lesions, 
grey matter atrophy, and poorer cognitive function (Riverol et al., 2015). 
Vascular cognitive impairment may be used as an umbrella term for 
numerous types of cognitive decline related to vascular pathology. This represents a 
spectrum of impairment ranging from vascular dementia (VaD) to vascular cognitive 
impairment-no dementia (VCI-ND), and including a “brain at risk” stage wherein 
there is not yet cognitive impairment (Bowler, 2007; Desmond, 2004). In some 
cases, it may also even include dementia of mixed-Alzheimer’s disease and vascular 
pathology, post-stroke dementia, and hereditary vascular dementias (Bowler, 2007; 
Wilson, Craig, McIlroy, & Passmore, 2004).  
The cognitive profile of vascular cognitive impairment-no dementia (VCI-
ND) has traditionally been defined as impairment in attention, executive functioning, 
and psychomotor speed, while memory functions remain relatively intact, with 
apathy and depression as a further probable feature (O’Brien, Reisberg, & 
Erkinjuntti, 2003). The National Institute of Neurological Disorders and Stroke–
Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards 
(Hachinski, Iadecola, & Petersen, 2006) however, say that all cognitive domains, 
including memory, may be affected, while impairment of executive function features 
most predominantly. They include “slowed information processing, impairments in 
the ability to shift from one task to another, and deficits in the ability to hold and 
manipulate information (i.e., working memory)” (p. 2222).  It is important to note 
that the profile of VCI is dependent on the location of cerebral lesions, meaning that 
a range of presentations are possible, especially in VCI-ND.  
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A recent meta-analysis has found that when compared with controls, people 
with VCI-ND diagnosed with brain imaging had significantly poorer cognitive 
functioning across a range of domains with moderate to large effect sizes (Vasquez 
& Zakzanis, 2015). From most to least impaired (largest to smallest effect size), 
these included processing speed (d = -1.36), immediate memory (d = -1.03), delayed 
memory (d = -1.02), overall cognitive functioning (d = -1.01), language (d = -.92), 
executive functions (d = -.90), visuospatial construction (d = -.63), and working 
memory (d = -.48). Meta-regression found that age, but not education, was a 
significant positive predictor of effect sizes for processing speed, language, and 
immediate memory. There is much evidence for impairment of executive function, 
attention and processing speed (Kramer, Reed, Mungas, Weiner, & Chui, 2002; 
Nordlund et al., 2007; Prins et al., 2005). Yet these meta-analytical findings counter 
the notion that these are the sole functions affected. Similarly, they evidence against 
the belief that memory functions are relatively preserved in VCI-ND (as had been 
previously proposed (O’Brien et al., 2003)). Furthermore, while executive 
functioning is certainly impaired, it may not be the most impaired of cognitive 
functions in VCI-ND or indeed the hallmark of VCI-ND. Indeed, large effect sizes 
were found for processing speed, immediate memory, delayed memory, overall 
cognitive functioning, and borderline large effect sizes were found for language and 
executive functions. Impairment of executive function may have an additive effect 
upon impairments of cognitive functions already evident. This may be the case if 
executive functions direct the use of other cognitive functions, as they are thought to 
do (e.g. Lezak, Howieson, Digler, & Tranel, 2012). Another research finding in 
cases of cerebral small vessel disease is worth noting. Some people – depending on 
lesion site – lack insight and may not be aware of their own cognitive impairment or 
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decline (Brookes, Hannesdottir, Markus, & Morris, 2013). In cases such as lack of 
awareness of deficits, people engaged in an inpatient rehabilitation programme for 
example, may not therefore draw clinicians’ attention to their cognitive impairment. 
In general, persons with vascular dementia have generalised cognitive 
impairment across the spectrum of cognitive functions, and can have a particularly 
high level of impairment in executive functioning. This includes impairments in 
planning and sequencing of tasks, processing speed, goal formation or performance 
on unstructured tasks, and verbal fluency (Poore, Rapport, & Fuerst, 2006), as well 
as attention (Desmond, 2004). Memory functions are thought to be less impaired 
than would be amongst persons with dementia of Alzheimer’s disease type, but 
impairment may be present in cases of medial temporal lobe lesion or infarction. 
Primary language functions appear to remain relatively unimpaired, with the 
probable exception of motor aspects of language production (Desmond, 2004).  
 
2.1.1.1 Peripheral Vascular Disease and Cognitive Impairment 
Ischaemic peripheral vascular disease is usually a marker of extensive 
arteriosclerosis elsewhere in the circulatory system, and is probably the reason that 
peripheral vascular disease itself has been associated with cognitive decline 
(Guerchet et al., 2011; Rafnsson et al., 2009).  
The ankle brachial pressure index (ABPI) is “a measure of the blood pressure 
in the arteries supplying legs relative to central, aortic pressure” and is frequently 
used in the diagnosis of PVD (Al-Qaisi, Nott, King, & Kaddoura, 2009, p. 834). 
Guerchet et al.'s (2011) systematic review of twelve cross-sectional and prospective 
cohort studies found that low scores on the ABPI – indicating vascular pathology –
predicted cognitive impairment. In cross-sectional studies, low ABPI was associated 
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with overall cognitive, memory, non-verbal reasoning, and executive function 
impairments, and with higher odds of developing dementias. It was also associated 
with cognitive decline and development of dementia in longitudinal studies. Hofman 
et al. (1997), for example, found that persons with PVD had adjusted odds ratios of 
2.5 (95% CI = 1.3 – 4.8) for development of vascular dementia (therein multi-infarct 
dementia, as defined by DSM-III-R (American Psychiatric Association, 1987)), and 
1.3 (95% CI = 0.9 – 1.8) for development of Alzheimer’s disease. Within Guerchet 
and colleagues’ (2011) review, nine of the twelve studies assessed cognitive 
impairment with the MMSE. However, the MMSE is not as sensitive a screening 
instrument for executive functioning elements of cognitive impairment as the 
Montreal Cognitive Assessment (Freitas, Simões, Alves, Vicente, & Santana, 2012; 
Markwick, Zamboni, & De Jager, 2012), meaning the relationship between low 
ankle brachial index (i.e. PVD) and cognitive impairment may even have been 
underestimated.  
Rafnsson et al. (2009) detailed research to date on cognitive functioning in 
people with PVD defined more generally. When compared with controls without 
PVD, people with PVD had poorer performance on measures of attention, reasoning 
(arithmetic (Lezak et al., 2012)), and “frontal lobe function”. It must be borne in 
mind that frontal lobe functions may not be fully equivalent to executive functions 
(Stuss, 2011). The frontal lobes are likely necessary but insufficient for executive 
function (Alvarez & Emory, 2006). Evidence exists of a relationship between 
severity of vascular pathology and cognitive functioning – visual immediate 
memory, and executive functioning and perceptuo-motor speed (Waldstein et al., 
2003). Participants with a history of stroke performed significantly worse than those 
with peripheral vascular disease (intermittent claudication), who in turn performed 
CHAPTER 2: LITERATURE REVIEW 
20 
 
significantly worse than people with hypertension; the best-performing were the non-
hypertensive controls. Hierarchical multiple regression found that visual delayed 
memory was predicted by blood plasma glucose levels, a cardiovascular risk factor. 
A more recent study examined PVD and cognitive functioning in two age cohorts 
aged 73 and 87 (Laukka, Starr, & Deary, 2014). There were no differences in 
cognitive functioning between those with and without PVD when cut-off scores were 
used. Yet, when continuous ABPI scores were examined, lower ABPI (i.e. worse 
PVD) was associated with poorer overall cognitive functioning and processing speed 
at 87 years and poorer processing speed at 73. The analysis controlled for age, sex, 
and childhood cognitive ability and excluded persons with abnormally high (good) 
ABPI and a history of cardiovascular or cerebrovascular disease. Mangiafico, 
Sarnataro, Mangiafico, and Fiore (2006) found that even persons with asymptomatic 
peripheral vascular disease performed significantly worse than control subjects on a 
battery of neuropsychological tests. Participants were identified with the ankle 
brachial index, and had no history of either stroke or transient ischaemic attack. The 
test group performed worse on tests of attention, working memory, perceptuo-motor 
speed, visuospatial cognition, and delayed visual memory. Two markers of vascular 
disease (levels of C-reactive protein and D-dimer) were significant, independent 
predictors of poorer neuropsychological test performance. 
In sum, peripheral vascular disease has a consistent relationship with 
cognitive impairment. The literature suggests that this applies even in the early 
stages of peripheral vascular disease such as intermittent claudication, and even 
asymptomatic peripheral vascular disease. Considering the high prevalence of 
peripheral vascular disease as a precipitant of lower limb amputation, it is reasonable 
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to suspect that people with lower limb amputations may suffer cognitive impairment 
relating to vascular pathology. 
 
2.1.2 Diabetes and Cognitive Impairment 
Type 2 diabetes, by far the most prevalent form of diabetes, has been associated with 
increased incidence of cerebral infarction (Arvanitakis, Schneider, et al., 2006), 
while insulin resistance has been linked to cerebrovascular pathology/small vessel 
disease (Hughes & Craft, 2016). Diabetes has also been associated with an increased 
rate of cerebral atrophy in the elderly (van Elderen et al., 2010), lower grey matter 
volume and larger lesions, as well as more frequent incidence of lesions 
longitudinally in elderly persons (Espeland et al., 2013). Diabetes confers increased 
risk for developing cognitive impairment (Strachan, Reynolds, Frier, Mitchell, & 
Price, 2008) in a range of specific cognitive functions (Palta, Schneider, Biessels, 
Touradji, & Hill-Briggs, 2014). Intervention for diabetes has improved cognitive 
outcome (Luchsinger et al., 2011).  
Meta-analysis has shown that people with diabetes are 1.2 times more likely 
to experience decline in overall cognitive functioning (cognitive screen) in cognitive 
ability over time. They are also 1.7 times more likely to experience decline in 
processing speed (Cukierman, Gerstein, & Williamson, 2005). A recent, separate 
meta-analysis found that episodic memory and cognitive flexibility, an executive 
function, were particularly impaired in people with diabetes (Sadanand et al., 2016). 
With a 12-year follow up period, Spauwen, Kohler, Verhey, Stehouwer, and van 
Boxtel (2013) found that people with diabetes had a steeper decline in each of the 
four cognitive functions measured –executive function, processing speed, immediate 
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and delayed memory, as well as global cognitive functioning (MMSE). A recent 
meta-analysis of longitudinal studies (Cheng et al., 2012) found that people with 
diabetes had a relative risk of 2.49 for vascular dementia (any dementia 1.51, 
Alzheimer’s 1.46) and 1.21 for mild cognitive impairment. Eight of the ten included 
studies found diabetes to be a significant risk factor for vascular dementia (ten of 
sixteen for Alzheimer’s disease, one of two for mild cognitive impairment). In 
Marseglia et al.'s (2014) study, 40% of people with diabetes but no dementia had 
global cognitive impairment (MMSE), and in over 65s, cognitive impairment was 
related to amputation incidence. Type 2 diabetes has also been shown to be a 
contributor to age-related cognitive decline (Hassing et al., 2004).  
Strachan, Deary, Ewing, and Frier (1997) reviewed studies to investigating 
cognitive function in diabetes. They found that the studies which found no difference 
between people with diabetes and controls were statistically underpowered. When 
impairments were seen, verbal memory – immediate and delayed (when one was 
impaired the other was also and vice versa) – was most frequently impaired. 
Evidence was less clear-cut for other domains – visuospatial memory, attention, 
executive functions, and psychomotor functions. Studies found both impairment and 
non-impairment in all domains. On all three instances on which a cognitive screen 
(always the MMSE) was employed, performance was impaired. A more recent meta-
analysis examined the profile of cognitive impairment in people with diabetes (Palta 
et al., 2014). People with diabetes had poorer cognitive functioning with small to 
medium effect sizes (d) in all of the domains examined. In order from most to least 
impaired, these were psychomotor functions (d = -.36), executive functions (d = -
.33), processing speed (d = -.33), verbal immediate and delayed memory (d = -.28; d 
= -.31 when heterogeneous studies were excluded from analysis), visual immediate 
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and delayed memory (d = -.26), and attention (d = -.22). After the two psychomotor 
tasks, immediate verbal memory, cognitive flexibility (an executive function), and 
delayed visual memory were the three tasks most discriminant between people with 
and without diabetes, each with effect sizes of d = .4 or just below. Attention span 
(digit span forward) was the only area not impaired at all, although it was measured 
only once. Visuospatial perception and construction, language, and general 
intellectual functioning and reasoning were not covered by the meta-analyses. 
Another meta-analysis (Brands, Biessels, de Haan, Kappelle, & Kessels, 2005) found 
that people with type 1 diabetes had a slightly different profile of impaired cognitive 
functioning. Impaired functions included cognitive flexibility, processing speed, 
attention (visual and sustained), fluid and crystallised intelligence, psychomotor 
efficiency, visual perception. Immediate and delayed memory, working memory, 
divided and selective attention, and language were unimpaired.  
Diabetes is consistently related to increased risk of developing dementia. 
Impairments of cognitive functions including overall cognitive functioning, 
psychomotor functions, information processing speed, attention, immediate and 
delayed memory and executive functions are also widespread. It is reasonable to 
conclude that people with lower limb amputations may have cognitive impairments 
relating to diabetic pathology when considering the high prevalence of diabetes as a 
contributing factor in lower limb amputation. 
 
2.2 Amputation and Cognitive Functioning  
With the majority of lower limb amputations occurring in older people with vascular 
disease or diabetes, cognitive functions are likely to be impaired. This has received 
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some research attention to date. Our recent systematic review of cognitive 
functioning in people with lower limb amputations emphasized the need for 
assessment of cognitive functioning in people with lower limb amputations (Coffey 
et al., 2012). The purpose of the review was to “synthesise current evidence 
regarding cognitive functioning in persons with lower limb amputations in terms of 
the prevalence of dementia and cognitive impairment, and to review the methods 
employed to assess cognitive ability, the areas of cognition most affected, and the 
outcomes associated with cognitive functioning” (p. 1951). Peer-reviewed, English-
language articles were included in the review if: a group or subgroup of participants 
had lower limb amputation (unilateral or bilateral), participants were aged 18 years 
and over, and one or more cognitive functions was assessed as a discrete variable. 
Articles were excluded from the review for the following reasons: participants with 
lower limb amputations were not examined as a distinct group, assessment of 
cognitive functioning was used solely as a means of screening potential participants, 
cognitive measures were employed incidentally in the research (e.g. use as a 
distractor tasks) and were not the focus of statistical analyses. 30 studies ultimately 
met the inclusion criteria and were reviewed. The review concluded that the studies 
reviewed were heterogeneous in design, quality, and methodology of assessment of 
cognitive functioning. Assessment of cognitive functioning all too frequently relied 
on diagnoses of dementia in medical records, or on brief cognitive screening tools. 
However, the review found that impaired cognitive functioning – whether diagnosed 
dementia or performance on neuropsychological assessments – is common amongst 
people with lower limb amputations. It also found that cognitive impairment was 
related to a range of less favourable outcomes. What follows is a review of firstly, 
the profile of cognitive functioning in people with lower limb amputations, and 
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secondly, relationships between cognitive functioning and rehabilitation outcomes. 
Included in this review are papers from the (Coffey et al., 2012) review, as well as 
the following more recent publications: Morgan, Kelly, Amtmann, Salem, and 
Hafner (2016), van Eijk et al. (2012), and Williams et al. (2014, 2015).   
 
2.2.1 Cognitive Functioning Profile  
In this section of the review, the question of whether cognitive impairment or 
dementia was present or absent will be examined. A more detailed examination of 
the profile of specific deficits will then follow.  
In people with LLA, a number of studies have attempted to simply determine 
whether cognitive impairment or dementia were present or absent in dichotomous 
terms. Overall, a number of studies reported higher dementia prevalence than the 
rates expected in general populations of over 65s. However, theses proportions of 
individuals diagnosed with dementia have ranged widely – from 5% (Campbell, 
Marriott, & Eve, 2001) to 49% (Taylor et al., 2007). 42% of participants (N = 30) in 
Donaghey et al.'s (2010) study obtained scores below the cut-off score for dementia 
on the Addenbrooke’s Cognitive Examination – Revised (ACE-R), a test with 
reported 100% specificity for the detection of dementia, and 84% sensitivity.
2
  
Often, this dichotomous determination was arrived at by examination of 
whether or not dementia was diagnosed in medical records (Aftabuddin, Islam, Jafar, 
& Haque, 1997; Campbell et al., 2001; Carmona et al., 2005; Couch, David, Tilney, 
& Crane, 1977; Fletcher et al., 2001; Mac Neill, Devlin, Pauley, & Yudin, 2008; 
                                                 
2 The ACE-R was developed to differentiate between dementia of Alzheimer’s type and 
frontotemporal dementia. 
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Pauley, Devlin, & Heslin, 2006; Taylor et al., 2005, 2007; Yu, Lam, Nettel-Aguirre, 
Donald, & Dukelow, 2010), by use of an unspecified measure of ‘confusion’ (Weiss, 
Gorton, Read, & Neal, 1990), or by an unspecified assessment by a psychologist 
(Chiu, Chen, Wang, Lin, & Lien, 2000; Pinzur, Graham, & Osterman, 1988). Other 
studies have used brief cognitive screening tools (Donaghey et al., 2010; Gooday & 
Hunter, 2004; O’Neill, Moran, & Gillespie, 2010; Remes et al., 2008; Remes, 
Isoaho, Vahlberg, Viitanen, & Rautava, 2009), which is preferable to unspecified 
methods of determination. While two of these studies used the ACE-R (Donaghey et 
al., 2010; O’Neill et al., 2010), others relied on Folstein, Folstein, and McHugh's 
(1975) MMSE to make the determination about cognitive functioning. Yet, the 
MMSE is not particularly sensitive to cognitive impairments that commonly result 
from cerebrovascular disease (Pendlebury, Mariz, Bull, Mehta, & Rothwell, 2012). 
In some instances, MMSE results (i.e. mean scores, etc.) were unreported and mixed 
with medical chart data to make determinations of cognitive impairment (Gooday & 
Hunter, 2004; Remes et al., 2009). 
Sample differences such as aetiology of amputation and age may have 
contributed to the variation in rates of dementia. Although, at times even mean age 
of the sample was unreported (Taylor et al., 2007). Additionally, O’Neill et al.'s 
(2010) study sample comprised 8 participants selected as they were experiencing 
difficulties with prosthesis use. Therefore, this was likely to represent a cohort with 
lower cognitive functioning than the general population of persons in LLA 
rehabilitation. Use of different methods of determining cognitive impairment, and 
even different cut-off scores on the MMSE – would also contribute to variation in 
rates of impairment or dementia. Recruitment setting may also affect the rate. For 
example, dementia was present in 14% of participants referred to an inpatient 
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rehabilitation programme, compared to 41% of persons not referred to rehabilitation 
(Fletcher et al., 2001). Overall, there appears to be high prevalence of cognitive 
impairment and even dementia among people with lower limb amputations. 
However, drawing conclusions is hampered by methodological differences and 
drawbacks. A number of studies used more comprehensive, validated and reliable 
neuropsychological assessment methods to attempt to create comprehensive profiles 
of cognitive functioning in people with LLA. These are discussed in further depth 
below.  
The earliest comprehensive examination of cognitive functioning was 
appears to be a study by Wang, Kaplan, and Rogers (1975). Using the original 
Wechsler Memory Scales (Wechsler, 1945), the authors compared orientation and 
memory between people with diabetic LLA and people with hemiplegia. People with 
LLA performed significantly better on tests of temporal, place, and self-orientation, 
and mental control (counting backwards), and digits backward (now considered 
mostly a measure of attention span (Lezak et al., 2012)). The groups did not differ on 
story memory, associative learning, or digits forward. The main limitation of this 
study was its neglect of cognitive functions other than orientation and memory. The 
original Wechsler Memory Scales were also criticised for poor norms, scoring 
criteria, and overreliance on immediate memory measures (see Strauss, Sherman, 
and Spreen (2006) for a brief review). Willrich, Pinzur, McNeil, Juknelis, and 
Lavery (2005) later examined cognitive functioning in three different diabetic 
diagnostic groups – amputation, ulceration, and a peripheral neuropathy control 
group. They used the MMSE cognitive screen and a clock drawing task. They found 
no evidence of a difference between the three groups. There are a few limitations. 
The use of only a cognitive screen and one other brief test limits the conclusions that 
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could be drawn about the full range of cognitive functioning. The MMSE is not 
particularly sensitive to mild cognitive dysfunction or executive functioning 
(Pendlebury et al., 2012). The groups may not be sufficiently different; persons with 
even asymptomatic vascular disease have been shown to exhibit cognitive 
functioning deficits (Mangiafico et al., 2006). Mean age and recruitment setting were 
not reported. O’Neill and Evans (2009) used a 9-hole peg test to assess psychomotor 
function, subtests from the RBANS (Randolph, Tierney, Mohr, & Chase, 1998) – a 
comprehensive cognitive screening battery – to assess delayed verbal and visual 
memory and visuospatial construction, a line bisection test to assess visuospatial 
cognition, two ACE-R cognitive screen (Mioshi, Dawson, Mitchell, Arnold, & 
Hodges, 2006) subtests to assess language, and a test of verbal fluency and a BADS 
(Wilson, Alderman, Burgess, Emslie, & Evans, 1996) planning subtest to assess 
aspects of executive functioning. The authors reported that people with amputation 
aetiologies of PVD, and both PVD and diabetes, had lower scores on an index of 
cognitive functioning (derived from summed z-scores from each of the cognitive 
assessments) than those with aetiologies of trauma, cancer and drug use-related 
dysvascularity. However, the authors did not report group scores on the cognitive 
assessments, and whether or not these differences were statistically significant. 
Another study by O’Neill and colleagues (O’Neill et al., 2010), examined overall 
cognitive functioning in their sample of people referred to an assistive technology 
trial following difficulty with prostheses. Six of eight participants had scores in the 
extremely low range on the RBANS, as well as one participant with a borderline 
score, and one with a score in the average range but with impaired executive 
function. The aggregate sample (N=8) mean scores on both the RBANS screening 
battery (mean scale score = 61.9) and ACE-R dementia screening tool (mean score = 
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72.9) placed the sample as a whole in the impaired range.
3
 Scores across a range of 
subtest indices were also almost uniformly lower than normative scores, but were not 
tested statistically. In terms of neuropsychological assessment, easily the most 
comprehensive attempt at a profile was a study by Phillips, Mate-Kole, and Kirby 
(1993) who used a broad neuropsychological battery. Their battery incorporated 
WAIS-R subtests (Wechsler, 1981) to assess functions like reasoning, information 
processing, language functions, working memory, WMS-R subtests (Wechsler, 
1987) and the Recognition Memory Test (Warrington, 1984) for memory, the Rey-
Osterrieth Complex Figure Test for visuospatial cognition, Graded Naming Test 
(Warrington, 1997) for confrontational naming, the Controlled Oral Word 
Association Test (verbal fluency/executive function), and the modified version of the 
WCST (Nelson, 1976) for executive functioning.
4
 They compared 14 people with 
lower limb amputations due to PVD with 14 elderly controls recruited in the 
community. They assessed functioning with a battery of 23 tests or subtests across a 
range of domains including reasoning, processing speed, memory, visuospatial 
functioning, language, and executive function. They found that people with LLA 
performed significantly worse on two assessments, WAIS-R digit symbol and a 
version of the Wisconsin Card Sort Test (WCST). The authors used the former to 
assess psychomotor speed but it could be considered more so a measure of 
information processing speed (Lezak et al., 2012). The WCST is a measure of 
executive functioning – usually held to be a measure of inhibition (Kolb & 
Whishaw, 2008). There were also non-significant trends toward poorer performance 
on tests of reasoning, visuospatial construction, and letter fluency (an executive 
                                                 
3 RBANS scale score mean = 100 (SD = 15); ACE-R dementia cut-off scores (Mioshi et al., 
2006): <88 = sensitivity 0.94, specificity 0.89; <82 = 82: sensitivity 0.84, specificity 1.0. 
4 Details of all unreferenced assessments may be found in Lezak et al.'s (2012) 
compendium.  
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measure of retrieval strategy and idea generation). Limitations of this study include 
its small sample size, exclusion of participants without PVD, and lack of 
measurement of different aspects of attention, immediate memory – list learning, and 
more basic visuospatial perception. The study also did not assess overall cognitive 
functioning. An aggregate measure of overall cognitive functioning can help to 
capture participants functioning or impairment across the full range of cognitive 
functioning. This is important considering findings of a broad spectrum of 
impairments in people with vascular disease (Vasquez & Zakzanis, 2015) and 
diabetes (Palta et al., 2014).   
A study by Williams et al. (2014) examined cognitive functioning in people 
with PVD-related LLA across three time points: pre-amputation baseline, 6 weeks 
post-surgery, and 4 months post-surgery. It is the only longitudinal examination of 
cognitive functioning in people with lower limb amputations known to this author. 
Assessments they used included: the SPMSQ brief cognitive screen (Pfeiffer, 1975), 
RBANS (Randolph et al., 1998) subtests as measures of memory (immediate list 
recall and delayed list recall) and semantic fluency (which assesses executive 
functioning/language) and the WAIS-III (Wechsler, 1997) digit span measure of 
working memory. Aggregate and individual scores across all of the tests ranged from 
the average range to the impaired range at all of the time points – no persons scored 
above average. They found that immediate recall and delayed recall improved from 
baseline to 6 weeks and 4 months post-surgery respectively. They also found that 
higher cognitive scores were associated with higher perceived general health. This 
study had some limitations. Firstly, it is worth noting that the SPMSQ (Pfeiffer, 
1975) focuses primarily on orientation rather than on overall cognitive functioning 
per se, and may have poor specificity and sensitivity (Dalton, Pederson, Blom, & 
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Holmes, 1987; Malhotra et al., 2013). Secondly, the narrow breadth of domains 
assessed – only two aspects of each of memory and executive function. This neglects 
aspects of cognitive functioning, such as information processing and attention, that 
are particularly likely to be impaired in people with vascular disease (e.g. Hachinski 
et al., 2006; Vasquez & Zakzanis, 2015). Of additional note is that one of the 
executive functioning measures used in this study by Williams et al. (2014), 
semantic fluency, can be impaired in cases of both frontal and temporal lobe damage 
(Henry & Crawford, 2004). Therefore, it may be difficult to ascertain whether poor 
performance on this test represents specifically a difficulty with executive 
functioning/generation of ideas, with semantic storage (Cerhan et al., 2002), or with 
retrieval, which is also dependent on frontal/executive processes (Habib, Nyberg, & 
Tulving, 2003).  
As well as studies employing standardised neuropsychological assessments, a 
recent study examined self-reported concerns with cognitive functioning (Morgan, 
Kelly, et al., 2016). The study employed just one self-report measure, the Neuro-
QoL Applied Cognition General Concerns Short Form (Gershon et al., 2012), 
assessing concerns over the previous week. Both people with dysvascular and 
traumatic amputations reported a greater number of concerns regarding their 
cognitive functioning than a normative sample. One issue with self-reporting of 
cognitive concerns is the potential for insufficient insight into functioning, and either 
over- or underestimation of functioning or impairment. A study of people with mild 
traumatic brain injury for example found that self-reports of cognitive functioning 
and impairment bore little relation to actual scores on standardised 
neuropsychological assessments (Spencer, Drag, Walker, & Bieliauskas, 2010). 
CHAPTER 2: LITERATURE REVIEW 
32 
 
Comprehensive neuropsychological assessment can reveal issues with cognitive 
functioning of which the assessed person is unaware.  
 
2.2.2 Cognitive Functioning and Rehabilitation Outcomes  
A number of studies examined relationships between cognitive functioning and a 
range of rehabilitation outcomes in people with lower limb amputations. Such 
outcomes included rehabilitative failure, successful prosthetic fit, prosthesis use, 
mobility, activities, social integration and participation, adherence to medical 
regimens, falls, and mortality.  
The relationship between cognitive impairment and overall rehabilitative 
failure has been examined by Aftabuddin et al. (1997) and Couch et al. (1977). Both 
found that presence of dementia was associated with rehabilitative failure. However, 
both of these studies measured cognitive functioning in terms of presence or absence 
of dementia diagnosis in medical charts, not with reliable and valid 
neuropsychological assessments. Secondly, both studies narrowly defined 
rehabilitative success or failure solely in terms of prosthetic and mobility functioning 
(i.e. without taking psychosocial factors into account).  
 
Prosthetic Outcomes 
Prosthesis use is the most frequently investigated of rehabilitation outcomes in terms 
of its relationship with cognitive functioning (Coffey et al., 2012). As early as 1972, 
it was noted that poor cerebral blood supply and consequent “forgetfulness” and 
“confusion” in elderly people with dysvascular amputations “mitigates against 
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successful prosthetic usage” and “makes prosthetic instruction difficult, since they 
do not readily retain recently acquired facts” (Hamilton & Nichols, 1972, p. 98). 
Learning to use a prosthesis is a complex process requiring correct sequencing of a 
number of novel behaviours, and involving memory, attention, and executive 
functions. Persons with impaired cognitive functioning potentially lack skills 
necessary to learn to and ultimately use prostheses optimally and safely (Donaghey 
et al., 2010; O’Neill et al., 2010).  
Studies have found a relationship between better cognitive functioning and 
successful definitive prosthetic fitting, albeit with cognitive functioning undefined 
(Fletcher et al., 2001) or determined by a psychologist using varying batteries 
(Pinzur et al., 1988). Other studies examined the relationships between cognitive 
functioning and prosthesis use. Some of these studies did not use standardised 
neuropsychological assessments (Kurichi et al., 2007; Taylor et al., 2007), some 
used just a single assessment or a cognitive screen plus a second measure (Bilodeau, 
Hébert, & Desrosiers, 2000; S. Larner, van Ross, & Hale, 2003; van Eijk et al., 
2012), two that used multiple assessments (O’Neill & Evans, 2009; Williams et al., 
2015), and a trial of a neurorehabilitation technique (Donaghey et al., 2010). Most 
studies defined prosthesis use in terms of number of hours worn. One exception was 
S. Larner et al. (2003), who combined it with mobility and defined it as learning to 
don and doff correctly and achieving at least indoor mobility. The other was van Eijk 
et al. (2012) who combined it with mobility and defined it as using a prosthesis for 
transfer or ambulation. All found relationships between higher cognitive functioning 
and prosthesis use, but there were shortcomings.  
Kurichi et al. (2007) did find that people who were in the highest category of 
functioning on the FIM measure of cognition were 1.67 times as likely to receive a 
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prosthesis as patients in the lowest category in a sample of N=2,375 elderly US 
veterans on 1
st
 admission to rehabilitation. Sample aetiologies and mean age were 
not fully reported. Taylor et al. (2005) found that persons with dementia were more 
likely not to wear prostheses in their retrospective study. Dementia is an umbrella 
term representing a range of conditions; how it was defined in medical records was 
not reported. S. Larner et al. (2003) found that scores on a test of learning ability 
(Kendrick Object Learning Test) within one week of admission to rehabilitation 
predicted whether or not a prosthesis was eventually fit, when included in a stepwise 
logistic regression model with level of amputation. Bilodeau, Hébert, and Desrosiers 
(2000) found that more prosthesis use in over 60s with unilateral LLA was related to 
better scores on the SPMSQ brief cognitive screen (which focuses chiefly on 
orientation) at an average of three years since amputation. Each of the above studies 
provided valuable information, but limited assessment of cognitive functioning is 
noted. Reporting was insufficient and broader based assessment with standardised 
neuropsychological assessments is required. In a study using multiple assessments of 
cognitive functioning, O’Neill and Evans (2009) found that higher executive 
function ability, specifically a verbal fluency measure of initiation and updating, 
predicted longer hours of prosthesis use at discharge from rehabilitation. In that 
instance prosthesis use was not related to a range of other cognitive functions. In a 
study by Williams et al. (2015), better attention, verbal memory, and working 
memory (an executive function) at six weeks post-amputation were associated with 
longer hours of prosthesis use 12 months post-amputation, although aside from a 
cognitive screen, those were the only aspects of cognitive functioning examined in 
that study. Neither of the above studies examined processing speed, a common 
psychological sequela of cerebrovascular disease (Vasquez & Zakzanis, 2015). 
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Donaghey et al. (2010) undertook a randomized controlled trial (RCT) of an 
errorless learning neurorehabilitation procedure to assist people to learn to don and 
doff a prosthesis. Those receiving the intervention remembered more correct steps in 
the sequence of donning and doffing, and made fewer errors. Assuming lack of 
environmental facilitators (e.g. home personal assistance), if a prosthesis user cannot 
successfully don and doff their prosthesis, it would seem unlikely that they would 
use it optimally, and/or as frequently as they might in the absence of cognitive 
impairment.  
 
Mobility Outcomes 
Studies have noted a relationship between higher mobility and higher orientation 
(Williams et al., 2015), psychomotor speed (Hanspal & Fisher, 1991), attention 
(Williams et al., 2015), learning/immediate memory (S. Larner et al., 2003; Williams 
et al., 2015), and delayed memory (O’Neill & Evans, 2009; Williams et al., 2015). 
One study used a functioning measure that was not a standardized 
neuropsychological assessment (Heinemann, Linacre, Hamilton, & Granger, 1994), 
while some studies used a single standardised measure of cognitive functioning 
(Hanspal & Fisher, 1991, 1997; S. Larner et al., 2003). Both (O’Neill and Evans, 
2009) and Williams et al. (2015) used a broader battery in their prospective studies.   
Hanspal and Fisher's (1991) cross-sectional study found significant 
correlations between orientation, general ‘mental ability’, and psychomotor skills, 
and the grade of mobility achieved by 100 people with unilateral amputations 
(aetiology unreported). Interestingly, two thirds of the 100 participants could not 
complete the psychomotor task – a maze. Failure to complete the psychomotor task 
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may have resulted from impairment of psychomotor functioning (e.g. exceeding a 
time limit, or drawing outside boundaries), or visuospatial or executive functioning, 
or for other reasons; the authors did not address this in their paper. A follow-up 
prospective cohort study had similar findings (Hanspal & Fisher, 1997). In both of 
Hanspal and Fisher's (1991, 1997) studies, they used an assessment tool with a rather 
narrow focus, the cognitive subscales of the Clifton Assessment Procedures for the 
Elderly (Pattie & Gilleard, 1979). While they report that the tool itself is easy to use 
in rehabilitation contexts and can be administered with little training, it does not 
capture sufficient breadth of cognitive functioning.  
S. Larner et al. (2003) found that learning predicted mobility at discharge 
when combined with amputation level. O’Neill and Evans (2009) reported 
correlations between mobility and delayed verbal and visual memory, as well as 
immediate memory, but not a range of other cognitive variables including executive 
functioning, attention, language, and visuospatial measures. Using regression 
analyses, immediate memory was the only memory variable predictive of mobility 
grade in their regression model, while delayed memory predicted a more 
comprehensive measure of mobility. Measured four months post amputation, 
Williams et al. (2015) found that better performance on an orientation-focused 
cognitive screen, attention, and verbal memory were associated with greater levels of 
mobility 12 months post-amputation. Executive functioning measures, including 
verbal fluency and working memory/WIAS-III digit span, did not related to mobility. 
Williams et al. (2015) used amputation surgery as an anchoring time point. This 
introduces a potentially confounding variable of time since amputation. In Ireland at 
least, time between amputation and commencement of rehabilitation varies. Thus, 
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measurements of outcomes may be biased by differing lengths of time spent in 
rehabilitation by time of assessment.  
Another mobility-related outcome that was investigated was instance and 
frequency of falls. Cognitive impairment has also been found to be related to both 
instance of falling and to higher number of falls (Gooday & Hunter, 2004; Pauley et 
al., 2006; Yu et al., 2010). In these instances, cognitive impairment was determined 
in an unspecified manner (Pauley et al., 2006; Yu et al., 2010), or according to 
MMSE scores and medical records (Gooday & Hunter, 2004).  
Overall, there appears to be a relationship between higher cognitive 
functioning and higher levels of mobility. Similarly, there appears to be a 
relationship between cognitive impairment and incidence of falls. Examinations of 
the relationship between cognitive functioning and mobility have not examined 
overall cognitive functioning with a comprehensive measure, information 
processing, or a range of aspects of attention and executive functioning. 
 
Activity and Participation Outcomes 
In people with lower limb amputations, the effects of cognition on activities other 
than mobility have received relatively little attention. The relationship between 
cognitive functioning and activities in people with amputations is thus unclear. In 
Weiss, Gorton, Read, and Neal's (1990) study, ADL performance was predicted by 
‘confusion’ (unlikely to have been measured with a standardised neuropsychological 
assessment) in combination with other clinical variables. Schoppen et al. (2003) used 
a cognitive screen and tests of delayed memory and inhibition (an executive 
function, although the authors termed this an information processing measure). In 
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combination with age and 1-leg balance, they found that delayed memory, predicted 
activity restriction. They did not find any relationships for inhibition or the cognitive 
screen. Williams et al. (2015) found no relationship (no correlations at p < .01) 
between activity restriction and any of immediate memory, delayed memory, 
working memory, sematic fluency (a language task dependent on executive-mediated 
retrieval strategy) or an overall cognitive screen in a sample of participants with 
dysvascular LLA. Thus, both ‘confusion’ and delayed memory have shown 
relationships to activities, but a range of other cognitive functions have not. 
To this author’s knowledge, the relationship between cognitive functioning 
and community participation has been measured just once in LLA. People with a 
diverse range of impairments have defined participation as “active and meaningful 
engagement/being a part of, choice and control, access and 
opportunity/enfranchisement, personal and societal responsibilities, having an impact 
and supporting others, and social connection, inclusion and membership” (Hammel 
et al., 2008, p. 1445). Participation incorporates involvement in productivity and 
economic activity, social activities and relationships, and leisure and recreational 
activities (Magasi, Hammel, Heinemann, Whiteneck, & Bogner, 2009). Participation 
is viewed as an important aspect of good health, and has reciprocal relationships with 
impairments and activities (World Health Organization, 2001). Cognitive 
impairment has been linked to lower levels of participation in a large study which 
sampled the population of community dwelling over 50’s (Wilkie, Peat, Thomas, & 
Croft, 2007). In people with LLA, Williams et al. (2015) examined the relationship 
of cognitive functioning with social integration and community participation. Social 
integration was defined as “the extent to which participants were an active part of 
their social network, including frequency of social interactions and breadth of social 
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network”. Community participation was defined as frequency of participation in four 
community activities outside the home. Cognitive variables included a cognitive 
screen, and tests of memory (immediate and delayed) and executive function 
(working memory and verbal fluency). They found that higher delayed list recall 
ability six weeks after dysvascular amputation was associated with better social 
integration and community participation 12 months post-amputation. Higher 
cognitive screen scores four months post amputation were also related to better 
social integration. Community participation was not related to any cognitive 
variable.  
Other Outcomes 
Other outcomes investigated include adherence to medical treatment, and mortality. 
Coetzee et al. (2008) found that prospective memory, but not language or planning, 
was related to adherence to medical treatment (a component of patient activation) in 
people with LLA. The relationship between cognitive functioning and mortality has 
also been examined (Campbell et al., 2001; Carmona et al., 2005; Remes et al., 2008; 
Taylor et al., 2005). Most of these defined cognitive impairment or functioning as 
presence or absence of dementia, except for Remes et al. (2008) who used a 
combination of MMSE (a cognitive screen) scores and ICD-10 codes (World Health 
Organization, 2010). Cognitive impairment was associated with increased mortality 
post-amputation in just one of these studies (Carmona et al., 2005).  
 To the knowledge of this author, there are no extant examinations of the 
relationship between cognitive functioning and other psychosocial outcomes. This 
includes a range of psychosocial outcomes important to people with lower limb 
amputations or for their rehabilitation. Examples include distress (including anxiety 
and depression) (Atherton & Robertson, 2006; Mckechnie & John, 2014), 
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adjustment to amputation and prosthesis (Atherton & Robertson, 2006; Gallagher, 
Franchignioni, Giordano, & MacLachlan, 2010; Horgan & MacLachlan, 2004), 
healthcare activation (Greene & Hibbard, 2012; Hibbard, Mahoney, Stockard, & 
Tusler, 2005; Hibbard, Stockard, Mahoney, & Tusler, 2004), perceived social 
support (Williams et al., 2004), or a broad range of aspects of participation 
(Gallagher, O’Donovan, Doyle, & Desmond, 2011; Hammel et al., 2008; Heinemann 
et al., 2013; Magasi et al., 2009).  
 
2.2.3 Review Summary 
In sum, cognitive impairment and dementia appear to be more prevalent amongst 
people with lower limb amputations than in the general population. However, 
cognitive functioning in LLA has rarely been studied comprehensively, and many of 
the studies have been retrospective in design or have suffered from reporting which 
is insufficiently comprehensive. This makes comparison between studies difficult. 
Most investigations used merely categorical definitions of cognitive functioning, 
including unspecified dementia diagnoses. There is some evidence of impaired 
memory (Williams et al., 2014), and information processing and executive 
functioning (Phillips et al., 1993) in LLA. Again however, studies examining 
cognitive profiles have utilized very or relatively narrow batteries (Wang et al., 
1975; Williams et al., 2014; Willrich et al., 2005). Some reported insufficient 
assessment results (O’Neill & Evans, 2009) or demographic and clinical information 
(Willrich et al., 2005) to make determinations about profile. Only one of these more 
comprehensive studies (O’Neill & Evans, 2009) included people with lower limb 
amputations of non-vascular aetiology for comparison and aetiology was not 
reported at all by O’Neill et al. (2010). Some studies were also restricted by small 
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sample sizes (O’Neill et al., 2010; Phillips et al., 1993) or samples with a selection 
bias that precludes generalisation (O’Neill et al., 2010).  
In studying the relationship between cognitive functioning and outcomes, a 
number of assessments have focused on rather blunt outcomes like mortality or 
rehabilitative success, defined solely in prosthetic and mobility terms. Indeed, 
prosthesis use and mobility are the rehabilitation outcomes that have most frequently 
been assessed. Studies have often not covered a full range of cognitive functions – 
information processing has been neglected, for example. This makes it difficult to 
draw conclusions about the relationship between certain functions and outcomes. 
Insufficiencies in reporting were also problematic. For example, Fletcher et al.'s 
(2001) retrospective study of people with lower limb amputations of dysvascular 
aetiology found that cognitive deficits and dementia were both associated with 
failure to fit a prosthesis, but did not report how either of these were defined or 
measured (notwithstanding possible heterogeneity of reporting in medical records). 
Nevertheless, there is some evidence that lower levels of cognitive functioning are 
related to lower levels of prosthesis use, mobility, and social integration, with 
conflicting information about activities/activity restriction. There exists much 
potential to examine psychosocial outcomes including distress, adjustment, 
activation, social support, and participation, and potential relationships with 
cognitive functioning.  
 
2.3 Rationale for the Current Study 
Lower limb amputation presents a myriad of challenges for individuals in terms of 
impairments, activities, and participation. PVD and diabetes are the principal causes 
CHAPTER 2: LITERATURE REVIEW 
42 
 
of lower limb amputation in societies with developed economies and the LLA 
population is largely ageing (Amputee Coalition of America, 2008). Both PVD 
and diabetes have been linked with a decline in cognitive functioning via vascular 
cognitive impairment and the ageing population is also susceptible to age-related 
cognitive decline and at increased risk for the development of dementia (Levy, 1994; 
Lindeboom & Weinstein, 2004; Rafnsson et al., 2009; Salthouse, 2009). 
Cognitive impairment and dementia seem to be more prevalent amongst 
people with lower limb amputations than in the general population. Cognitive 
functioning in LLA has rarely been studied comprehensively. Most investigations 
used merely categorical definitions of cognitive functioning, including undetermined 
dementia diagnoses. Studies have been limited by methodological shortcomings 
including unreported definitions of dementia, use of cognitive screens that are not 
sensitive to sequelae of vascular disease, or use of narrow assessment batteries. 
Inadequate reporting has also been an issue. People with different aetiologies of 
amputation – i.e. with and without dysvascularity – are likely to have different 
profiles of cognitive functioning. Yet, different aetiological groups have rarely been 
compared in terms of cognitive functioning. Small sample sizes or presence of 
selection bias also make generalization difficult.  
There is thus a clear need for comprehensive neuropsychological assessment 
of people with lower limb amputations. Neuropsychological assessment should 
assess a wide range of domains with standardised assessment tools. Assessment 
should be sensitive to cognitive functions which have been demonstrated to be 
impaired in people with vascular diseases, but which have infrequently been 
examined in the LLA population. These functions include, but are certainly not 
limited to information processing, attention functions, and executive functions. 
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Additionally, assessments of cognitive functioning should employ valid, reliable, 
and standardised neuropsychological assessments, as is customary in clinical and 
research neuropsychology (Lezak et al., 2012; Puente & Puente, 2013; Strauss et al., 
2006). Neuropsychological assessment also has the potential to uncover subtle 
cognitive functioning deficits which are not, and cannot, be recorded in simple 
diagnoses of dementia in medical records. Similarly, a wide-ranging 
neuropsychological assessment can much better reveal the nature and extent of 
cognitive functioning and impairment than would a brief cognitive screen. 
Standardized neuropsychological assessments also allow for comparison to 
normative values to compare samples to the general population.  
There is also a need to examine relationships between cognitive functioning 
and a wide range of rehabilitation outcomes. Rehabilitation programmes for people 
with lower limb amputations are “not simply prosthetic services” (Kent & Fyfe, 
1999, p.43). The goal of rehabilitation is to maximise functional independence in 
terms of activities and participation, the corollary being the improvement of quality 
of life (Cox, Williams, & Weaver, 2011). According to the ICF (World Health 
Organization, 2001), health conditions are influenced by body functions and 
structure, activities, and participation. Each of these factors is also influenced by 
each other, and all are also influenced by environmental factors and personal factors. 
Outcomes of interest for prosthetic rehabilitation span the breadth of ICF framework 
domains from activities such as ambulation or walking, prosthesis use and dressing; 
to personal factors such as prosthesis satisfaction; to participation in leisure, 
employment and the community. A prospective cohort study would help to 
determine more precisely the effects of cognition on rehabilitation outcomes over 
time, and provide an evidence base for the individualised tailoring of rehabilitation 
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programmes by clinicians, in order to maximise post-rehabilitation functioning. 
Research into prediction of rehabilitation outcomes – prosthetic, mobility, and 
psychosocial – is warranted in order to optimize outcomes of service users and help 
to maximise the efficacy of prosthetic rehabilitation service delivery.  
Advocating accurately and precisely for optimal prosthetic design, fit and 
comfort, assessing how and when to maintain the prosthesis or request refit, and 
appropriately caring for associated materials such as the liner, socks etc., are all 
facets of prosthesis use. These are activities that likely require cognitive functions, 
particularly executive functions. These are also factors that may affect prosthesis 
satisfaction. In fact, a relationship between prosthesis use and satisfaction has been 
demonstrated (Murray & Fox, 2002). Negotiating everyday environments with a 
prosthesis, and evaluation of the utility of the prosthesis in assisting same, also likely 
requires a range of cognitive functions – executive, working memory, attention, 
visuospatial skills. There is evidence that the effects of impaired cognitive 
functioning on learning to use a prosthesis are modifiable with errorless learning 
techniques (Donaghey et al., 2010). This suggests that understanding additional 
cognitive contributors to prosthetic outcomes may unearth opportunities to provide 
support to rehabilitation participants to optimise prosthesis use and maximize 
prosthesis satisfaction. Other outcomes may also benefit similarly and accordingly.   
Impaired cognitive functioning may affect ability to perform activities, or 
participate optimally in social roles or community events. Inability to plan and 
organize activities, initiate behaviours, attend to, learn and remember sequences of 
behaviour, plans or directions, or to concentrate on activities may negatively impact 
on activities and participation. An example might be legal restrictions on driving and 
consequent utilization of public transportation. This in turn might necessitate 
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cognitively demanding planning and arranging for the provision of enabling ramps 
and planning for the limitations relating to limb loss such as reduced standing time. 
As far as this author is aware, there has not yet been an assessment of the 
relationship between cognitive functioning and general activity limitations and 
participation restrictions. That is, difficulties that people experience in performing 
activities and participation. Nor has there been an examination of cognitive 
functioning and subjective elements of participation engagement. Neither of the 
measures used to assess participation in Williams et al.'s (2015) study capture 
whether each aspect of participation is meaningful to the individual in question. This 
is important with such a broad range of participation domains – any of which may be 
important or unimportant to certain people (Resnik & Plow, 2009). Participation 
enfranchisement has also not been assessed. Participation enfranchisement is a 
reflection of whether people are respected in the communities in which they wish to 
participate, and the presence of opportunities (Heinemann et al., 2013).  
Distress and difficulties with adjustment often feature in the lives of people 
with lower limb amputations (Atherton & Robertson, 2006; Horgan & MacLachlan, 
2004; Mckechnie & John, 2014; Rybarczyk, Nyenhuis, Nicholas, Alioto, & Blair, 
1992). People with impaired cognitive functioning may lack abilities to use 
strategies to minimise distress and maximise adjustment. Furthermore, should 
cognitive functioning or impairment impact prosthetic outcomes, mobility, activities 
or participation there may be an associated increase (or lack of decrease) in distress 
or lack of increase (or decline) in adjustment over time. Activation represents ability 
to self-manage, and has been shown to be predictive of favourable outcomes in 
differing populations (Greene & Hibbard, 2012). Difficulties with reasoning, 
attention, memory, or executive functioning could impact decisions to act in one’s 
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self-interest, know and remember to seek medical advice, or sustain new, healthy 
behaviours. Perceived social support may potentially be impacted by cognitive 
impairments, and could be a potential contributor to, for example, the wide variation 
in social support levels seen in Williams et al.'s (2004) study. Forgetting 
appointments, lack of concentration during conversations, or lack of inhibition may 
cause friction in social relationships. Social support is a likely contributor to better 
adjustment following amputation (Horgan & MacLachlan, 2004). Understanding the 
relationships of cognitive functioning to these constructs could provide useful 
information. If there are any extant studies on the relationship between cognitive 
functioning and distress, adjustment, activation, or perceived social support in LLA, 
they are unknown to this author.  
It stands to reason that outcomes of rehabilitation may be influenced by the 
process of rehabilitation. Similarly, cognitive functioning may bear some relation to 
such a process. A person’s engagement in the rehabilitation process may be one such 
influence. Engagement in healthcare has been researched in the fields of mental 
health, chronic illness, social work, and physical rehabilitation, and has been 
conceptualised as both a process of ‘engaging with’ and a state of being ‘engaged in’ 
(Bright, Kayes, Worrall, & McPherson, 2015). A model of rehabilitation engagement 
has been proposed which is influenced by both the person-level variables of 
willingness and capacity, and the social and physical environment (Lequerica & 
Kortte, 2010). Rehabilitation engagement was defined as “a deliberate effort and 
commitment to working toward the goals of rehabilitation interventions, typically 
demonstrated through active, effortful participation in therapies and cooperation with 
treatment providers” (p. 416). The incorporation of a capacity component offers a 
mechanism by which cognitive functioning may affect rehabilitation engagement via 
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impaired understanding or memory of the need for rehabilitation services. Similarly, 
cognitive impairment may affect motivation, thus influencing engagement via the 
willingness component of the model. Thus, research on the relationship between 
cognitive functioning and rehabilitation engagement is justified. This relationship 
has not yet been examined in the literature. Understanding any relationships between 
cognitive functioning and rehabilitation engagement presents fresh possibilities for 
the improvement of engagement and ultimately rehabilitation outcomes.  
In sum, an examination of cognitive functioning in people with lower limb 
amputations is warranted. This examination should be a comprehensive 
neuropsychological assessment utilizing valid and reliable assessment tools. The 
battery of neuropsychological assessment should comprise assessments of a wide 
range of functions, and should assess functions susceptible to impairment as a result 
of vascular or diabetic pathology. Such functions should at least include overall 
cognitive functioning, reasoning, psychomotor function, information processing, 
attention (including focused, sustained, and divided), memory (immediate and 
delayed recall, delayed recognition), visuospatial cognition, language, and a range of 
executive functions (including working memory, inhibition, cognitive flexibility, and 
planning). Longitudinal measurement of rehabilitation outcomes is also warranted. 
The relationships between cognitive functioning and rehabilitation outcomes over 
time should be examined. Such outcomes should include not just prosthetic and 
mobility outcomes, but also psychosocial outcomes. Relationships with 
rehabilitation engagement should also be examined. Chapter 3, which follows, states 
the aims and objectives of the current research study.  
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AIMS, OBJECTIVES, AND 
HYPOTHESES  
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This chapter introduces the aims, objectives, and related hypotheses of the present 
research, as well as brief justifications for same. 
 
3.1 Aim One 
The first aim was to obtain a comprehensive neuropsychological profile of people 
who attended comprehensive rehabilitation with a lower limb amputation. Aspects of 
cognitive functioning to assess included estimated premorbid intellectual 
functioning, overall cognitive functioning, reasoning, psychomotor speed, 
information processing, attention, memory, visuospatial perception and construction, 
language, and executive function.  
 
3.1.1 Objective 1  
The first objective was to determine whether a sample of people with LLA had 
significant differences in cognitive functioning relative to normative populations, in 
terms of mean scores, and proportions of the sample with scores in the borderline 
and impaired ranges.  
 
3.1.1.1 Hypothesis 1  
Cognitive functioning, across the range of domains assessed (including overall 
cognitive functioning, reasoning, psychomotor speed, information processing, 
attention, memory, visuospatial perception and construction, and executive 
functions) will be significantly lower in a sample of people with lower limb 
amputations, in comparison to standardised normative population values.  
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3.1.2 Objective 2  
The second objective was to determine whether participants with vascular aetiology 
had significant differences in cognitive functioning relative to participants with non-
vascular aetiology.  
 
3.1.2.1 Hypothesis 2 
Cognitive functioning across the range of domains assessed is significantly lower in 
people with dysvascular amputations (i.e. peripheral vascular disease, diabetes, 
osteomyelitis with co-occurring diabetes) than in those with amputations relating to 
other aetiologies (i.e. trauma, cancer, etc.).  
 
3.1.3 Rationale for Objectives One and Two 
People with lower limb amputations are probably more likely to have cognitive 
impairment than the general population (Coffey et al., 2012). This is assumed to be 
as a result of the high prevalence of dysvascularity, i.e. peripheral vascular disease 
(PVD) and diabetes, as precipitating factors of limb loss. Amputation may be seen as 
the final stage of peripheral vascular disease in the affected body part – following 
asymptomatic, claudication, ischaemic and gangrenous stages, while similar can be 
said of amputation due to diabetic peripheral neuropathy or ischaemia. PVD has 
been associated with cognitive impairment (Mangiafico et al., 2006; Price et al., 
2006; Waldstein et al., 2003) via vascular cognitive impairment (i.e. cognitive 
impairment due to cerebrovascular disease). Diabetes has been associated with 
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diabetic encephalopathy and an increased risk of developing cardiovascular disease, 
thus placing persons with diabetes at risk of vascular cognitive impairment 
(Luchsinger, 2012), while diabetes has itself been associated with cognitive 
impairment (Mehrabian et al., 2012; Reijmer, van den Berg, Ruis, Jaap Kappelle, & 
Biessels, 2010). The advanced age at which amputations for dysvascularity are 
generally performed may also present the risk of age-related cognitive decline – 
cognitive impairment concomitant with advancing age beyond what might 
reasonably be expected as a result of the ‘normal’ aging process. On the other hand, 
people with amputations relating to trauma, or other non-dysvascular aetiologies, are 
less likely to have vascular cognitive impairment, as they are generally younger and 
are less likely to have PVD or diabetes.  
 
3.2 Aim Two 
The second broad aim was to assess the relationships between cognitive functions 
and prosthetic, mobility, and psychosocial outcomes and rehabilitation engagement 
in people with lower limb amputations in a rehabilitation programme.   
 
3.2.1 Objective 3 
The third objective was to investigate changes in prosthetic, mobility and 
psychosocial constructs longitudinally, from discharge (time 2/T2) to six months 
(time 3/T3) to 12 months (time 4/T4).
5
  
 
                                                 
5 The exceptions to this were the three aspects of participation (participation engagement, 
importance and meaning, control), for which changes are investigated from six to 12 
months, as participation constructs were not measured at discharge. 
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3.2.1.1 Hypothesis 3 
Outcomes will improve over time (i.e. from discharge to six to 12 months). 
 
3.2.2 Objective 4  
The fourth objective was to investigate whether rehabilitation engagement was 
associated with prosthetic, mobility and psychosocial rehabilitation outcomes at 
discharge, six and 12 months.  
 
3.2.2.1 Hypothesis 4 
Higher levels of rehabilitation engagement are associated with higher levels of 
prosthesis use, prosthesis satisfaction (aesthetic and functional), mobility, activation, 
adjustment (general, social, and to limitation), social support, and community 
participation (engagement, importance and meaning, and control over participation). 
Higher levels of rehabilitation engagement are associated with lower levels of 
distress and activity limitation and participation restriction.  
 
3.2.3 Objective 5 
The fifth objective was to examine the bivariate relationships between cognitive 
functioning and both rehabilitation engagement (at discharge) and prosthetic, 
mobility, and psychosocial rehabilitation outcomes (at discharge, six months and 12 
months).  
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3.2.3.1 Hypothesis 5  
a. Higher levels of baseline cognitive functioning are associated with higher 
levels of rehabilitation engagement at discharge.  
b. Higher levels of baseline cognitive functioning are associated with higher 
levels of prosthesis use, prosthesis satisfaction (aesthetic and functional), 
mobility, activation, adjustment (general, social, and to limitation), social 
support, and community participation (engagement, importance and meaning, 
and control over participation) at times 2, 3, and 4. Higher levels of baseline 
cognitive functioning are associated with lower levels of distress and activity 
limitation and participation restriction at times 2, 3, and 4.  
 
 
3.2.4 Objective 6 
The sixth objective was to investigate whether, using hierarchical regression 
controlling for rehabilitation engagement, overall cognitive functioning and 
executive function predict prosthetic, mobility, and psychosocial rehabilitation 
outcomes at six months.  
 
3.2.4.1 Hypothesis 6 
Overall cognitive functioning and cognitive flexibility (an executive function) are 
significant predictors of prosthesis use, prosthesis satisfaction (functional and 
aesthetic), mobility, activation, adjustment (general, social, and to limitation), 
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distress, activity limitation and participation restriction, and participation 
(engagement, importance and meaning, and control over participation) at six months.  
 
3.2.5 Objective 7 
The seventh objective was to investigate whether participants with cognitive 
functioning scores in the impaired or borderline ranges have different rehabilitation 
engagement, prosthetic and mobility outcomes, or psychosocial outcomes than 
participants without impairment on these same functions at  
a) discharge from rehabilitation; and, 
b) from discharge, to six months, to 12 months6.  
This was to be investigated for overall cognitive functioning, delayed memory, 
attention/processing speed, visuospatial construction, or executive function 
(cognitive flexibility and planning) in turn. 
 
3.2.5.1 Hypothesis 7 
Participants with cognitive functioning scores in the impaired or borderline ranges 
have lower rehabilitation engagement, prosthetic, mobility, and psychosocial 
outcomes than participants without impairment on these same functions at  
a) discharge from rehabilitation; and, 
b) from discharge, to six months, to 12 months7.  
                                                 
6 Except the three aspects of participation (engagement, importance and meaning, control 
over participation), which are investigated from six months to 12 months, as they are not 
measured at discharge. 
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3.2.6 Objective 8 
The final objective was to investigate whether there were differences in prosthetic, 
physical, or psychosocial outcomes, or rehabilitation engagement for participants 
with impairment on either a) both, b) one of, or c) neither of overall cognitive 
functioning and cognitive flexibility at discharge.  
 
3.2.6.1 Hypothesis 8 
Persons with both impaired overall cognitive functioning and impaired executive 
function will have poorer rehabilitation engagement, prosthetic, mobility and 
psychosocial outcomes than persons with just impairment of one overall cognitive 
functioning and executive function, who in turn will have poorer outcomes than 
persons without impairment on either of cognitive function at discharge.  
 
3.2.7 Rationale for Objectives Relating to Aim 2 
Impairments, activities, and participation are seen as interactive components of 
health within the framework of the International Classification of Functioning, 
Disability and Health (ICF) (World Health Organization, 2001). Therefore, impaired 
cognitive functioning could negatively affect rehabilitation outcomes in the areas of 
activity (and limitations thereof) and participation (and restrictions thereof). This 
would confer utility on cognitive functioning as a predictor of rehabilitation 
outcomes in a clinical setting.  
                                                                                                                                          
7 Except the three aspects of participation (engagement, importance and meaning, control 
over participation), which are investigated from six months to 12 months, as they are not 
measured at discharge. 
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Amongst people with lower limb amputations, cognitive functioning has 
been shown to predict some rehabilitation outcomes. These include prosthetic fit 
(Fletcher et al., 2001; S. Larner et al., 2003), prosthesis use (Bilodeau et al., 2000; 
O’Neill & Evans, 2009), mobility (Chiu et al., 2000; O’Neill & Evans, 2009), and 
activity restriction and perceived health (Schoppen et al., 2003). However, in most 
cases blunt categorical measures of cognitive functioning or narrow 
neuropsychological assessment batteries were used. Psychosocial outcomes such as 
participation and overall adjustment have been largely neglected, as have prosthetic 
satisfaction outcomes. An investigation of relationships between cognitive 
functioning and rehabilitation engagement is warranted, due to the potential 
influence on outcomes. Similarly, research on relationships between rehabilitation 
engagement and outcomes is warranted.  
Impairments in cognitive functioning have been associated with impaired 
performance of activities and impaired participation in a range of samples. Examples 
include ADL performance in older adults (Royall et al., 2005), self-management 
activities in older people with diabetes (Feil, Zhu, & Sultzer, 2012) and both 
activities and employment participation in people with multiple sclerosis 
(Goverover, Strober, Chiaravalloti, & DeLuca, 2015). Executive functions may be 
particularly important. Royall et al. (2007) found that executive function predicted a 
greater share of variance in more complex behaviours like household duties than 
simpler ADLs, suggesting the particular importance of. Processing speed has 
however been linked with Reppermund et al. (2011) found that all cognitive domains 
(attention, executive function, language, memory, and visuospatial function) were 
associated with performance of high cognitive demand instrumental activities of 
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daily living (IADL) in adults with MCI. They also found that attention and executive 
functioning were associated with IADL with low cognitive demand.  
Rehabilitation outcomes may also be affected by engagement in 
rehabilitation (Kortte, Falk, Castillo, Johnson-Greene, & Wegener, 2007). The 
potentially important link between cognitive functioning and rehabilitation 
engagement has not been examined in people with lower limb amputations (or in 
relevant reference groups – to this author’s knowledge). Impaired cognitive 
functioning may affect ability to engage maximally in rehabilitation via impaired 
attention to and memory of instructions, via impaired executive control of 
behaviours – i.e. initiation of novel behaviours and planning and problem solving on 
a busy rehabilitation programme, and so on. In particular, executive function may 
predict a proportion of rehabilitation engagement similar to the manner in which it is 
predictive of IADLs, as rehabilitation physiotherapy and occupational therapy 
involves the initiation and coordination of complex behaviours (Royall et al., 2007).  
Examining the effects of cognitive functioning on rehabilitation outcomes 
over time will provide important information on rehabilitation outcomes in the 
contexts of discharge from rehabilitation and return to the community. It will also 
provide information on any potential post-rehabilitation changes in outcomes. 
Examining outcomes with both scalar and dichotomous classifications of cognitive 
functioning may provide information on how best to use cognitive functioning to 
understand and predict rehabilitation outcomes. No research to date has addressed 
this question. Additional information on relating to selection of cognitive functioning 
variables for analysis related to Aim 2 is presented in section 6.2 Cognitive 
Functioning and Rehabilitation Outcomes: Variable Selection.   
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4.1 Research Design 
The study was a prospective cohort longitudinal study, which incorporated a cross-
sectional profile of neuropsychological functioning. A range of neuropsychological 
variables were collected during inpatient rehabilitation (T1). A clinician-rated 
measure of rehabilitation engagement, prosthetic, mobility, and psychosocial 
outcomes were collected at discharge (T2), and prosthetic, mobility, and 
psychosocial outcomes were collected at 6 months post-discharge (T3), and 12-
months post-discharge (T4). Discharge was approximately 8 weeks post-admission. 
A cross-sectional profile of neuropsychological functioning at T1 was 
described. Then, cross-sections of prosthetic outcomes and psychosocial functioning 
at T2, T3, and T4 were examined, including whether there were differences in same 
according to impairment status on a range of neuropsychological functions. Finally, 
T1 neuropsychological functioning was used to predict prosthetic, mobility, and 
psychosocial outcomes at T3. 
 
4.2 Setting 
Participants were recruited at the National Rehabilitation Hospital (NRH), Dún 
Laoghaire, Co. Dublin, Ireland. The NRH is a specialist rehabilitation hospital 
providing “Complex Specialist Rehabilitation services to patients who, as a result of 
an accident, illness or injury, have acquired a physical or cognitive disability and 
who require specialist medical rehabilitation” (National Rehabilitation Hospital, 
2013a). The NRH is a tertiary rehabilitation service provider, and clients requiring 
complex specialist rehabilitation for acquired brain injury (including stroke and other 
neurological conditions), spinal cord injury, or limb absence (acquired or 
congenital), may be referred to the NRH from acute hospitals, GPs, or community 
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agencies. Referrals are assessed on an individual basis, with clients in general a) 
being medically stable, b) consenting to referral (or with next of kin’s consent), c) 
having potential to benefit from specialist rehabilitation within a specified 
timeframe, and d) having needs (medical, physical, social, behavioural, 
psychological, or vocational) related to the neurological injury or disease process 
which cannot be met in an acute hospital, community or home rehabilitation setting. 
The NRH is accredited by the Commission on the Accreditation of Rehabilitation 
Facilities (CARF, 2013).   
 
4.2.1 Prosthetic, Orthotic, and Limb Absence Rehabilitation Programme 
Participants were recruited from the limb loss rehabilitation programme, the POLAR 
(Prosthetic, Orthotic & Limb Absence Rehabilitation) programme. POLAR services 
are provided by an interdisciplinary team of rehabilitation clinicians to persons who 
have undergone amputation as a result of any aetiology (e.g. trauma, vascular 
disease, cancer, infection) or who have congenital limb absence, whether or not 
prosthesis provision is appropriate (National Rehabilitation Hospital, 2013b). 
POLAR services include medical, nursing and clinical support, therapy services, and 
patient services (administration). Clinical or therapy services can include prosthetic 
and orthotic services, physiotherapy, occupational therapy, hydrotherapy, vocational 
assessment, chiropody, nutrition & dietetics, psychology, and medical social work. 
Services are delivered by an interdisciplinary rehabilitation team comprising a 
consultant in rehabilitation medicine (team lead), clinical psychologist, dietician, 
medical social worker, nurse(s), occupational therapist, orthotist, physician, 
physiotherapist, and prosthetist.   
NEUROPSYCHOLOGICAL FUNCTIONING & LOWER LIMB LOSS 
61 
 
Upon admission to the POLAR programme, the interdisciplinary team 
members, in collaboration with the client and the client’s family, develop 
personalised, holistic treatment plans to address the client’s individual needs, which 
may include medical, physical, cognitive, psychological, social, behavioural, 
vocational, educational, cultural, family, spiritual and leisure or recreational needs. 
Clients are encouraged to actively participate in determining their rehabilitation 
programme.  
The POLAR programme offered services to clients with lower limb 
amputations on an inpatient basis initially. During the period of recruitment for this 
study, the POLAR service expanded to include day patient services, in which service 
provision was equivalent except that clients did not occupy a bed in the NRH. The 
day-patient programme commenced in September 2013, and thus overlapped with 
the recruitment period.  
In 2013, the mean age of POLAR programme clients was 63 (range 21 to 
89), with 90 discharges from the inpatient programme during that year, 83% of 
which were to home, with average length of stay being 51 days. There were 70 
discharges from the inpatient programme in 2014, 90% of which were to home, and 
the average length of stay was seven weeks (50 days) (NRH, 2014).  
 
4.3 Recruitment 
Three groups of participants were recruited to this study. Group A consisted of 
prospectively recruited participants eligible for both the neuropsychological 
assessment and the follow-up. Group B consisted of participants for whom only 
assessments and psychosocial follow-up measures completed as part of routine 
inpatient clinical engagement were made available and utilised. Group B can be 
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further split into two subsets of participants. Group B1 comprised participants who 
were recruited in the same manner as the prospective Group A participants, were 
happy to consent to involvement in a research programme, but did not want to 
undergo additional neuropsychological assessment or complete follow-up 
questionnaires. Group B2 comprised participants who were retrospectively contacted 
to seek inclusion of extant clinical data – similar to Group B1. Only a small number 
of participants who had undergone rehabilitation between ethical approval for the 
study and commencement of Group A recruitment were considered for this. The 
Group B participation track was instigated to boost recruitment for the 
neuropsychological profile portion of the present research study. Reporting on tests 
for differences in socio-demographic and clinical characteristics between Group 
A and Group B is included in section 4.8.2  Differences Between Group A and 
Group B Participants.  
 
4.3.1 Inclusion and Exclusion Criteria 
Potential participants were identified based on the study inclusion and exclusion 
criteria.  
Inclusion criteria were as follows: 
 Presence of a major lower limb amputation (i.e. unilateral or bilateral 
amputation from ankle level to hip level) 
 Enrolment in the NRH inpatient or day-patient POLAR rehabilitation 
services 
 Fluent English language speaking (sufficient to complete 
neuropsychological assessments) 
 Aged 18 years or over 
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Exclusion criteria were as follows: 
 Major upper limb amputation, i.e. wrist disarticulation or above (people 
with upper limb amputation are generally considered a different 
population, as the majority of upper limb amputations result from 
trauma). Participants with lower limb amputations and transphalangeal or 
partial hand amputation amputation(s) were not excluded (provided 
participants could manipulate neuropsychological assessment materials), 
as these were seen as minor upper limb amputations.  
 Deemed too medically unwell to participate by the POLAR 
interdisciplinary team.  
 
4.3.2 Recruitment Procedures 
Based on the study inclusion and exclusion criteria, potential participants were 
identified from consecutive admissions to the POLAR programme between March 
2012 and April 2014 by the researcher in collaboration with the POLAR team senior 
clinical psychologist.  
A cover letter (Appendix B) and information sheet (Appendix C) 
describing the research project was initially provided to potential participants. 
Within two days, the researcher returned to the potential participants, and 
explained the research in more detail. If the potential participants indicated that 
they were interested in participation, the researcher discussed the study with 
them in as much detail as required and answered any questions they may have 
had, before they decided whether or not to take part. POLAR service users who 
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agreed to participate were asked to sign a consent form (Appendix D). A total of 
72 participants were recruited in this manner (Group A participants).  
In order to increase participation due to a slower than expected rate of 
recruitment, participants who did not wish to take part were asked whether they 
would consent to the use of any extant clinical data in the study (i.e. clinical 
measures used during routine clinical referrals to the psychology department 
such as Hospital Anxiety and Depression Scale, MoCA, some 
neuropsychological measures). If participants agreed to this, they signed the 
same informed consent form as above, but were not contacted further regarding 
the research. These participants were described as Group B1 participants (n = 13).  
A number of former POLAR service users (N=9), who had participated in 
the programme in the period between the granting of ethical approval for study 
commencement and the beginning of prospective recruitment, were also 
contacted regarding retrospective inclusion of their existing clinical 
neuropsychological assessment results in the study. Only service users who had 
completed some neuropsychological assessments, as identified by the POLAR 
senior clinical psychologist, during that time period were contacted. These 
service users were contacted in order to maximise the sample size for the cross-
sectional neuropsychological assessment. A cover letter (Appendix B) and 
consent form (Appendix D) were sent to potential participants by post. This was 
subsequently followed up with a telephone call to request return of written 
consent if the participant was willing to take part. Two participants were 
recruited in this manner (Group B2).  
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4.3.3 Prospective Recruitment Challenges 
There were a number of challenges in the recruitment of participants. The 
POLAR rehabilitation programme is a comprehensive rehabilitation programme 
situated within an active hospital environment. Varying lengths of inpatient 
rehabilitation duration – some with early discharges – meant that potential 
participants were discharged – usually back to acute hospitals – before the 
recruitment process could be completed. Potential participants’ often reduced levels 
of premorbid functioning and literacy, and ostensibly impaired cognitive 
functioning, meant that potential participants often did not attend to, could not read, 
or did not remember receiving introductory letters (to be read in their own time, i.e. 
without the presence and influence of the researcher, as per ethics procedure). Many 
would request additional time to read letters, and time to take participants through 
information and consent forms in a quiet setting (off-ward) was scheduled as needed. 
There were difficulties in scheduling time and locations in which to have these 
discussions. This was due to limited space in the hospital, limited free time being 
available on participants’ timetables, and restrictions on entering non-clinical 
appointments onto official schedules. Additionally, for persons recruited from the 
outpatient programme, appointments could only be made on days for which 
recruitment was scheduled.  
 
4.3.4 Ethical Approval 
Ethical approval was sought and received from the National Rehabilitation Hospital 
Ethics Committee prior to research commencement and ethical standards were 
maintained throughout the research by adhering to an ethics protocol that addressed the 
following types of issues. 
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4.4 Procedure 
When participants gave consent, socio-demographic and clinical data as well as 
any relevant neuropsychological assessments already administered clinically 
were collected from participants’ healthcare records . Details of data that were 
collected, including socio-demographic, clinical, and neuropsychological data 
are provided in section 4.5 Measures. A time and location were arranged to 
complete neuropsychological assessments administered by the researcher. The 
same procedure was followed for subsequent assessment sessions. Available 
time slots in the rehabilitation therapy timetable were usually one hour in 
duration. Sessions were usually fifty minutes in duration (nominally one hour, 
with time allowed for set-up and wrap-up). Longer sessions of up to two hours in 
duration were arranged as participant schedules allowed. The number of sessions 
scheduled varied per participant; sessions were arranged until either the test 
battery was completed, participants no longer wanted to continue with 
assessment, or there was no further time available within a participants in-
patient or out-patient stay. The majority of participants engaged in at least two 
sessions. Data for length of time spent undergoing neuropsychological 
assessment were not recorded. Rehabilitation engagement was measured at 
discharge with a clinician-rated measure, which was completed by either an 
occupational therapist or physiotherapist on the POLAR rehabilitation 
programme
8
.   
  
                                                 
8 Ratings of occupational therapists and physiotherapist have been found to be equivalent 
(Kortte et al., 2007) 
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4.4.1 Follow-Up Procedure 
At discharge, six months post-discharge, and 12 months post discharge, 
participants were telephoned to complete follow-up questionnaires (Appendix 
E). During the phone call, participants were asked to complete the questionnaire 
with the researcher if available to do so at that time or alternatively to arrange 
another time within two to three days to do so. Up to three attempts were made 
to contact participants by telephone; if these attempts were unsuccessful, follow-
up questionnaires were sent by post to participants for self-completion.  
Death notices
9
 were consulted prior to making contact with participants 
for follow-up to prevent potential incidence of distress for surviving family 
members or next-of-kin in cases of participant mortality.  
 
 
4.4.2 Procedural Challenges 
Collecting data from service users’ healthcare records was a time consuming process 
for administrative reasons within the hospital as healthcare records were coded and 
stored securely. This often resulted in long delays between the initial request and the 
receipt of these records.  
The completion of the neuropsychological assessment battery also presented 
a number of challenges. Availability of participants for research participation was 
restricted, due to prioritisation of clinical rehabilitation slots and the limited amount 
of free time on participants' rehabilitation therapy timetables. Free time available for 
research became more limited over the course of the study due to changes in the 
                                                 
9 RIP.ie was the primary death notice service consulted. Additional notice services were 
consulted in cases of uncertainty.  
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delivery of rehabilitation programmes. For data protection reasons participants’ 
research sessions could not be officially scheduled in advance. Instead, research 
appointments were added manually to participants’ on-ward timetables when they 
consented to participate in the study. Thus, research appointments were not on 
official timetables, and participants were often scheduled for additional therapy 
sessions – overriding research appointments. However, an arrangement was reached 
in December 2013 (with approximately 25% of time 1 (neuropsychological) data 
collection time remaining), whereby it became possible to place research assessment 
periods on the official timetable in advance, via POLAR programme administrative 
personnel.  
It proved challenging to complete the entire battery with all participants. This 
was anticipated as a possible challenge considering the inpatient setting which 
presents the challenges of a busy rehabilitation programme and even busier/more 
time-constrained day-patient programme, variety in length of inpatient rehabilitation 
duration, participants’ and potential participants’ often reduced levels of cognitive 
functioning and occasional poor literacy. The structure of assessments was adapted 
to best fit within participants’ timetables. Usually a one-hour session was scheduled 
(as this was usually the maximum available), which allowed for less than an hour’s 
assessment time in practice.  
During the course of the research period, the order of administration of the 
neuropsychological assessment battery was altered to prioritise certain measures 
(RBANS, the trail making test and other executive function tests, elements of the 
WAIS-IV, WMS logical memory) during the study in order to maximise the amount 
of data collected in prioritised areas. These areas included measures of overall 
cognitive functioning (RBANS total scale), combined information processing and 
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attention (WAIS symbol search), delayed memory (WMS-IV logical memory II), 
and measures of executive functions (WAIS digit span, DKEFS colour-word 
inhibition, DKEFS trail making test number-letter switching, DKEFS verbal 
fluency). This prioritization was undertaken to maximize participants’ completion of 
comprehensive measures of cognitive functioning, that were both sensitive to 
vascular cognitive impairment (executive functions particularly), with some 
consideration also of utility in predicting outcomes in various contexts.  
 
4.4.3 Ethical Considerations 
 
4.4.3.1 Informed Consent and Participation 
Information about the study was provided in both written and oral form to 
potential participants. To ensure informed consent was obtained, the researcher 
ensured that the participants understood and retained information regarding the 
research, and communicated their decision clearly. Participants were asked 
whether they had any questions about the research project. Those who agreed to 
participate were asked to sign a consent form. Participants were informed about 
their right to refuse to participate or to withdraw at any time. Each participant 
retained control within the study process, and could withdraw from the research at any 
point without affecting future healthcare or medical treatment. See Appendix D for 
the Consent form, which was completed by all participants. Participants 
contacted for retrospective inclusion of their neuropsychological assessment 
results in the study (N=9) were contacted by post, with an information letter and 
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consent form, and telephone follow-up to request written consent for use of their 
data.  
 
4.4.3.2 Clinical and Research Assessment Overlap 
There was overlap between clinical and research assessments insofar as 
participants who participated in the research assessments may have completed 
some of the assessment battery as part of clinical assessment by the POLAR team 
Senior Clinical Psychologist. Duplication of assessments was avoided in these 
cases, and assessment data obtained from clinical assessments was incorporated 
into the research data. Potential participants were informed of this prior to 
participation via the patient information leaflet during the informed consent 
process.  
 
4.4.3.3 Feedback 
If requested by participants, feedback about neuropsychological test results was 
provided by the Senior Clinical Psychologist on the POLAR rehabilitation team.  
 
4.4.3.4 Data Protection 
Neuropsychological assessments and all identifying information were stored in locked 
filing cabinets in the National Rehabilitation Hospital. Psychosocial follow-up data was 
anonymised and identifiable by code only. This code was retained by the researcher. 
For analysis, anonymised (coded) data were transferred to a laptop with an encrypted 
hard disk drive. Access to computer files was by password only. Participants were 
informed about arrangements to safeguard their confidentiality. 
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4.4.3.5 Issues Arising During the Research Process 
Detailed protocols were agreed and put in place prior to data collection to ensure that 
the psychological health and wellbeing of service users were prioritised at all times. If 
the researcher was concerned about the wellbeing of a participant, appropriate 
mechanisms were in place to ensure patient safety and well-being; notification of such 
concerns was relayed to the POLAR team Senior Clinical Psychologist, or to the 
POLAR Physical and Rehabilitation Medicine Consultant post-discharge. If 
appropriate, participants were offered psychological support during inpatient admission 
– this was managed by the POLAR clinical team.  
 
 
4.5 Measures 
 
In the sections that follow measures are described according to the following 
headings: socio-demographic and clinical data, neuropsychological assessments, 
rehabilitation engagement, mobility and prosthetic outcomes, psychosocial measures, 
activity limitation and participation restriction, and community participation.  
Summaries of measures collected are presented in tables 1 to 7 for 
neuropsychological measures, and in table 8 for prosthetic and psychosocial 
measures. Information regarding the Hospital Anxiety and Depression Scale (HADS) 
is presented with the psychosocial follow-up measures, although it was also 
administered on admission.  
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4.5.1 Socio-demographic and Clinical Data 
Socio-demographic and clinical data were collected from healthcare records on 
admission to rehabilitation. Socio-demographic data collected included: date of 
birth/age on admission, gender, years of formal education, and marital status. 
Clinical data collected included: amputation aetiology, amputation level (below 
knee, above knee, or bilateral), co-morbidities, and time since amputation. Length of 
stay was extracted from healthcare records on discharge. 
 
4.5.2 Neuropsychological Assessment 
The battery of neuropsychological assessments was selected in order to a) provide a 
comprehensive profile of cognitive functioning and impairment, b) while being 
sensitive to vascular cognitive impairment (i.e. information processing, executive 
functioning impairment, etc.), and c) to keep participant burden as low as possible. A 
summary of the neuropsychological assessment battery, organised by cognitive 
domain, is presented in Tables 1 to 7. Information regarding neuropsychological 
assessments, i.e. tests or subtests, is presented alphabetically with subtests grouped 
together according to parent batteries. As subtests are regularly developed and 
normed together, this method of organization avoids repetition in reporting 
assessment procedures, reliability, etc. Accordingly, tests/subtests are presented in 
the following order: Behavioural Assessment of the Dysexecutive Syndrome 
(BADS) – zoo map, California Verbal Learning Test-II-short form (CVLT-II-sf), 
Delis-Kaplan Executive Function System, Frontal Systems Behavior Rating Scale 
(FrSBe), Montréal Cognitive Assessment (MoCA), Repeatable Battery for the 
Assessment of Neuropsychological Status (RBANS), Test of Everyday Attention 
(TEA), The Visual Object and Space Perception Battery (VOSP), Wechsler Adult 
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Intelligence Scale-Fourth Edition (WAIS-IV), Wechsler Memory Scale-Fourth 
Edition (WMS-IV), Wechsler Test of Adult Reading (WTAR).  
 
Table 1 
Estimated Premorbid and Overall Cognitive Functioning Assessment 
Measures 
Domain Assessment 
Premorbid estimate of intellectual ability  Wechsler Test of Adult Reading  
Brief cognitive screen Montreal Cognitive Assessment  
Overall cognitive functioning RBANS total scale 
 
 
Table 2 
General Intellectual Functioning and Reasoning Assessment Measures 
Domain Assessment 
Abstract verbal reasoning WAIS-IV similarities 
Visuospatial reasoning WAIS-IV block design 
Fluid reasoning (visual) WAIS-IV matrix reasoning 
 
 
Table 3 
Psychomotor Speed, Information Processing, and Attention Assessment 
Measures 
Domain Assessment 
Psychomotor speed DKEFS motor speed (trail making) 
Information processing speed RBANS coding 
WAIS-IV symbol search * 
DKEFS colour naming  
DKEFS word reading 
Attention span RBANS digit span 
Focused attention DKEFS visual scanning 
DKEFS number sequencing  
DKEFS letter sequencing 
Sustained attention TEA telephone search 
Divided attention TEA telephone search with distraction 
* WAIS-IV symbol search also measures aspects of attention 
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Table 4 
Memory Assessment Measures 
Domain Assessment 
Immediate recall RBANS list learning  
RBANS immediate story memory  
CVLT-II-sf  
WMS-IV logical memory I 
Delayed recall RBANS delayed list recall  
RBANS delayed story recall  
RBANS figure recall  
WMS-IV logical memory II 
Delayed recognition RBANS list recognition 
Cued recall CVLT-II-sf cued recall 
 
 
Table 5 
Visuospatial Cognition Assessment Measures 
Domain Assessment 
Visuospatial perception VOSP position discrimination  
RBANS line orientation 
Visuospatial construction RBANS figure copy 
 
 
Table 6 
Language Assessment Measures 
Domain Assessment 
Confrontational naming Graded Naming Test,  
RBANS picture naming 
 
 
Table 7 
Executive Functioning Assessment Measures 
Domain Assessment 
Working Memory  WAIS-IV digit span 
Inhibition DKEFS colour-word switching 
Cognitive flexibility DKEFS trail making number-letter switching 
Self-monitoring & retrieval 
strategy 
RBANS semantic fluency, DKEFS category 
fluency, DKEFS letter fluency 
Planning BADS zoo map 
Self-rated everyday executive 
functioning 
FrSBe self-rated 
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4.5.2.1 Behavioural Assessment of the Dysexecutive Syndrome (BADS) (Wilson et 
al., 1996) 
The zoo map subtest of the Behavioural Assessment of the Dysexecutive Syndrome 
(BADS) (Wilson et al., 1996) was used to assess planning. Inter-rater reliability was 
found to be high for the zoo map subtest, ranging from 0.90 to 1.00 for individual 
elements of the subtest (Wilson et al., 1996). Espinosa et al. (2009) used the BADS 
Zoo Map as an ecologically valid test of executive functioning in mild cognitive 
impairment and mild Alzheimer’s disease. The zoo map requires participants to visit 
designated locations on a map of a zoo in a certain order while adhering to certain 
rules. There are two trials. The first trial examines planning in an unstructured 
environment. The second trial utilises the same route and objectives, but participants 
are given the route they must follow for completion of the trial without errors in the 
instructions – a structured environment. Raw scores based on following the correct 
routes, with deductions for errors, were prorated and converted to standard scores 
based on the six subtests of the BADS – these could then be compared to normative 
values. Thus, an ordinal scale of scores with four points (1 – 4) served as a measure 
of general planning ability, with higher scores representing better ability.  
   
4.5.2.2 California Verbal Learning Test-II-short form (CVLT-II-sf) (Delis, Kramer, 
Kaplan, & Ober, 2000) 
The California Verbal Learning Test-II-short form (CVLT-II-sf) (Delis et al., 2000), 
a short form of the CVLT-II, is an auditory memory test with immediate recall, 
delayed recall, and delayed recognition measures. The CVLT-II has been widely 
used in studies of dementia, can be used to aid differential diagnosis of vascular 
dementia and dementia of Alzheimer’s type (Rosenstein, 1998), and has been 
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demonstrated to be a reliable measure (Paul, Delis, Scott, Kramer, & Holdnack, 
2006).  
 Raw scores on the CLVT-II-sf are converted to age-standardized standard 
scores, which represent deviation from the mean score (e.g. -0.5 = 0.5 standard 
deviations below the mean score). The CVLT-II-sf was used as a measure of cued 
recall, with higher scores indicating higher recall ability.  
 
4.5.2.3 Delis-Kaplan Executive Function System (DKEFS) (Delis, Kaplan, & 
Kramer, 2001) 
Three subtests from the Delis-Kaplan Executive Function System were used to 
assess different aspects of executive functioning: the trail making test (TMT), the 
verbal fluency test, and the color-word [sic] inhibition test (Delis, Kaplan, & 
Kramer, 2001). Each of the subscales is a modified form of an established test, and 
was originally designed to be used alone (Swanson, 2005).  
 The TMT has five trials: visual scanning, number sequencing, letter 
sequencing, number-letter switching, and motor speed. Raw scores are based on 
completion time, and scale scores (1 – 19) are calculable, with higher raw scores 
indicating higher ability.  
 Two trials from the verbal fluency test were used: letter fluency, and category 
fluency. Scores were obtained for the number of correct responses within the 60 
second time limit. Higher raw scores indicate better functioning.  
 Three conditions from Color-Word Interference were used: colour naming, 
word reading, and inhibition. Scores were based on completion time – one point per 
second. Higher raw scores indicate poorer functioning.  
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Raw scores for each subtest were then converted to DKEFS standardised 
scores (M=10, SD=3). Higher standard scores are indicative of a greater level of 
executive functioning.  
 The DKEFS subtests used herein were shown to have discriminant validity in 
correlations with a test of verbal memory (the California Verbal Learning Test – a 
version of which was also used within this study) (Homack, Lee, & Riccio, 2005; 
Swanson, 2005). The DKEFS subtests have been shown to be moderately to highly 
reliable (Homack et al., 2005; Swanson, 2005).  
 
4.5.2.4 Frontal Systems Behavior Rating Scale (FrSBe) (Grace & Malloy, 2001) 
Participants’ perception of their level of everyday executive functioning was 
measured by the Frontal Systems Behavior Rating Scale (FrSBe) – self rating form, 
a 46-item behaviour rating scale, designed to measure behaviour associated with 
frontal lobe lesions (Grace & Malloy, 2001). When compared with performance on 
executive function tasks, it will also give a proxy estimate of participants’ insight 
into their own level of executive functioning. 
 The 46 items are split into three subscales: Apathy, Disinhibition, and 
Executive Dysfunction. Scores on these are then summed for a Total score. Raw 
scores range from 1 (almost never) – 5 (almost always). Higher scores indicate 
higher everyday executive function ability. The FrSBe test manual (Grace & Malloy, 
2001) recommends that T-scores of 60 to 64 (corresponding to z scores of 1.0 to 1.4) 
should be regarded as borderline, while T-scores of 65 (z = 1.5) or higher should be 
regarded as impaired. This is a more conservative cut-off than the z=-1.5 and z=-2.0 
cut-off scores used for borderline and impaired elsewhere throughout the study. An 
exception was applied here in adherence to the above recommendation.  
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 The FrSBe has been found to be a reliable measure, with α = 0.88 for the 
Total scale, and α = 0.72, α = 0.75, and α = 0.79 for the Apathy, Disinhibition, and 
Executive Dysfunction subscales respectively (Grace & Malloy, 2001). Reid-Arndt, 
Nehl, and Hinkebein (2007) found that the Apathy and Executive Dysfunction 
subscales of the FrSBe predicted community integration in people with traumatic 
brain injuries.  
 
4.5.2.5 Montréal Cognitive Assessment (MoCA) (Nasreddine et al., 2005) 
The Montréal Cognitive Assessment (MoCA) (Nasreddine et al., 2005) is a 
screening tool for mild cognitive impairment and was used to ascertain the presence 
of mild cognitive impairment. Advantaged by its brief nature, the MoCA is a 30-item 
measure, with items grouped into categories: orientation, abstraction, attention, 
immediate recall, delayed recall, naming, language (including expressive language 
and verbal fluency), and visuospatial/executive. Individual item scores are summed 
to produce a total score (range = 0 - 30).  
 Freitas, Simoes, Maroco, Alves, and Santana (2012) found the MoCA to have 
good internal reliability (Cronbach’s α = 0.905). Using ROC curve analysis, they 
also found high diagnostic accuracy (AUC 0.856, 95% CI 0.796-0.904) for mild 
cognitive impairment and excellent accuracy for Alzheimer’s disease (AUC 0.980, 
95%CI 0.947-0.995). Importantly, the MoCA has been validated for use with a range 
of populations with vascular diseases (Koski, 2013). A cut-off score of <24 
indicative of cognitive impairment in people with cardiovascular diseases has been 
recommended (Godefroy et al., 2011; McLennan, Mathias, Brennan, & Stewart, 
2011). While specificity has varied, this cut-off score has shown high sensitivity in 
both cardiovascular disease and post-stroke cognitive impairment. Sensitivity was 
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100% for amnestic MCI, 83% for multi-domain MCI in cardiovascular disease 
(McLennan et al., 2011), and 88% for cognitive impairment in post-stroke (Godefroy 
et al., 2011). Specificity ranged from 50 – 52% (McLennan et al., 2011) to 71% 
(Godefroy et al., 2011). 
 The MMSE (Mini-Mental State Examination), a similar screening tool to the 
MoCA, is in widespread use and would frequently form part of a neuropsychological 
assessment battery (Hachinski et al., 2006). Pendlebury, Cuthbertson, Welch, Mehta, 
and Rothwell (2010) have shown the MoCA to be more sensitive than the MMSE 
(Folstein et al., 1975) in the detection of mild cognitive impairment (in particular 
vascular cognitive impairment), as the MoCA has more of a focus on executive 
functioning, and is more sensitive to executive function impairment. Stewart, 
O’Riley, Edelstein, and Gould (2012) also found that the MMSE was less sensitive 
than the MoCA for detection of cognitive impairment in a sample of adults with a 
range of diagnoses including dementia and psychiatric disorders.  
   
 
4.5.2.6 Repeatable Battery for the Assessment of Neuropsychological Status 
(RBANS) (Randolph et al., 1998) 
The Repeatable Battery for the Assessment of Neuropsychological Status (UK 
version) (RBANS) (Randolph et al., 1998) comprises a total scale, and 12 subtests 
organized into five domains immediate memory, visuospatial/constructional, 
language, attention, and delayed memory. The total scale was used as a measure of 
overall cognitive functioning, whilst its subtests were used as measures of their 
respective domains.  
 Immediate memory: 
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o List learning: 10-item word list, to be recalled immediately after aural 
presentation, over four learning trials; 
o Story memory: 12-item story for immediate recall, presented aurally 
over two trials. 
 Visuospatial/constructional: 
o Figure copy: 10-part geometric figure, each part with a two-point 
score (accuracy & placement); 
o Line orientation: 10-item line orientation test. Each item is a radiating 
array of thirteen lines spanning 180°, below which are two target lines 
which are equal in orientation to two lines from the array. The 
matching lines must be identified. 
 Language: 
o Picture naming: 10 line drawings which must be named; 
o Semantic fluency: The participant is asked to generate exemplars for a 
given semantic category (e.g. fruit & vegetables) within 60 seconds. 
 Attention: 
o Digit span: Strings of digits, increasing in length from two digits to 
nine, are presented aurally. Participants must recall each string 
immediately post-presentation; 
o Coding: A key matching numbers to symbols is presented visually. A 
two-row grid, with symbols in the top row, while the bottom row is 
blank is presented. The task is to insert numbers into the bottom row, 
which match symbol in the top row. Participants must complete as 
many of these as possible within 90 seconds. 
 Delayed memory: 
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o List recall: Free recall of items presented in the List Learning subtest; 
o List recognition: Yes/no recognition of items presented in the List 
Learning subtest; 
o Story recall: Free recall of the items presented in the Story Memory 
subtest; 
o Figure recall: Free recall of the figure from the Figure-Copy subtest. 
Raw scores for each of the items are grouped by scale and converted to age-
standardised index scores (max = 160) and percentiles. Index scores for each of the 
subscales are summed and converted to a total index score. Higher scores indicate 
higher levels of functioning.  
Duff, Hobson, Beglinger, and Bryant (2010), using ROC curves, found that 
in discriminating between cognitively intact, and mildly cognitively impaired 
participants, the RBANS showed very good specificity but poor to moderate 
sensitivity. The RBANS, or elements thereof, has been used in studies of LLA 
populations previously, once using the RBANS total scale (O’Neill, Moran, & 
Gillespie, 2010), once with three subtests (O’Neill & Evans, 2009), and twice with 
two of the memory subtests (Williams et al., 2014, 2015).  
In a sample of people with brain injuries, RBANS subtest scores 
demonstrated moderate to high correlations with more comprehensive 
neuropsychological assessments, such as the California Verbal Learning Test (e.g. 
Paul, Delis, Scott, Kramer, & Holdnack, 2006), the WAIS-III, and the Benton Visual 
Retention Test (McKay, Casey, Wertheimer, & Fichtenberg, 2007). Evidence is also 
available for the 12-month predictive validity of the RBANS in stroke rehabilitation, 
for cognitive functioning (Larson, Kirschner, Bode, Heinemann, & Goodman, 2005). 
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4.5.2.7 Test of Everyday Attention (TEA) (Robertson, Ward, Ridgeway, & Nimmo-
Smith, 1994) 
Two subtest of the Test of Everyday Attention (Robertson, Ward, Ridgeway, & 
Nimmo-Smith, 1994) were used. Telephone Search, in which participants search an 
imitation telephone directory for particular symbols, was used to measure sustained 
attention. The Telephone Search subtest has also been used as a measure of focused 
or selective attention (Spikman & van Zomeren, 2012; van der Leeuw et al., 2016). 
However, the task is quite structured, with a requirement to maintain concentration 
during a repetitive task. Telephone Search While Counting, wherein participants 
search for symbols as above in an alternate form imitation telephone directory while 
simultaneously counting strings of aurally presented tones, was used to measure 
divided attention. Focused attention is important for the Telephone Search subtest. 
Points are awarded for number of symbols correctly identified, divided by 
completion time (Telephone Search), with similar scoring for the Telephone Search 
Dual Task, but weighted for the number of correctly counted tones. Dual task 
decrement can be calculated by subtracting the Telephone Search score from the 
Telephone Search Dual Task score. Raw scores are converted to standard scores 
(range = 0 - 19), with higher scores denoting better attention functioning.  
 
4.5.2.8 The Visual Object and Space Perception Battery (VOSP) (Warrington & 
James, 1991) 
The position discrimination subtest of the Visual Object and Space Perception 
Battery (VOSP) (Warrington & James, 1991) was used as a measure of visual spatial 
perception. Participants are presented with pairs of stimuli, each consisting of a dot 
within a square. One of the dots in each of the pairs is centred, whilst the other is 
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slightly off-centre. Participants are asked to indicate which dot is centred, and to 
guess if they are uncertain. Higher scores indicated higher spatial perception ability; 
each correct response scores 1 point (range = 0 - 20). Performance is assessed on a 
pass/fail basis using a 5% cut-off score below the maximum, as the normal group 
within the standardisation sample did not find the test difficult and there is a 
consequent ceiling effect. Persons with right hemisphere lesions are significantly 
more likely than those with left-side lesions to obtain a deficit score. 
 Confirmatory factor analysis has found that the two factor theory of object 
and space perception on which the VOSP is based fit the data well (Rapport, Millis, 
& Johnson, 1998). 
 
 
4.5.2.9 Wechsler Adult Intelligence Scale-Fourth Edition (WAIS-IV) (Wechsler, 
2008a) 
Five of the ten core subscales of the Wechsler Adult Intelligence Scale-Fourth 
Edition (WAIS-IV) (Wechsler, 2008a) were used. Raw scores for each of the 
subscales were converted to age-standardised scale scores, ranging from 0 – 19 (M = 
10, SD = 3). Higher scores indicate higher levels of functioning. The following 
subscales were used.   
 Block design was used to assess visuospatial reasoning. Participants are 
shown a 2D picture which they must replicate in 3D using blocks within a 
time limit. Scores are awarded for total accuracy, and are graded according to 
completion time for more difficult items. A score of 0 is awarded for non-
completion within the set time limit. The subtest is discontinued after 2 
consecutive incorrect items. 
CHAPTER 4: METHODOLOGY 
84 
 
 Similarities was used to assess abstract verbal reasoning. Participants must 
describe the similarity between two words. Each is representative of a 
common concept. Scores are 0 (incorrect), 1 (partially correct), or 2 (correct). 
The subtest is discontinued after 3 consecutive incorrect items. 
 Digit Span was used to assess working memory. Digit span comprises three 
conditions: 
o Digit Span Forwards: Participants are asked to recall a sequence of 
numbers in the order in which they are presented. 
o Digit Span Backwards: Participants are asked to recall a sequence of 
numbers in reverse order to the order in which they are presented. 
o Digit Span Sequencing: Participants are asked to recall a sequence of 
numbers in ascending order. 
In all conditions, the subtest is discontinued after 2 consecutive 
incorrect items. A total score is computed from summed scores of 
each of the three conditions.  
 Matrix reasoning was used to assess fluid reasoning. Participants are 
presented with an incomplete series or matrix, and must select a response to 
correctly complete the series/matrix. Items are scored 0 (incorrect) or 1 
(correct). The subtest is discontinued after 3 consecutive incorrect items. 
 Symbol Search was used to assess information processing speed. Participants 
copy symbols paired with numbers by key, within a time limit. Each correct 
item is scored 1. Incorrect items are scored -1. 
  
 
NEUROPSYCHOLOGICAL FUNCTIONING & LOWER LIMB LOSS 
85 
 
4.5.2.10 Wechsler Memory Scale-Fourth Edition (WMS-IV) 
Two subtests from the Wechsler Memory Scale-Fourth Edition (WMS-
IV)(Wechsler, 2008b) were used: logical memory I – immediate recall of two 
separate stories, and logical memory II – delayed recall of the same stories. Raw 
scores for both the logical memory I and II were summed from responses to each of 
the two stories presented. Raw scores were converted to age-standardised standard 
scores (range: 0 - 19), with higher scores indicating better immediate or delayed 
memory. The WMS-IV has been co-validated, by confirmatory factor analysis, with 
the WAIS-IV (Holdnack, Zhou, Larrabee, Millis, & Salthouse, 2011).  
 
4.5.2.11 Wechsler Test of Adult Reading (WTAR) (Wechsler, 2001) 
The Wechsler Test of Adult Reading (Wechsler, 2001) consists of 50 words with 
atypical grapheme to phoneme relationships, i.e. unconventional pronunciations. The 
participant is asked to read each word aloud, and their pronunciation of each word is 
marked as correct or incorrect, according to the pronunciation guide provided on the 
scoring sheet. The raw score is then converted to a standard score, for which US and 
UK standardisations are available, higher scores indicating higher ability. The UK 
standardisations were used in the current research.  
The WTAR is often used as a measure of premorbid cognitive functioning, 
except in cases of dyslexia (Evans, 2011), and has been used for that purpose in 
studying dementias (Braaten et al., 2006). Correlation between the WTAR and 
WAIS-III Full Scale IQ scores ranged from 0.70 (Mathias, Bowden, & Barrett-
Woodbridge, 2007).  
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4.5.2.12 Order of Administration 
The neuropsychological assessment battery was designed to be administered across 
three sessions of approximately an hour each. Each session was designed to avoid 
stimuli from one assessment influencing performance on another. The first session 
was designed to include the RBANS, HADS, FrSBe, WTAR, TEA, and Graded 
Naming Test. The second was to include WMS logical memory, CVLT-II-s, VOSP, 
BADS, and DKEFS subtests. The third was to include the WAIS-IV subtests and 
MoCA. In cases, changes were made to session contents, as some participants may 
already have completed a standardised assessment as part of routine clinical 
assessment. The order of administration was altered during the course of the 
research. This was in order to maximize collection of priority data. These alterations, 
and reasons for same are outlined in section 4.4.2 Procedural Challenges above.   
 
4.5.2.13 Limitations of Assessments Regarding Normative Data  
Comparison to normative values was limited by the normative data which was 
available for some of the assessment tools used in this research. Norms for the 
Graded Naming Test,  despite being updated since the test’s initial development 
(Warrington, 1997), are not sufficiently precise to allow for comparison in research. 
The Graded Naming Test was selected instead of the similar Boston Naming Test 
(see (Lezak et al., 2012; Strauss et al., 2006)) as its stimuli were deemed more 
culturally familiar to Irish participants. Norms for the Test of Everyday Attention 
(TEA) are restricted to four age bands. Within this research project, results of 
participants over 80 years of age were scored according to normative values for the 
65-80 age group as the TEA has an age ceiling of 80. Strauss, Sherman, and Spreen 
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(2006) argue that the normative samples were not well described for either the TEA 
or the BADS (B. A. Wilson et al., 1996).  
The inability to directly assess or observe a current state makes the estimation 
of premorbid cognitive functioning challenging. Caution must be exercised when 
interpreting WTAR scores as indicators of premorbid cognitive functioning. 
Mathias, Bowden, and Barrett-Woodbridge (2007) found that WTAR-based 
estimates of WAIS-III IQ tended to overestimate the IQ of people with below 
average WAIS-III scores, and underestimate the IQ of people with above average 
WAIS-III scores, by up to 30 and 36 IQ points respectively. They found a greater 
disparity between actual and WTAR-estimated IQ scores the further away from the 
mean a person’s score lay. Recent years have seen the development of the Test of 
Premorbid Functioning (TOPF; Wechsler, 2011), which was co-normed with the 
WAIS-IV (Wechsler, 2008a). Recent research comparing the WTAR to the TOPF, 
and variants of the similar National Adult Reading Test (NART; Nelson, 1982), has 
found that the TOPF is preferable to the WTAR for the purpose of estimating 
premorbid IQ (Watt, Gow, Norton, & Crowe, 2016). The TOPF was a more accurate 
estimator in cases of low IQ, whereas the NART was more accurate in high IQ, 
while the NART-2 and WTAR were both more accurate than the TOPF in the 
average range. Yet, the NART and WTAR both have floor and ceiling effects. 
Ultimately, Watt et al. (2016) recommended that demographic information be 
incorporated into an equation to estimate premorbid functioning.  
The availability of precise normative data is an important consideration in the 
selection of neuropsychological assessments, though it is not the sole consideration. 
Assessments with accurate but not particularly precise normative data were chosen 
for this research – for example the wide age bands of the TEA and the broad 
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functioning categories of the BADS. Taking the BADS as an example: 1) it has been 
demonstrated to comprise ecologically valid subtests, 2) the Zoo Map subtest is easy 
and relatively quick to administer while, 3) providing important information on the 
planning element of executive functioning, 4) within a comprehensive and well-
validated theoretical framework, the Supervisory Attentional System.  
 
 
4.5.2.14 Theoretical Orientation Regarding Executive Functions  
Evidence suggests that executive functions are a set of related but separable 
functions (Diamond, 2013; Miyake et al., 2000). Component functions include at 
least working memory/updating, inhibition, and cognitive flexibility (Miyake et al., 
2000). Such basic functions may also include other aspects of cognition such as 
executive-mediated memory interfacing/retrieval (Fisk & Sharp, 2004). It has been 
argued that complex executive functions such as planning are composed of these 
more basic executive functions. The supervisory attentional system (SAS) is a theory 
of executive functioning developed by Norman and Shallice (see Shallice & Cooper, 
2011; Shallice, 1988). It posits that said system controls information flow, similar to 
Baddeley’s (e.g. 1998, 2007, 2012) central executive component of working 
memory. The SAS theory proposes that certain behaviours or cognitions are 
automatic, while others are directed by a central executive system. Automatic 
processes – contention scheduling – comprise single or multiple, sequential schema. 
When a measure of executive control is required for non-automatic processes, the 
SAS is said to be involved in the planning and sequencing, monitoring, inhibition, 
switching and feedback of schema. As Miyake et al. (2000) and Diamond's (2013) 
accounts of executive functioning are more descriptive than explanatory, within this 
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research project the executive functions they documented are together held to be 
approximations of the functions of the SAS.  
 
 
4.5.3 Rehabilitation Engagement 
The Hopkins Rehabilitation Engagement Rating Scale was developed by Kortte, 
Falk, Castillo, Johnson-Greene, and Wegener (2007) to measure engagement in 
rehabilitation. The HRERS is a 5-item measure, rated by clinicians. The following is 
a sample item: ‘The patient required verbal or physical prompts to actively 
participate in my therapy/ rehabilitation activity’. Each item is rated on a six point 
scale – from “Never” to “Always”. Item scores are then summed (item 2 is reverse 
scored), to provide a summary score. Higher scores indicate greater patient 
rehabilitation engagement.  
Internal consistency was found to be high; the HRERS was found to have a 
Cronbach’s α of 0.92 when completed by physiotherapists, and 0.91 when completed 
by occupational therapists (Kortte et al., 2007). Inter-rater reliability of the HRERS, 
assessed using intraclass correlation coefficients was found to be 0.733, for all raters 
combined. Construct validity was assessed with factor analysis – a single factor was 
observed with loadings ranging from 0.75 to 0.96 in the study’s amputation group 
(assumed to be mixed upper and lower limb), for all raters combined (Kortte et al., 
2007). Herein, the HRERS was completed either by an occupational therapist or 
physiotherapist who was familiar with the participant in question.  
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4.5.4 Prosthetic and Mobility Outcomes  
See Table 8 for a summary of prosthetic domains and associated measures. 
 
Table 8 
Prosthetic, Mobility and Psychosocial Variables and Associated Measures 
Outcome Measures Assessment
 a
 
Admission 
(T1) 
Discharge 
(T2) 
6 M 
(T3) 
12 M 
(T4) 
Rehabilitation engagement HRERS     
Mobility SIGAM Mobility 
Grades 
    
Prosthesis use (hours) TAPES-R     
Aesthetic satisfaction TAPES-R     
Functional satisfaction TAPES-R     
General adjustment TAPES-R     
Social adjustment TAPES-R     
Adjustment to limitation TAPES-R     
Activation PAM-13     
Distress HADS     
Activity limitation & 
participation restriction 
WHODAS-2.0     
Participation engagement CPI     
Importance & meaning of 
participation 
CPI     
Control over participation CPI     
Perceived social support MSPSS     
Note. HRERS = Hopkins Rehabilitation Engagement Rating Scale, TAPES-R = Trinity Amputation 
and Prosthesis Experience Scales-Revised, PAM-13 = Patient Activation Measure-13, HADS = 
Hospital Anxiety and Depression Scale, WHODAS 2.0 = WHO Disability Assessment Schedule 2.0, 
CPI = Community Participation Indicators, MSPSS = Multidimensional Scale of Perceived Social 
Support 
a 
Collected with follow-up questionnaires, except for the rehabilitation engagement measure – 
completed by an occupational therapist or physiotherapist 
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4.5.4.1 Prosthesis Use and Prosthesis Satisfaction 
The Trinity Amputation and Prosthesis Experience Scale-Revised (TAPES-R) 
(Gallagher et al., 2010; Gallagher & MacLachlan, 2000) was developed as an 
amputation population-specific measure, sections of which were used to assess 
prosthesis use and prosthesis satisfaction.  
Prosthesis use was measured with a single item: how many hours do you 
wear your prosthesis every day? There were three measures of prosthesis 
satisfaction. Overall prosthesis satisfaction was measured using an eleven-point scale 
(0 – 10), with a higher score indicating greater satisfaction. Functional satisfaction 
and aesthetic satisfaction were measured with 5- and 3-item scales, respectively; 
each rated 1= dissatisfied, 2 = satisfied, and 3 = very satisfied. Higher scores indicate 
greater satisfaction.  
These satisfaction measures were found to have construct validity (Gallagher 
& MacLachlan, 2000), good reliability with Cronbach’s α=.85 (aesthetic) or α=.86 
(functional), and are capable of delineating hierarchies of participants in terms of 
satisfaction (Gallagher et al., 2010).   
 
4.5.4.2 Mobility 
The SIGAM Mobility Grades (Ryall, Eyres, Neumann, Bhakta, & Tennant, 2003) is 
an outcome measure for mobility, developed specifically for the lower limb amputee 
population, and recommended by the British Society of Rehabilitation Medicine 
(British Society of Rehabilitation Medicine, 2003). It allows participants’ mobility to 
be classified as one of six different grades: A, prosthesis abandoned or used for 
cosmetic appearances only; B, used for transfers, nursing or therapy; C, prosthesis 
used with walking aid(s) for ambulating <50 on even ground; D, prosthesis used 
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with walking aid(s) for ambulating >50 on uneven ground; E, occasional use of 
walking aid(s); F, near normal ambulation.  
Rasch analysis with items from the Rivermead Mobility Index provided some 
evidence for the validity of the SIGAM Mobility Grades (Ryall et al., 2003). The 
SIGAM Mobility Grades have been developed from the Harold-Wood Stanmore 
mobility grades, a well-validated, reliable instrument and widely-used, with the 
purpose of improving accuracy of allocation of grades (British Society of 
Rehabilitation Medicine, 2003; Condie, Scott, & Treweek, 2006). The SIGAM 
mobility grades questionnaire has also been developed and validated for self-
completion (Ryall et al., 2003).  
Clinician-rated SIGAM mobility grades were obtained from medical records 
at admission/T1, and from self-report completion of the measure at discharge/T2, six 
months/T3, and 12 months/T4.   
 
4.5.5 Psychosocial Aspects of Rehabilitation 
See Table 8 for a summary of psychosocial domains and associated measures.  
 
4.5.5.1 Activation 
The Patient Activation Measure (PAM) measures health activation. The following is 
a sample item: “I am confident I can tell my health care provider concerns I have 
even when he or she does not ask.” The PAM was developed using Rasch analysis 
and was found to be a reliable and valid measure (Hibbard, Stockard, Mahoney, & 
Tusler, 2004). A patient’s health activation is defined by Hibbard et al. (2004) as 
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1. Belief they have an important role in self-management of care, 
collaboration with healthcare providers, and maintaining their health.  
2. Knowledge of how to manage their condition, maintain functioning and 
prevent decline in health;  
3. Possession of the skills and behavioural repertoire to manage their 
condition, collaborate with their health providers, maintain health 
functioning, and access appropriate and high-quality care.  
The short form, 13-item version of the PAM (PAM-13) (Hibbard, Mahoney, 
Stockard, & Tusler, 2005) was used in this study. For each of 13 items, there are five 
possible responses, ranging from strongly disagree to strongly disagree, and not 
applicable. A total score is then obtained with a Rasch-based scoring sheet (which 
converts curvilinear summated raw scores to linear, interval scores) available from 
the developers (Hibbard et al., 2005).  
Scores can then also be classified into four categories corresponding to stages 
of activation: 1) believes active role important, 2) confidence and knowledge to take 
action, 3) taking action, and 4) staying the course under stress. Scores in the former 
two indicate that participants “likely need to work on self-awareness of their role in 
the care process and in gaining the basic knowledge about their conditions”, while 
participants with either of the latter classifications are “beginning to gain confidence 
in their ability to take on self-management behaviors [sic] and make life- style 
change” (Hibbard et al., 2005, p. 1295).  
The authors ( Hibbard et al., 2005) employed Rasch analysis to determine 
reliability and validity of the PAM-13. Except for poor self-rated health (r = .73) and 
age over 85 (r =.69), real person reliability values were at least moderately high (r ≥ 
.75) for all subgroups analysed. Of particular relevance to this study, the diabetes 
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group within the chronic condition subgroup had a real person reliability value of r = 
.79. In terms of validity, the PAM-13 activation scores were all strongly, 
significantly linked with disease preventive behaviours, disease-specific self-
management behaviours, and prudent consumer behaviours. Skolasky et al. (2011), 
using classical test theory, tested the reliability and validity of the original PAM in 
older adults with multiple morbidities. The PAM had high internal consistency 
(Cronbach’s α = .87). Using Bayesian analysis, they found in favour of construct 
validity, as PAM scores had strong, positive associations with functional status, 
health-related behaviours, and healthcare quality. They also found that multiple 
morbidities bore no relationship to activation.  
  The PAM-13 has been used previously in research with people with chronic 
illness, such as multiple sclerosis, in which it was found to relate to depression, 
quality of life, and self-efficacy (Stepleman et al., 2010).  
 
4.5.5.2 Adjustment  
The Trinity Amputation and Prosthesis Experience Scale-Revised (TAPES-R) 
(Gallagher et al., 2010; Gallagher & MacLachlan, 2000) has been developed as a 
limb loss population-specific measure, and the psychosocial adjustment to 
amputation section was used to examine the subjective experience of adjustment to 
amputation.  
The TAPES-R was validated with classical test theory (factor analysis) and 
Rasch analysis was used to confirm item validity. The psychosocial adjustment scale 
comprised three factors – general adjustment, social adjustment, and adjustment to 
limitation. All sections had high internal consistency (α=.86 to .90) (Gallagher et al., 
2010).  
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 Each of the subscales (general adjustment, social adjustment, and adjustment 
to limitation) contains five items. Responses on a four-point rating scale range from 
strongly disagree to strongly agree, with items 9 (social adjustment item 4) and 11–
15 (adjustment to limitation items) being reverse-scored. Higher scores indicate 
greater levels of adjustment.  
 
4.5.5.3 Distress 
The Hospital Anxiety and Depression Scale (HADS) (Zigmond & Snaith, 1983), 
developed to assess feelings of anxiety and depression, was used as a measure of 
general distress. The HADS comprises two 7-item scales; seven items assessing 
feelings of general anxiety, and seven items assessing feelings of depression as 
represented primarily by anhedonia (Snaith, 2003), with four possible response to 
each item (0 – 3). The two scales were summed to provide a measure of general 
distress in a manner consistent with that suggested by Crawford, Henry, Crombie, 
and Taylor (2001).  
 Wilkinson and Barczak (1988a, 1988b) argue for utility of the HADS as a 
psychiatric screening tool, and the HADS has been used in numerous studies of 
people with lower limb amputations (Hawamdeh, Othman, & Ibrahim, 2008; S. 
Larner et al., 2003; Singh et al., 2009). An advantage of the HADS as a measure of 
anxiety and depression for a lower limb amputation population is that its items focus 
on non-somatic symptoms, and it is responsive to change (Herrmann, 1997).  
Bjelland, Dahl, Tangen, and Neckelmann's (2002) review of the validity of 
the HADS concluded that it possessed internal consistency, good to very good 
concurrent validity, and “excellent case finding abilities”, i.e. sensitivity and 
specificity (p. 74). Desmond and MacLachlan (2005) investigated the factor structure 
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of the HADS amongst people with amputations, and found that a number of factor 
structures had good fit. A two-factor structure consistent with the original theory 
behind the HADS (bi-dimensionality between the anxiety items and the depression 
items) showed good fit, although a three-factor structure, where the depression items 
loaded on one factor – ‘anhedonic depression’ – and the anxiety items loaded onto 
either factors of ‘negative affectivity’ (items 1, 5, 7, 11), or ‘autonomic anxiety’ 
(items 3, 9, 13) showed better fit. Norton, Cosco, Doyle, Done, and Sacker (2013) 
conducted a meta-confirmatory factor analysis of factor structure, and concluded that 
the above three-factor structure was most acceptable. They also found that the 
HADS had a strong general factor and so the HADS was considered to be suitable as 
a measure of general distress.  
 
4.5.5.4 Perceived Social Support 
The Multidimensional Scale of Perceived Social Support (MSPSS) (Zimet, Dahlem, 
Zimet, & Farley, 1988) provides a subjective measure of participants’ perceptions of 
social support received from family, friends, and a significant other. The MPSS is a 
self-report measure, consisting of 12 items. Choice of response ranges from 1 (very 
strongly disagree) to 7 (very strongly agree). Mean total perceived social support 
scores are then obtainable in total, as well as for family friends, and significant other 
subscales. Higher scores indicate higher perceived social support.  
Zimet et al. (1988), when developing the MSPSS with undergraduate 
university students, found that internal consistency of the MSPSS was high for each 
subscale (Cronbach’s αs = .91, .87, .85, for significant other, family, and friends 
respectively). Two to three months after initial testing, whole-scale test-retest 
reliability was high (r = .85; significant other r = .72; family r = .85; friends r = .75). 
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To investigate construct validity, Zimet et al. (1988) analysed correlations between 
the MSPSS and measures of depression and anxiety, hypothesising negative 
correlations. The MSPSS significantly negatively correlated with depression (r = -
.25, p < .01). Individual subscales had significant negative correlations with anxiety 
(family) and depression (family, friends, and significant other). The authors also 
found a three-factor structure based on family, friends, and significant others. 
Stanley, Beck, and Zebb (1998) studied the MSPSS in older adults (M = 
67.53, SD = 6.77). Their findings concurred with Zimet et al.'s (1988) findings in 
showing high internal consistency, and test-retest reliability. They found that the 
MSPSS had a three-factor structure aligned with the concept of support from family, 
friends, and significant others. They also found that married people reported higher 
levels of perceived social support. The MSPSS was used by Williams et al. (2004) to 
examine social support following lower limb amputation. The MSPSS predicted life 
satisfaction and mobility.  
 
4.5.5.5 Activity Limitations and Participation Restrictions 
The World Health Organisation Disability Assessment Schedule-2.0 (WHODAS) is 
a measure of general health and functioning in terms of activity limitation and 
participation restriction (Üstün, Chatterji, et al., 2010). The WHODAS aligns with 
the International Classification of Functioning, Disability, and Health (WHO; World 
Health Organisation, 2001), and was developed using both classical test theory, and 
item response theory. There are both 36-item, and 12-item versions of the 
WHODAS-2.0. Both versions assess functioning in six domains:  
 cognition (understanding & communication);  
 mobility;  
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 self-care;  
 getting along (interaction with others);  
 life activities (e.g. meeting home/work/school responsibilities), and;  
 participation in society. 
Factor analysis of the 36-item version showed a robust factor structure on two levels 
comprising: 
 A general disability factor 
 The six WHODAS domains 
The 12-item version was chosen for this study. The 12-item version takes 
approximately five minutes to administer. It explained 81% of the variance of the 36-
item version
10
, and was capable of identifying over 90% of individuals who had even 
mild disabilities as tested on the 36-item version. Andrews, Kemp, Sunderland, Von 
Korff, Ustun (2009) provided normative data for the 12-item version, and, similarly 
to Üstün et al.'s (2010) findings for the 36-item version, the researchers found with 
factor analysis that a single second-order factor (general disability), and six first 
order factors (based on each of the WHODAS domains) best fit the data of the 12-
item scale. Garin et al. (2010) found the WHODAS-2.0 (36-item) to have good 
reliability and validity for persons with chronic illness, although they found that a 
similar factor structure with seven first order factors (Life activities was split into 
Life activities: household, and Life activities: work or school) instead of six were 
appropriate for their data – one item from each of these factors is included in the 12-
item version. 
                                                 
10 The WHODAS-2.0 36-item showed very good internal consistency, as measured by 
Cronbach’s α, for all 36 items (0.96), and for each domain individually. It also fulfilled the 
criteria for a robust measure when Rasch analysed using the partial credit model. The 
WHODAS-2.0 36-item also had high test-retest reliability, with intraclass correlation 
coefficient ranging from: 0.69 to 0.89 at item level; 0.93 to 0.96 at domain level, and; 0.98 
overall (Üstün, Chatterji, et al., 2010).  
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 The self-report version of the WHODAS was used. Scores range from 1 = 
none (i.e.no difficulty in the past 30 days) to 5 = extreme or cannot do. Summary 
scores may range from 12 – 60, with higher scores indicating greater health difficulty 
in the preceding 30 days. There are three additional items addressing the number of 
days a) difficulties were present, b) the respondent was totally unable to carry out 
their usual activities or work because of any health condition, and c) the respondent 
had to cut back or reduce their usual activities or work because of any health 
condition. These are not included in the summary score. 
 
4.5.5.6 Community Participation  
The Community Participation Indicators (CPI) was used to measure three aspects of 
participation: participation engagement, importance and meaning of participation, 
and control over participation. The latter two constructs are elements of participation 
enfranchisement. The CPI, developed using Rasch analysis has been developed with 
rehabilitation outcome measurement and measurement of participation in people 
with disabilities in mind and with the input of multiple stakeholders, including 
people with disabilities (Hammel et al., 2008; Heinemann et al., 2011, 2013; Magasi 
et al., 2009).  
The CPI comprises two sections. The first contains 20 items measuring 
activity frequency, whether or not the activity is important (yes/no), and whether the 
participant feels they are doing enough of said activities (not enough, enough, too 
much). The second section examines participation enfranchisement in two 
categories, control over participation and importance and meaning of participation – 
responses range from all the time to almost never.  
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Raw total/mean scores were used in analyses for this study. The CPI has been 
found to be a reliable and valid measure of enfranchisement in a sample of people 
with disabilities (Heinemann et al., 2013).  
As the CPI is a measure of community participation and participants were 
generally engaged in inpatient rehabilitation for approximately 6 to 8 weeks prior to 
discharge, the CPI was not completed at discharge but was completed at six months 
post-discharge and 12 months post-discharge only.  
 
 
4.6 Statistical Analysis 
 
Statistical analyses were undertaken with IBM SPSS Statistics 21 (IBM, 2012). 
Statistical methods employed included descriptive statistics, comparison of 
neuropsychological assessments to standardised norms, and inferential statistics 
(including chi-square tests, t-tests, Spearman’s rho correlation, linear regression, and 
analysis of variance). Analyses, and use of SPSS, were broadly guided by Pallant 
(2007), Fidell and Tabachnick (2003), Field (2012a, 2012b, 2012c), Dancey, Reidy, 
and Rowe (2012), and Tabachnick and Fidell (2007). A discussion of the statistical 
issues underpinning analyses in Chapters 5 and 6 is provided below.  
 
4.6.1 Power Analyses  
A priori power analysis was conducted to determine the number of participants 
required for multiple regression analysis with 6 predictor variables, α=.05, 1-β = .80, 
with a medium effect size. A software package, G*Power 3.1, was used to conduct 
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this analysis. Calculations indicated a sample size of N=98 would be required to 
fulfil these criteria.  
 With a final sample of N=55 completing discharge follow-up, N=40 at six 
months, and N=30 at 12 months, insufficient participants were recruited to meet the 
power analysis criteria outlined above. Proceeding on the basis that ‘something is 
better than nothing’ (Roberts, 2007), regression analyses were undertaken for the six 
month time point only, with fewer predictor variables in each of the regression 
analyses. All of the prosthetic and psychosocial constructs were measured at this 
time point, but participation was not measured at discharge. Additionally, the six 
month sample size was larger than that obtained for the 12 month time point. Three 
predictors were chosen as priority variables to analyse. Details on why specific 
cognitive predictor variables were chosen are provided in section 6.2 Cognitive 
Functioning and Rehabilitation Outcomes: Variable Selection.   
 
4.6.2 Null Hypothesis Significance Testing 
Two-tailed tests of significance were used (i.e. testing the null hypothesis of no 
difference between groups). Ruxton and Neuhäuser (2010) argued that “one-tailed 
testing requires an explanation why the authors would treat a large observed 
difference in the unexpected direction no differently from a difference in the 
expected direction that was not strong enough to justify rejection of the null 
hypothesis” (p. 114). Argyrous (2005, p. 228) commented that the “decision to use a 
one-tail test is arbitrary, and can lead to a statement of the alternative hypothesis 
using directional difference simply as a means of increasing the chance of rejecting 
the null hypothesis.” Sawilowsky and Blair (1992) also found that t-tests for example 
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are more robust when two-tailed hypotheses are used. In addition to p values, effect 
sizes are provided wherever possible.  
Risk of type one error was controlled by applying a family-wise Holm 
correction (Holm, 1979) to p-values obtained from t-tests and analyses of variance. 
A family of tests was defined as a group of similar analyses, e.g. the group of 
ANOVA analyses or paired-sample t-tests undertaken to assess differences between 
impairment groups for particular cognitive functions on follow-up measures. Aickin 
and Gensler (1996) argued that there is no valid reason to continue using the 
Bonferroni method, due to the ease of calculation of the Holm method, and 
demonstrating that it maximises statistical power. The Holm method is slightly less 
conservative than the Bonferroni method (Abdi, 2007). The Holm method has been 
used previously in studies of cognitive profiles of mild cognitive impairment 
(Nordlund, 2008), prediction of outcomes of mild cognitive impairment (Lonie et al., 
2010), and participation in people with CID (Yorkston, Bamer, Johnson, & 
Amtmann, 2012). Correlations were not corrected with the Holm method, as the 
sheer number of correlations would likely have resulted in over-correction and type-
II error. It has been argued that p-values are unnecessary and potentially misleading 
in the interpretation of correlations (Field, 2012b). A similar number of correlations 
were calculated without correction in a similar recent study (Coffey, 2012). 
Regression analyses were treated in the same manner as correlation.  
 
4.6.3 Outliers and Distribution 
Normality of distribution was judged by visual examination of plots, and the 
Kolmogorov-Smirnov statistic. Transformations (square root, log10, or inverse) were 
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not used as they did not appreciably improve the distribution of scores on various 
follow-up measures, and if they did, different transformations were required for 
different time-points. To minimize the effects of non-normal distribution, Spearman 
rho correlations (a Pearson correlation performed on rank transformed data) were 
employed for correlation analyses, and bootstrapping was used for regression 
analyses. ANOVA analyses were also used for three reasons: 1) no non-parametric 
alternative was available for factorial mixed between-within repeated measures 
analysis, and 2) Hunter and May (1993) argued that with common research designs, 
“results produced by what appear to be traditional parametric analyses provide good 
estimates of the results produced by nonparametric tests” (p. 388), and 3) use of 
ANOVA was seen as preferable to not performing any analysis. 
It was seen as desirable to retain outlying scores for analyses, as all outliers 
were seen as valid (i.e. no outliers were found that seemed to be from a different 
population). Outliers further than 3.3 standard deviations from the mean were 
recoded as ±3.3 standard deviations from the mean (Tabachnick & Fidell, 2001). 
This is more liberal than the 2.58 standard deviations suggested for this sample size 
to accommodate as much data as possible with their original values. Spearman ρ 
analyses account for monotonic ranked relationships (McDonald, 2014) meaning 
outliers are in any case irrelevant for that procedure, whilst there were no 
multivariate outliers in regression analyses.  
 
 
4.6.4 Effect Size  
Four effect size statistics were used; either the phi coefficient or Cramer’s V for chi-
square tests, Hedges’ g for t-tests, and partial eta squared for ANOVA. Phi 
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coefficient effect sizes, as applied to 2x2 chi-square tests, were deemed small, 
medium, or large at or above the following thresholds respectively: .10, .30, and .50 
(Cohen, 1988). For chi-square test tables larger than 2x2, strength of effect was 
measured with Cramer’s V according to criteria detailed in Pallant (2007). For 
example, for a 2x3 table, effects were deemed small, medium, or large at or above 
the following thresholds respectively: .10, .30, and .50.  
 Hedges’ g was used as the effect size for t-test statistics. Hedges g is similar 
to Cohen’s d and is recommended by Lakens (2013), who reports that it may be 
interpreted the same way as Cohen’s d, and allows comparability between studies.  
Partial eta squared (η2), ranging from 0 to 1, denotes the proportion of 
dependent variable variance explained by the independent variable (Tabachnick & 
Fidell, 2007). According to Pallant (2007), Cohen's (1988) interpretation of η2 can be 
used to assess the magnitude of partial η2. Thus, partial eta squared values of .01 ≤ η 
≥ .059 denote a small effect size, .60 ≤ η ≥ .79 denote a medium effect size, and η ≥ 
.138 denote a large effect size. A value of η = .01 corresponds to 1% of variance 
explained.  
 
4.6.5 Differences Between Groups 
4.6.5.1 Chi-square test 
Chi-square tests of observed versus expected values were employed in chapter 4 to 
determine whether there were increased proportions of this sample impaired on 
cognitive functions, relative to normative populations (objective one). For example, 
a chi-square test was used to determine whether a greater proportion of participants 
had overall cognitive functioning scores in the borderline or impaired ranges than the 
normative population.  Chi-square tests were also employed in chapter 5 to 
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determine whether there were longitudinal differences in categorical variables such 
as mobility.  
 
4.6.5.2 Student’s t-test 
In chapter 4, one-sample t-tests were used to compare participants’ scores to the 
mean normative scores, and independent samples t-tests were used to assess whether 
the vascular and non-vascular groups of participants differed in their scores on 
cognitive variables. In chapter 5, paired-samples t-tests were used to examine 
differences in community participation variables from six months to 12 months. 
Independent samples t-tests were used to examine whether participants who were 
impaired on a particular cognitive function at discharge differed from those who 
were not, in terms of rehabilitation engagement, prosthetic outcomes, and 
psychosocial functioning.  
 
4.6.5.3 Analysis of Variance 
In chapter 5, one-way repeated measures analysis of variance was used to assess 
changes in prosthetic, physical, and psychosocial variables over time. A Friedman 
test was used as an alternative to one-way ANOVA for the examination of two 
ordinal variables, mobility and activation. Despite Finch's (2005) findings about the 
relative superiority of ANOVA for non-normally distributed data, a Friedman test 
was judged to be more appropriate for the examination of these variables as mobility 
and activation were collapsed variables with just three and two levels respectively. 
Mixed between-within ANOVA (2 x 3 factorial) was used to analyse differences 
between participants impaired on a range of cognitive functions (e.g. overall 
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cognitive functioning) on prosthetic, physical, and psychosocial variables over time. 
One-way ANOVA was used to analyse differences between participants impaired on 
neither, one, or both of overall cognitive functioning and cognitive flexibility at 
discharge. 
 Finch (2005) found that parametric ANOVA techniques were more powerful 
than non-parametric alternatives, even in cases of violation of the assumption of 
normality, so ANOVA was favoured over non-parametric alternatives in cases of 
non-normally distributed data. In any case, no non-parametric alternative to mixed 
between-within subjects repeated measures ANOVA was found. In cases of violation 
of the assumption of sphericity, a Greenhouse-Geisser correction was employed 
(Field, 2009). List-wise analysis/deletion of cases was employed for ANOVA to 
ensure equal group sizes in longitudinal analyses.  
 
4.6.6 Correlation and Regression 
4.6.6.1 Correlation 
Spearman ρ correlations (rs) were used to investigate relationships between variables 
for objectives four and five (chapter 5). For example correlations were calculated to 
examine the relationships between rehabilitation engagement and each of the 
prosthetic and psychosocial outcomes. The Spearman ρ statistic is equivalent to a 
Pearson product-moment correlation on rank transformed data. Spearman ρ thus 
accommodates a) deviations from normality of distribution in this small sample, b) 
any potential monotonic non-linear relationships between variables, and c) 
correlation of ordinal measures (such as the planning and mobility variables used in 
this study) (Mukaka, 2012; Pallant, 2007). The strength of correlations was judged 
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according to criteria outlined by Cohen (1988) (also suggested by Pallant (2007)), 
i.e. .10 ≤ r ≥ .29 was considered small, .30 ≤ r ≥ .49 was considered medium, and .50 
≤ r ≥ 1.0 was considered large.  
 
4.6.6.1 Regression 
Hierarchical multiple regression was employed to examine the relationship between 
the predictor variables overall cognitive functioning, cognitive flexibility, and 
rehabilitation engagement, and six month prosthetic, mobility, and psychosocial 
outcome criterion variables (see Chapter 6). Regardless of significance of 
correlations between predictors and the response variable, predictors were entered 
into the regression procedure in two blocks; rehabilitation engagement was 
controlled for in the first block, and overall cognitive functioning (RBANS total), 
and cognitive flexibility (DKEFS TMT number-letter switching) were entered 
together in the second block. Limitations on the number of variables that could be 
entered in regression analyses arose from the sample size at six months. Overall 
cognitive functioning and cognitive flexibility were seen as priority cognitive 
variables to measure across the range of prosthetic and psychosocial constructs due 
to the association between cerebrovascular disease/vascular cognitive impairment 
and impairment across the spectrum of functions (represented by overall cognitive 
functioning – RBANS total) and the traditional association of CVD/VCI with 
frontal/executive deficits (represented by cognitive flexibility – DKEFS TMT 
number-letter switching).  The six month time point was chosen to allow for a) 
prediction of medium term outcomes – with participants having time to settle into 
community living, b) allow for prediction of participation variables, which were not 
collected at discharge as they were dependent upon being embedded in the 
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community rather than in inpatient rehabilitation, and c) as more data points existed 
for the six month follow-up than for the 12 month follow-up.   
The maximum number of predictors was determined by reasonably liberal 
interpretation of Stevens’ criteria of 15 cases per predictor (i.e. 45+ cases for 3 
predictors) as 40 participants completed the six month follow-up. This interpretation 
was made in the context of a liberal rule of thumb of 10 cases pre predictor versus 
much more stringent criteria (Field, 2009), and was driven by pragmatic concerns 
regarding maximisation of data use.  
Bootstrapping (Dancey et al., 2012; Field, 2012c, 2012d; Wright & Field, 
2009) involves computerized repeated sampling from the sample of participants for 
individual analyses, and was used as a robust method of analysis when using linear 
regression. Bootstrapping provides robust confidence intervals of the mean, allowing 
more confident use of parametric statistics (e.g. instead of potentially less powerful 
non-parametric techniques) and can be used to assess statistical significance in linear 
regression when data are not normally distributed (Wright & Field, 2009). For the 
present study, 1000 bootstrap samples were performed, with bias-corrected and 
accelerated 95% confidence intervals (reported to be more accurate than standard 
bootstrapped 95% confidence intervals (Field, 2012d)). These bootstrapped 
confidence intervals were then examined to assess the statistical significance of 
results. 
 
 
4.7 Reporting: Classifications/Descriptions of Quantitative Data 
Performance on neuropsychological assessments, where normative values were 
available, was categorised as impaired, borderline or not impaired. Scores two 
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standard deviations or more below the mean (i.e. z≤-2.0; ≤2nd percentile) were 
classified as impaired whilst scores 1.5 to 1.99 standard deviations below the mean 
(z≤-1.5; ≤7th percentile approx.) were classified as borderline (see Table 9). The 
impaired classification is equal to that used in the Wechsler classification system 
(see also Table 9), whilst the z= -1.5 cut-off for the borderline classification is 
typically used as a cut-off in studies which examine mild cognitive impairment: 
“[T]he cut-off of the 7th percentile is 1.5 SD below the mean, which is a typical 
demarcation point for cognitive deficits in MCI” (Duff et al., 2010). It is also similar 
to, but slightly more conservative than, the Wechsler borderline classification of -
1.3SD).  
There is considerable heterogeneity in the research literature in the 
application of classifications or descriptions to neuropsychological test scores 
(Guilmette, Hagan, & Giuliano, 2008).  Descriptions such as ‘average’, ‘low 
average’, etc., such as they may be used to describe mean scale scores, are again 
based on the Wechsler classification system (see Table 2). Here, scale scores of 1 to 
3 are considered impaired, scores of 4 and 5 are considered borderline, and scores of 
6 or higher are considered not impaired (Himelstein, n.d.).  
 Two assessments are exceptions to this rule: The Frontal Systems Behaviour 
Rating Scale, a self-report measure of everyday executive functioning, and the 
Visual Object and Space Perception Battery (VOSP) position discrimination, a test 
of space perception. The Frontal Systems Behaviour Rating Scale (FrSBe) manual 
(Grace & Malloy, 2001) recommends that T-scores of 60 to 64 (corresponding to z-
scores of 1.0 to 1.4) should be regarded as borderline, while T-scores of 65 (z=1.5) 
or higher should be regarded as impaired. Higher FrSBe scores indicate greater 
impairment, which is opposite to the other assessments.  For perspective, the level at 
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which scores on other tests are considered borderline in these analyses is the level at 
which FrSBe scores are considered impaired. This recommendation has been 
followed for these analyses. The VOSP’s categories of impaired and borderline are 
derived from its manual. Position discrimination is not normed (at least not with 
scale scores (normally distributed); there is a ceiling effect). Position discrimination 
raw scores of 19 or 20 are considered not impaired, 18 as borderline, and 17 or lower 
as impaired.   
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Table 9 
Classifications of Neuropsychological Functioning 
This Study Z-score Lower limit of percentile range Scale score 
Very superior ≥ 2.0 98 ≥ 16 
Superior 1.5 to 2.0 93 15 
High average .6 to 1.5 75 13 to 14 
Average ±.6 25 8 to 12 
Low average -.6 to -1.5 7 6 to 7 
Borderline -1.5 to -2.0 2 4 to 5 
Impaired ≤ -2.0 - ≤ 3 
    
Wechsler Z-score Lower limit of percentile range Scale score 
Very superior ≥ 2.0 98 ≥ 16 
Superior 1.3 to 2.0 91 15 
High average .6 to 1.3 75 13 to 14 
Average ±.6 25 8 to 12 
Low average -.6 to -1.3 9 6 to 7 
Borderline -1.3 to -2.0 2 4 to 5 
Extremely low ≤ -2.0 - ≤ 3 
 Wechsler classification system as detailed by Strauss, Sherman, and Spreen (2006, p.91) 
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4.8 Participants 
There were 198 admissions with lower limb amputations to the POLAR inpatient or 
day-patient programmes during the study period. Three of these were deemed too 
medically unwell to participate in the research, whilst one potential participant was 
non-English speaking and was thus excluded.  
Of 194 potential participants taking part in the rehabilitation programme from 
March 2012 to April 2014, 85 (43.8%) were recruited. Of those 85 participants 
recruited, 13 (15.3%) refused participation in the follow-up portion of the study, 
solely agreeing for the research study to collect already existing clinical 
neuropsychological data; ‘clinical data only’ participants. Two additional 
participants (from a potential nine) were recruited retrospectively for the 
neuropsychological profile only (i.e. these participants were not eligible for 
participation in the follow-up portion of the study), resulting in a total of 87 
participants at Time 1 (neuropsychological assessment data). Seventy-two 
participants were eligible for follow-up.  
55 participants (76.4% of a potential 72) completed follow-up measures at 
discharge. Of those who did not complete follow-up at discharge, one was deceased 
four were too medically unwell, five declined, and seven were lost to follow-up (this 
includes early or sudden discharges from rehabilitation). Forty participants 
completed follow-up measures at six months post-discharge. By this time point, four 
participants were deceased, four were too ill to participate, five had declined, and 19 
were lost to follow up (could not be contacted or did not return follow-up pack). At 
12 months post discharge, 30 participants completed follow-up measures. At this 
point, eight participants were deceased, four were too unwell, six had declined, and 
23 had been lost to follow up, with an additional one participant returning the 
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questionnaire pack past the deadline. Figure 2 summarizes recruitment and 
participation. Persons lost to follow-up at an earlier time-point were still invited to 
participate in subsequent time points. In Figure 2 consequently, boxes for reasons for 
non-participation between Time 2 and Time 3 and between Time 3 and Time 4 
account for differences between the n = 72 eligible for follow-up and the total 
respondents at Time 3 (n = 40 ) and Time 4 (n = 30). 
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Figure 2: Flow Diagram of Recruitment and Participation  
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4.8.1  Socio-demographic and Clinical Characteristics on Admission (Time 1) 
Socio-demographic and clinical characteristics of the sample are summarized in 
tables 10 and 11. On admission, the mean age of the sample was 58.57 years (SD = 
15.27, range: 21 – 86), and the mean number of years of education was 12.5 (SD = 
3.2, range: 4 - 23) (See Table 1). Above knee amputations were most common 
(47.1%, n=41), followed by below knee (37.9%, n=33), bilateral (13.8%, n=12), and 
through-knee (1.1%, n=1). For these analyses, the through-knee amputation was 
included in the below-knee amputation group.  
Almost 80% of participants (79.3%, n = 69) were recorded in medical 
records as having had amputations relating to vascular aetiology, including PVD 
(44.8%, n = 39), diabetes (16.1%, n = 14), combined PVD & diabetes (12.6%, n = 
11), or osteomyelitis (5.7%, n = 5, all of whom had comorbid diabetes). A further 
18% (n = 16) of amputations were accounted for by trauma (13.8%, n = 12) or 
cancer (4.6%, n = 4). The remaining two amputations were related to intra-venous 
drug use (1.1%) and congenital causes (amputation performed while participant was 
an adult) (1.1%). Thus, 32.2% were classified as having PVD (n = 28), and 25.3% as 
having PVD & diabetes (n = 22).  For analysis, aetiologies were grouped into 
vascular (including PVD, diabetes, combined PVD & diabetes, and osteomyelitis) 
and non-vascular groups. Osteomyelitis was classified as vascular, as all participants 
whose aetiology was osteomyelitis also had diabetes
11
. Thus, 69 participants (79.3%) 
were classified as vascular cases, whilst 18 (20.7%) were classified as non-vascular 
cases. The mean number of comorbidities was 2.6 and median was 2, so a cutoff was 
used: two or fewer versus three or more.   
                                                 
11 Diabetic ulceration is associated with osteomyelitis incidence, while having diabetes is 
also associated with greater likelihood of amputation in people with osteomyelitis 
(Thomas-Ramoutar, Tierney, & Frykberg, 2010). 
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Time since amputation (to nearest month) ranged from 1 month (5 weeks) to 
535 months. Mean time since amputation was 23.51 months (SD = 73.68, median = 
6 months). The vascular group had a shorter mean time since amputation (due to a 
number of non-vascular ‘established amputees’ returning for prosthetic services). 
The median number of times a participant had been admitted for rehabilitation was 
1; 75 participants were recruited during their first admission, 10 during their second 
admission, and 2 during their third admission. Length of stay ranged from 1 week to 
22 weeks, with a mean of 8.4 (SD=4.05), and median of 8. Socio-demographic and 
clinical data for each time point are summarized in table 10 and table 11.  
 
4.8.2  Differences Between Group A and Group B Participants 
Differences were investigated, in terms of socio-demographic and clinical variables, 
between Group A participants and Group B participants (who only agreed for their 
routine clinical data to be used). Group B participants were significantly older than 
other participants (M = 68.9, SD = 14.9, t(85) = -3.022, p = .003). Group B 
participants were also more likely to have 3 or more comorbidities (80% had 3+ 
comorbidities, χ2 = 5.851, df = 1, p = .016). There were no other socio-demographic 
or clinical differences between the two groups.  
 
4.8.3  Differences Between Follow-up Responders and Non-Responders 
Differences at each time point compared with baseline (admission) between 
responders and non-responders in terms of socio-demographic and clinical variables 
were investigated. Participants who completed the follow-up assessments at any time 
point had spent significantly longer in education (discharge t (84) = -2.289, p = .025; 
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six months t (84) = -2.341, p =.017; 12 months t (84) = -2.614, p = .018) compared 
to the baseline (neuropsychological assessment) sample. There were no other 
significant socio-demographic or clinical differences between responders and non-
responders for any time point.   
Analyses were undertaken to determine whether there were differences in 
terms of cognitive functioning between the proportion of the sample that completed 
each of the follow-up questionnaires (discharge, six months, 12 months) and the full 
sample (admission). Two neuropsychological measures were used for this analysis; 
overall cognitive functioning (RBANS total), and cognitive flexibility (an executive 
function; DKEFS TMT number-letter switching). These two important assessments 
of cognitive functioning were chosen in lieu of excessive testing involving every 
cognitive function. Differences between those who did and did not complete follow-
up at discharge were significant for overall cognitive functioning (OCF), but not 
cognitive flexibility (OCF t(71) = -2.855, p = .006, gs = .722; cognitive flexibility 
t(51) = -1.884, p = .07, gs = .528). Completers had higher scores on both measures. 
Those who completed follow-up at six months had both significantly higher overall 
cognitive functioning and cognitive flexibility scores (OCF t (71) = -2.303, p = .024, 
gs = .533; cognitive flexibility t (51) = -2.107, p = .04, gs = .574). Differences in 
overall cognitive functioning and cognitive flexibility between those who did and did 
not complete 12 month follow-up were non-significant, although completers’ scores 
were higher (OCF t(71) = -1.717, p = .09, gs = .412; cognitive flexibility t(51) = -
1.952, p = .056, gs = .533).  
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Table 10 
Socio-demographic Characteristics of the Sample 
Variable Level Admission (T1) Discharge (T2) 6 M (T3) 12 M (T4) 
  n % or M (SD) n % or M (SD) n % or M (SD) n % or M (SD) 
N  87  55  40  30  
Age (years)   58.6 (15.3)  56.2 (13.2)  57.48 (12.2)  58.57 (13.8) 
Gender Male 65 74.7 38 69.1 26 65.0 21 70.0 
 Female 22 25.3 17 30.9 14 35.0 9 30.0 
Education (years)   12.5 (3.4)  13.1 (3.4)  13.4 (3.4)  13.7 (3.6) 
Marital status Married/cohabiting 44 51 27 49 21 52.5 16 53 
 Not married 43 49 28 51 19 47.5 14 47 
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Table 11 
Clinical Characteristics of the Sample 
Variable Level Admission (T1) Discharge (T2) 6 M (T3) 12 M (T4) 
  n % or M (SD) n % or M (SD) n % or M (SD) n % or M (SD) 
Amputation  Below knee 
a
  34 39.0 23 41.8 16 40.0 14 46.7 
 Above knee 41 47.1 25 45.5 20 50.0 12 40.0 
 Bilateral 12 13.8 7 12.7 4 10.0 4 13.3 
Aetiology Vascular 69 79.3 45 81.8 35 87.5 27 90.0 
 Non-vascular 18 20.7 10 18.2 5 12.5 3 10.0 
Comorbidities 0 to 2 45 51.7 31 56.4 20 50.0 19 63.3 
 3+ 42 48.3 24 43.6 20 50.0 11 36.7 
Months since 
amputation at 
admission/ T1 
  23.5 (73.7)  15.0 (39.6)  8.43 (8.0)  7.7 (6.9) 
Length of stay 
(weeks) 
  8.4 (4.1)  8.4 (3.6)  8.3 (3.3)  8.1 (2.9) 
Admission type Inpatient 75 86 45 82 35 87.5 25 83 
 Day-patient 12 14 10 18 5 12.5 5 17 
a
 Includes n=1 through-knee amputation 
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5  
 
A NEUROPSYCHOLOGICAL 
PROFILE OF PEOPLE WITH 
LOWER LIMB AMPUTATIONS 
IN A COMPREHENSIVE 
REHABILITATION 
PROGRAMME  
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5.1 Overview  
 
5.1 Aim and Objectives  
This chapter relates to the first aim outlined in Chapter 2, with the associated 
objectives one and two. The first aim was to obtain a comprehensive 
neuropsychological profile of people who attended comprehensive rehabilitation 
with a lower limb amputation. Aspects of cognitive functioning to be assessed 
include estimated premorbid intellectual functioning, overall cognitive functioning, 
reasoning, psychomotor speed, information processing, attention, memory, 
visuospatial perception and construction, language, and executive function.  
 
5.1.1 Objective 1  
The first objective was to determine whether this sample had significant differences 
in cognitive functioning relative to normative populations, in terms of mean scores, 
and proportions of the sample with scores in the borderline and impaired ranges. The 
first hypothesis was that cognitive functioning, across the range of domains assessed 
(including overall cognitive functioning, reasoning, psychomotor speed, information 
processing, attention, memory, visuospatial perception and construction, and 
executive functions), is significantly lower in this sample of people with lower limb 
amputations, in comparison to standardised normative population values. 
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5.1.2 Objective 2  
The second objective was to determine whether participants with vascular aetiology 
had significant differences in cognitive functioning relative to participants with non-
vascular aetiology. The second hypothesis was cognitive functioning across the 
range of domains assessed is significantly lower in people with dysvascular 
amputations (i.e. peripheral vascular disease, diabetes, osteomyelitis with co-
occurring diabetes) than in those with amputations relating to other aetiologies (i.e. 
trauma, cancer, etc.).  
 
5.2.2 Neuropsychological Assessment Normative Values 
Normative values (norms) are available for almost all neuropsychological 
assessments. There are no comprehensive norms for the Montreal Cognitive 
Assessment, but a cut-off score for the identification of cognitive impairment 
caseness is outlined below. The Graded Naming Test norms are not precise enough 
to calculate scale scores for all participants. Neither can scale scores be calculated 
for Visual Object and Space Discrimination Battery (VOSP) position discrimination. 
The Frontal Systems Behaviour Rating Scale for everyday executive functioning is 
standardised by age and gender. All other neuropsychological measures for which 
norms are available are standardised by age.  
 
5.2.3 Statistical Methods 
Statistical analytical methodology is detailed in chapter 3. A brief outline is provided 
here. For neuropsychological measures with normative values, one-sample t-tests 
were used to determine whether sample means differed significantly from the 
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normative mean (e.g. scale score, or z score if applicable). Chi-square tests of 
observed versus expected values were used to determine whether the proportion of 
participants with scores in each of the non-impaired, borderline, and impaired 
categories differed from proportions which would be expected in a normally 
distributed population. Independent samples t-tests were used to determine whether 
there were differences on neuropsychological variables according to vascular or non-
vascular aetiology of amputation. For variables which were not normally distributed, 
the equivalent Mann-Whitney U test was used.  
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5.2 Sample Characteristics 
Socio-demographic and clinical characteristics of the sample are reported in chapter 
4, as are other sample characteristics (see section 4.8 Participants). Mean scores, 
standard deviation (SD), minimum, maximum, median, and normality or otherwise 
of distribution, are reported for neuropsychological variables below in this chapter 
(see section 5.3 Results for Objective One: Neuropsychological Assessment). Levels 
of distress (anxiety and depression) are also presented below. Unless otherwise 
stated, higher scores indicate better performance. Exceptions to this rule are distress 
– measured with the Hospital Anxiety and Depression Scale – where higher scores 
indicate greater distress, and everyday executive functions as measured with the 
Frontal Systems Behaviour Rating Scale, where higher scores indicate poorer 
everyday executive functioning.  
 
5.2.1 Differences in Cognitive Functioning According to Socio-demographic and 
Clinical Variables 
Aetiology (see results for hypothesis 2 below), amputation level (below knee, above 
knee, bilateral), length of stay, marital status, and distress during admission 
(measured with Hospital Anxiety and Depression Scale) were unrelated to 
neuropsychological assessment scores. Older age was significantly related to lower 
RBANS line orientation (visuospatial perception, rs = -.443, p < .001) and lower 
MoCA (cognitive screen, rs = -.503, p < .001) scores. Neuropsychological 
assessment results did not differ between comorbidity groups – dichotmoised as 
having two or fewer versus three or more comorbidities, except for RBANS coding, 
a measure of information processing (t (71) = 3.576, p = .001).  
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Higher number of years spent in education was related to higher levels of a 
number of aspects of cognition: premorbid cognition (WTAR rs = .492, p < .001), 
overall cognitive functioning (RBANS total rs =.579, p < .001), reasoning (WAIS 
block design rs = .517, p < .001, WAIS similarities rs = .502, p < .001), information 
processing (DKEFS word reading rs = .494, p < .001, colour naming rs =.445, p = 
.001, RBANS coding rs = .650, p < .001, WAIS symbol search rs = .479, p < .001), 
immediate recall (RBANS list learning rs = .400, p = .001), delayed recall (RBANS 
figure recall rs = .373, p = .001), visuospatial perception (RBANS line orientation rs 
= .389, p = .001), language (RBANS picture naming rs = 429, p < .001), and 
executive functions (WAIS digit span rs = .415, p = .002, RBANS semantic fluency 
rs =.423, p < .001, DKEFS colour-word switching rs = .446, p = .001).   
 
5.2.1 Distress 
The Hospital Anxiety and Depression Scale (HADS) was used to measure feelings of 
distress. The HADS was completed by 55 participants, and results are summarised in 
Table 12. Anxiety and depression subscale scores are also presented. Cut-off scores 
for determining anxiety or depression were those recommended by Crawford et al. 
(2001). 14.5% of the sample scored above the cut-off for symptoms of anxiety 
(including the categories moderate and severe as described by the HADS). 10.9% 
scored above the cut-off for symptoms of depression (including the categories 
moderate and severe as described by the HADS). 27.3% and 25.5% would have been 
above the threshold for anxiety and depression respectively were the HADS mild 
category included.   
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Table 12 
Distress on Admission 
 
HADS  N M SD Median Min / Max 
a
 
% above  
distress cut-off 
b
 
% with 
mild or 
worse 
distress 
Overall 
(distress) 
55 10.96 8.01 9.0 0 / 35  
 
Anxiety 55 5.58 4.63 4.0 0 / 18 14.5 27.3 
Depression 55 5.40 4.59 4.0 0 / 19 10.9 25.5 
a
 Minimum and maximum possible scores are 0 and 42 for the overall scale and 0 and 
21 for the subscales. 
b
 Percentage above cut-off score for either anxiety or depression (i.e. % classified as 
having moderate or severe distress). The cut-off on each subscale is ≥ 11.   
 
 
 
5.3 Results for Objective One: Neuropsychological Assessment 
Cognitive functions have been grouped into the following categories for reporting.  
1. Estimate of pre-morbid cognitive functioning  
2. Brief cognitive screen and overall cognitive functioning (as measured by 
RBANS total scale) 
3. General intellectual ability/reasoning  
4. Psychomotor speed information processing, and attention and information 
processing 
5. Memory 
6. Visuospatial cognition 
7. Language 
8. Executive functions  
Neuropsychological assessments, completion rate for each test, and percentages of 
scores in the borderline, impaired, and borderline & impaired combined ranges are 
summarised in Table 13. Results of chi-square tests of expected versus observed 
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frequencies of scores in the impaired, borderline, and not impaired ranges are also 
included in Table 13.   
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Table 13 
Neuropsychological Assessments and Proportions of Scores in the Borderline or Impaired Ranges 
Domain Subdomain Assessment N 
% 
bord. 
% 
impaired 
% 
impaired 
or bord. 
p 
 
χ2 (df 
= 2) 
Estimated premorbid 
functioning 
- WTAR standard score 50 12.0 10.0 22.0 .001* 22.11 
Overall cognitive 
functioning 
Brief cognitive screen MoCA 57 n/a n/a 52.6** n/a n/a 
 Overall cognitive functioning RBANS total index 72 12.3 21.9 34.2 <.001* 158.47 
Reasoning Visuospatial  WAIS block design 60 13.3 5.0 18.3 .017 11.86 
 Abstract (verbal) WAIS similarities 60 10.0 6.7 16.7 .021 10.14 
 Fluid  WAIS matrix reasoning 56 17.9 3.6 21.4 .003* 20.46 
Psychomotor speed Psychomotor function DKEFS motor speed 42 7.1 11.9 19.0 .001* 21.64 
Information processing Processing speed: colour naming DKEFS colour naming 52 7.7 3.8 11.5 .438 1.76 
 Processing speed: word reading DKEFS word reading 52 1.9 1.9 3.8 .676 1.04 
 Processing speed (complex)  RBANS coding 73 16.4 41.1 57.5 <.001* 597.05 
 Processing speed (& focused attention) WAIS symbol search 60 26.7 6.7 33.3 <.001* 67.34 
Attention Attention span RBANS digit span 76 7.9 2.6 10.5 <.001* 1.53 
 Focused (visual scanning) DKEFS visual scanning 52 9.6 9.6 19.2 0.001* 18.13 
 Focused (sequencing) DKEFS number sequencing 54 5.6 24.1 29.6 <.001* 134.37 
 Focused (sequencing) DKEFS letter sequencing 53 5.7 30.2 35.8 <.001* 215.36 
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 Sustained TEA telephone search 32 17.2 24.1 41.4 <.001* 83.44 
 Divided TEA telephone search while counting 32 10.3 3.4 13.8 .393 2.11 
Memory Immediate free recall – list RBANS list learning 76 7.9 27.6 35.5 <.001* 257.58 
  CVLT trials 1-4 free recall T-score 56 7.1 14.3 21.4 <.001* 44.03 
 Immediate free recall – story RBANS immediate story memory 76 6.9 16.1 23 <.001* 106.79 
  WMS logical memory I 59 16.9 16.9 33.9 <.001* 87.36 
 Short delay free recall – list CVLT short delay free recall 53 11.3 15.1 26.4 <.001* 51.82 
 Long delay free recall –  list RBANS delayed list recall 76 17.1 14.5 31.6 <.001* 86.34 
  CVLT long delay free recall 52 7.7 19.2 26.9 <.001* 80.17 
 Long delay free recall – story RBANS delayed story recall 76 2.6 21.1 23.7 <.001* 141.07 
  WMS logical memory II 59 5.1 28.8 33.9 <.001* 216.69 
 Long delay free recall –  visual RBANS figure recall 77 13.0 9.1 22.1 <.001* 31.07 
         
 Long delay cued recall CVLT form cued recall 52 11.5 25.0 36.5 <.001* 146.87 
 Long delay:  recognition, list RBANS List Recognition 76 2.6 38.2 40.8 <.001* 506.99 
Language Naming RBANS picture naming 76 1.1 15.8 17.1 <.001* 75.15 
 Naming Graded Naming Test 39 n/a n/a n/a n/a n/a 
Visuospatial cognition Visuospatial construction RBANS figure copy 77 14.3 28.6 42.9 <.001* 295.75 
 Visuospatial perception RBANS line orientation 77 5.2 16.9 22.1 <.001* 87.17 
 Spatial perception VOSP position discrimination 43 14 14 28 n/a n/a 
Executive functions Working memory WAIS digit span 62 6.5 4.8 11.3 .265 2.88 
 Cognitive flexibility DKEFS number-letter switching 53 7.5 39.6 47.2 <.001* 384.98 
 Inhibition DKEFS colour-word inhibition 50 12.0 26.0 38.0 <.001* 154.07 
 Verbal fluency - semantic RBANS semantic fluency 76 18.4 22.4 40.8 <.001* 194.36 
 Verbal fluency - semantic DKEFS category fluency 57 17.5 8.8 26.3 <.001* 33.25 
 Verbal fluency - phonemic DKEFS letter fluency 57 8.8 10.5 19.3 <.001* 23.27 
 Planning BADS zoo map 41 51.2 36.6 87.8 n/a n/a 
 Apathy, disinhibition, executive 
dysfunction 
FrSBe self-rated total 35 9.1 36.4 45.5 n/a n/a 
* significant after the Holm method of correction for multiple comparisons was employed (see Appendix F) 
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5.3.1 Estimate of Premorbid Cognitive Functioning 
The Wechsler Test of Adult Reading (WTAR) was used to assess premorbid 
functioning. The WTAR was completed by 50 participants (57.47%). Standard 
scores ranged from 50 to 123, and were normally distributed. The mean standard 
score was 96.20, classified as average range (SD = 19.35, median = 99.5). A one-
sample t-test was used to compare the mean score with the normative mean of 100 
(SD = 15). Participants’ mean score did not differ significantly from the normative 
mean (t (49) = -1.388, p = .171).  
The range of scores obtained (50 - 123) suggest a wide range of premorbid 
cognitive functioning. 78% of people were classified as not impaired in terms of 
premorbid cognitive functioning. However, 10% of participants who completed the 
WTAR had scores in the impaired range, while 12% had scores in the borderline 
range (see Table 13), a significantly higher frequency than would be expected in the 
normal population (χ2 = 22.110, df = 2, p = .001 exact). Proportions with scores in 
the combined impaired or borderline ranges are illustrated in Figure 3.  
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Figure 3: Proportions of scores in the impaired or borderline ranges for 
premorbid cognitive functioning, overall cognitive functioning, and reasoning 
12
 
  
                                                 
12 Includes reference line at the threshold for normative populations (7%) 
CHAPTER 5: NEUROPSYCHOLOGICAL PROFILE 
132 
 
5.3.2 Brief Cognitive Screen and Overall Cognitive Functioning 
Overall cognitive functioning was measured both with a brief cognitive screen, the 
Montreal Cognitive Assessment (MoCA), and a more comprehensive measure, the 
Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). The 
MoCA is a brief screening tool, sensitive to vascular cognitive impairment (Koski, 
2013). It is regularly administered in the National Rehabilitation Hospital POLAR 
programme as part of routine clinical practice. The main measure of overall 
cognitive functioning in this study is the total index score of the RBANS.  
 
5.3.2.1 Brief Cognitive Screen  
The Montreal Cognitive Assessment, a cognitive screen sensitive to vascular 
cognitive impairment used to assess cognitive functioning in general, was completed 
by 58 participants. MoCA scores in this study ranged from 9 to 30, which is the 
maximum possible score, and were normally distributed. The mean MoCA score was 
22.90 (SD = 3.99, median = 23).  
Normative data are not provided as a reference for the MoCA – its utility lies 
in its use as a screening (case finding) tool
13
. McLennan, Mathias, Brennan, and 
Stewart (2011) suggest a cut-off score of <24 for the detection of mild cognitive 
impairment in people with cardiovascular disease, with 100% sensitivity, and 50 – 
52% specificity. 30 participants (51.7%) had scores <24, whilst 28 (48.3%) had 
scores of 24 or higher (see Table 13). Proportions with scores in the combined 
impaired or borderline ranges are illustrated in Figure 3. 
                                                 
13 It may in future be possible to compare these scores with normative data for the Irish 
population derived from the TILDA study (Kenny et al., 2013). However, to date only data 
for people aged 50 and over has been published.  
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5.3.2.2 Overall Cognitive Functioning 
Participants’ scores on the RBANS total index ranged from 45 to 121 (the normative 
possible range is from 40 to 160), scores were normally distributed, and are available 
for 72 participants (82.76%). The mean RBANS total scale score was 84.96 (SD = 
16.90, median = 86). The mean score was significantly different from the normative 
mean (t (72) = -7.605, p < .001). 21.9% of scores were in the impaired range and 
12.3% were in the borderline range. The difference between this proportion of 
impaired and borderline scores and the expected frequency was statistically 
significant (χ2 = 158.47, df = 2, p < .001) (see Table 13). Proportions with scores in 
the combined impaired or borderline ranges are illustrated in Figure 3. Results of 
individual RBANS subtests, as analysed below according to domain, are summarised 
in domain-relevant tables.  
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5.3.3 General Intellectual Ability and Reasoning 
Subtests from the Wechsler Adult Intelligence Scale-IV (WAIS) were used to assess 
general intellectual ability or reasoning. Visuospatial reasoning was assessed using 
WAIS block design. Verbal abstract reasoning was measured with WAIS 
similarities. Broader fluid reasoning was measured with WAIS matrix reasoning, a 
visuospatial test which also recruits verbal abilities. Results on reasoning measures 
are summarised in table 14.  
Sixty (69.0%) participants completed both block design, and similarities, and 
56 (64.4%) completed matrix reasoning. Mean subtest scores were at the lower end 
of the average range for all three subtests: block design (mean = 8.20, SD = 3.17, 
median = 8.0), similarities (mean = 8.13, SD = 2.90, median = 8.0), and matrix 
reasoning (mean = 8.34, SD = 3.16, median = 8.0). A wide range of scale scores was 
obtained by participants for each subtest, from 1 to 17 (block design), 1 to 15 
(similarities), and 2 to 15 (matrix reasoning). Scores were not normally distributed 
on any of the three subtests. Results from one sample t-tests (see Table 14) showed 
significant differences between participants’ mean scores, and those obtained by the 
normative sample for each of the subdomains.   
 Of those who completed these subtests, 16.7%, 18.3%, and 21.4% had scores 
in the borderline or impaired ranges for block design, similarities, and matrix 
reasoning respectively. Chi-square tests showed that these are significantly greater 
proportions than would be expected in the normative population for fluid reasoning 
(matrix reasoning), but not for visuospatial reasoning (block design) or abstract 
reasoning (similarities) when corrected for multiple comparisons (block design χ2 = 
11.862, df = 2, p<.017 exact; similarities χ2 = 10.136, df = 2, p=.021 exact; and 
matrix reasoning χ2 = 20.459, df = 2, p = .003 exact; see Table 13). Proportions with 
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scores in the combined impaired or borderline ranges are illustrated in Figure 3. See 
Appendix F for details of Holm method significance corrections.  
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Table 14 
Reasoning 
Assessment N M Median SD Min / Max Normality t-test sig. t (df) 
WAIS block design 60 8.20 8 3.177 1 / 17 No < .001* -4.388 (59) 
WAIS similarities 60 8.13 8 2.902 1 / 15 No < .001* -4.982 (59) 
WAIS matrix reasoning 56 8.34 8 3.164 2 / 15 No < .001* -3.928 (55) 
Note. Normative mean = 10. Minimum and maximum possible scores are 1 and 19 respectively.  
* significant after the Holm method of correction for multiple comparisons was employed (see Appendix F) 
 
 
 
NEUROPSYCHOLOGICAL FUNCTIONING AND LOWER LIMB LOSS 
137 
 
5.3.4 Psychomotor Speed, Information Processing, and Attention  
Psychomotor speed, information processing, and attention measures were outlined in 
chapter 3 (see Table 3). Information processing includes simple and more 
complex/effortful aspects. Aspects of attention assessed included span (capacity), 
focused attention, sustained attention, and divided attention. Results of the sample 
are summarised in Table 15. Proportions with scores in the combined impaired or 
borderline ranges are illustrated in Figure 4 for psychomotor speed and processing 
speed, and in Figure 5 for attention.   
 
5.3.4.1 Psychomotor Speed 
The DKEFS TMT motor speed subtest was used to assess psychomotor speed, and 
was completed by 42 (48%) participants. The median score was 8 (‘average’ range, 
mean=7.71, not normally distributed). The sample mean was significantly lower than 
the normative mean (t (41) = -4.693, p <.001). 14.3% of participants were in the 
impaired range, and 4.8% were in the borderline range. Chi-square tests of expected 
values revealed that there were proportionally significantly more scores in the 
impaired and borderline ranges than would be expected in the normal population (χ2 
= 21.643, df = 2, p = .001).  
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Table 15 
Psychomotor Speed, Information Processing and Attention 
Assessment N M Median SD Min / Max Normality t-test sig. t (df) 
         
Psychomotor Speed         
DKEFS motor speed 42 7.71 8 3.16 1 / 12 Yes < .001* -4.693 (42) 
         
Information Processing         
DKEFS colour naming 52 8.23 8 2.52 3 / 15 No < .001* -5.068 (51) 
DKEFS word reading 52 9.29 9.5 2.49 1 / 13 Yes .045 -2.059 (51) 
RBANS coding 
a
 73 -1.77 -1.65 1.41 -5.08 / +1.54 Yes < .001* -10.699 (72) 
WAIS-IV symbol search 60 6.98 6.5 2.94 1 / 18 No < .001* -7.940 (59) 
RBANS digit span 
a
 76 .066 0.18 1.12 -2.47 / +2.29 Yes .314 1.014 (75) 
         
Attention         
DKEFS visual scanning 52 7.85 9 3.10 1 / 13 No < .001* -5.007 (51) 
DKEFS number sequencing 54 7.17 8 3.88 1 / 14 No < .001* -5.367 (53) 
DKEFS letter sequencing 53 6.81 8 3.93 1 / 14 No < .001* -5.911 (52) 
TEA telephone search 30 5.84 6 2.96 1 / 13 Yes < .001* -7.934 (31) 
TEA telephone search with counting 30 9.13 8.5 4.14 1 / 19 No .241 -1.195 (31) 
Note. Normative mean = 10, minimum = 1, maximum = 19. Except 
a
 z-scores (normative mean = 0, SD = 1). 
* significant after the Holm method of correction for multiple comparisons was employed (see Appendix F) 
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Figure 4: Proportions of scores in the impaired or borderline ranges for 
psychomotor speed and processing speed 
14
 
 
5.3.4.2 Information processing speed 
DKEFS colour naming is considered to assess visual information processing, while 
DKEFS word reading is considered to tap into both visual information processing 
and verbal information processing. RBANS coding measured information processing 
speed with a motor/written response. WAIS symbol search also measured 
information processing speed. 
Mean DKEFS colour naming (8.23, SD = 2.52, median = 8) and DKEFS 
word reading (9.29, SD = 2.49, median = 9.5) scores were in the ‘average’ range, 
                                                 
14 Includes reference line at the threshold for normative populations (7%) 
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and were each completed by 52 participants (60%). One-sample t-tests found colour 
naming was significantly poorer than the normative population (t (51) = -5.086, p < 
.001), but word reading was not (t (51) = -2.095, p = .045) when a correction for 
multiple comparisons were applied. 11.54% and 3.85% of participants’ scores for 
colour naming and word reading respectively were in the impaired or borderline 
range were. Chi-square tests of expected values showed that these did not differ 
significantly from the expected/normative proportions.  
RBANS coding was completed by 73 participants (83.91%). Z scores ranged 
from -5.08 to 1.54. The mean z score of -1.77 (SD = 1.41) was in the ‘borderline’ 
range, and corresponded to a scale score of 4.69. The mean was significantly lower 
than the normative mean (t = -10.699, df = 72, p < .001). 57.5% (n = 42) of 
participants who completed coding had scores in the borderline or impaired range (χ2 
= 597.05, df = 2, p < .001), a significantly greater proportion than the 
normative/expected frequency.  
60 participants (69%) completed WAIS symbol search. The mean scale score 
(6.98, SD = 2.94) was in the ‘low average’ range. The symbol search mean scale 
score was significantly lower than the normative mean (t (59) = -7.940, p < .001). Of 
those who completed the tests, 6.7% of participants had scores in the impaired 
category, whilst 26.7% had scores in the borderline category. When tested with chi-
square tests of observed versus expected values, a significantly greater proportion of 
participants were in the impaired and borderline categories on symbol search (χ2 = 
67.341, df = 2, p < .001).  
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5.3.4.3 Span of Attention 
RBANS digit span (digit-forward condition only) was completed by 76 participants 
(87.36%). Z scores ranged from -2.47 to 2.29. The mean z-score of .066 (SD = 1.12) 
was in the ‘average’ range, and corresponded to a scale score of 10.2. The mean was 
not significantly different from the normative mean (t (72) = 1.014, p < .001). 10.5% 
(n = 8) of participants who completed digit span had scores in the borderline or 
impaired range, which did not differ significantly from the normative/expected 
frequency (χ2 = 1.53, df = 2, p =.466).  
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Figure 5: Proportions of scores in the impaired or borderline ranges for 
attention 
15
 
 
5.3.4.4 Focused attention  
DKEFS trail making subtests visual scanning, number sequencing and letter 
sequencing were completed by 52 (59.8%), 54 (62%), and 53 (60.9%) participants 
respectively. Median scores (trails scores were not normally distributed) were as 
follows: visual scanning: 9 (‘average’ range, mean = 7.85); number sequencing: 8 
(‘average’ range, M = 7.17); and letter sequencing: 8 (‘average’ range, M = 6.81). 
Mean scores were significantly lower than the normative mean for all three 
assessments of focused attention (visual scanning t (51) = -5.01, p < .001; number 
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sequencing t (53) = -5.37, p < .001; letter sequencing t (52) = -5.91, p < .001). 
Proportions of participants whose scores were in the impaired range (bottom 2
nd
 
percentile) were 15.4% for visual scanning, 25.9% for number sequencing, and 
32.1% for letter sequencing. When scores which fall into the borderline range were 
included, the proportions rose to 19.23%, 29.63%, and 35.85% respectively. Chi-
square tests of expected values revealed that each of these proportions was 
significantly larger than would be expected in the normal population (visual 
scanning χ2 = 18.13, df = 2, p = .001; number sequencing χ2 = 134.37, df = 2, p < 
.001; letter sequencing χ2 = 215.36, df = 2, p < .001).  
 
5.3.4.5 Sustained attention 
32 (37%) participants completed TEA telephone search, assessing sustained 
attention. Two participants aged over 80, for whom norms do not exist due to their 
age were scored using norms for the 65 – 80 age group. The mean scale score for the 
telephone search subtest of the Test of Everyday Attention fell into the ‘low average’ 
range (M = 5.84, SD = 2.96, median = 6, range = 1 - 13).  The mean score was 
significantly lower than the normative mean (t (31) = -7.934, p < .001). 41% (n = 12) 
of those who completed the TEA had scores in the impaired or borderline range. 
Chi-square tests of expected values showed that the proportion of participants 
scoring within the impaired and borderline range on telephone search was greater 
than would be expected in the normative population (χ2 = 83.44, df = 2, p < .001).  
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5.3.4.6 Divided attention 
32 (37%) participants completed TEA telephone search while counting, which was 
used to assess divided attention. Two participants aged over 80, for whom norms do 
not exist due to their age were scored using norms for the 65 – 80 age group. The 
mean scale score for telephone search while counting, assessing divided attention, 
was in the ‘average’ range (M = 9.13, SD = 4.14, median = 8.5, range = 1 - 19). The 
mean score was not significantly lower than the normative mean (t (31) = -1.195, p = 
.241) when corrected for multiple comparisons (see Appendix F. 13.8% of those who 
completed telephone search while counting had scores in the impaired or borderline 
ranges; a proportion that did not differ significantly from the normative population 
(χ2 = 2.105, df = 2, p = .393).  
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5.3.5 Memory  
Immediate, delayed, and cued recall, and delayed recognition memory were 
assessed. Memory assessment tools are outlined in chapter 3 (see Table 4). 
Immediate recall was assessed using RBANS list learning, CVLT-II-short form trials 
1 – 4 immediate free recall, RBANS story memory, and WMS logical memory I. 
Short delay recall was measured using CVLT-II-short form short delay free recall. 
Long delay recall was measured using RBANS delayed list recall, CVLT-II-short 
form long delay free recall, RBANS delayed story recall, WMS logical memory II 
(two more complex stories than RBANS story recall). Long delay visual free recall 
was measured with RBANS figure recall. Long delay recognition was measured with 
RBANS list recognition. Long delay cued recall was measured with CVLT-II-short 
form cued recall. Memory descriptive statistics and results of one-sample t-tests 
versus normative values are summarised in Table 16. Proportions with scores in the 
combined impaired or borderline ranges, and are illustrated in Figure 6. 
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Table 16 
Memory 
Assessment N M Median SD Min. / Max. Normality t-test sig. t (df) 
         
Immediate Recall         
RBANS list learning 
b
 76 -1.03 -.96 1.20 -3.88 / +1.38 Yes < .001* -6.940 (75) 
CVLT free recall T-score (list) 
a
 56 44.95 47 11.97 18 / 66 No .003* 28.116 (55) 
RBANS immediate story memory 
b
 76 -.41 -.11 1.54 -4.65 / +1.76 No .042 -2.070 (75) 
WMS logical memory I (story) 
c
 59 8.07 8 4.15 1 / 16 Yes .001* -3.578 (58) 
         
Delayed Recall         
CVLT short delay recall (list) 
b
 53 -.41 -.50 1.37 -2.5 / 4.0 No .036 -2.151 (52) 
RBANS delayed list recall 
b
 76 -.90 -.83 1.19 -3.61 / +1.39 Yes < .001* -6.351 (75) 
CVLT long delay recall (list) 
b
 52 -.62 -.50 1.04 -2.5 / 2.0 No < .001* -4.281 (51) 
RBANS delayed story recall 
b
 76 -.79 -.50 1.32 -3.68 / +0.91 No < .001* -4.973 (75) 
WMS logical memory II (story) 
c
 59 7.68 8.0 4.07 1 / 16 Yes < .001* -4.377 (58) 
RBANS figure recall 
b
 77 -.55 -.59 1.14 -3.48 / +1.97 Yes < .001* -3.867 (76) 
         
Cued Recall         
CVLT cued recall 
b
 52 -.86 -.50 1.06 -3.0 / 1.0 No < .001* -6.044 (51) 
         
Delayed Recognition         
RBANS list recognition 
b
 76 -2.18 -1.17 3.64 -25.43 / +0.67 No < .001* -5.051 (75) 
a
 T-score: normative mean = 50 (SD = 10). 
b
 z-score: normative mean = 0 (SD = 1). 
c 
Scale score: normative mean = 10 (SD=3), min. = 1, max. = 19.  
* significant after the Holm method of correction for multiple comparisons was employed (see Appendix F) 
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Figure 6: Proportions of scores in the impaired or borderline ranges for 
memory 
16
 
 
 
5.3.5.1 Immediate Verbal Recall (list) 
RBANS list learning tested immediate list recall with a 10 item list over 4 trials (but 
did not allow for further analysis of cued recall, etc.). It was completed by 76 
participants (87%). Z scores ranged from -3.88 to 1.38. The mean z-score of -1.03 
(SD = 1.20) corresponds to a scale score of 6.91 (i.e. low average range). This was 
significantly lower than the normative mean (t (75) = -6.940, p < .001) (see Table 
16). 35.5% (n = 27) of participants who completed list learning had scores in the 
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borderline or impaired range (χ2 = 257.58, df = 2, p < .001), a significantly greater 
proportion than the normative/expected frequency (see Table 13).   
CVLT-II-s free recall (trials 1 – 4 total) measured immediate list recall of 9 
items in three semantically related clusters over four trials. It was completed by 56 
(64%) participants. The mean T-score was 44.95 (SD = 11.96), which was 
significantly lower than the normative mean (t (55) = 28.116, p = .003) when tested 
with a one-sample t-test. 21.4% of participants who completed the CVLT-II-s had T-
scores in either the borderline or impaired range (14.3% of participants had scores in 
the impaired range). This was found to be a significantly larger proportion than 
would be expected in the normal population (χ2 = 44.031, df = 2, p < .001).  
 
5.3.5.2 Immediate Verbal Recall (story) 
RBANS immediate story memory, testing immediate episodic recall with a single 
story, was completed by 76 participants (87%). Z scores ranged from -4.65 to 1.76. 
The mean z-score of -.41 (SD = 1.54) corresponds to a scale score of 8.77, which 
would place it in the ‘average’ range. The mean score was not significantly lower 
than the normative mean when the Holm method of correction for multiple 
comparisons was employed (t (75) = -2.070, p = .042). 26.3% (n = 20) of 
participants who completed immediate story memory had scores in the borderline or 
impaired range (χ2 = 106.79, df = 2, p < .001), a significantly greater proportion than 
the normative/expected frequency.  
WMS logical memory I was used to test immediate episodic recall with two 
stories, both of which were longer than the RBANS story. It was completed by 59 
participants (67.82%). Scale scores ranged from 1 to 16, and were normally 
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distributed. Mean scale scores were in the ‘average’ range (8.07, SD = 4.148, median 
= 8). A one-sample t-test confirmed however that the mean score was significantly 
lower than the normative mean (t (58) = -3.578, p = .001). 33.9% (n = 20) of 
participants who completed logical memory I, a significantly greater proportion than 
the normative/expected frequency, had scores in the borderline or impaired range (χ2 
= 87.364, df = 2, p < .001).  
 
5.3.5.3 Short Delay Verbal Recall 
CVLT-II-s short delay free recall measured short delay (30 seconds) list recall of the 
9 words from the 4 free recall trials, and was completed by 53 (61%) participants. A 
median z-score of -.50 (not normally distributed, mean = -.41, SD=1.37) was 
obtained. The mean was not significantly different from the normative mean (p = 
.036), after Holm correction for multiple comparisons (see Appendix F). 15.09% of 
participants who completed the CVLT-II-s had z scores impaired range, and 11.32% 
had scores in the borderline range. There were significantly more 
borderline/impaired scores in this sample than in the normative population (χ2 = 
51.82, df = 2, p < .001).  
 
5.3.5.4 Long Delay Verbal Recall 
RBANS delayed list recall was completed by 76 participants (87.36%). The mean z-
score of -.90 (SD = 1.19) corresponds to a scale score of 7.30, which would place it 
in the low average range, and it was significantly lower than the normative mean (t 
(75) = -6.351, p < .001). Delayed list recall z scores ranged from -3.61 to 1.39. 31% 
(n = 24) of participants who completed delayed list recall had scores in the 
CHAPTER 5: NEUROPSYCHOLOGICAL PROFILE 
150 
 
borderline or impaired range (χ2 = 86.34, df = 2, p < .001), a significantly greater 
proportion than the normative/expected frequency.  
The median CVLT-II-s long delay free recall z-score was -.50 (not normally 
distributed, M = -.615, SD = 1.04). The mean was found to be significantly different 
from the normative mean (t (51) = -4.281, p <.001), when tested with a one-sample 
T-test (although the scores were not normally distributed). 19% of participants who 
completed the CVLT-II-s had z scores impaired range, and 7.7% had scores in the 
borderline range. There were significantly more borderline and impaired scores in 
this sample than would be expected in the normally distributed population (χ2 = 
80.167, df = 2, p < .001).  
RBANS delayed story recall, also testing delayed episodic recall with the 
story from RBANS immediate story memory, was completed by 76 (87%) 
participants. Delayed story recall z scores ranged from -3.68 to 0.91. The mean z-
score of -.79 (SD = 1.32) corresponds to a scale score of 7.63, which would place it 
in the ‘low average’ range, and it was significantly lower than the normative mean (t 
(75) = -4.973, p < .001). 24% (n = 18) of participants who completed list learning 
had scores in the borderline or impaired range (χ2 = 141.07, df = 2, p < .001), a 
significantly greater proportion than the normative/expected frequency.  
WMS logical memory II, testing delayed episodic recall (of WMS logical 
memory I items), was completed by 59 participants (68%). Scale scores ranged from 
1 to 16, and were normally distributed. Mean scale scores were in the ‘low average’ 
range (7.68, SD = 4.974, median = 8), and were significantly lower than the 
normative mean (t (58) = -4.377, p < .001). 34% (n = 20) of participants who 
completed logical memory II had scores in the borderline or impaired range, which 
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was a significant difference from the normative/expected frequency (χ2 = 216.686, df 
= 2, p < .001).  
 
5.3.5.5 Long Delay Visual Recall  
RBANS figure recall, testing delayed visual recall of the item used in RBANS figure 
copy, was completed by 77 participants (89%). Z scores ranged from -3.48 to 1.97. 
The mean z-score of -.55 (SD = 1.14) corresponds to a scale score of 8.35, which 
would place it in the ‘average’ range, but it was significantly lower than the 
normative mean (t (76) = -3.867, p < .001). 22.1% (n = 17) of participants who 
completed delayed list recall had scores in the borderline or impaired range (χ2 = 
31.07, df = 1, p < .001), a significantly greater proportion than the 
normative/expected frequency.  
 
5.3.5.6 Long Delay Cued Verbal Recall 
CLVT long delay cued recall, testing delayed, cued recall of the 9 items CVLT-II-s 
word list, was completed by 52 participants (60%). Z scores ranged from -3.0 to 1.0, 
and were not normally distributed. The median z-score of -.50 (SD = 1.06) 
corresponds to a scale score of 8.5, which would place it in the ‘average’ range, but 
it was significantly lower than the normative mean (t (51) = -6.044, p < .001). 25% 
of participants who completed the CVLT-II-s had z scores in the impaired range, and 
11.5% had scores in the borderline range. There were significantly more scores in 
the borderline or impaired range than would be expected in the normally distributed 
population (χ2 = 146.865, df = 2, p < .001).  
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5.3.5.7 Long Delay Verbal Recognition 
RBANS list recognition was completed by 76 participants (87.36%). Z scores ranged 
from -25.43 to 0.67. The mean z-score of -2.18 (SD = 3.64) corresponds to a scale 
score of 3.46, placing it in the ‘extremely low’ range, and it was significantly lower 
than the normative mean (t (75) = -5.051, p < .001). 41% (n = 31) of participants 
who completed delayed list recall had scores in the borderline or impaired range (χ2 
= 506.99, df = 2, p < .001), a significantly greater proportion than the 
normative/expected frequency.  
 
5.3.6 Visuospatial Cognition  
Visuospatial perception was assessed with VOSP position discrimination, and 
RBANS line orientation. Visuospatial construction was assessed with RBANS figure 
copy. Results are summarized in Table 17. Proportions with scores in the combined 
impaired or borderline ranges are illustrated in Figure 7.  
 
Table 17 
Visuospatial Perception and Construction 
Assessment N M Median SD Min / Max Normal t-test sig. t (df) 
VOSP 
position 
discrimination 
raw 
a
 
43 18.98 20 1.61 12 / 20 No n/a n/a 
RBANS 
figure copy 
b
 
77 -1.11 -.85 2.05 -8 / +1.29 No < .001* -4.745 
(76) 
RBANS line 
orientation
 b
 
77 -.28 .12 1.68 -5.5 / +4.62 No .149 -1.458 
(76) 
a
 Possible scores range from 0 – 20; pass ≥19/20, pass borderline = 18/20, fail = ≤17/20. b z-scores. 
* significant after the Holm method of correction for multiple comparisons was employed (see 
Appendix F) 
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5.3.6.1 Visuospatial Perception 
The VOSP position discrimination subtest was completed by 43 participants (49%). 
72.1% of those who completed the VOSP (n=31) were classified above the pass 
mark, while 14% (n=6) were classified as having failed the VOSP, whilst another 
14% (n=6) were classified as passed but borderline. The VOSP is not normed for 
scale scores, thus it was not possible to use a one sample t-test to ascertain whether 
or not a significant difference existed between scores in this study and the normative 
sample. Neither was it possible to use a χ2 test to examine observed versus expected 
frequencies.  
RBANS line orientation was completed by 77 participants (89%). Z scores 
ranged from -5.5 to 4.62. The mean z-score of -.28 (SD = 1.68) was in the ‘average’ 
range and corresponds to a scale score of 9.01. The mean z-score did not differ 
significantly from the normative mean (t (76) = -1.458, p = .149). However, 22.1% 
(n = 17) of participants who completed line orientation had scores in the borderline 
or impaired range, a significantly greater proportion than the normative/expected 
frequency (χ2 = 87.168, df = 2, p < .001).  
 
5.3.6.2 Visuospatial Construction 
RBANS figure copy, assessing visuospatial construction, was completed by 77 
participants (89%). Z scores ranged from -8 to 1.29. The mean z-score of -1.11 (SD 
= 2.05) was in the ‘low average’ range, and corresponded to a scale score of 6.64. 
The mean was significantly lower than the normative mean (t (76) = -4.745, p < 
.001). 42.9% (n = 33) of participants who completed figure copy had scores in the 
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borderline or impaired range (χ2 = 295.75, df = 2, p < .001), a significantly greater 
proportion than the normative/expected frequency.  
 
 
Figure 7: Proportions of scores in the impaired or borderline ranges for 
visuospatial cognition and for language 
17
 
 
 
5.3.7 Language  
Language ability (naming) was assessed with the Graded Naming Test, and RBANS 
naming. The Graded Naming Test, with 30 items, is more comprehensive than 
RBANS naming, which has 10 items. Verbal fluency measures are reported with 
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executive functioning measures, due to their dependence upon executive-mediated 
retrieval strategies. Results are summarised in Table 18. Proportions with scores in 
the combined impaired or borderline ranges are illustrated in Figure 7.  
The mean raw score on the Graded Naming Test, completed by 39 
participants (45%), was 16.59 (out of a possible 30). Scale scores have been 
published by Warrington (1997), but are not available, or reliably calculable for all 
raw scores. A raw score of 17 (as per mean = 16.59 above) would correspond to a 
scale score of 8, which would be at the lower end of the ‘average’ range. For this 
reason, Graded Naming Test scores have not been included in Figure 7.  
RBANS picture naming was completed by 76 participants (87.36%). Z scores 
ranged from -7.40 to 1.00. The mean z-score of -.41 (SD = 1.79) was in the ‘average’ 
range, and corresponded to a scale score of 8.77. The mean was not significantly 
lower than the normative mean when the Holm method for correction for multiple 
comparisons was applied (t(75) = -2.044, p = .044). 17.1% (n = 13) of participants 
who completed picture naming had scores in the borderline or impaired range – a 
significantly greater proportion than the normative/expected frequency (χ2 = 75.154, 
df = 2, p = .002).   
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Table 18 
Language 
Assessment N Mean Median SD Min / Max t-test sig. t (df) 
Graded Naming Test raw 
score 
39 16.59 18.0 6.44 3 / 27 n/a n/a 
RBANS picture naming 76 -.41 .55 1.79 -7.4 / +1 .044 -2.044 (75) 
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5.3.8 Executive Functions 
A number of executive functions were assessed: working memory, inhibition, 
cognitive flexibility (set-shifting), organization of information and self-monitoring 
(verbal fluency), planning, and everyday executive functioning. The WAIS-IV digit 
span subtest was used to measure working memory, inhibition was assessed using 
the Delis-Kaplan Executive Function System (DKEFS) colour word inhibition, and 
cognitive flexibility was assessed with the DKEFS TMT number-letter switching. 
Organization of information and self-monitoring was assessed with DKEFS letter 
fluency, DKEFS category fluency, and RBANS semantic fluency. Planning was 
assessed with the Behavioural Assessment of the Dysexecutive Syndrome (BADS) 
zoo map. Self-reported everyday executive functioning was assessed using the 
Frontal Systems Behaviour Rating Scale (FrSBe). Executive functioning results of 
the sample are summarised in Table 19. Proportions with scores in the combined 
impaired or borderline ranges are illustrated in Figure 8 . 
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Table 19 
Executive Functions 
Measure N M 
a
 SD Median Min / Max Normal t-test sig. t (df) 
WAIS digit span  62 9.52 10 3.2 2 / 17 Yes .238 -1.192 (61) 
DKEFS colour-word switching 50 7.00 3.95 8.0 1 / 13 No < .001* -5.365 (49) 
DKEFS number-letter switching 53 5.81 3.99 6.0 1 / 13 No < .001* -7.651 (52) 
RBANS semantic fluency 76 -.91 1.22 -1.0 -3 / +2 Yes < .001* -6.309 (75) 
DKEFS category fluency 57 8.42 3.74 8.0 3 / 17 No .002* -3.186 (56) 
DKEFS letter fluency 57 8.12 3.73 8.0 2 / 19 Yes < .001* -3.802 (56) 
BADS zoo map 41 n/a n/a 2 1 / 4 No n/a n/a 
FrSBe total 35 59.80 16.66 53 33 / 103 Yes .001* 3.481 (34) 
a 
Normative mean = 10 (SD = 3), minimum = 1, maximum = 19, except Zoo map – ordinal scale from 1 to 4, FrSBe – mean = 50, SD = 10. * significant after 
the Holm method of correction for multiple comparisons was employed (see Appendix F) 
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Figure 8: Proportions of scores in the impaired or borderline ranges for 
executive functions 
18
 
 
 
5.3.8.1 Working Memory 
62 (71%) participants completed WAIS digit span subtest. The digit span mean scale 
score was in the average range (M = 9.52, SD = 3.20, range 2 - 17). The mean scale 
score did not differ significantly from the normative mean when tested with a one-
sample t-test (t (61) = -1.192, p=.238). Of those who completed the tests, 4.8% of 
participants were in the impaired range, and 6.5% were borderline (see Table 13). 
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When tested with chi-square tests of observed versus expected values the difference 
between observed and expected frequencies of scores in the borderline and impaired 
categories did not differ significantly from that which would be expected in the 
normative population (χ2 = 2.882, df = 2, p = .265).  
 
5.3.8.2 Response Inhibition 
DKEFS colour word interference was used to assess response inhibition. Scale 
scores on colour word switching ranged from 1 to 13, while the median of 8 was in 
the ‘average’ range (not normally distributed; M = 8, SD = 3.95). A one-sample t-
test found the mean to differ significantly from the normative mean (t (49) = -5.365, 
p < .001). 38% of participants who completed colour-word switching had scores in 
the impaired or borderline range. Chi-square tests of expected values showed that 
this differed significantly from the expected normative values (χ2 = 154.067, df = 2, 
p < .001).  
 
5.3.8.3 Cognitive Flexibility (set-shifting) 
DKEFS number-letter switching was used to assess cognitive flexibility. The median 
scale score (trails scores were not normally distributed) on the DKEFS TMT 
number-letter switching was 6 (‘low average’ range, mean=5.81), while scale scores 
ranged from 1 to 13. One-sample t-tests found the number-letter switching mean 
differed significantly from the normative mean (t (52) = -7.651, p < .001). 47.2% 
were in either the impaired or borderline ranges; 45.3% of participants had scores in 
the impaired range alone. Chi-square tests of expected values revealed that a 
significantly greater proportion of participants than would be expected in the normal 
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population had scores in the borderline/impaired range (χ2 = 348.98, df = 2, p < 
.001).  
 
5.3.8.4 Verbal Fluency (Organization of Information and Self-Monitoring) 
Verbal fluency tests assess organization of information, self-monitoring, and 
executive-mediated memory retrieval strategies. Two measures of category fluency 
were used; the RBANS semantic fluency subtest (completed by 76 participants; 
87%), and DKEFS category fluency (completed by57 participants; 66%). An 
assessment of phonemic fluency, DKEFS letter fluency, was completed by 57 
participants (66%).  
RBANS semantic fluency assessed category fluency with a single response 
condition. Z scores ranged from -3.00 to 2.00. The mean z-score of -.91 (SD = 1.22) 
was in the ‘low average’ range, and corresponds to a scale score of 7.27. The mean 
was significantly lower than the normative mean (t (75) = -6.309, p < .001). 41% (n 
= 31) of participants who completed semantic fluency had scores in the borderline or 
impaired ranges, a significantly greater proportion than the normative/expected 
frequency (χ2 = 194.361, df = 2, p < .001).  
DKEFS category fluency had two response conditions, and letter fluency had 
three. Mean DKEFS category (8.42, SD = 3.74) and letter (8.12, SD = 3.73) fluency 
scores fell into the lower end of the ‘average’ range. Scale scores ranged from 3 to 
17 on category fluency, and from 2 to 19 on letter fluency. Mean scores on both were 
significantly lower than the normative means (category fluency t(56) = -3.186, p = 
.002; category fluency t(56) = -3.802, p < .001). Chi-square tests of expected 
frequencies found that 17.2% of participants had scores in the borderline or impaired 
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range on category fluency, and 12.6% had scores that were in the impaired or 
borderline range on letter fluency. These frequencies were significantly different 
from expected values (category fluency χ2 = 33.249, df = 2, p <.001; letter fluency χ2 
= 23.268, df = 2, p <.001).  
 
5.3.8.5 Planning  
41 participants (47% of the sample) completed the Behavioural Assessment of the 
Dysexecutive Syndrome (BADS) zoo map subtest, which assessed planning. Pro-
rating of scores was used to obtain a classification (zoo map is one of six BADS 
subtests). 36.6% of those who completed the test (n=15) were classified as 
‘impaired’, 51.2% (n=21) as ‘borderline’, and just 12.2% (n=5) of participants had 
scores in non-impaired categories. It was not possible to compare zoo map scores to 
normative values.   
 
5.3.8.6 Everyday Executive Functions (Self-Rated) 
The Frontal Systems Behaviour Rating Scale (FrSBe) total scale score was used to 
assess self-reported everyday executive functioning. The total scale comprised three 
subscales measuring apathy, disinhibition, and general executive dysfunction. 35 
(40.2%) participants completed the FrSBe. Total T-scores ranged from 33 to 103. 
Higher FrSBe scores indicate greater impairment, which is opposite to the other 
assessments. The mean of 59.8 (SD = 16.66) was significantly different from the 
normative mean (t (34) = 3.481, p < .001). As noted in Chapter 3 (4.5.2.4 Frontal 
Systems Behavior Rating Scale (FrSBe)), the FrSBe manual (Grace & Malloy, 2001) 
recommends that T-scores of 60 to 64 (corresponding to z scores of 1.0 to 1.4) 
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should be regarded as borderline, while T-scores of 65 (z = 1.5) or higher should be 
regarded as impaired. A chi square analysis of observed versus expected frequencies 
was not undertaken, as there was insufficient information about expected 
distribution. The mean score in this sample lies just below the threshold for a 
borderline score, indicating that self-rated executive dysfunction (including apathy) 
was widespread in this sample.  
 
5.4 Results for Objective Two: Differences between Participants with Vascular 
and Non-vascular Aetiologies 
 
5.4.1 Socio-demographic and Clinical Characteristics 
Chi-square and independent samples t-test analyses were used to examine whether 
there were differences between vascular and non-vascular aetiology groups on a 
range of demographic variables. The vascular group (M = 62.93, SD = 12.02, range: 
33 – 86) was significantly older than the non-vascular group (M = 41.89, SD = 
15.13, range: 21 – 73) (t (85) = 6.256, p < .001). The groups did not differ on 
number of years of formal education completed (t (84) = - .413, p = .681), gender (χ2 
= .00, df = 1, p = 1.0), marital status (χ2 = .720, df = 1, p = .396), amputation level 
(χ2 = .367, df = 2, p = .832), number of comorbidities (χ2 = 2.362, df = 1, p = .184), 
distress (t (53) = -.286, p = .776), or length of stay in rehabilitation (t (85) = .602, p = 
.549). The non-vascular group had significantly greater time between amputation and 
admission expressed in months (Mann-Whitney p < .001).
19
  
 
                                                 
19 Mann-Whitney test statistic not provided in SPSS output.  
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5.4.2 Neuropsychological Assessments 
It was hypothesised that the vascular group would perform worse on all assessments, 
across all domains, than the non-vascular group. There were no significant 
differences in neuropsychological assessment scores between aetiology groups when 
analysed with Mann-Whitney U tests. A summary of neuropsychological assessment 
descriptive statistics for both groups is presented in the following tables 20 – 27.   
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Table 20 
Vascular Group versus Other Group: Premorbid Cognitive Functioning, Brief Screen, and Overall Cognitive Functioning 
Assessment Aetiology N M Median SD Min % impaired % borderline % impaired or border. 
a
 
WTAR (estimated 
premorbid) 
vascular 38 95.71 99.5 20.56 50 / 123 10.5 13.2 23.7 
other 12 97.75 100 15.61 64 / 120 8.3 8.3 16.7 
MoCA (brief screen) vascular 49 22.41 23 3.99 9 / 30 n/a n/a 61.2 
other 9 25.56 26 2.96 19 / 29 n/a n/a 11.1 
RBANS total (overall 
cognitive functioning) 
vascular 58 83.5 84.5 17.43 45 / 121 24.1 13.8 37.9 
other 15 90.6 92 13.73 69 / 109 13.3 6.7 20.0 
a
 % scoring 23 or less for the MoCA brief cognitive screen 
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Table 21 
Vascular Group versus Other Group: Reasoning 
Assessment Aetiology N M Median SD 
% 
impaired 
% 
borderline 
% impaired 
or 
borderline 
WAIS block design (visuospatial ) vascular 48 8.02 8 3.1 4.2 16.7 20.8 
  other 12 8.92 9 3.53 8.3 0 8.3 
WAIS similarities (abstract verbal) vascular 48 8.13 8 2.89 8.3 6.3 14.6 
  other 12 8.17 8.5 3.07 0 25 25 
WAIS matrix reasoning (fluid) vascular 44 8.11 8 2.98 4.5 18.2 22.7 
  other 12 9.17 8.5 3.79 0 16.7 16.7 
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Table 22 
Vascular Group versus Other Group: Psychomotor Speed, Information Processing, and Attention 
Assessment Aetiology N M Median SD % impaired % borderline % impaired or border. 
DKEFS motor speed (psychomotor 
speed)  
vascular 32 7.72 8 3.25 12.5 6.3 18.8 
other 10 7.7 9 3.02 10 10 20 
DKEFS colour naming (information 
processing) 
vascular 40 8.1 8 2.45 2.5 10 12.5 
other 12 8.67 9 2.81 8.3 0 8.3 
DKEFS word reading (info. 
processing) 
vascular 40 9.28 10 2.49 2.5 2.5 5 
other 12 9.33 8.5 2.61 0 0 0 
RBANS coding (info. processing & 
att’n) 
vascular 58 -1.87 -1.83 1.44 46.6 19 65.5 
other 15 -1.23 -0.97 1.05 20 6.7 26.7 
WAIS-IV symbol search (info. 
processing & att’n) 
vascular 49 6.86 6 2.91 6.1 30.6 36.7 
other 11 7.55 7 3.17 9.1 9.1 18.2 
RBANS digit span (attention span) 
vascular 60 0.16 0.18 1.16 3.3 5 8.3 
other 16 0.03 0.18 1.14 0 18.8 18.8 
DKEFS visual scanning (focused 
att'n)  
vascular 42 7.64 9 3.3 11.9 11.9 23.8 
other 10 8.7 8 2 0 0 0 
DKEFS number sequencing (focused 
att'n) 
vascular 43 6.72 8 4.14 30.2 7 37.2 
other 11 8.91 9 1.87 0 0 0 
DKEFS letter sequencing (focused 
att'n) 
vascular 42 6.6 8 3.99 33.3 4.8 38.1 
other 11 7.64 9 3.75 18.2 9.1 27.3 
TEA telephone search (sustained 
att’n)  
vascular 24 5.38 5.5 2.67 26.1 21.7 47.8 
other 8 7.25 7.5 3.54 25 0 25 
TEA telephone search w/ counting 
(divided att’n)  
vascular 24 9 8 4.36 4.3 13 17.3 
other 8 9.5 9 3.63 12.5 0 12.5 
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Table 23 
Vascular Group versus Other Group: Immediate Memory 
 Assessment  Aetiology N M Median SD 
% 
impaired 
% 
border. 
% 
impaired 
or border. 
RBANS list learning 
a
 
vascular 60 -1.01 -0.96 1.24 30 5 35 
  
other 16 -0.8 -0.79 1.14 18.8 18.8 37.5 
CVLT trials 1-4 free recall T-score 
b
 
vascular 44 44.02 46 12.12 15.9 9.1 25 
  
other 12 48.33 52 11.19 8.3 0 8.3 
RBANS immediate story recall 
a
 
vascular 60 -0.46 -0.11 1.59 23.3 5 28.3 
  
other 16 0.025 0.2 1.17 0 18.8 18.8 
WMS logical memory I (story) 
c
 
vascular 48 8.02 8 3.91 16.7 16.7 33.3 
  
other 11 8.27 8 5.27 18.2 18.2 36.4 
a
 z-score: normative mean = 0 (SD = 1). 
b
 T-score: normative mean = 50 (SD = 10). 
c 
Scale score: normative mean = 10 (SD=3), min. = 1, max. = 19. 
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Table 24 
Vascular Group versus Other Group: Delayed Memory 
 Assessment  Aetiology N M Median SD 
% 
impaired 
% 
border. 
% 
impaired 
or border. 
CVLT short delay recall vascular 42 -0.46 -0.5 1.38 16.7 11.9 28.6 
  other 11 -0.18 -0.5 1.38 9.1 9.1 18.2 
RBANS delayed list recall  vascular 60 -0.89 -0.87 1.13 15 18.3 33.3 
  other 16 -0.73 -0.837 1.37 12.5 12.5 25 
CVLT long delay recall  vascular 42 -0.58 -0.5 1.06 19 7.1 26.2 
  other 10 -0.75 -0.5 0.98 20 10 30 
RBANS delayed story recall vascular 60 -0.85 -0.5 1.41 25 3.3 28.3 
  other 16 -0.35 -0.5 0.78 6.3 0 6.3 
WMS logical memory II  vascular 48 7.71 8 3.89 29.2 2.1 31.3 
  other 11 7.55 6 5.01 27.3 18.2 45.5 
RBANS figure recall  vascular 62 -0.6 -0.7 1.07 8.1 16.1 24.2 
  other 15 -0.16 -0.03 1.53 13.3 0 13.3 
CVLT cued recall  vascular 42 -0.94 -0.75 1.07 28.6 11.9 40.5 
  other 10 -0.65 -0.5 1 10 10 20 
RBANS list recognition  vascular 60 -1.91 -1.17 2.36 40 3.3 43.3 
  other 16 -2.66 0.16 6.44 31.3 0 31.3 
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Table 25 
Vascular Group versus Other Group: Visuospatial Perception and Construction 
Assessment Aetiology N M Median SD 
% 
impaired 
%  
borderline 
% impaired 
or 
borderline 
RBANS line orientation (space 
perception) 
vascular 61 -0.54 -0.207 1.75 21.3 6.6 27.9 
other 16 0.72 0.73 0.866 0 0 0 
VOSP position discrimination (space 
perception) 
vascular 34 18.82 19.5 1.73 17.6 11.8 29.4 
other 9 19.56 20 0.88 0 22.2 22.2 
RBANS figure copy (visuospatial 
construction) 
vascular 62 -1.35 -1.4 2.08 33.9 16.1 50 
other 15 -0.13 0.5 1.64 6.7 6.7 13.3 
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Table 26 
Vascular Group versus Other Group: Language 
Assessment Aetiology N M Median SD % impaired 
%  
borderline 
% impaired 
or borderline 
RBANS picture naming 
(confrontational naming)  
vascular 60 -0.46 0.57 1.88 15 1.7 16.7 
other 16 -0.21 0.55 1.13 18.8 0 18.8 
Graded naming test 
(confrontational naming) 
vascular 30 16.63 17.5 6.61    
other 9 16.44 18 6.23    
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Table 27 
Vascular Group versus Other Group: Executive Function 
Assessment Aetiology  N Mean Median SD 
% 
impaired 
% 
border. 
% 
impaired 
or border. 
WAIS-IV digit span (working memory) vascular 50 9.38 9.5 3.17 4 8 12 
  other 12 10.08 11 3.4 8.3 0 8.3 
DKEFS colour-word inhibition 
(inhibition)  
vascular 34 59.41 68 25.53 41.2 50 91.2 
  other 7 75.43 68 30.03 14.3 57.1 71.4 
DKEFS trails number-letter switching 
(cognitive flexibility) 
vascular 42 5.38 5 3.83 42.9 7.1 50 
  other 11 7.45 9 4.34 27.3 9.1 36.4 
RBANS semantic fluency vascular 60 -0.84 -0.87 1.22 20 18.3 38.3 
  other 16 -1.38 -1.37 1.6 31.3 18.8 50 
DKEFS category fluency  vascular 45 8.38 8 3.94 8.9 20 28.9 
  other 12 8.58 8.5 3.03 8.3 8.3 16.7 
DKEFS letter fluency  vascular 45 8.44 8 3.84 8.9 8.9 17.8 
  other 12 6.92 7.5 3.15 16.7 8.3 25 
BADS zoo map (planning) vascular 25 61.04 59 17.27 37.5 12.5 50 
  other 10 56.7 53.5 15.42 33.3 0 33.3 
FrSBe self-rated everyday executive 
dysfunction 
vascular 39 6.31 6 3.9 30.8 15.4 46.2 
  other 11 9.45 10 3.21 9.1 0 9.1 
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5.5 Discussion  
5.5.1 Summary of Findings 
Sample demographics were consistent with the literature, i.e. the majority of 
amputations (79%) were of vascular aetiology, people with vascular amputations 
were older, and the mean age of the sample was 59.  
Results indicated broad but qualified support for hypothesis 1. Many areas of 
cognitive functioning, across a range of domains, were impaired in this sample. This 
impairment was evident both in terms of significantly lower mean scores and 
significantly higher proportions of scores in the borderline and impaired ranges 
compared to normative values. Some cognitive functions were impaired in terms of 
either mean scores or proportions in the borderline and impaired ranges, but not 
both. A small number of functions showed no significant impairment.  
Half of participants had scores below the cut-off for cognitive impairment on 
the brief cognitive screen. Impaired (in terms of both means and proportions) aspects 
of cognition included overall cognitive functioning and functions such as fluid 
reasoning, psychomotor speed, information processing, focused attention, sustained 
attention, immediate recall, delayed recall, delayed recognition, visuospatial 
construction, and executive functions including inhibition, cognitive flexibility, 
executive-mediated memory retrieval (verbal fluency), planning, and self-rated 
everyday executive functioning. Two of three reasoning measures and a measure of 
simple information processing (colour naming) were impaired in terms of mean 
scores, but did not have higher proportions in the borderline or impaired range than 
normative populations. Impairment is also suggested by scores on two measures 
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which could not be compared with normative populations – more complex 
confrontational naming, and a measure of spatial perception.  
A number of aspects of cognitive functioning were not impaired in terms of 
mean scores, but had higher proportions of scores in the borderline and impaired 
range than normative populations. These areas of functioning were attention span, 
two aspects of immediate/short delay verbal recall, one of two spatial perception 
tasks, one of two confrontational naming tasks, and an estimate of premorbid 
cognitive functioning. Working memory, divided attention and one element of 
simple information processing (word reading) did not differ significantly from 
normative populations either in terms of mean scores or sample proportions 
impaired.  
Results also indicate that hypothesis 2 should be rejected. There were no 
significant differences between the vascular and non-vascular groups on 
neuropsychological assessments. The vascular group was older, but the groups did 
not differ in terms of years of education completed, nor in terms of number of 
comorbidities. The non-vascular group was however much smaller in number than 
the vascular group. Presence of vascular comorbidities or traumatic brain injury in a 
number of participants with non-vascular amputation aetiologies may help to explain 
the lack of differences in cognitive functions. This is discussed in further detail 
below.  
 
5.5.2 Premorbid Functioning 
Estimated premorbid cognitive functioning (WTAR) was not significantly different 
from the normative mean. Nevertheless, a wide range of premorbid functioning was 
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evident. Over a fifth of participants had scores in the impaired and borderline ranges 
– at more than double the number expected in the normal population, this was 
significant.  
It is possible that greater percentage of those undergoing amputation have 
premorbid cognitive functioning in the borderline and impaired ranges. This might 
suggest that impaired premorbid cognitive functioning is a contributory factor in 
amputation incidence – at least for a subsample of people undergoing amputation. 
Self-care behaviours are an important part of maintaining optimal health and 
functioning in people with chronic diseases (Shrivastava, Shrivastava, & Ramasamy, 
2013). Cognitive functioning has been associated with less engagement in self-care 
behaviour and monitoring of diabetes for example (Sinclair, Girling, & Bayer, 2000). 
This may explain the large proportion of scores in the borderline and impaired range 
in this sample.  
Lower estimated premorbid functioning was related to fewer years of formal 
educational completed. Lower education, and associated issues of lower literacy 
levels and less familiarity with test conditions, may have negatively impacted scores 
on the assessment used. As far as this author is aware, this is the first study to report 
an estimate of premorbid cognitive functioning in people with lower limb 
amputations.  
 
5.5.3 Overall Cognitive Functioning  
More than half of the participants who completed the MoCA scored below 
McLennan et al.'s (2011) and Godefroy et al.'s (2011) screening cut-off for mild 
cognitive impairment. Considering the sensitivity and specificity of the cut-off 
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point
20
, this suggests that approximately a quarter – and perhaps more – of those 58 
participants who completed the measure met criteria for mild cognitive impairment. 
The diagnosis of ‘mild cognitive impairment’ was not an aim or purpose of this 
study, and other criteria such as third party reports (Winblad et al., 2004) would need 
to be taken into account to do so. Nonetheless, these findings do point to widespread 
incidence of impaired cognitive functioning in this sample. That half of the sample 
scored below the screening cut-off suggests that referral for comprehensive 
neuropsychological assessment is indicated for at least half of the admissions to 
lower limb loss rehabilitation.  
The MMSE (Folstein et al., 1975), SPMSQ (Pfeiffer, 1975), and ACE-R 
(Mioshi et al., 2006) cognitive screening instruments have been used in studies of 
cognitive functioning in people with lower limb amputation. However, the MMSE is 
less sensitive to the impairment profile of vascular cognitive impairment than the 
MoCA (Pendlebury et al., 2012), the SPMSQ primarily focuses on orientation and is 
unlikely to be sufficiently sensitive to milder cognitive impairments, and the ACE-R 
has not been validated for use with the wide range of cerebrovascular disorders as 
has the MoCA (Koski, 2013; A. J. Larner, 2013). Using the ACE-R, 42% of 
Donaghey et al.'s (2010) sample scored below the cut-off for mild cognitive 
impairment. This 42% is notably different from the present study’s 53%. While the 
ACE-R may have higher specificity, it is possibly also less sensitive to cognitive 
impairments in this population.  Provision of descriptive statistics in the present 
study provides valuable information on vascular-sensitive screen performance for 
                                                 
20 Sensitivity: 100% for amnestic MCI, 83% for multi-domain MCI in cardiovascular disease 
(McLennan et al., 2011), and 88% in post-stroke cognitive impairment (Godefroy et al., 
2011). Specificity: 50 – 52% (McLennan et al., 2011), 71% (Godefroy et al., 2011). 
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this population. It may also act as a starting point for research on mild cognitive 
impairment in LLA, and the empirical determination of an appropriate cut-off score.  
When examined with the RBANS, overall cognitive functioning in this 
sample was impaired in terms of a lower mean score and a third of the sample 
having scores in the borderline and impaired ranges. 79% of the sample in this study 
had amputations due to dysvascularity – PVD or diabetes – in line with what would 
be expected in developed countries’ rehabilitation programmes. PVD has been 
linked to impairment of a range cognitive functions, whether in people with 
amputations (Phillips et al., 1993), awaiting vascular surgery (stage 3 – 4 PVD) 
(Rao, Jackson, & Howard, 1999), with intermittent claudication (stage 2 PVD ) 
(Waldstein et al., 2003), and even with asymptomatic PVD (Mangiafico et al., 2006). 
Similarly, the scientific literature has consistently shown a relationship between 
diabetes and cognitive impairment (Rotkiewicz-Piorun & Snih, 2006; van Elderen et 
al., 2010; Verdelho et al., 2010). Thus, it was expected that overall cognitive 
functioning would be impaired across this sample. This study provides evidence of 
the utility of the RBANS in obtaining an estimate of overall cognitive functioning in 
this population, and provides a fuller range of descriptive statistical data than was 
provided when this measure was used previously with LLA samples (Donaghey et 
al., 2010; O’Neill & Evans, 2009; O’Neill et al., 2010). Although assessing functions 
which are dependent upon the frontal lobe and subcortical structures, the RBANS 
lacks coverage of some areas of cognitive functioning. Assessment of executive 
functioning, in addition to use of the RBANS is recommended in this population.   
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5.5.4 General Intellectual Functioning and Reasoning 
Participants had lower mean scores on tests of visuospatial reasoning, abstract verbal 
reasoning, and matrix reasoning than the normative sample suggesting difficulties in 
various aspects of fluid reasoning across the group as a whole. There was a wide 
range of obtained scale scores, indicating heterogeneous ability levels within the 
group. While group mean and median scores for each of the reasoning tests fell 
within the average range, each was significantly lower than the normative mean. 
While large proportions (17% to 21%) of those who completed these subtests were 
in the borderline or impaired ranges, chi-square tests showed that these proportions 
are significantly greater than would be expected in a normal population for fluid 
reasoning. This may be a result of the matrix reasoning test being more sensitive to 
global impairment of cognitive functioning in this sample.  
There is evidence that fluid reasoning is compromised in dysvascularity 
(baseline hypertension and subsequent vascular pathologies) (Raz, Rodrigue, 
Kennedy, & Acker, 2007), in older adults with cerebrovascular disease (matrix 
reasoning; Keage et al., 2015), and people with vascular cognitive impairment 
(visuospatial reasoning; Nordlund, Rolstad, Göthlin, et al., 2010). Marseglia et al. 
(2014) found abstract reasoning impairment in a sample of people with diabetes, 
although they also concluded that abstract reasoning was less impaired than other 
functions they assessed including memory, processing speed, and executive 
functioning. White matter lesions (WML) may be one cause of impaired fluid 
reasoning (Deary, Penke, & Johnson, 2010). WML related to vascular pathology 
were linked to 5-year declines in fluid reasoning in a sample of older adults (Raz et 
al., 2007). Phillips et al. (1993) documented a non-significant trend toward poorer 
abstract reasoning and problem solving in persons with amputations of dysvascular 
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origin (n = 14).  Thus, findings in this sample broadly accord with findings from the 
literature, but are the first to demonstrate that fluid reasoning functioning is 
significantly worse in people with LLA than in normative populations. 
Compromised reasoning functioning has implications for managing day-to-day 
activities, with fluid reasoning likely being important when encountering novel 
problems.  
 
5.5.5 Information Processing and Attention 
The present findings indicate that as a group, participants had difficulties with 
psychomotor speed (DKEFS motor speed) and complex information processing 
(RBANS coding, WAIS symbol search), but not simpler information processing 
(colour naming, word reading) or attention span (digit span). The findings also 
indicate that there were difficulties with focused and sustained attention (DKEFS 
trails, TEA telephone search). Divided attention did not appear to be any more 
impaired than in a normative sample, though this may have related to a measurement 
issue.  
 
5.5.5.1 Psychomotor Speed 
Scores on DKEFS motor speed suggest some psychomotor impairment. While 
impaired psychomotor speed has been documented as a feature of subcortical 
cerebrovascular disease, it is not frequently assessed in VCI (Paul et al., 2005; 
Selnes & Vinters, 2006). Declining psychomotor speed has been associated with 
cerebral small vessel disease (cortical atrophy/subcortical atrophy/white matter 
lesion volume/medial temporal lobe atrophy) (Jokinen et al., 2012). Psychomotor 
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speed has only been investigated once before in lower limb amputation, in an 
aetiologically heterogeneous sample aged 60 and over (Hanspal & Fisher, 1991). 
Hanspal and Fisher (1991) noted that 66% of 100 participants were unable to 
complete the psychomotor task in their assessment battery, although no reason was 
reported and no comparison was made to standardised values. In the context of these 
findings, it is not particularly surprising that impaired psychomotor speed was seen 
in this sample – both in terms of a significantly lower mean, and a greater percentage 
of participants with scores in the impaired and borderline ranges. However, this 
study is the first to report comparisons to normative values. 
Higher psychomotor speed (as well as fewer task errors) has been associated 
with higher level of prosthetic mobility achieved (Hanspal & Fisher, 1991). Persons 
with psychomotor slowing may have difficulties walking with prostheses due to 
slowed motor response to environmental changes or feedback from prosthesis. This 
may result in unsafe gait or navigation of obstacles, thus affecting prosthetic 
prescription.   
 
5.5.5.2 Information Processing 
There did not appear to be difficulties with either colour naming or word reading in 
this sample, but there were difficulties on symbol search and coding tasks, both of 
which are considered to be more cognitively demanding tasks. Difficulties with the 
WAIS symbol search subtest in a third of this sample indicate impaired processing 
speed. This is consistent with findings on the RBANS coding subtest, with 57.5% in 
the impaired or borderline range on that subtest. These tests of information 
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processing require an interaction with stimuli and a written response and so require 
more effortful processing than colour naming or word reading.  
Impaired processing speed has been linked to the cerebral white matter 
hyperintensities (Jouvent et al., 2011; van den Heuvel et al., 2006). Jouvent et al. 
(2011) argued that when frontal-subcortical white matter circuits suffered damage in 
cerebral small vessel disease it resulted in information processing speed deficits. 
White matter hyperintensities are a hallmark of cerebral small vessel disease that 
results in vascular cognitive impairment (Paul et al., 2005; Wahlund et al., 2009). 
This population’s difficulties on timed information processing tasks – indicating 
difficulties with speed of processing – are consistent with vascular cognitive 
impairment.  
Processing speed difficulties (on complex tasks, such as digit-symbol – 
equivalent to coding) have been documented in people with VCI-ND (Nordlund et 
al., 2007) and coronary heart disease (Roberts et al., 2010), and use of such tasks has 
been recommended for VCI diagnosis (Hachinski et al., 2006). People with 
dysvascular amputations (n = 14) had significantly poorer complex information 
processing than controls, when measured with a similar measure to the coding 
measure in this study (Phillips et al., 1993). Decline in processing speed has been 
linked with decline in other cognitive functions, due to both cognitive operations not 
being executed in time, and because early-processed information may no longer be 
available by the time processing is completed (Salthouse, 1996). The relationship of 
processing speed to rehabilitation outcomes has not yet been assessed in people with 
lower limb amputations.   
 
CHAPTER 5: NEUROPSYCHOLOGICAL PROFILE 
182 
 
5.5.5.3 Attention Span 
For attention span (i.e. forward digit span), neither the mean, nor the proportion of 
scores in the impaired range differed significantly from normative values. Preserved 
attention span has been documented in asymptomatic PVD (Mangiafico et al., 2006), 
and VCI-ND (Nordlund et al., 2007) and is usually not impaired in mild cognitive 
impairment or even early dementia (Lezak et al., 2012). It may however be impaired 
in people with vascular dementia (Graham, Emery, & Hodges, 2004). Attention span 
data, with an isolated digit forward condition, has not been previously reported in an 
LLA population. O’Neill, Moran, and Gillespie (2010) found that seven of eight 
participants, referred to their assistive technology study due to difficulty learning to 
use a prosthesis, had attention scores in the borderline or impaired range. The 
attention measure in that case was a composite of two RBANS subtests: forward 
digit span (identical to this study) and coding, which is a complex measure of 
information processing speed. Digit span score were possibly in the impaired range, 
but were not reported separately. That study’s sample is likely to represent a 
particularly impaired subset of persons attending inpatient rehabilitation. Basic 
attention span abilities appear to be generally intact in this population, and may 
represent a relative strength.  
 
5.5.5.4 Sustained, Focused, and Divided Attention 
Regarding sustained attention, between 19% and 36% of scores on visual scanning 
or sequencing were in the impaired or borderline range. Difficulties with focused 
attention (TEA telephone search) were evident, with 41% of scores within the 
impaired or borderline range. The divided attention (telephone search while 
counting) mean scale score was comparable to the normative sample. Also, there 
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was not a significant difference in the proportion of people who scored in the 
impaired or borderline range, compared with normative values. 
Attentional functions are dependent upon networks which utilize frontal lobe 
areas (Petersen & Posner, 2012). Sustained attention difficulties have been 
documented in asymptomatic PVD (Mangiafico et al., 2006), and in cerebrovascular 
disease (n = 12) (de Jager, Hogervorst, Combrinck, & Budge, 2003). Graham et al. 
(2004) found that focused attention was significantly poorer in cases of vascular 
dementia, compared to both controls and persons with Alzheimer’s disease. Results 
from this study accord with these findings in related populations. 
 Similar to findings in the present study, Nordlund et al. (2007) did not find a 
significant difference in divided attention ability between controls and persons with 
vascular cognitive impairments. In the present study, the TEA divided attention test 
may not have been sufficiently sensitive to divided attention. One speculation is that 
it is possible that the dual task stimuli served as bottom-up reorientation aids, 
meaning that performance was in part directed by parietal areas (as per the ventral 
orienting network summarized by Petersen and Posner (2012)) – areas perhaps less 
affected by vascular disease than frontal/subcortical areas.  
Prior to the present study, no assessments of sustained, focused, or divided 
attention had yet been reported in people with lower limb amputations. Scores on an 
overall subscale assessing attention and orientation from a cognitive screen were 
reported for a clinical trial of an errorless learning intervention, but these subtests 
require less effortful processing than the tests used in the present study, and no 
comparison to normative scores was reported (Donaghey et al., 2010).  
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Attentional functions are likely important factors in engagement on 
rehabilitation programmes. These results may be the impetus for further research on 
whether and how attentional variables affect therapeutic engagement. Attention is 
also important in community living; for example impaired attention has been 
associated with impaired performance of activities of daily living in stroke survivors 
(Stephens et al., 2005).  
 
5.5.6 Memory 
As a group, participants’ performance in immediate, delayed and cued recall, and 
delayed recognition indicated impairment. Up to one third of participants’ scores 
were in the impaired or borderline range for both immediate and delayed episodic 
recall (both auditory), while 22% of participants’ scores were in the same range for 
visual delayed recall. 41% of participants’ scores were in the impaired or borderline 
range for delayed recognition. 
 
5.5.6.1 Immediate Memory 
Between 21% (4 trials x 9 words, CVLT) and 35.5% (4 trials x 10 words, RBANS) – 
were in the impaired range for immediate list recall, with mean scores that were 
significantly lower than the norm. Significantly greater proportions were also 
impaired for story memory: 26% (2 trials x 1 story, RBANS) to 34% (1 trial x 2 
stories, WMS). Again, there were significantly lower means than in the normal 
population on the more comprehensive WMS (but not RBANS).  Together, these 
results suggest difficulties with immediate memory/new learning – possibly 
encoding of new information to memory – in this sample. 
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Garrett et al. (2004), using a measure similar to the CVLT-II-short form, 
found that a sample with VCI-ND had significantly poorer learning ability than 
elderly controls. In a recent study by Williams et al. (2014), four months post-
amputation participants obtained a mean z score of -.87, with 19% of the sample 
impaired on the RBANS list learning subtest, compared to this study’s z = -1.03, and 
27.6%. This would accord with vascular-type frontal lobe damage, as the frontal lobe 
has been linked with episodic memory encoding (Habib et al., 2003). A relationship 
between better immediate memory/new learning and learning to use a prosthesis has 
already been demonstrated in the literature (S. Larner et al., 2003), while an errorless 
learning intervention reduced errors related to prosthesis use (Donaghey et al., 
2010). Immediate memory and new learning are important factors on LLA 
rehabilitation programmes. A host of new skills need to be learned, such as donning 
and doffing prostheses, learning appropriate gait patterns, and learning how to 
ambulate in everyday environments. The present study contributes to evidence of 
immediate memory/new learning deficits in the lower limb amputation population, 
and provides data across a range of immediate memory measures. Awareness of 
immediate memory impairment in this population allows clinicians to adapt service 
delivery accordingly – use of repetition and memory aids are examples of potential 
adaptations.  
 
5.5.6.2 Short-Delay Recall: Encoding/Rehearsal 
Mean short delayed free recall score was not significantly poorer than the normative 
mean, but a significantly greater proportion (26%) of the sample had scores in the 
impaired and borderline ranges. Short delayed free recall has not been assessed in 
people with amputations, nor to this author’s knowledge, in similar dysvascular 
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samples. These findings indicate that for a substantial proportion of this population, 
encoding/rehearsal of new information may be more susceptible to distraction than 
in the general population. Rehabilitation environments are often busy – the 
physiotherapy gym being one example. Reducing distraction in rehabilitation may 
help some service users to retain learned information that may otherwise be 
forgotten.  
 
5.5.6.3 Delayed Recall and Recognition 
There are multiple lines of evidence to suggest that delayed recall for both verbal 
information and visual information is impaired in this sample. Long delayed list 
recall and story recall mean scores were significantly lower than normative means 
across all six assessments administered, with significant proportions of scores in the 
impaired/borderline ranges; 27 – 32% for lists, 23 – 34% stories (the WMS is 
considered a more difficult assessment than the RBANS). Delayed visual recall was 
significantly poorer than in the norms with almost a quarter of scores in the 
impaired/borderline range. Recognition and cued recall were impaired also. Both 
RBANS list recognition and CLVT long delay cued recall mean score were 
significantly lower than the normative mean. Wide prevalence of retrieval 
difficulties was suggested by 36% (cued) and 41% (recognition) of scores lying in 
the borderline/impaired ranges. 
 Williams et al. (2014) measured RBANS delayed list recall across three time 
points, starting from time of amputation. They found that people with amputations 
obtained mean z scores ranging of -1.0 to -.48, with from 30% to 9% of the sample 
impaired. This was compared to this study’s -.90, and 14.5%.  
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The findings of the current study are in accordance with findings of 
significant and substantial impairment of delayed memory in VCI-ND in recent 
meta-analysis (Vasquez & Zakzanis, 2015), and contrast with earlier findings 
indicating that recognition memory is relatively intact in VCI (Erkinjuntti, 2008) and 
in diabetes (Mehrabian et al., 2012), and that cued recall in very elderly participants 
was not associated with vascular pathologies (Wahlin, Nilsson, & Fastbom, 2002).  
Delayed memory has potential to affect a range of rehabilitation outcomes 
and rehabilitation engagement. This includes remembering steps in donning, using, 
and maintaining prostheses, remembering therapeutic instructions, and remembering 
social engagements. Awareness of delayed recall, delayed recognition, and even 
cued recall impairments will help clinicians to tailor service delivery to individual 
needs, and encourage confirmation that information has been retained. It also may 
encourage research into cognitive rehabilitation for people with LLA.  
 
5.5.7 Visuospatial Perception and Construction 
Approximately a quarter of participants’ scores are borderline or impaired on 
visuospatial perception (22% VOSP to 25% RBANS line orientation). 43% of those 
who completed the RBANS figure copy were borderline or impaired, suggesting 
widespread difficulty with visuospatial construction ability. Visuospatial functions 
are largely dependent upon the posterior cortex – the parietal lobe in particular. 
White matter lesions, as are seen in cerebral small vessel disease, though most 
prevalent in frontal lobe regions are also present in the parietal lobe (Tullberg et al., 
2004). Additionally, lesion volume in the parietal cortex grows at a faster rate as 
cerebrovascular disease progresses to the latter stages (i.e. it ‘catches up’ with frontal 
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lesion volume) (Tullberg et al., 2004). Strategic stroke may also affect superior 
parietal cortical regions (Paul et al., 2005), associated with the dorsal ‘where’ stream 
of visuospatial processing.  
 Waldstein et al. (2003) found that people with PVD did not have significantly 
different visuospatial perception (line orientation) than controls. In this study, 
significantly more participants (22%) than expected were borderline or impaired, 
although the group as a whole was not significantly different from the normative 
population. It is difficult to interpret the VOSP results in the absence of normative 
values. Nonetheless, 14% of those who completed the VOSP failed the task, whilst 
another 14% borderline-passed. In a normative sample, 7% of scores would be 
expected to be in the borderline or impaired ranges. At four times that amount in 
total, these proportions would suggest that a greater number of participants than 
might be expected had difficulties with visuospatial perception.  
Results from this study would also suggest widespread impairment in 
visuospatial construction; 43% of those who completed the RBANS figure copy had 
scores in the borderline or impaired ranges. People with vascular cognitive 
impairment have been shown to have poorer visuospatial construction than controls 
(Nordlund, Rolstad, Klang, et al., 2010). Phillips et al. (1993) also reported a trend 
toward poorer visuospatial construction performance in lower limb amputation, 
although the finding was non-significant. Visuospatial construction has been 
conceptualized as a higher order visuospatial function that additionally recruits 
motor function and planning (Paul et al., 2005). Difficulties in planning (which are 
present in this sample – see below) may thus contribute additionally to visuospatial 
construction deficits. Overall, the difference between the more basic visuospatial 
perceptual functions – showing some impairment with inconclusive findings – and 
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the much more widespread difficulties with visuospatial function may result from the 
effects of white matter damage (Paul et al., 2005). Subcortical white matter lesion 
damage would impair the ability to draw upon the functions necessary to complete 
construction tasks, e.g. planning and psychomotor functioning. Additionally, deficits 
in processing speed as a result of white matter damage might result in the required 
information not being present within the allotted time limits.  
Visuospatial functions may affect abilities to correctly perceive and 
manipulate complex prosthetic components or items in the occupational therapy 
kitchen. Impaired visuospatial perception in the community may affect judgement of 
terrain, gravel, curb height, steps, or gaps between the curb and the modes of 
transport, et cetera. It may thus make community ambulation, independent travel, or 
other activities difficult. Difficulties with independent travel may subsequently 
contribute to social isolation and lack of community participation. Research is 
warranted into the potential effects of visuospatial function on a range of 
rehabilitation outcomes.  
 
5.5.8 Language 
The lack of availability of standardised scores makes it difficult to interpret Graded 
Naming Test results. However the mean raw score obtained here was lower than that 
which has been observed in vascular dementia (Graham et al., 2004), yet slightly 
higher than the mean score in a small LLA sample that was not significantly 
impaired relative to controls (Phillips et al., 1993). On RBANS picture naming, the 
mean score was not significantly different from the normative mean, but a greater 
percentage of the sample had scores in the borderline and impaired ranges than 
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would be expected. This suggests some impairment in this sample. Garrett et al. 
(2004) found that although a VCI-ND sample had poorer confrontational naming 
than elderly controls, the mean score was within the normal range, and scores were 
not significantly different. Selnes and Vinters (2006) comment that language 
functioning is generally relatively preserved in cases of subcortical vascular disease. 
Their findings tally somewhat with the findings of the current study – a relatively 
preserved confrontational naming ability. Language abilities are largely dependent 
upon temporal lobe structures. The temporal lobes are, compared to the frontal lobes, 
considered to be relatively spared of subcortical white matter damage (Tullberg et 
al., 2004). Language functions may thus be relatively spared in LLA populations 
admitted to rehabilitation programmes. While some service users may have 
difficulties, language comprehension and expression is likely to be a relative strength 
of this population. One caveat is that such preservation of language function can 
obscure the presence of impairment in other cognitive domains.  
 
5.5.9 Executive Functions 
As noted by Hachinski, Iadecola, and Petersen (2006), impairment in executive 
functioning is common in people with vascular cognitive impairment. Thus it is 
reasonable to suspect that there will be impairment of executive functions in this 
sample. Indeed, two of the three core executive functions – working memory, 
inhibition, and cognitive flexibility (set shifting) (Diamond, 2013; Miyake et al., 
2000) – were impaired in this sample. Working memory was not impaired, but this 
was likely a result of measurement. 45% of cognitive flexibility scores (trail making 
number-letter switching) and 38% of inhibition scores (colour-word switching) were 
in the borderline and impaired ranges. In addition to impaired inhibition and 
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cognitive flexibility, significant proportions of this sample had scores in the impaired 
range on verbal fluency tests. Verbal fluency tasks assess organization of 
information/initiation of retrieval strategy and self-monitoring. There were 
widespread difficulties with planning: 88% (n = 36) of scores were in the ‘impaired’ 
or ‘borderline’ range.  
 
5.5.9.1 Working Memory  
Results from the WAIS-IV digit span, a working memory task with combined digit 
forward, backward, and ordered conditions, did not differ significantly from 
normative values. It is possible that working memory is not impaired in this sample 
as a group. However, working memory is dependent upon the dorsolateral prefrontal 
cortex, and tasks dependent upon the frontal lobes are expected to be impaired in this 
sample – much as the other executive functions are.  
It has been argued that digit forward assesses different constructs to digit 
backward and is likely not a good measure of working memory (Lezak et al., 2012). 
Digit forward assesses attention span, or the amount of information which might be 
held within working memory, but without requiring the manipulation of information 
typical of working memory. The digit forward condition of the WAIS-IV digit span 
is very similar to the RBANS digit span subtest used to assess attention span (see 
section 5.3.4.3 Span of Attention in this chapter). Attention span was not impaired in 
this sample, and this may have contributed in part to inflation of working memory 
scores. It did not differ significantly from normative values either (see Table 15) 
indicating that attention span/working memory capacity was not impaired in this 
sample either. 
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A number of studies have reported impairments in dysvascular populations 
without amputation. In a meta-analysis, while Vasquez and Zakzanis (2015) found 
working memory to be impaired in VCI-ND compared with controls, it was the least 
impaired of functions. Within the meta-analysis, digit forward conditions were 
included as measures of working memory. Working memory impairment has been 
reported when using digit backward alone, in MRI-diagnosed cerebral small vessel 
disease (O’Sullivan, Morris, & Markus, 2005), VCI-ND (Nordlund et al., 2007), and 
symptomatic PVD compared to controls (Mangiafico et al., 2006).  
When digit conditions have been combined, similar to this study, dysvascular 
populations have not been found to be impaired. Arvanitakis, Wilson, Li, Aggarwal, 
and Bennett (2006) used digit forward, backward, and ordered, yet reported no 
significant differences in working memory in people with diabetes (n=116). This is 
also true in studies of people with dysvascular amputations. Williams et al. (2014) 
used a combination of digit forward and backward (WAIS-III). They reported that 
0%, 1.2%, and 0% of participants with dysvascular amputations had impaired (z = -2 
or lower) working memory at pre-surgery, and six weeks and four months post-
amputation, respectively. Phillips et al. (1993) used the same measure as Williams et 
al. (2014) and found no impairment in their small sample.  
Using other measures of working memory, Raz, Rodrigue, Kennedy, and 
Acker (2007) found that dysvascularity (baseline hypertension and subsequent 
vascular pathologies) was a contributor to poorer verbal working memory. Using an 
n-back task, Dahle, Jacobs, and Raz (2009) found that vascular risk factors were 
linked to reduced working memory accuracy and slowed working memory 
processing respectively.  
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Overall, evidence suggests that the inclusion of digit forward in working 
memory measures may lead to underestimation of the level of working memory 
impairment. Future investigations of working memory in people with lower limb 
amputations should consider using a digit backward or ordered task, or an n-back 
task (Lezak et al., 2012) rather than a measure in which is digit forward is 
inseparable from other conditions.   
 
5.5.9.2 Inhibition 
38% of scores on the measure of response inhibition (DKEFS colour-word 
switching), were in the borderline or impaired group, compared to non-significant 
proportions in the same ranges for associated tests of simple information processing 
(DKEFS colour naming and word reading). This suggests that difficulties in 
response inhibition are highly prevalent in this sample, separately from attention 
difficulties. Nordlund et al. (2007) also found significantly poorer inhibition in those 
with vascular cognitive impairment than controls. Schoppen et al. (2003) 
documented widespread difficulties with inhibition in people with lower limb 
amputations using a similar task to the one in this study. Inhibition on colour-word 
switching (i.e. Stroop tasks) is related to the lateral and superior medial frontal lobes, 
the anterior cingulate cortex, and potentially a range of other frontal and non-frontal 
areas (Alvarez & Emory, 2006). Inhibition is an important component of executive 
functions (Diamond, 2013). Lower inhibition was correlated with activity restriction, 
but not a predictor of same in Schoppen et al.'s (2003) LLA study. Impairments may 
have an effect on social behaviour, affecting participation and social support.  
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5.5.9.3 Cognitive Flexibility 
This study used a trail making number-letter switching task to assess cognitive 
flexibility (set-shifting). Cognitive flexibility was the second most-frequently 
borderline or impaired cognitive function (47%). Cognitive flexibility requires the 
frontal lobe (Demakis, 2004). Using the same assessment, cognitive flexibility has 
been found to be significantly poorer than controls in people with cerebral small 
vessel disease (O’Sullivan et al., 2005), in VCI-ND (Garrett et al., 2004), and in 
women with diabetes (Yaffe et al., 2004). Rao, Jackson, and Howard (1999) found 
that while there were not significantly different group means, 25% of patients with 
PVD (without history of stroke) had scores within the bottom 5% of controls’ scores. 
The findings from this study broadly accord with these previous findings in related 
populations. There is much greater prevalence of impairment in this study compared 
to that in Rao et al.'s (1999): 47% of test completers had flexibility scores in the 
borderline or impaired range. Rao et al.'s (1999) sample was older, but may have had 
cerebrovascular disease that had not progressed as far as it had in the vascular group 
in this study. With less systemic vascular disease, there may have been less 
impairment. Cognitive flexibility is an important aspect of executive functioning 
(Diamond, 2013; Miyake et al., 2000). It underlies creative thinking and the ability 
to adapt to changing conditions. It is therefore potentially important in managing 
participation on busy rehabilitation programmes and in negotiating community 
living.   
 
5.5.9.4 Self-Monitoring and Retrieval Strategy (Verbal Fluency) 
Three measures of verbal fluency were used in this study: two of category fluency 
(RBANS semantic fluency which had one response condition and DKEFS category 
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fluency which had two response conditions), and one of letter fluency (DKEFS letter 
fluency). All three were impaired in this sample, both in terms of means and 
proportions impaired. Category fluency is sensitive to lesions of both the frontal and 
temporal lobes, while letter fluency is sensitive to lesions of the frontal lobe but less 
so the temporal lobe (Henry & Crawford, 2004).  
Verbal fluency measures are sensitive to frontal and/or temporal lobe 
damage. Yet, as verbal fluency measures rely on a number of different processes, it 
is difficult to ascertain which cognitive functions might be contributing to task 
deficits. Semantic fluency tests may be affected by lesions in either frontal or 
temporal lobes (Henry & Crawford, 2004). Carew, Lamar, Cloud, Grossman, and 
Libon (1997) found that performance deficits on verbal fluency tasks, for persons 
with dementia of vascular origin, were likely due to impaired retrieval
21
. Interfacing 
with long-term memory is a feature of Baddeley’s working memory model of 
executive function (A. Baddeley, 2007). Verbal fluency was separable from Miyake 
et al.'s (2000) three core executive functions in Fisk and Sharp's (2004) examination 
of the model, probably representing connection with long-term memory similar to 
what Baddeley had in mind.   
 Garrett et al. (2004) found that a VCI-ND sample had verbal fluency scores 
no different from elderly controls. Mehrabian et al. (2012) found that participants 
with type II diabetes had significantly poorer letter fluency, but not category fluency 
than controls. Rao et al. (1999) found that while there were not significantly different 
group means, 25% of participants with PVD had scores within the bottom 5% of 
controls’ scores. Williams et al. (2014) found that 7.5% of participants 4 months 
post-amputation had impaired organization of information and self-monitoring 
                                                 
21 The authors note that impaired mental flexibility may also contribute to these deficits. 
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(category fluency). This compares with 22% of participants in this study on the same 
measure (RBANS semantic fluency), and 8.8% on the two-trial measure (DKEFS). 
As the two-trial measure is more comprehensive, this is possibly more likely to 
reflect the true rate of impairment in this sample. It may also be the case that the 
sample had become more familiar with fluency tests during the assessment period, 
and the former is more reflective of the level of impairment. Reasons for different 
rates of impairment between these comparable samples are unclear, although 
exclusion of participants from the Williams et al. (2014) study for low scores on a 
cognitive screen may be a contributory factor. Phonemic/letter fluency had not yet 
been assessed in LLA.  Understanding difficulties with these aspects of executive 
function may offer insight into how people with LLA use executive-directed 
memory and self-monitor behaviours. Higher verbal (semantic) fluency ability has 
previously been associated with more hours spent ambulating with prosthesis 
(Williams et al., 2015).   
 
5.5.9.5 Planning 
Whilst caution must be exercised in interpreting planning/problem solving (BADS 
zoo map) results, due to the pro-rated nature of the classifications, 88% (n = 36) of 
those who completed the BADS zoo map were classified as either ‘impaired’ or 
‘borderline’. Thus, a clear majority of participants had difficulty completing the 
tasks correctly, suggesting difficulties with the executive function of planning.  
Planning has not been assessed in a dysvascular sample, to my knowledge, nor has it 
been assessed in a sample with lower limb amputations. The presence of impaired 
planning ability is not unexpected. Planning, as an executive function, is likely 
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largely dependent up the frontal lobes. It likely also draws on other cognitive 
functions. Impairment in these functions would likely affect planning efficacy.   
 
5.5.10 Cognitive Functioning: Overarching Discussion 
The overall picture which emerged of cognitive functioning is consistent with 
findings in the literature of a preponderance of frontal lobe and subcortical white 
matter damage in cerebrovascular disease. Subcortical ischaemic vascular disease 
(SIVD) is a common form of vascular cognitive impairment (Wahlund et al., 2009), 
and expected to be most common in this sample (i.e. a sample with vascular 
pathology but without incident of stroke or vascular dementia). White matter 
hyperintensities resulting from SIVD are higher in volume in the frontal lobes, 
though they may be present in all regions (Tullberg et al., 2004). Subcortical white 
matter hyperintensities may also be linked to hypometabolism/atrophy of cortical 
regions to which they are linked (Tullberg et al., 2004). The location and size of 
cerebrovascular lesions differs on a person-by-person basis. Lesions in in the frontal 
lobes and in subcortical white matter may affect functions including overall 
cognitive functioning, information processing speed, attention to stimuli, encoding to 
and retrieval from memory, visuospatial construction, and executive functions.   
Psychomotor speed and information processing are dependent upon the 
integrity of subcortical white matter (Gunning-Dixon & Raz, 2000), while executive 
functions and are impaired in the presence of white matter lesions or lacunes 
(Geerlings, Appelman, Vincken, & Mali, 2009). Many cognitive functions are 
dependent upon frontal lobe structures, including: executive functions (Alvarez & 
Emory, 2006), attentional functions such as focused and sustained attention (Lezak 
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et al., 2012; Petersen & Posner, 2012; Stuss & Levine, 2002), and memory encoding, 
retrieval, and recognition (e.g. Davidson, Troyer, & Moscovitch, 2006; Habib, 
Nyberg, & Tulving, 2003). Fluid reasoning is also dependent upon a range of frontal 
lobe (and parietal, temporal and occipital) areas within a fronto-parietal network 
(Jung & Haier, 2007). Functions that are highly dependent on the frontal lobe are 
also dependent on white matter integrity, as it is heavily linked to other cortical and 
subcortical regions (Tullberg et al., 2004). Indeed, it is these functions which are 
impaired in this sample. A recently published meta-analysis found that impairment is 
evident across the spectrum of cognitive functions in VCI-ND (Vasquez & Zakzanis, 
2015). Processing speed was the most affected area of functioning, whilst 
visuospatial construction and working memory were the least impaired – but still 
worse relative to controls. When compared with non-vascular mild cognitive 
impairment, there was greater impairment in aspects of executive functioning in 
VCI-ND, but relatively less impairment in terms of delayed memory. A pattern of 
impairment across a wide range of domains is similar to what is seen in this sample.  
Results in the current study also suggest some impairment in terms of 
visuospatial perception, and language/confrontational naming. As vascular cognitive 
impairment progresses and additional cortical areas suffer damage, additional areas 
of functioning become impaired. While impairment is often generalised across a 
broader range of cognitive domains in the latter stages of VCI – vascular dementia – 
relatively less impairment is to be expected in the earlier stages in language and 
perceptual functions (Garrett et al., 2004; Paul, Cohen, Ott, & Salloway, 2005). 
Visuospatial functions are largely dependent upon the parietal lobes, while language 
functions are quite dependent upon the temporal lobes. Temporal and parietal 
regions, upon which language and visuospatial processes depend, are generally 
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affected later in the SIVD process than frontal regions. Separately, impairment of 
visuospatial construction, often impaired in vascular dementia, may be partially 
influenced by impairment of planning ability (Paul et al., 2005). Indeed, impaired 
executive functions have previously been shown to affect performance of a range of 
other cognitive functions in both mixed neurologically impaired and non-impaired 
samples (Burgess, Alderman, Evans, Emslie, & Wilson, 1998). This tallies with the 
idea that executive functions mediate ‘how’ other cognitive functions are expressed 
(Lezak et al., 2012). Confrontational naming also requires access to semantic 
memory for objects – again most associated with temporal lobe structures. In this 
sample, scores did not differ from the norm on the confrontational naming 
assessment with everyday/high frequency objects (RBANS naming subtest). There 
was more evidence of confrontational naming difficulty on the more difficult naming 
assessment – one with line drawings of many uncommon/low frequency objects – 
but comparisons to norms were not possible. Naming impairment may be a 
consequence of impaired information processing due to presence of white matter 
hyperintensities (Paul et al., 2005).  
Relatively low processing burden may explain why some of the cognitive 
functions were not impaired in terms of mean scores. Attention span was assessed 
with a relatively easy task – forward digit span – that is more less likely to be 
impaired prior to the moderate stage of dementia (Lezak et al., 2012). For 
immediate/short-delay recall memory tasks, it was the less demanding of two 
immediate list tasks and a 30-second delayed semantically-related list recall that 
were not impaired. This suggests that new learning/immediate memory tasks with a 
lower processing burden – lists with repeated trials (as opposed to narratives) and 
semantically related lists – are more manageable in this sample. Confrontational 
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naming of everyday objects (RBANS naming) is also not particularly demanding, 
and neither was the VOSP spatial perception task, a task with a low ceiling in the 
normative sample. The higher frequency of impaired and borderline scores than in 
normative populations on these tasks with low processing burden suggests perhaps 
the presence of subgroup of participants who were particularly impaired. A small 
cohort of such participants, with difficulties in these areas otherwise unimpaired in 
the sample, may not have been sufficient to significantly reduce the overall mean 
score. Relative preservation of some language and spatial perception functions is not 
unexpected; as Brandt and Munro (2004, p. 135) state succinctly, “frank aphasia, 
apraxia, agnosia and amnesia are rare” in subcortical dementing processes. These 
less effortful aspects of cognitive functioning may represent relative strengths in this 
population, and may mask other difficulties with executive functioning.   
Measurement issues may have contributed to the absence of findings of 
impairment in two of the three areas that did not show impairment in this sample in 
terms of mean scores or proportions impaired. Findings of no difference in working 
memory performance compared to norms do not fit with the profile of vascular 
cognitive impairment. Working memory is dependent upon frontal lobe regions and 
fronto-striatal circuits (e.g. D’Esposito & Postle, 2014). It may be the case that the 
measure used, WAIS-IV digit span, is not sensitive enough to subtle vascular 
changes that may be evident in this group. Divided attention was also not impaired in 
this sample. Again, this may be due to the TEA telephone search with counting 
(Robertson, Nimmo-Smith, Ward, & Ridgeway, 1994) measure not being 
sufficiently sensitive for use with this sample.  
Other factors may have affected performance on neuropsychological 
assessments. Older age was significantly related only to the Montreal Cognitive 
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Assessment cognitive screen, and a test of visuospatial perception (RBANS line 
orientation). Age-normed scores were used for almost all measures, but the Montreal 
Cognitive Assessment was an exception to this. Unlike the rest of the battery, this 
cognitive screen may be sensitive additionally to normal age-related cognitive 
changes.  Education was significantly correlated with assessment results across most 
tests. Educational attainment may have contributed to better scores via familiarity 
with test scenarios. Educational attainment may also have contributed to cognitive 
reserve. Cognitive reserve may take the form of optimization of normal performance 
or compensation via use of alternative brain structures in cases of brain damage 
(Stern, 2002). Higher educational attainment is frequently used as a measure of 
reserve and has frequently been linked to greater preservation of function in cases of 
brain damage (Giogkaraki, Michaelides, & Constantinidou, 2013; Stern, 2002). In 
cases of vascular dementia, education moderated the relationship between 
subcortical white matter hyperintensity volume and cognitive function (Lane, Paul, 
Moser, Fletcher, & Cohen, 2011). Nevertheless, time spent in education is unlikely 
to fully account for either the high frequency of impairment or the amount of deficit 
in this sample relative to normative populations.  
 
5.5.12 Reasons for Impairment in the Non-vascular Group 
Differences between the vascular and non-vascular aetiology groups were not 
significant across neuropsychological functions. Ostensibly, this lack of differences 
was not because the vascular group performed well but because the non-vascular 
group performed poorly. An examination of comorbidities revealed that a third of the 
non-vascular amputation aetiology group had vascular risk factors – including 
diabetes, hypertension, and cardiovascular disease. Such risk factors have been 
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associated with cerebrovascular pathology and cognitive impairment (Cheng et al., 
2012; Reijmer et al., 2010; Roberts et al., 2010; Sierra, Doménech, Camafort, & 
Coca, 2012). Thus, some in the non-vascular aetiological group may thus also have 
had vascular cognitive impairments. A higher rate of traumatic amputation incidence 
has been previously recorded in people with diabetes than without (Fosse et al., 
2009). This, and a majority of the non-vascular group being in mid-life or older, may 
explain why so many had vascular risk factors. One participant in the non-vascular 
group had a traumatic brain injury – a frontal haematoma. A frontal lobe injury could 
produce a similar profile of impairments as vascular cognitive impairment, such as 
difficulties in areas of attention and executive function. This was borne out by an 
examination of this participant’s profile of neuropsychological assessment results. 
Differences in group sample size may also have affected the ability to detect group 
differences – there were just 18 non-vascular participants compared to 69 vascular 
participants. Thus, the aetiological groups were not split for subsequent analyses (i.e. 
analyses in chapter 5). 
 
5.5.11 Limitations  
Variability in the completion rates for neuropsychological assessments was a 
limitation of the present study. Lower completion rates were largely related to 
restrictions in scheduling and availability of participants for research, early discharge 
from rehabilitation back to acute hospital settings, refusal (ostensibly due to fatigue), 
and the length of time required to complete the assessment battery. Fractionation of 
testing sessions due to test-fatigue and scheduling difficulties has been previously 
reported (Phillips et al., 1993). This was the only other study to employ a 
comparably comprehensive neuropsychological assessment. Low completion rates 
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mean potential for sampling bias exists. Furthermore, it reduces the ability to 
examine bivariate relationships with rehabilitation outcomes, and curtails the utility 
of the neuropsychological assessment in predicting rehabilitation outcomes. The 
large difference in aetiology group sizes, though an expected consequence of 
studying consecutive admissions to limb loss rehabilitation, makes statistical 
comparison between aetiology groups difficult. The choice of the WAIS-IV digit 
span as a measurement of working memory may be confounded by the integrated 
attention span measure. An n-back or digit backward only task may be a more 
appropriate measure of working memory for any future research. A further limitation 
of this study is the absence of imaging data for the participants. National 
Rehabilitation Hospital POLAR service users are not routinely referred for brain 
imaging, unless significant impairment on neuropsychological assessment and 
significant concerns regarding functioning are noted. Future research could benefit 
from incorporation of brain imaging and linking this to neuropsychological 
assessment findings.  
 
5.5.12 Cognitive Profile in a Sample with Lower Limb Amputations: Conclusion  
This study was the first to assess cognitive functioning in lower limb amputation 
with such a broad battery of standardised neuropsychological assessments. It was 
also the first study to employ a battery that is also sensitive to the most frequent 
cognitive sequelae of cerebrovascular disease – impaired information processing, 
attention, and executive functions. For example, simple and complex measures of 
information processing, sustained, focused, and divided attention, cognitive 
flexibility, inhibition, and planning were measured for the first time in this 
population. This study obtained, for the first time, an estimation of premorbid 
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cognitive functioning. The study also incorporated a brief cognitive screen – the 
MoCA – which is considered to be more sensitive to vascular disease sequelae but 
had not yet been reported in the research with this population.  
 The study provides evidence for indication of comprehensive 
neuropsychological assessment in at least half of people with lower limb 
amputations, based on findings from the use of a brief cognitive screen. This study 
provides evidence that impaired cognitive functioning is widespread in the 
population of people with lower limb amputations. Evidence is presented for a 
profile of cognitive functioning that is largely consistent with vascular cognitive 
impairment. This includes frequently impaired overall cognitive functioning, fluid 
reasoning (visuospatial and verbal), information processing (especially 
complex/time-pressured), attention (including sustained and focused), memory 
(including immediate and delayed recall and delayed recognition, susceptibility to 
distraction), spatial perception and visuospatial construction, naming of low 
frequency objects, and executive functions (including inhibition, cognitive 
flexibility, and planning). This study provides evidence that even persons admitted to 
lower limb amputation rehabilitation for non-vascular aetiologies may have 
difficulties with cognitive functions – potentially resulting from comorbid vascular 
risk factors, ageing, or acquired brain injury. There is evidence that referral for 
comprehensive neuropsychological assessment is warranted in many cases in order 
to understand the nature and extent of cognitive functioning and impairment, to 
identify relative strengths and weaknesses, to identify its impact on rehabilitation 
and everyday functioning, and to support rehabilitation plans as best as possible. 
Potential implications of these findings are manifold. Understanding of the 
difficulties with cognitive functioning present in LLA may inform potential research 
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on cognitive rehabilitation interventions to improve cognitive functioning or 
ameliorate any ill effects of impaired cognitive functioning. This is discussed further 
in Chapter 7. 
 
5.6 Considerations for Further Research 
Questions arise as to whether impairments of cognitive functioning affect 
rehabilitation outcomes, including prosthetic, mobility, and psychosocial outcomes. 
Relationships between cognitive functioning and rehabilitation outcomes have been 
examined previously, but only a limited range of outcomes have been examined 
overall. Studies have tended to focus on outcomes relating to prosthesis use, 
mobility, falls, independence, and mortality. Examinations of a wider range of 
outcomes better representing the multifaceted nature of functioning and health are 
warranted. Whether cognitive functioning is related to engagement in rehabilitation 
itself also warrants study.  
Prosthesis use/non-use or successful/unsuccessful fit (Bilodeau et al., 2000; 
Fletcher et al., 2001; Kurichi et al., 2007; S. Larner et al., 2003; Pinzur et al., 1988; 
Taylor et al., 2005) and hours of prosthesis use (O’Neill & Evans, 2009; Williams et 
al., 2015) has been the most frequently examined outcome in relation to cognitive 
function. Cognitive functioning and mobility/ambulation have also been examined in 
people with LLA (Chiu et al., 2000; Hanspal & Fisher, 1991, 1997; Heinemann et 
al., 1994; O’Neill & Evans, 2009; Schoppen et al., 2003). However, no study has 
examined the relationship between cognitive function and prosthesis satisfaction. 
Impaired cognitive functioning can result in difficulties donning, doffing, and 
learning to use prostheses (Donaghey et al., 2010). Such difficulties are likely to 
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impact upon prosthetic comfort and utility, reducing prosthetic satisfaction. Impaired 
cognitive functions – especially executive functions which would drive goal-directed 
behaviour (Lezak et al., 2012) – may also impact a person’s ability to maintain 
prosthesis, identify issues with prosthetic fit, or initiate the process of a prosthetic 
refit when appropriate.  
Where rehabilitative success or failure was examined (Aftabuddin et al., 
1997; Couch et al., 1977), it was defined solely in terms of prosthesis use and/or 
ambulation. Little attention has been given to psychosocial rehabilitation outcomes. 
As participation in valued activities is considered an important outcome by people 
with amputations (Gallagher et al., 2011) and is an acknowledged component of 
health and quality of life (World Health Organization, 2001), it should be considered 
part and parcel of ‘rehabilitative success’. While Williams et al. (2015) found that 
aspects of cognitive functioning predicted participation, a narrow measure of 
participation was used examining only frequency of participation and not whether 
activities were valued. The relationship between cognitive functioning and 
participation enfranchisement (Heinemann et al., 2013) has not been measured in 
people with lower limb amputations. Participation enfranchisement includes self-
rated control over participation and importance and meaningfulness of participation. 
Adjustment following amputation and to prostheses has received much 
research attention in recent years (Coffey, 2012; Horgan & MacLachlan, 2004; 
Sinha, van den Heuvel, & Arokiasamy, 2014), but its relationship with cognitive 
functioning has yet to be investigated. Healthcare activation (which includes self-
management, negotiation of the healthcare system, engagement in behaviours which 
maintain health, etc.) is important, especially in community living post-
rehabilitation. The relationship between cognitive functioning and activation has not 
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yet been examined. People with executive dysfunction generally have difficulties 
engaging in goal directed behaviours (Lezak et al., 2012), which are an important 
feature of activation.   
Prospective examinations of the relationship between cognitive functioning 
and outcomes are rare. Most studies employ cross-sectional or retrospective designs 
(Coffey et al., 2012). Of those prospective studies that do exist, O’Neill and Evans 
(2009) examined outcomes at six months post-first prosthetic clinic attendance and 
Williams et al. (2015) examined outcomes only at 12 months post-amputation. 
Therefore, it is necessary to examine the relationships between cognitive functioning 
and rehabilitation outcomes over time. A number of months may pass from 
amputation to admission to rehabilitation. Measurement of outcomes from the point 
of discharge from rehabilitation may avoid bias resulting from early or delayed 
commencement of rehabilitation. Examining outcomes across one year from 
discharge (e.g. at discharge, 6 months and 12 months) may provide useful 
information on the longer-term relationships between cognitive functioning at 
admission and rehabilitation outcomes. 
It is also important to note that when relationships between cognitive 
functioning and rehabilitation outcomes have been examined, it has not been with 
the use of a broad range of cognitive functions. Studies have tended to use brief 
cognitive screens; most frequently the MMSE (Folstein et al., 1975). The MMSE is 
not particularly sensitive to mild cognitive impairments, nor the likely profile of 
vascular cognitive impairment (Damian et al., 2011; Pendlebury et al., 2012). Recent 
examination of cognitive functioning and rehabilitation outcomes by Williams et al. 
(2015) used a more comprehensive neuropsychological assessment including a 
cognitive screen, learning, delayed memory, working memory and category fluency. 
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However, the assessment did not include a broad measure of overall cognitive 
functioning, or measures of complex information processing, or visuospatial 
construction. While the study did include measures of working memory and verbal 
fluency, opportunities exist to examine other aspects of executive functioning. 
O’Neill & Evans (2009) also used a battery of neuropsychological assessments, 
although many of these were subtests from the ACE brief cognitive screen, or from 
the – albeit more comprehensive – RBANS overall cognitive functioning screening 
battery.  
Of interest also is how cognitive functioning might affect the lower limb 
amputation rehabilitation process. Rehabilitation engagement – the extent to which 
participants are actively involved in rehabilitation activities – is one measure of the 
rehabilitation process. Relationships between rehabilitation engagement and 
outcomes have been demonstrated previously (Kortte et al., 2007). Rehabilitation 
engagement has not been assessed in a sample comprising solely of people with 
lower limb amputations. Relationships between cognitive functioning and 
rehabilitation engagement have not been researched previously. Impaired ability to 
process information in a busy/time-pressured environment, to recall instructions or 
procedures, to switch from one important task to another (cognitive flexibility), and 
ultimately engage in goal directed behaviour may affect engagement in rehabilitation 
activities. Chapter 6, which follows, attempts to address relationships between 
cognitive functioning and rehabilitation engagement and rehabilitation outcomes. 
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6  
 
COGNITIVE FUNCTIONING AND 
REHABILITATION 
ENGAGEMENT AND 
PROSTHETIC, MOBILITY AND 
PSYCHOSOCIAL 
REHABILITATION OUTCOMES 
IN PEOPLE WITH LOWER LIMB 
AMPUTATIONS  
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6.1 Relevant Objectives 
 
This chapter addresses the second aim of the present research, namely to assess the 
relationships between cognitive functions and prosthetic, mobility, and psychosocial 
outcomes, and rehabilitation engagement in people with lower limb amputations in a 
rehabilitation programme. There were six objectives associated with this chapter; 
these are outlined below.  
 
6.1.1 Objective 3 
The third objective of the overall study was to investigate changes in prosthetic, 
mobility and psychosocial constructs longitudinally, from discharge (time 2/T2) to 
six months (time 3/T3) to 12 months (time 4/T4).
22
  
 
6.1.2 Objective 4  
The fourth objective was to investigate whether rehabilitation engagement was 
associated with prosthetic, mobility and psychosocial rehabilitation outcomes at 
discharge, six and 12 months.  
 
                                                 
22 The exceptions to this were the three aspects of participation (participation engagement, 
importance and meaning, control), for which changes are investigated from six to 12 
months, as participation constructs were not measured at discharge. 
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6.1.3 Objective 5 
The fifth objective was to examine the bivariate relationships between selected 
cognitive functions and both rehabilitation engagement and prosthetic, mobility, and 
psychosocial rehabilitation outcomes.  
 
6.1.4 Objective 6 
The sixth objective was to investigate whether, using hierarchical regression 
controlling for rehabilitation engagement, overall cognitive functioning and 
executive function predict prosthetic, mobility, and psychosocial rehabilitation 
outcomes at six months.   
 
6.1.5 Objective 7 
The seventh objective was to investigate whether participants with cognitive 
functioning scores in the impaired or borderline ranges have different rehabilitation 
engagement, prosthetic and mobility outcomes, or psychosocial outcomes than 
participants without impairment on these same functions at a) discharge from 
rehabilitation; and, b) from discharge, to six months, to 12 months.
23
 
 
6.1.6 Objective 8 
The final objective was to investigate whether there were differences in prosthetic, 
physical, or psychosocial outcomes, or rehabilitation engagement for participants 
                                                 
23
 Except the three aspects of participation (engagement, importance and meaning, control over 
participation), which are investigated from six months to 12 months, as they are not measured at 
discharge. 
CHAPTER 6: COGNITIVE FUNCTIONING AND REHABILITATION 
212 
 
with impairment on either a) both, b) one of, or c) neither of overall cognitive 
functioning and cognitive flexibility at discharge.   
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6.2 Cognitive Functioning and Rehabilitation Outcomes: Variable Selection 
 
In examining the relationship between cognitive functioning and rehabilitation 
outcomes, selection of measures sensitive to vascular cognitive impairment was 
deemed important. The following six aspects of cognitive functioning were selected 
for further analysis in terms of their relationship with rehabilitation engagement, and 
prosthetic, mobility, and psychosocial outcomes: overall cognitive functioning 
(measured by RBANS total index), complex information processing (WAIS-IV 
symbol search), delayed recall (WMS logical memory II), visuospatial construction 
(RBANS figure copy subtest), cognitive flexibility (TMT number-letter switching), 
and planning (BADS zoo map). The aforementioned functions and associated 
measures were chosen for the following reasons.  
The RBANS total index is the more comprehensive of two overall cognitive 
functioning measures included in this study. The other, the MoCA, is a brief 
cognitive screen, but was also completed by fewer participants. A measure of overall 
cognitive function may capture the breadth of difficulties across a range of cognitive 
domains that exists in vascular cognitive impairment (Vasquez & Zakzanis, 2015). 
In this sample, a third of participants had impaired or borderline scores in terms of 
overall cognitive functioning as measured with the RBANS total scale. A systematic 
review found overall cognitive functioning to be the most predictive of all aspects of 
cognitive functioning of activities (and occasionally participation) across a range of 
populations (Royall et al., 2007). In people with lower limb amputation specifically, 
overall cognitive functioning (measured four months post amputation, albeit with a 
cognitive screen which was likely insensitive to milder forms of cognitive 
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impairment) has been linked to mobility and social integration – participation – in a 
dysvascular sample 12 months post-amputation (Williams et al., 2015). 
White matter lesions play a prominent role in VCI (Black, 2011; Verdelho et 
al., 2010) and information processing is dependent upon cerebral white matter 
(Gunning-Dixon & Raz, 2000; Lezak et al., 2012). Information processing has been 
reported as the most impaired cognitive function in vascular cognitive impairment 
(Vasquez & Zakzanis, 2015). Indeed, a third of participants in this sample had 
impaired or borderline scores on the chosen measure of complex information 
processing (WAIS-IV symbol search). Processing speed has been linked with both 
activities and participation in a recent study of people with multiple sclerosis 
wherein the authors employed a very similar assessment to the WAIS-IV symbol 
search (Goverover et al., 2015). The WAIS-IV symbol search measure may also 
capture some difficulties with focused attention, and even working memory 
(Wechsler, 2008a).  
Delayed episodic recall impairment is a common feature of vascular 
cognitive impairment (Vasquez & Zakzanis, 2015). The WMS logical memory II 
assessment is the most comprehensive of the delayed memory assessments in this 
study. 34% of participants had scores in the borderline or impaired ranges on logical 
memory II in this sample. Delayed memory was found to be a predictor of mobility 
in people with lower limb amputations (O’Neill & Evans, 2009).   
43% of participants in this sample had scores in the borderline or impaired 
ranges on visuospatial construction. Visuospatial construction difficulties are often a 
feature of vascular cognitive impairment (Graham et al., 2004; Paul et al., 2005). 
Even if visuospatial construction is one of the least impaired functions in the earlier 
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stages of VCI (Vasquez & Zakzanis, 2015), it may capture cognitive impairments 
resulting from posterior cortical damage. Additionally, visuospatial construction may 
be affected by impairments in executive functions. The other measures in this study 
are mostly sensitive to frontal and subcortical damage. Visuospatial cognition has 
been linked with overall disability (Barnfield, 1997). Impaired visuospatial 
perception could have implications for the ability to ambulate in the community with 
potential consequences for participation and other psychosocial constructs like social 
support and overall adjustment.  
Executive functions are important in carrying out goal-directed behaviours. 
Impaired executive function is one of the hallmarks of vascular cognitive impairment 
(Hachinski et al., 2006; Moorhouse et al., 2010; Paul et al., 2005). The executive 
functions chosen for analysis were cognitive flexibility and planning. Planning 
(88%; BADS zoo map) and cognitive flexibility (47%; trail making number-letter 
switching) respectively were the executive functions with scores in the borderline or 
impaired ranges most and second-most frequently. Cognitive flexibility is one of the 
three core executive functions (Diamond, 2013; Fisk & Sharp, 2004; Miyake et al., 
2000). It represents the ability to ‘think outside the box’, change perspectives, and 
adapt to changing circumstances (Diamond, 2013, p. 135). Planning may be 
considered a higher order executive function which relies upon the three core 
executive functions – working memory, inhibition, and cognitive flexibility 
(Diamond, 2013). Both of these aspects of cognitive functioning were considered 
important in terms of facilitating functioning in the home and community 
environment in a sample of people with LLA. The ability to plan ahead and to adapt 
to changing circumstances is important in participation for example. People using 
lower limb prostheses may have difficulty accessing public transport, standing for 
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long periods of time, ambulating long distances, etc. and may need to plan journeys 
and adapt to unfavourable circumstances accordingly. Executive functions have been 
found to mediate the relationship between other cognitive functions and general 
functioning in people with cognitive impairment (O’Bryant et al., 2011), and to be 
stronger predictors of daily functioning than other cognitive domains (Royall et al., 
2007). In particular, Royall et al. (2007) found that executive function predicted a 
greater share of variance in more complex behaviours like household duties than 
simpler ADLs, suggesting the particular importance of executive function in 
complex community participation situations. Nordlund, Rolstad, Göthlin, et al. 
(2010) found that, of a range of executive functions, cognitive flexibility (including a 
trail making task) was the best predictor of vascular dementia. Some aspects of 
executive functioning have been measured previously in people with lower limb 
amputations. Working memory was not impaired in one study (Williams et al., 
2014)
24
, but was related to prosthesis use 12 months post-amputation (Williams et 
al., 2015). Impaired inhibition was documented by Schoppen et al. (2003) using a 
Stroop task. Verbal fluency tasks may represent another basic executive function, 
that of interfacing with long-term memory (Fisk & Sharp, 2004). Category fluency 
(a form of verbal fluency) has been linked with six month prosthesis use in a study 
by O’Neill and Evans (2009), but was not a significant predictor of a range of 
outcomes in a recent study by Williams et al. (2015). However, information relating 
to cognitive flexibility (a definite core executive function) and planning (complex 
function) was deemed to be of more interest in this study as a) neither have been 
investigated previously in lower limb amputation, b) they represent both the core and 
                                                 
24 This may have been as a result of insensitivity of the digit span measure used, as 
discussed earlier in Chapter 5.  
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higher levels of executive function, and c) both may be important to rehabilitation 
outcomes. 
Due to limits on the number of predictors that can reasonably be entered into 
the regression models based upon this study’s sample size, prioritisation of a subset 
of cognitive functions was also required. Overall cognitive function and cognitive 
flexibility (an aspect of executive function) were prioritised for regression analyses. 
This decision was informed by the literature suggesting the preponderance of 
impaired executive function in dysvascular populations (Moorhouse & Rockwood, 
2008; Moorhouse et al., 2010), that overall cognitive functioning and executive 
function are the most predictive cognitive functions in terms of activities and 
participation (Royall et al., 2007), and that executive functions potentially mediate 
the influence of other cognitive functions (O’Bryant et al., 2011).  
The lack of cognitive functioning differences between the two aetiological 
groups, and potential for incident vascular disease or comorbid traumatic brain 
injury in people with non-vascular LLA suggests that all participants can be analysed 
together in terms of the prosthetic, mobility, and psychosocial functioning follow-up 
measures.  Thus, this chapter is an analysis of a broad population of people with 
lower limb amputations which largely comprises, but is not limited to, people with 
dysvascular amputations.  
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6.3 Results for Objective Three: Profile of Rehabilitation Engagement and 
Rehabilitation Outcomes 
 
Descriptive statistics were compiled for rehabilitation engagement, and prosthetic 
(prosthesis use, prosthesis satisfaction), mobility, and psychosocial (activation, 
activity limitation & participation restriction, adjustment, distress, social support, 
participation – engagement, importance and meaning of participation, and control 
over participation) variables. One-way repeated measures ANOVAs were generally 
used to analyse differences across the three follow-up time points. Exceptions 
included use of a Friedman test in the case of ordinal variables (mobility and 
activation), while paired-samples t-tests were used to assess changes in community 
participation variables from six to 12 months, as community participation data was 
not collected at discharge. Descriptive statistics for each time point are summarised 
in Table 28 and 29. Relationships with socio-demographic and clinical variables 
were also examined, with Spearman rho correlation, or a t-test or one-way ANOVA, 
or chi-square test; only significant relationships are reported.   
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Table 28 
Rehabilitation Engagement and Outcomes : Descriptive Statistics and Longitudinal Differences 
Variable (possible range) Discharge 6 M 12 M Longitudinal Changes 
a
 Post-hoc Test p 
 N M SD N M SD N M SD F(df) p ηp
2
 
Dc 
x 
6M 
Dc x 
12M 
6M 
x 
12M 
Rehabilitation engagement (5 – 30) 85 27.75 2.60             
Prosthesis use (hrs daily)
 b
 53 7.20 3.70 38 7.59 4.35 29 8.59 5.08 
9.34 
(1.57, 20) * 
.001 .31 .06 
.005 
* 
.082 
Prosthesis satisfaction (0 – 10) 54 6.89 2.25 37 7.03 2.09 29 7.21 2.06 .23 (2, 22) .797 .01 - - - 
Aesthetic satisfaction (3 – 9) 54 6.13 1.73 36 6.25 1.96 29 6.34 2.02 .50 (2, 22) .621 .01 - - - 
Functional satisfaction (5 – 15) 54 9.54 2.42 36 10.36 2.92 29 10.24 2.77 3.72 (2, 22) .032 .14 - - - 
Distress (0 – 32) c 55 9.91 6.45 40 9.53 6.54 30 10.70 7.93 1.20 (2, 24) .309 .05 - - - 
General adjustment (1 – 4) 54 2.94 0.70 38 2.97 0.67 30 3.17 .78 2.43 (2, 22) .099 .10 - - - 
Social adjustment (1 – 4) 54 3.16 0.72 38 3.20 0.56 30 3.34 .67 1.79 (1.59, 22) .187 .07 - - - 
Adjustment to limitation (1 – 4) 54 1.95 0.66 38 1.99 0.75 30 1.82 .87 .24 (2, 22) .791 .01 - - - 
Social support ( 1 – 7) 55 5.89 1.29 40 6.15 1.04 30 5.81 1.21 .96 (1.49, 24) .370 .04 - - - 
Activity limitation & participation restriction (0 – 100)c 55 25.73 7.66 40 25.58 10.16 30 29.60 10.74 2.44 (1.61, 24) .110 .09 - - - 
Participation engagement     40 57.65 25.63 30 58.06 27.78 -.122 (26)
 b
 .904 .02 - - - 
Participation: importance & meaning     40 38.11 11.69 30 39.63 13.62 .928 (26)
 b
 .362 .12 - - - 
Control over participation    40 48.48 8.26 30 48.89 11.79 -.261 (26) 
b
 .796 .04    
Note. Effect sizes: .01 ≤ η ≥ .059 is small, .60 ≤ η ≥ .79 is medium, and η ≥ .138 is large. 
a 
Repeated measures ANOVA 
b 
Prosthesis use is calculated only for those identified (with SIGAM) as prosthesis users 
c 
Higher scores indicated greater limitation/restriction 
and greater distress respectively  
*significant after Holm method correction
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Table 29 
Descriptive Statistics and Longitudinal Differences of Mobility and Activation 
Variable Level Discharge Six Months 12 Months 
Longitudinal  
Differences 
a
 
  Frequency % Frequency % Frequency % χ2(df) p 
Prosthesis User No 2 2.33 3 7.5 1 3.3 - - 
 Yes 84 97.7 37 92.5 29 96.7   
Mobility Dependent 14 16.3 6 15 5 16.7 4.71 (2) .095 
 Independent indoors 21 24.4 3 7.5 4 13.3   
 Independent outdoors 51 59.3 31 77.5 21 70.0   
Activation Level 1 or 2 (low) 8 14.5 10 25 9 30 2.571 (2) .276 
 Level 3 or 4 (high) 47 85.5 30 75 21 70   
a
 Friedman test  
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6.3.1 Rehabilitation Engagement 
Possible rehabilitation engagement scores range from six to 30, with higher scores 
indicating greater engagement.  The mean rehabilitation engagement score was 27.7 
(SD = 2.6), suggesting a ceiling effect in the measurement of rehabilitation 
engagement. Higher rehabilitation engagement was related to younger age (rs = -.32, 
p < .05), and longer time spent in education (rs = .445, p < .05). 
 
6.3.2 Prosthetic and Mobility Outcomes  
Small numbers of participants reported non-use of prostheses at discharge (n=2; 
3.6%), six months (n=3; 7.5%), and 12 months (n=1; 3%). Amongst functional 
prosthesis users, daily hours of prosthesis use increased from 7.2 to 7.59 to 8.59 
from discharge to six months to 12 months respectively. This was a statistically 
significant overall change of large effect size (F1.57, 20 = 9.34, p = .001, ηp
2
 = .308). 
Post-hoc tests indicated that a statistically significant increase was evident only from 
discharge to 12 months. Results of longitudinal change analyses are summarised in 
Table 28. Changes in aesthetic satisfaction, functional satisfaction, and overall 
prosthesis satisfaction were not statistically significant (all p > .05; see Table 28). 
Longer hours of prosthesis use were related to longer time spent in education at six 
months (rs = .34, p < .05), and higher aesthetic satisfaction was related to older age 
at discharge (rs = .31, p < .05) and six months (rs = .37, p < .05). 
 Rates of non-independence for mobility remained stable across time (15 – 
17%). Greater proportions of participations were independent outdoors than 
independent solely indoors at each of the three time points, peaking at six months 
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(59.3% to 77.5% to 70%). The change was not statistically significant (χ2 = 4.71, df 
= 2, p = .095) (See Table 29).  
 
6.3.3 Psychosocial Outcomes 
Psychosocial outcomes assessed included distress, general adjustment, social 
adjustment, adjustment to limitation, activation, and perceived social support. 
Descriptive statistics and the results of repeated-measures (longitudinal) analyses are 
summarised in table 28 (distress, adjustment, perceived social support, activity 
limitation and participation restriction, all aspects of community participation) and 
table 29 (activation). An additional breakdown of participation engagement items is 
provided in table 30. Higher distress (HADS) and activity limitation and 
participation restriction (WHODAS) scores reflect poorer outcomes. For all other 
measures, higher scores indicate higher levels of functioning.  
Distress levels did not change statistically significantly over time when 
analysed with a repeated-measures ANOVA (see Table 28). To examine anxiety and 
depression caseness, HADS scores can additionally be broken to individual anxiety 
and depression subscales.
25
 A subscale cut-off of 10 or below versus 11 or above 
was used to identify caseness (Crawford et al., 2001). This revealed caseness rates of 
12.7%, and 10%, and 13.3% for anxiety at discharge, six, and 12 months. These 
were roughly equivalent to the 12.6% prevalence rate for anxiety Crawford et al.'s 
(2001) non-clinical normative sample. For depression at discharge, six, and 12 
months, caseness rates were 7.3%, 7.5%, and 6.7% respectively. These were roughly 
double the 3.6% prevalence of depression in Crawford et al.'s (2001) study. At 
                                                 
25 Caseness is whether or not a person has a particular condition (Burger & Neeleman, 
2007) 
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discharge, younger age was also associated with higher levels of distress (rs = .35, p 
< .01).  
Both general and social adjustment trended upward over time, i.e. toward 
higher levels of adjustment. Adjustment to limitation remained virtually unchanged. 
No changes in aspects of adjustment – general, social, or to limitation – were 
statistically significant (all p > .05; see Table 28).  
Activation was measured with the Patient Activation Measure, but there were 
too few cases in some of the PAM-13 categories to examine change over time 
meaningfully. Thus, activation was operationalised into two categories (high and 
low). The proportion of participants reporting high activation levels decreased at 
each time point – from 82.5% to75% to 70%. However, this change was not 
statistically significant (χ2 = 2.571, df = 2, p = .276) (see Table 29). Mean perceived 
social support peaked at six months, but changes over time were not statistically 
significant (see Table 28).  
Activity limitation and participation restriction rose overall from discharge to 
12 months. However, changes over time were not statistically significant (F1.61, 24 = 
2.44, p = .110, ηp
2
 = .089) (see Table 28). The mean scores at each time point 
correspond roughly with the 94
th
 percentile – just 6% of the normative population 
have greater limitation and restriction (Üstün, Kostanjsek, Chatterji, & Rehm, 2010).  
Importance and meaning of participation and control over participation are 
both aspects of participation enfranchisement. Neither importance and meaning of 
participation (t = .928, p = .362, grm = .118) nor control over participation (t = -.261, 
p = .796, grm = .04) mean scores changed significantly from six months to 12 
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months. Mean participation engagement scores were similar at both six months and 
12 months (t (26) = -.122, p = .904, grm = .015) (see Table 28).  
A descriptive breakdown of frequencies of participation elements from the 
participation engagement measure is presented in Table 30. It includes whether 
participants rated each aspect of participation as important, whether they considered 
they were doing enough of each aspect of participation, and whether they were 
performing important activities enough. Of these 20 elements, getting out and about, 
spending time with family, spending time with friends, and keeping in touch with 
friends by phone or internet, were endorsed as important by 90%+ of participants at 
both six months and 12 months. Both keeping in touch with family by phone or 
internet, and participation in sports or active recreation were each rated as important 
by 90+% participants at six months and 83.3% at 12 months. In contrast, just 22.5% 
of participants reported that participation in community clubs or organizations was 
important to them at six months, and 16.7% at 12 months. Of note are the differences 
between the frequency of classifying an element as important on one hand and 
actually engaging in that same element enough when classifying it as important. For 
example, 97.5% to 100% of participants rated getting out and about as important, yet 
just over half of those participants reported getting out and about enough at either six 
months or 12 months.  
When activities were endorsed as important, the following ones were the 
most frequently engaged in enough: managing household bills and expenses (6 
months and 12 months), keep in touch with family by phone/internet (6 months & 12 
months), spending time with family (6 months & 12 months), caring for a 
child/loved one (6 months), and keeping in touch with friends by phone/internet (6 
months), participation in religious or spiritual activities (12 months), and cooking, 
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cleaning and looking after the home (12 months). Most of these activities relate to 
spending time with or being in contact with family, or household tasks – the 
exception being participation in religious activities. Conversely, participation in civic 
or political activities (6 & 12 months), in classes or learning activities (6 & 12 
months), in volunteering, in paid employment (6 & 12 months), in sports or active 
recreation (6 months), in support groups or self-help meetings (6 months), in 
community clubs or organizations (12 months), and in attending 
movies/sport/entertainment events (12 months) were rated as least frequently 
engaged in enough when considered important. As well as active/sports recreation, 
most, if not all of these least-frequently performed activities are based outside of the 
home, and many additionally require social interaction with persons other than 
immediate family. These important activities performed most and least often enough 
were the ones in the top and bottom frequency quartiles respectively. Figures 9 – 11 
summarise changes in percentages of participants doing enough of activities they 
rated as important.   
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Table 30 
Longitudinal Descriptive Statistics for Participation Engagement Elements 
 Six Months 12 Months 
 
Importan
t % 
Do Enough  
% 
% Doing 
Enough if 
Important 
Importan
t % 
Do Enough  
% 
% Doing 
Enough if 
Important 
Get out and about  97.5 48.7 51.3 100 55.2 53.3 
Spend time with family 95.0 80.0 79.0 90.0 82.8 77.8 
Keep in touch with family (phone/internet)  90.0 87.5 86.1 83.3 93.1 88.0 
Spend time with friends 92.5 50.0 48.7 96.7 69.0 65.5 
Keep in touch with friends (phone/internet)  90.0 75.0 77.8 90.0 69.0 70.4 
Go to parties/dinner/other social activities  57.5 62.5 47.8 60.0 72.4 55.6 
Spend time with a significant other/partner  85.0 57.5 52.9 73.3 58.6 50.0 
Work for money 52.5 55.0 19.1 44.8 55.2 15.4 
Cook, clean, and look after your home  67.5 75.0 70.4 79.3 79.3 82.6 
Manage household bills and expenses 65.0 90.0 88.5 58.6 96.6 100 
Look after/care for child/loved one  35.0 87.5 78.6 48.3 72.4 50.0 
Go to classes/learning activities  45.0 70.0 33.3 51.7 62.1 40.0 
Volunteer 37.5 72.5 26.7 44.8 69.0 53.9 
Participate in religious or spiritual activities  47.5 85.0 73.7 36.7 83.3 81.8 
Go to support groups or self-help meetings 30.0 70.0 16.7 26.7 80.0 62.5 
Engage in hobbies or leisure activities 87.5 60.0 54.3 86.7 46.7 42.3 
Go to movies/sport/entertainment events  72.5 52.5 37.9 56.7 53.3 35.3 
Participate in sports or active recreation 90.0 37.5 30.6 83.3 56.7 52.0 
Participate in community clubs or organizations 35.0 75.0 35.7 46.7 60.0 35.7 
Participate in civic or political activities 22.5 80.0 33.3 16.7 73.3 40.0 
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Figure 9: Participation engagement - general and relationships - % doing enough if important 
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Figure 10: Participation engagement - work, household, education, volunteering - % doing enough if important 
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Figure 11: Participation engagement - social, active, recreational - % doing enough if important 
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6.3.4 Summary 
Most constructs remained stable from discharge to six months to 12 months with no 
statistically significant differences when constructs were examined with one way 
repeated-measures ANOVA (paired samples t-tests for participation measures, chi-
square tests for mobility and activation). The exception was daily hours of prosthesis 
use, for which there was a statistically significant increase from discharge to 12 
months. Compared to normative population data, there were elevated levels of 
depression caseness and activity limitation and participation restriction in this 
sample. Important activities rated as most frequently performed enough included 
family/friend interaction and communication, household activities, and religion or 
spiritual activities. As well as active/sports recreation, the activities considered 
important but least frequently performed enough were often those that required 
participation outside the home and/or with persons other than close relatives.  
 
 
6.4 Results for Objective Four: Rehabilitation Engagement and Outcomes 
 
Spearman ρ correlations were calculated to determine whether rehabilitation 
engagement correlated with prosthetic outcomes and psychosocial variables at each 
time point (discharge, 6 months, 12 months). Correlation results are summarized in 
Table 31. 
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Rehabilitation engagement was not related to prosthesis use or satisfaction at 
any time point. Higher rehabilitation engagement was significantly associated with 
higher levels of mobility at discharge (rs = .393), but not at six or 12 months.  
Higher levels of rehabilitation engagement were related to better adjustment 
and lower levels of distress. It was significantly positively correlated with general 
adjustment at 12 months (rs =.539), adjustment to limitation at both 6 months (rs 
=.458) and 12 months (rs =.458), and negatively correlated with distress at 12 
months (rs = -.694). Higher rehabilitation engagement was also related to higher 
perceived social support at 12 months (rs = .554), but not to activation at any time 
point.  
Higher rehabilitation engagement was significantly correlated with lower 
activity limitation and participation restriction (12 M), higher participation 
engagement (12 M), importance and meaning of participation (6 M and 12 M), and 
control over participation (12 M).  
In sum, rehabilitation engagement was mostly related to better longer term 
outcomes (i.e. 12 months). These included better adjustment (general and limitation), 
lower distress, and higher perceived social support, as well as greater levels of 
community participation (engagement, importance, and control), and less limitation 
and restriction. Rehabilitation engagement was also related to better discharge 
mobility – the only outcome to which it was related at discharge. At six months, 
rehabilitation engagement was related to adjustment to limitation and importance 
and meaning of participation.  
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Table 31 
Correlations Between Rehabilitation Engagement and Prosthetic, Mobility and 
Psychosocial Outcomes 
Variable Discharge Six Months 12 Months 
Prosthesis use -.012 .024 .122 
Functional satisfaction .138 .149 .240 
Aesthetic satisfaction -.055 .002 .079 
Mobility .393
**
 .111 .078 
Activation .063 .041 .337 
General adjustment .219 .251 .539** 
Social adjustment .131 .149 .308 
Adjustment to Limitation .203 .458** .458* 
Distress -.124 -.249 -.694** 
Social support .095 .062 .554** 
Activity limitation and participation restriction .014 -.175 -.557** 
Participation engagement  .153 .414* 
Participation importance and meaning  .326* .511** 
Control over participation  .144 .456* 
Note. Effect sizes: r ≥ .1 is small, r ≥ .3 is medium, r ≥ .5 is large 
* rs significant at p<.05 ** rs significant at p<.01 
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6.5 Results for Objective Five: Bivariate Relationships Between Cognitive 
Functioning and Rehabilitation Engagement and Rehabilitation Outcomes 
 
Spearman’s ρ correlations were calculated to determine the bivariate relationships 
between six aspects of cognitive functioning and rehabilitation engagement and 
rehabilitation outcomes at each time point – discharge, six months post-discharge, 
and 12 months post-discharge. Rehabilitation outcomes examined included 
prosthesis use (hours), prosthesis satisfaction (both aesthetic and functional), 
mobility, activation, adjustment (general, social, and to limitation), distress, social 
support, activity limitation & participation restriction, participation engagement 
(important activities done enough), control over participation, and importance & 
meaning of participation. The six aspects of cognition were overall cognitive 
functioning (assessed with RBANS total scale), combined processing speed and 
attention (assessed with WAIS-IV symbol search), delayed memory (assessed with 
WMS-IV logical memory II), visuospatial construction (assessed with RBANS 
figure copy subtest), and two aspects cognitive flexibility (an executive function 
assessed with trail making – number letter switching), and planning (an executive 
function incorporating reasoning, assessed with BADS zoo map). Results are 
summarised in tables 32 to 35.  
 
6.5.1 Rehabilitation Engagement  
Higher rehabilitation engagement was significantly correlated with higher overall 
cognitive functioning, combined processing speed and attention, delayed memory, 
and visuospatial construction (all rs > .3). Rehabilitation engagement was not 
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significantly correlated with either measure of executive functioning (cognitive 
flexibility or planning) (both rs < .2). Results are summarized in Table 32.  
 
Table 32 
Correlations Between Cognitive Functions and Rehabilitation Engagement  
Variable OCF PS&A DMem VsC EF-CF EF-P 
Rehabilitation 
engagement 
.427** .398** .315* .368** .187 .199 
Note 1. OCF = overall cognitive functioning (RBANS total), PS&A = processing speed and attention, 
DMem = delayed memory, VC = visuospatial construction, EF-CF = cognitive flexibility, EF-P = 
planning. Note 2. Effect sizes: r ≥ .1 is small, r ≥ .3 is medium, r ≥ .5 is large. 
* rs significant at p<.05 ** rs significant at p<.01 
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6.5.2 Prosthetic and Mobility Outcomes  
Higher overall cognitive functioning was correlated with higher mobility and lower 
aesthetic satisfaction at discharge, and with higher prosthesis use at six months 
(medium effect size). The combined processing speed and attention assessment was 
not significantly correlated with any prosthetic or mobility outcomes at any time 
point. Higher delayed memory was correlated with higher mobility (small effect 
size) at discharge. Higher visuospatial construction was correlated with higher 
mobility at discharge. Higher cognitive flexibility was correlated with lower 
functional satisfaction at all three time points, and with lower prosthesis use at 12 
months.  Planning was not significantly associated with prosthetic or mobility 
outcomes at any time point. See tables 33 – 35 for a summary of results.  
 
6.5.3 Psychosocial Variables 
Overall cognitive functioning, combined processing speed and attention, delayed 
memory and visuospatial construction were not significantly associated with 
psychosocial outcomes at any time point. Higher cognitive flexibility was correlated 
with lower activation at both discharge and six months, with lower general 
adjustment, higher distress, and lower control over participation at six months only, 
and with lower prosthesis use at 12 months only.  Higher planning scores were 
associated with higher activity limitation & participation restriction at discharge and 
lower general adjustment at six months. See tables 33 – 35 for a summary of results.  
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Table 33 
Correlations Between Cognitive Functions and Rehabilitation Outcomes at 
Discharge 
Outcomes OCF PS&A DMem VsC EF-CF EF-P 
Prosthesis use .174 .123 .295 .138 -.019 .091 
Functional 
satisfaction 
-.212 -.07 -.108 -.082 -.436
**
 .12 
Aesthetic 
satisfaction 
-.308
*
 .187 .091 -.192 -.304 -.124 
Mobility .299
*
 .155 .262
*
 .253
*
 .005 .128 
Activation -.084 -.023 -.127 -.068 -.334
*
 -.091 
General 
adjustment 
.131 .093 .139 .201 -.209 .064 
Social 
adjustment 
.072 .15 .146 .097 .04 .053 
Adjustment to 
limitation 
.037 -.072 -.055 -.093 -.169 .06 
Distress .195 .155 .055 .052 .2 .254 
Social support .111 .05 .254 .175 -.255 -.08 
Limitation & 
restriction 
.053 .228 .092 .066 .251 .372
**
 
Note 1. OCF = overall cognitive functioning (RBANS total), PS&A = processing speed and attention, 
DMem = delayed memory, VsC = visuospatial construction, EF-CF = cognitive flexibility, EF-P = 
planning. Note 2. Effect sizes: r ≥ .1 is small, r ≥ .3 is medium, r ≥ .5 is large. 
* rs significant at p<.05 (overall cognitive functioning x mobility p = .01) ** rs significant at p<.01 
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Table 34 
Correlations Between Cognitive Functions and Rehabilitation Outcomes at Six 
Months 
Outcomes OCF PS&A DMem VsC EF-CF EF-P 
Prosthesis use .366
*
 .079 .338 .183 -.254 .262 
Functional satisfaction -.021 -.065 .087 -.021 -.551
**
 -.042 
Aesthetic satisfaction -0.1 .131 .308 -.033 -.12 -.098 
Mobility .062 -.265 -.12 .208 -.325 -.1 
Activation -.142 -.113 -.06 -.145 -.474
**
 -.433
*
 
General adjustment .079 .184 .15 -.068 -.418
*
 -.196 
Social adjustment .049 .322 -.133 .044 -.178 .067 
Adjustment to 
limitation 
.218 .172 .188 .07 -.184 .037 
Distress .229 .059 -.046 .151 .498
**
 .343 
Social support .148 .048 .238 .067 -.344 -.039 
Limitation & 
restriction 
-.245 -.022 -.178 -.055 .264 .155 
Participation 
engagement 
.038 -.048 .133 -.056 -.314 .248 
Participation 
importance & meaning 
.005 -.078 .183 -.086 .063 -.147 
Control over 
participation 
.06 -.07 .127 -.023 -.372
*
 -.203 
Note 1. OCF = overall cognitive functioning (RBANS total), PS&A = processing speed and attention, 
DMem = delayed memory, VsC = visuospatial construction, EF-CF = cognitive flexibility, EF-P = 
planning. Note 2. Effect sizes: r ≥ .1 is small, r ≥ .3 is medium, r ≥ .5 is large.  
* rs significant at p<.05 (overall cognitive functioning x mobility p = .01) ** rs significant at p<.01 
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Table 35 
Correlations Between Cognitive Functions and Rehabilitation Outcomes at 12 
Months 
Outcomes OCF PS&A DMem VsC EF-CF EF-P 
Prosthesis use  .181 .129 .327 .276 -.510
*
 .163 
Functional 
satisfaction 
.051 .117 .142 .157 -.498
*
 .008 
Aesthetic 
satisfaction 
-.017 .255 .287 .196 -.164 -.163 
Mobility -.18 -.101 -.146 -.235 -.348 -.106 
Activation -.073 .001 .127 -.118 -.174 .087 
General 
adjustment 
.047 .364 .275 -.068 -.403 .174 
Social 
adjustment 
-.111 .263 .066 .093 -.246 .054 
Adjustment to 
limitation 
.225 .003 .093 .173 -.269 .119 
Distress -.315 -.156 -.23 -.104 -.081 -.178 
Social support .307 .224 .224 .309 -.177 .176 
Limitation & 
restriction 
-.355 -.133 -.263 -.168 -.159 -.129 
Participation 
engagement 
.159 -.096 .359 .073 -.393 .119 
Participation 
importance and 
meaning 
.375 .128 .363 .235 .362 -.045 
Control over 
participation 
.208 .129 .234 .077 .022 .097 
Note 1. OCF = overall cognitive functioning (RBANS total), PS&A = processing speed and attention, 
DMem = delayed memory, VsC = visuospatial construction, EF-CF = cognitive flexibility, EF-P = 
planning. Note 2. Effect sizes: r ≥ .1 is small, r ≥ .3 is medium, r ≥ .5 is large.  
* rs significant at p<.05 (overall cognitive functioning x mobility p = .01)  
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6.6 Results for Objective Six: Prediction of Rehabilitation Outcomes 
 
The sixth objective was to investigate whether, using hierarchical regression 
controlling for rehabilitation engagement, overall cognitive functioning and 
executive function predict prosthetic, mobility, and psychosocial rehabilitation 
outcomes at six months (for the rationale, see section 4.6.6.1 Regression). It was 
hypothesised that overall cognitive functioning and cognitive flexibility (an 
executive function) would predict outcomes when controlling for rehabilitation 
engagement. A hierarchical forced entry regression model with rehabilitation 
engagement entered in block one, and overall cognitive functioning (RBANS total) 
and cognitive flexibility (DKEFS trail making number-letter switching) entered in 
block two was used to test this hypothesis. Multiple linear regression was used for all 
variables, except for mobility and activation, for which the equivalent hierarchical 
logistic regression models were used.  
 
6.6.1 Prosthetic and Mobility Outcomes  
For prosthesis use, the overall model was non-significant (F3, 20 = 1.822, p = .176). 
Neither the first block (R
2
adj = -.026, ΔF1, 22 = .42, p = .525), nor the second (R
2
adj = -
.097, ΔF2, 20 = 2.496, p = .108), predicted prosthesis use. Although the second block 
as a whole was not a significant predictor of prosthesis use, overall cognitive 
functioning (RBANS total) was a significant individual predictor (β = .452, 95% CI 
= .002 - .292, p = .048).  
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For aesthetic satisfaction, the overall model was non-significant (F3, 19 = .235, 
p = .871). Neither the first block (R
2
adj = -.028, ΔF (1, 21) = .405, p = .532), nor the 
second (R
2
adj = -.117, ΔF (2, 19) = 1.82, p = .176), predicted aesthetic satisfaction.  
For functional satisfaction, although approaching significance, the overall 
model was non-significant (F3, 19 = 3.041, p = .054). The first block including only 
rehabilitation engagement did significantly predict functional satisfaction (R
2
adj = 
.148, ΔF(1, 21) = 4.813, p = .040; rehabilitation engagement β = .432, 95% CI = .032 - 
1.192, p = .040). The second block was not a significant predictor (R
2
adj = -.218, 
ΔF(2, 19) = 1.940, p = .176).  
The overall logistic regression model for mobility was not significant (χ2 = 
6.605, df = 3, p = .086). Mobility was dichotomised as non-independently 
ambulatory (SIGAM grades A and B) versus independently ambulatory (SIGAM 
grades C to F).  
 
6.6.2 Psychosocial Variables  
The overall logistic regression model for activation was not significant (χ2 = 4.974, 
df = 3, p = .174).  
Adjustment variables were not predicted by the regression models. For 
general adjustment, the overall model was non-significant (F3, 20 = 1.406, p = .270). 
Neither the first block (R
2
adj = .026, ΔF (1, 22) = 1.621, p = .216), nor the second (R
2
adj 
= .050, ΔF (2, 20) = 1.279, p = .300), predicted general adjustment. For social 
adjustment, the overall model was non-significant (F3, 20 = .499, p = .687). Neither 
the first block (R
2
adj = -.034, ΔF (1, 22) = .246, p = .625), nor the second (R
2
adj = -.070, 
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ΔF (2, 20) =.630, p = .543), predicted social adjustment. Similarly, for adjustment to 
limitation, the overall model was non-significant (F3, 20 = 1.521, p = .240). Neither 
the first block (R
2
adj = .108, ΔF (1, 22) = 3.778, p = .065), nor the second (R
2
adj = .064, 
ΔF (2, 20) =.482, p = .625), predicted adjustment to limitation.  
The overall regression model significantly predicted distress (F3, 22 = 4.124, p 
= .018). The first block including rehabilitation engagement did not significantly 
predict functional satisfaction (R
2
adj = -.042, ΔF(1, 24) = .00, p = .992). The second 
block was a significant predictor (R
2
adj = .273, ΔF(2, 22) = 6.186, p = .007). Higher 
overall cognitive functioning (RBANS total) was individually associated with higher 
levels of distress at six months post discharge (β = .462, 95% CI = .040 - .457, p = 
.022).  
For social support, the overall model was non-significant (F3, 22 = 1.123, p = 
.361). Neither the first block (R
2
adj = -.015, ΔF (1, 24) = .633, p = .434), nor the second 
(R
2
adj = .015, ΔF (2, 22) = 1.359, p = .278), predicted social support.  
For activity limitation and participation restriction, the overall model was 
non-significant (F3, 22 = 1.910, p = .157). Neither the first block (R
2
adj = -.036, ΔF (1, 
24) = .127, p = .725), nor the second (R
2
adj = .098, ΔF (2, 22) = 2.793, p = .083), 
predicted activity limitation and participation restriction.  
Community participation variables were not significantly predicted by the 
regression models. For participation engagement, the overall model was not 
significant (F3, 22 = 1.635, p = .210). Neither the first block (R
2
adj = -.008, ΔF (1, 24) = 
1.208, p = .283), nor the second (R
2
adj = .071, ΔF (2, 22) = 1.808, p = .188), predicted 
participation engagement. For importance and meaning of participation, the overall 
model was not significant (F3, 22 = 1.039, p = .395). Neither the first block (R
2
adj = 
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.038, ΔF (1, 24) = 1.996, p = .171), nor the second (R
2
adj = .005, ΔF (2, 22) = .595, p = 
.560), predicted importance and meaning of participation. For control over 
participation, the overall model was non-significant (F3, 22 = 2.111, p = .128). Neither 
the first block (R
2
adj = -.040, ΔF (1, 24) = .046, p = .832), nor the second (R
2
adj = .118, 
ΔF (2, 22) = 3.140, p = .063), predicted importance and meaning of participation.  
 
6.6.3 Results Summary for Prediction of Outcomes with Regression Models  
Most variables were not significantly predicted by the regression models. Distress 
was an exception, with the overall model being significant and with higher overall 
cognitive functioning (RBANS total) being independently associated with higher 
levels of distress. In a non-significant overall regression model, overall cognitive 
functioning (RBANS total) was also independently associated with higher levels of 
prosthesis use. In another non-significant overall model, rehabilitation engagement 
was a significant predictor within the initial block of functional satisfaction.  
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6.7 Results for Objective Seven: Differences between Cognitive Impairment 
Groups 
 
Prosthetic and mobility, and psychosocial outcomes measured at follow-up were 
compared in two groups of participants: those impaired (determined by z-scores of -
1.5 or below) and non-impaired, on each of a number of cognitive functions – 
overall cognitive functioning, combined processing speed and attention, delayed 
memory, and visuospatial construction, and cognitive flexibility. Planning was 
excluded from these analyses as it was measured with an ordinal variable and was 
unsuited to ANOVA. Also, the distribution of scores was such that the vast majority 
were in the impaired and borderline ranges, with very few in the non-impaired range.  
Mixed between-within subjects ANOVA analyses were used to investigate 
the effect of impairment group membership on outcomes across three time periods 
(discharge, six months post-discharge, and 12 months post-discharge).
26
 Participants 
in the non-impaired delayed memory group had higher levels of social support (F1, 15 
= 18.054, p = .001, ηp
2
 = .546). There were no other differences between impairment 
groups on any of the other cognitive functions on prosthetic/mobility outcomes or 
psychosocial variables. Separately, independent-samples t-tests were used to 
determine differences between groups on rehabilitation engagement, prosthetic 
outcomes, and psychosocial variables at just the discharge time point (or six months 
in the case of community participation variables), to allow for analysis of as many 
cases as possible. With moderate effect sizes, rehabilitation engagement was 
significantly higher in the group of participants without impaired overall cognitive 
                                                 
26 For the ANOVA analyses, only between-groups F tests are reported, as there were no 
statistically significant interactions between impairment group and time point of 
measurement for the variables analysed.  
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functioning (t(71)=-3.178, p = .002, gs=.776). There were no other significant 
differences between groups with and without impaired overall cognitive functioning 
scores. There were no significant differences based on processing speed and 
attention, delayed memory, or visuospatial construction or cognitive flexibility. 
Results of all of these analyses are presented in Appendix G.  
 
6.8 Results for Objective Eight 
One-way analysis of variance was used to examine differences in prosthetic, 
physical and psychosocial outcomes between people with impairment in neither, 
one, or both of overall cognitive functioning and cognitive flexibility at discharge, 
except for mobility and activation, for which chi square analysis of frequencies were 
undertaken instead. Six month and 12 month time points were not analysed as cell 
counts sizes for the ‘both’ group were prohibitively small. Exceptions to the above 
were the three aspects of participation (engagement, importance and meaning, and 
control over participation), which were examined with one-way analysis of variance 
at six months, as participation data was not collected at discharge. Descriptive 
statistics are provided for all time points in Appendix H. Results indicated no 
differences between impairment categories across the range of prosthetic, mobility 
and psychosocial outcomes, or for rehabilitation engagement. Results are 
summarized in Appendix H. 
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6.9 Discussion 
6.9.1 Summary 
Most rehabilitation outcomes remained stable from over time. The exception was 
daily hours of prosthesis use, which increased from discharge to 12 months. There 
were elevated levels of depression caseness and activity limitation and participation 
restriction in this sample compared to normative populations. Important activities 
rated as most frequently performed enough included family/friend interaction and 
communication, household activities, and religion or spiritual activities. As well as 
active/sports recreation, the activities considered important but least frequently 
performed enough were often those that required participation outside the home 
and/or with persons other than close relatives.  
Higher levels of rehabilitation engagement were mostly related to better 
longer term outcomes including better general and limitation adjustment, lower 
distress, and higher perceived social support, as well as greater levels of community 
participation (engagement, importance, and control), and less limitation and 
restriction. Rehabilitation engagement was also related to better discharge mobility. 
There were significant relationships between overall cognitive functioning, 
combined information processing and attention, delayed memory, and visuospatial 
construction and rehabilitation engagement. Neither executive function – cognitive 
flexibility or planning – was significantly related to rehabilitation engagement.  
Cognitive functioning seemed to have stronger relationships with prosthetic 
and mobility outcomes than psychosocial outcomes. Higher overall cognitive 
functioning, better delayed memory ability and better visuospatial construction 
ability were each related to higher levels of mobility at discharge. Higher overall 
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cognitive functioning but lower cognitive flexibility was related to more prosthesis 
use at six months and in the longer term respectively. Higher cognitive functioning 
had relationships with lower satisfaction with prostheses. Higher overall cognitive 
functioning and cognitive flexibility were related to lower aesthetic (discharge) and 
functional satisfaction (all time points) respectively.  
In terms of psychosocial functioning, overall cognitive functioning, 
combined processing speed and attention, delayed memory and visuospatial 
construction were not significantly associated with psychosocial outcomes at any 
time point. Higher executive functioning (cognitive flexibility or planning) was 
related to a range of unfavourable discharge and six month outcomes including: 
lower activation, with lower general adjustment, higher distress, lower control over 
participation and higher activity limitation & participation restriction at discharge. 
Controlling for rehabilitation engagement, higher cognitive functioning predicted 
higher levels of distress at six months, with overall cognitive functioning being a 
significant individual predictor. No other regression models were significant overall.  
Persons with impaired/borderline delayed memory scores had poorer 
perceived social support. There were no other significant differences between groups 
with and without impaired overall cognitive functioning scores. Results indicated no 
differences between people who were impaired on neither, one or both of overall 
cognitive functioning and cognitive impairment categories across the range of 
prosthetic and psychosocial outcomes, or for rehabilitation engagement at discharge. 
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6.9.2 Rehabilitation Outcomes and Rehabilitation Engagement 
Stability in prosthetic and mobility outcomes, psychosocial functioning and 
participation, was the key finding from longitudinal analyses, suggesting that most 
service users maintain equilibrium after discharge. Prosthesis use was the only 
outcome to change over time; hours of use increased significantly from discharge to 
twelve months.  
 
6.9.2.1 Prosthetic and Mobility Outcomes 
Prosthesis use was the only construct to change significantly over time, showing a 
significant increase from discharge to 12 months. Longitudinal increases in hours 
spent using prostheses were also found by Zidarov, Swaine, and Gauthier-Gagnon 
(2009a), although that study only examined the period from discharge to three 
months. Hours of prosthesis use at six months in the current study were very similar 
to those reported by Roth, Pezzin, McGinley and Dillingham (2014) in a vascular-
only – yet similar – sample.27 Increased prosthesis use over time may result from a 
range of factors. Prosthetic efficiency and comfort may improve via attendance at 
prosthetic clinics – this may be through adjustment of the prosthesis, or provision of 
ancillary components such as liners which may be more suitable for clients. 
Improving balance confidence and ability may have played a role in increased 
prosthesis use. Wong, Young, Ow-Wing, and Karimi (2015) found, in a similar 
sample, that balance confidence was one factor which affected mobility – it may also 
affect prosthesis use. Miller, Deathe, Speechly, and Koval (2001) also found that 
balance confidence affected mobility in a sample of community dwelling people 
                                                 
27 This was roughly comparable with the present study, where mean time since amputation 
was approximately six months upon admission to rehabilitation.  
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with LLA. Increasing physical fitness resulting from exercise regimens and regular 
mobility may also have had a reciprocal effect, increasing the number of hours for 
which a prosthesis was worn. Participants may also have simply become 
increasingly capable of using prostheses. Overall increases in the amount of time 
spent wearing prostheses suggest gradual adaptation to prosthetic use and increase in 
activity levels.  
Aesthetic, functional, and overall satisfaction did not change over time. 
Scores on each of these measures were close to the middle of the range in each case. 
This is the first known, longitudinal examination of prosthesis satisfaction in people 
with lower limb amputations, as far as this author is aware.  
A high proportion of the sample (70%) was ambulating independently 
outdoors by 12 months post-discharge. Nevertheless, over time there were no 
significant increases in the number of participants ambulating independently – either 
outdoors or indoors. A significant increase in mobility levels overall was expected. 
Zidarov et al. (2009a), for example, documented increases in mobility level from 
discharge to three months post-discharge in a small-sized but similar sample. In this 
sample – largely older and with primarily dysvascular aetiology, it is possible that 
persons reached particular levels of mobility concordant with premorbid function 
more or less by discharge (and/or had a ceiling of potential mobility). Some 
participants may have maintained this function over time and not sought to increase 
their level of mobility. Some participants may have been satisfied with a level of 
mobility below their premorbid level – independent indoors rather than outdoors for 
example. Norvell, Turner, Williams, Hakimi, and Czerniecki (2011) studied mobility 
in people who underwent lower limb amputation for dysvascular aetiology. While 
they found that 37% achieved a level of mobility equalling or exceeding their 
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premorbid level, as many as 57% were satisfied with their level of mobility. In the 
current study, the percentage of participants who were not independently ambulatory 
remained stable from discharge (16.3%), to six months (15%), to 12 months 
(16.3%). Qualitative examination of these cases at each time point revealed that they 
represented a mix of individuals had low levels of ambulatory independence across 
time, and others who began with low levels but improved and vice versa. Reasons 
for any changes in ambulatory status were not solicited. They may have included 
physical fitness and deconditioning issues. The majority of participants had vascular 
pathology. Vascular pathologies may have affected the ability to ambulate 
successfully with prostheses. Contrary to this, some participants’ fitness may have 
improved in the post-rehabilitation period with the help of exercise regimens and, in 
some cases, continued use of physiotherapy or occupational therapy services. 
Prosthetic issues including refitting, damage and repair of prostheses, or comfort 
may also have affected mobility. Following the inpatient rehabilitation period, 
attendance at outpatient prosthetic clinics for adjustment and refitting of prostheses 
is a feature of the NRH POLAR rehabilitation process. Service users may have to 
wait for appointments, or may choose to wait until a scheduled appointment to have 
a prosthetic refit. This may periodically affect their level of independence of 
mobility. Anecdotal evidence obtained during the administration of follow-up 
questionnaires supported this. Psychosocial issues such as changes in an individual’s 
social support, or in barriers or facilitators to mobility may have also have been 
factors. Adaptation of accommodation is one example of change in the environment 
which may occur in the post-rehabilitation period to facilitate a person’s mobility. 
Provision of support rails and ramps for example may allow a person to transition 
from using a prosthesis strictly for transfers to being able to use the prosthesis for 
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ambulation indoors. While the above may affect mobility independence or cause it to 
fluctuate, there was nevertheless a cohort who did not achieve independent mobility 
with a prosthesis. For some service users, the ability to transfer safely and effectively 
with a prosthesis – from a wheelchair into a shower for example – provides 
sufficient independence, though this would not be captured as independent by the 
mobility measure in this study.  
 
6.9.2.2 Psychosocial Outcomes 
While caseness for probable anxiety in this sample was similar to Crawford, Henry, 
Crombie, and Taylor's (2001) normative sample, caseness rates for probable 
depression at discharge, six and 12 months were just under double the 3.6% they 
outlined. This indicates elevated levels of depressive symptomology in this sample. 
Atherton and Robertson’s (2006) study of demographically similar people with 
lower limb amputation using the same measure and cut-offs found that 13.4% had 
probable depression and 29.9% had probable anxiety – much higher rates than in this 
sample. Atherton and Robertson’s (2006) participants may have been more likely to 
disclose feelings of anxiety and depression than the present study’s sample, as 
participation was by postal questionnaire. Many of the participants in this sample 
completed the follow-up battery over the phone and may have been reluctant to 
make disclosures in that manner. Participants responding to telephone interviews are 
more likely to engage in socially desirable responding and underreport sensitive 
health issues (Bowling, 2005). Further longitudinal research examining the time 
course of distress in this population is required. Comparison of overall mean distress 
scores to non-clinical norms also suggests that there is a higher level of distress in 
this sample than the non-clinical population. There are no examinations of combined 
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distress scores in people with lower limb amputations to compare with this sample. 
Of note, mild anxious or depressive symptomatology is not included in these 
estimates. The HADS may underestimate the levels of emotional distress – up to 
70% of people with LLA reported emotional distress in Gallagher et al.'s (2011) 
study. If indeed the HADS is most valid or useful as a measure of general distress 
(Crawford et al., 2001), then these initial results are an important starting point for 
future investigations. The relatively high prevalence of probable depression (despite 
being much lower than other estimates) in this sample and elevated levels of overall 
distress, suggests the importance of screening for difficulties with distress in this 
population and referral for psychological assessment and intervention when needed. 
Aside from the intrinsic worth in screening for, monitoring, and treating distress, it is 
also worth monitoring it for its potential effects on rehabilitation outcomes – 
prosthetic prescription and use for example (Webster et al., 2012).  
 The pattern of higher general and social adjustment scores relative to 
adjustment to limitation scores was similar to those reported across a range of studies 
(Gallagher, Desmond, & MacLachlan, n.d.) using the previous version of the TAPES 
(Gallagher & MacLachlan, 2000). This has held whether measured at six months 
post-discharge (Coffey, Gallagher, & Desmond, 2014) having had an amputation in 
the previous five years (Atherton & Robertson, 2006), or between two months and 
many years since prosthetic provision (Gallagher & MacLachlan, 2004). Adjustment 
to limitation is more so a behavioural measure (as opposed to the more attitudinal 
measures of general and social adjustment) which likely accounts for this pattern of 
scores (Gallagher et al., 2010).   
Proportions of this sample reporting activation levels of three or four (i.e. 
higher activation) are similar to the proportions documented in people with chronic 
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illnesses (Hibbard & Cunningham, 2008). They are similar, for example, to a sample 
of people with a long-established diagnosis of multiple sclerosis (mean 8 years since 
diagnosis, younger, 4/5 female) (Stepleman et al., 2010), but much higher 
proportions in this study report high activation than in a recent sample of people with 
diabetes (Hendriks & Rademakers, 2014). These relatively high levels of activation – 
compared to people with diabetes – may result from participation in a 
comprehensive rehabilitation programme with the advantages of patient education 
and peer support. Overall stability in activation scores in the present study could be 
influenced by the mutual negation of upward and downward changes for different 
participants. Chubak et al. (2012) assessed patient activation twice in persons aged 
65+ with diabetes or heart disease with a year’s interval. The authors found that half 
of the participants’ activation level changed in that period, with approximately half 
of those increasing and half decreasing. At discharge, levels of perceived social 
support were similar to those found by Williams et al. (2004) one month post-
amputation. As Williams et al. (2004) not, perceived social support is thought to be 
remain stable over time.  
Relative to a normative study (Andrews et al., 2009), mean activity limitation 
and participation restriction scores in this study were above the 95
th
 percentile for 
both non-clinical and chronic physical condition samples. This suggests that the 
majority of people with lower limb amputations experience serious activity 
limitations and participation restrictions relative to both the general population, and 
populations with chronic impairments. This is consistent with previous findings. 
Activity limitation and participation restriction are common amongst people with 
amputations, and a wide range of life areas are affected. As documented by 
Gallagher et al. (2011), over 80% and almost 90% experienced limitations in 
NEUROPSYCHOLOGICAL FUNCTIONING AND LOWER LIMB LOSS 
253 
 
standing for long periods and walking long distances respectively, 70% experienced 
emotional difficulties, 45-55% experienced limitation in terms of household 
responsibilities, day-to-day work, and joining community activities, and roughly a 
fifth experienced limitations of basic activities such as washing and dressing. 
Regarding participation, approximately half of people with lower limb amputations 
experience restrictions in the areas of socializing, leisure, and employment, and up to 
four in five experience restriction in physical recreation (Gallagher et al., 2011).  
This study is the first to examine participation engagement, importance and 
meaning of participation and control over participation in a sample of people with 
lower limb amputations. Previous attempts at assessing participation in samples of 
people with lower limb amputations have only examined limitation and restriction 
(with the WHODAS as above (Gallagher et al., 2011)), or used GPS/map data 
(Hordacre, Barr, & Crotty, 2014) which does not capture the richness of 
participation. Walker, Mellick, Brooks, and Whiteneck (2003) studied a sample of 
people with a range of impairments including people with amputations. They found 
that both people with physical limitations and people with cognitive limitations (FIM 
≤5) had poorer participation scores overall, and in a range of specific areas including 
occupation and social integration. Their study used the CHART which emphasises 
objective measurement of frequencies of engagement in activities. What this does 
not capture is whether or not a person values particular aspects of participation, and 
whether they feel they perform them enough. Thus, more subjective experiences of 
participation are unrecorded. The present research now provides data on these 
aspects of participation. While some people with lower limb amputations may have 
been included in Heinemann et al.'s (2013) study of enfranchisement, a breakdown 
of types of impairment was not provided. There have not yet been any other 
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examinations of enfranchisement in people with lower limb amputations. 
Enfranchisement is a set of values that give meaning to participation and is a 
reflection of whether people think the communities in which they want to participate 
respect their participation, and may also reflect the presence of opportunities 
(Heinemann et al., 2013, p. 2158). Understanding enfranchisement in people with 
lower limb amputations is important to obtain a rounded picture of participation. 
Comparison to a set of unpublished norms suggests that this sample of people with 
lower limb amputations have similar if slightly better participation engagement (54
th
 
percentile) than a sample of people with self-rated impairments (Heinemann et al., 
2013). The present sample had worse participation enfranchisement; at six and 12 
months, importance and meaning scores were equivalent to the 37
th
 and 42
nd
 
percentiles respectively. At six and 12 months, control over participation was 
equivalent to the 42
nd
 and 45
th
 percentiles respectively. Sample differences may 
account for some of this difference – either differences in impairment or in the 
circumstances of recruitment, as participants were recruited from a range of sources, 
not solely during inpatient rehabilitation.  
In this present study, the persistence of activity limitations and participation 
restrictions and lack of change in other participation constructs over time (despite 
increasing hours of prosthesis use) may be illustrative of the persistence of social and 
environmental barriers.  Environmental barriers to activity and participation are a 
component of disability according to ICF criteria (World Health Organization, 
2001). People with impairments frequently experience barriers to participation in 
community participation (Keysor, Jette, Coster, Bettger, & Haley, 2006; Noreau & 
Boschen, 2010) and sports (Jaarsma, Dijkstra, Geertzen, & Dekker, 2014). A third of 
people with lower limb amputations in Ireland reported environmental barriers such 
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as transport, access to information, and laws/regulations/entitlements, whilst 
climatological (55%) and physical barriers (57%) were even more frequently 
reported (Gallagher et al., 2011). Almost two thirds of people with amputations 
(majority lower limb, also including upper limb) reported experiencing persistent 
barriers to activity or participation (Ephraim & MacKenzie, 2006). Significant 
change in such barriers is unlikely to occur in the 12 months following discharge 
from rehabilitation. Additionally, while there was an increase in hours of prosthesis 
use, there were no significant changes in other factors which may affect limitation 
and restriction, such as mobility (e.g. linked to social engagement in overs 65s 
(Rosso, Taylor, Tabb, & Michael, 2013)), adjustment (associated with various 
aspects of quality of life (Gallagher & MacLachlan, 2004)), prosthetic functional 
satisfaction (related to ADL performance (Zidarov, Swaine, & Gauthier-Gagnon, 
2009b)), activation (related to post-operative mental health outcomes (Andrawis et 
al., 2015)), or amputation level (related to physical limitations (Raya, Gailey, 
Fiebert, & Roach, 2010)).  
 
6.9.2.3 Response Shift 
A potential contributor to stability in prosthetic and psychosocial outcomes may be 
response shift. Response shift has been defined as  
“change in the meaning of one's self-evaluation of a target construct as a 
result of: (a) a change in the respondent's internal standards of measurement 
(scale recalibration, in psychometric terms); (b) a change in the respondent's 
values (i.e. the importance of component domains constituting the target 
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construct); or (c) a redefinition of the target construct (i.e. 
reconceptualization)” (Sprangers & Schwartz, 1999, p. 1508).   
The frame of reference used by a person while making judgements about health-
related quality of life may be important, whether comparing current status to prior 
status, ideal status, or the presumed status of another (Rapkin & Schwartz, 2004). 
Different frames of reference may be used by the same person for different aspects 
of health related quality of life (HRQL) (Barclay-Goddard, Epstein, & Mayo, 2009) 
– for example, one frame of reference for prosthesis satisfaction, another for social 
adjustment, and yet another for participation. Thus, some participants in this study 
may have compared HRQL with pre-rehabilitation or pre-morbid status at discharge, 
or they may have made comparisons with other persons on the rehabilitation 
programme. At six and 12 months, different frames of reference may have been used 
again. This may account for stability in subjective outcomes and functioning 
responses over time. For example, hours of prosthesis use increased significantly, yet 
outcomes such as prosthesis satisfaction, social adjustment, and participation 
engagement did not increase in turn.  
Participants may have expected a return to ‘normality’ post-rehabilitation 
(Ostler, Ellis-Hill, & Donovan-Hall, 2013), i.e. a return to pre-morbid 
functioning/participation, and be in the process of adjusting to a ‘new normal’ – 
perhaps even a second ‘new normal’ incorporating prosthesis use, having already 
begun adjusting to the ‘new normal’ of amputation without prosthesis use. Divergent 
frames of reference based on such conceptualisations of ‘normality’ may contribute 
to stability in self-rated functioning, with a person for example feeling reasonably 
well-adjusted to each new stage in expectation of further gains in functioning over 
time. While rates of engagement rose over time, satisfaction with same remained 
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level – perhaps participants were gradually recalibrating, with satisfaction keeping 
apace with gradually improving participation (for some) or remaining level for those 
who experienced restoration of pre-morbid mobility and function but did not desire 
greater intensity of participation. The use of structural equation modelling in similar 
future investigations may assist in the identification of response shift; such an 
approach was suggested by Oort (2005), while various other methods were described 
by Barclay-Goddard et al. (2009).  
 
6.9.2.4 Rehabilitation Engagement  
This was the first study to examine rehabilitation engagement in a sample comprised 
solely of people with lower limb amputations. Reported rehabilitation engagement 
was broadly similar to that reported by Kortte et al. (2007) in a sample of people 
with a range of impairments, with both samples indicating high levels of 
rehabilitation engagement. 
Rehabilitation engagement was not related to prosthesis use, prosthesis 
satisfaction or activation any time point. However, higher rehabilitation engagement 
was related to a range of favourable outcomes at different time points, including: 
higher mobility (discharge), better adjustment or lower levels of distress (general 
adjustment – 12 months, adjustment to limitation – 6 months & 12 months, and 
distress – 12 months), better activity and participation outcomes (lower activity 
limitation and participation restriction – 12 months, higher participation engagement 
– 12 months, importance and meaning of participation – 6 months & 12 months, and 
control over participation – 12 months), and higher 12 month perceived social 
support. Rehabilitation engagement was also a significant individual predictor of 
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functional satisfaction when prediction of six month outcomes was examined 
(objective six).  
 Higher rehabilitation engagement has been similarly related to a range of 
outcomes in a sample of people with a range of impairments three months post-
discharge: greater gain in functional/ADL independence, higher positive affect, 
higher levels of participation (in terms of frequency of engagement in activities; 
CHART), and lower depression and negative affect (Kortte et al., 2007). In this 
present sample, higher rehabilitation engagement was particularly frequently related 
to better outcomes at 12 months, which may suggest that those who were more 
engaged, or better able to engage in rehabilitation, were either better able to maintain 
functional gains long term, or to improve more over time relative to those who did 
not engage as well. The present study can thus be said to add to the evidence base for 
the association between rehabilitation engagement and a range of favourable 
mobility and psychosocial outcomes. A range of cognitive functions were related to 
rehabilitation engagement (discussed in section 6.9.2 below), and it is possible that 
cognitive abilities are differentiating factors in rehabilitation engagement.  
 
6.9.2 Cognitive Functioning and Rehabilitation Engagement 
This is the first known examination of the relationships between rehabilitation 
engagement and cognitive functioning assessed with standardised instruments in the 
population with lower limb amputations – and possibly in any physical rehabilitation 
context (to the knowledge of this author). Higher overall cognitive functioning, 
combined processing speed and attention, delayed memory, and visuospatial 
construction were related to higher levels of rehabilitation engagement. Neither 
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executive functions of cognitive flexibility or planning (objective four) were related 
to rehabilitation engagement. There were also significant differences in rehabilitation 
engagement between people with and without impaired overall cognitive 
functioning, but not between participants with and without impairment in any other 
cognitive function (objective seven). 
Overall cognitive functioning may be an important factor in rehabilitation 
engagement. Rehabilitation is a complex process requiring a broad range of 
cognitive skills. Attention and information processing may be important for 
rehabilitation via attending to instructions, concentrating on physical exercises, and 
processing information related to multifaceted tasks in an occupational therapy 
setting. Memory may also play an important role in rehabilitation engagement. 
Remembering the correct steps in a task, such as donning and doffing a prosthesis, 
performing a physiotherapy routine, or meal preparation in the occupational therapy 
kitchen while wearing a prosthesis is important to full engagement with 
rehabilitation. Furthermore, retention and recall of the correct sequencing of tasks, 
subtasks, or steps to ensure safe and/or optimal conduct with a prosthesis is 
important. Difficulty in recalling instructions given, in the context of poor problem 
solving in this sample, may have affected rehabilitation engagement. This is the first 
examination of the relationship between cognitive functioning and rehabilitation in 
this kind of sample. In a survey of physiotherapists and occupational therapists, 
clinicians reported that difficulties with “cognition, dementia, confusion, aphasia, 
decreased attention span, distractibility” were barriers to engagement in 
rehabilitation therapies (Lequerica, Donnell, & Tate, 2009, p. 756).    
The relationship between visuospatial construction and rehabilitation 
engagement may result from perceptual difficulties affecting therapy engagement. 
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Visuospatial construction is also a construct that is partially dependent upon 
executive function abilities, such as monitoring and updating of information, and 
strategy formation. These aspects of cognition may also influence engagement. Yet, 
while the processing speed/attention measure could be said to have a partial loading 
on working memory (Lezak et al., 2012), which is an executive function, it is unclear 
why the executive function measures – cognitive flexibility and planning – did not 
have a relationship with rehabilitation engagement. Impairment in executive 
functions, such as goal formation, execution of and adherence to plans, adaptation to 
changing circumstances (Goldstein & McNeil, 2004), was thought likely to have a 
relationship with rehabilitation engagement, as these are all skills that would 
facilitate therapeutic engagement in busy environments. For example, poor 
awareness of the importance of goals such as physical fitness and lack of executive-
driven initiation of behaviours to effect same has been integrated into a view of a 
downward-spiralling cycle by Zeeman (2009) – persons with poorer executive 
function are less likely to appropriately self-regulate.  
Perhaps, in structured, clinician-directed physiotherapy and occupational 
therapy environments, executive function is less important than when people must 
direct their own behaviour outside of the rehabilitation context; external sources of 
direction may compensate for poorer executive function skills. Clinicians may 
already compensate in some way specifically for cognitive difficulties that service-
users experience (Lequerica et al., 2009), though why this might differentially affect 
executive functioning is unclear. Other aspects of executive functioning including 
working memory and inhibition (Miyake et al., 2000) may have stronger 
relationships with rehabilitation engagement. It may be worth noting that although 
the correlations between rehabilitation engagement and the executive functioning 
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measures were not significant, both correlations approached rs = .2. The number of 
participants completing the cognitive flexibility and planning measures may have 
limited the statistical power of the analyses, resulting in a false negative finding. 
Further research examining the relationship between cognitive functions and specific 
aspects of rehabilitation engagement may facilitate understanding.  
All in all, clinicians need to be particularly aware that overall cognitive 
functioning, as well as processing speed and attention, delayed memory, and 
visuospatial cognition each have relationships with rehabilitation engagement. The 
relationship with executive functioning is less clear. In any case, service users with 
difficulties in executive functioning are likely to have difficulties optimizing the 
utilization of other cognitive functions anyway, since facilitating the expression of 
other functions is a major aspect of executive functions (Lezak et al., 2012). 
 
6.9.3 Cognitive Functioning and Rehabilitation Outcomes 
6.9.3.1 Cognitive Functioning and Prosthetic and Mobility Outcomes 
Higher overall cognitive functioning was associated with more hours of prosthesis 
use at six months. It was also a significant individual predictor of prosthesis use at 
six months when controlling for rehabilitation engagement, albeit in a non-
significant overall regression model. Higher overall cognitive functioning, delayed 
memory, and visuospatial construction were related to higher mobility at discharge. 
Contrary to these findings, higher cognitive flexibility was associated with fewer 
hours of prosthesis use at 12 months.  
CHAPTER 6: COGNITIVE FUNCTIONING AND REHABILITATION 
262 
 
The present study was the first to assess a) overall cognitive functioning with 
a more comprehensive tool, b) processing speed and attention, c) visuospatial 
construction, and d) cognitive flexibility. Particular difficulties in populations with 
dysvascularity with processing speed, attention, and executive functions meant it 
was important to assess these aspects of cognitive functioning. This is the first study 
to report a relationship between mobility in people with lower limb amputations and 
overall cognitive functioning. It is also the first to find a relationship between 
prosthesis use and overall cognitive functioning using a measure more 
comprehensive than a brief cognitive screen. Correlations between mobility and 
delayed memory accord with previous evidence of links between the two constructs 
at discharge – O’Neill & Evans (2009) found that immediate memory predicted 
mobility on the SIGAM mobility grades (the measure used in this study), whilst 
delayed memory predicted a more comprehensive measure of mobility. The 
relationship between visuospatial construction and mobility has not previously been 
investigated.  
Impaired overall cognitive functioning can represent a decline across a range 
of cognitive functions, or can be affected by issues in one or more areas. Participants 
possibly had different profiles of difficulties across learning to, attending to, 
recalling how or the correct sequences in don and doffing prostheses, transferring, 
ambulating with prostheses, monitoring and adjusting gait for changes in terrain or 
obstacles, and prosthetic management and maintenance. For the relationship with 
delayed memory, this may relate to impaired recall – perhaps via difficulties with 
executive management of recall. Difficulties with new learning that arise in cases of 
frontal lobe damage (Habib et al., 2003) may also be reflected in delayed memory 
scores - Larner, van Ross, and Hale (2003) for example found that ‘learning skills’ – 
NEUROPSYCHOLOGICAL FUNCTIONING AND LOWER LIMB LOSS 
263 
 
similar to immediate memory – predicted mobility when combined with amputation 
level in people with dysvascular LLA. Visuospatial construction scores may capture 
difficulties in visuospatial perception, which would have implications for navigation, 
perceiving environmental obstacles or changes in terrain, or perceiving aspects of 
visual prosthetic training or aspects of the prosthesis itself. Prostheses often have 
multiple components and mechanisms, belts and straps, and ancillary garments like 
liners and socks. Small, relatively visually imperceptible differences or changes 
could affect prosthetic comfort or efficiency, and consequently use or mobility. This 
may be especially true in cases of poor visual sensory acuity, as may frequently be 
the case both in the older persons in this sample and in people with diabetic 
retinopathy. Visuospatial construction scores may also reflect executive function 
abilities, i.e. the ability to plan, manage, and update (Lezak et al., 2012). A 
relationship between executive functioning and mobility was anticipated, due to the 
findings of O’Neill and Evans (2009) in people with lower limb amputations, as well 
as findings in samples of older people more generally (e.g. Gothe et al., 2014). As 
executive functions have both unity and diversity (Miyake et al., 2000), differences 
may reflect the use of a different measures of executive functioning – cognitive 
flexibility and planning as opposed to verbal fluency. That relationships between 
cognitive functioning and both prosthesis use and mobility do not seem to persist 
over time may be a reflection of increasing familiarity with prosthetic ambulation, 
restriction of activities engaged in, or reintegration into structured social and 
physical environments with lesser need to anticipate and negotiate changes and 
challenges on a daily basis. There is also a caveat in terms of outcome measurement; 
hours of prosthesis use may not capture quality of prosthesis use and may include 
hours of wear wherein the wearer is inactive or not ambulating.  
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There was a pattern of higher cognitive functioning being associated with 
lower prosthesis satisfaction (cognitive flexibility and functional satisfaction at all 
three time points; overall cognitive functioning and aesthetic satisfaction at 
discharge). While the effects of cognitive functions on lower limb amputation 
rehabilitation outcomes such as mobility and prosthesis use have been assessed 
previously, the impact of cognitive functioning on prosthetic functional satisfaction 
has not. Understanding these relationships is intrinsically valuable in helping to 
maximize satisfaction with prostheses and understand reasons for dissatisfaction. It 
also has value in helping to contextualise and understand prosthesis use – 
satisfaction has been associated with prosthesis use (Murray & Fox, 2002). The 
findings from this study run contrary to what was expected. It was expected that 
participants with lower cognitive functioning would have lower satisfaction, and that 
this might result from difficulties in assessing problems and issues with prostheses or 
in advocating for or seeking prosthetic refitting. The current inverse relationship may 
relate to persons with higher functioning having higher expectations in terms of a 
return to premorbid levels of functioning, with disappointment being reflected in 
lower prosthesis satisfaction. Persons with higher cognitive functioning may be more 
aware of alternative products and services and may thus be more likely to make 
unfavourable comparisons. By virtue of having intact cognitive functioning, they 
may also have greater insight into problems and issues related to the prosthesis.  
Assessment of overall cognitive function is particularly recommended as 
useful in the understanding and prediction of prosthesis use and mobility, but a 
broader battery assessing a range of cognitive domains is recommended. Further 
research on the relationship between cognitive functioning and prosthesis 
satisfaction may be warranted to understand linking mechanisms. 
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6.9.3.2 Cognitive Functioning and Psychosocial Outcomes  
This study was the first to examine the relationships between cognitive functioning 
and psychosocial rehabilitation outcomes in people with lower limb amputations. 
Cognitive functions were largely not related to psychosocial outcomes, with some 
interesting exceptions. There were associations between higher executive 
functioning – usually cognitive flexibility, but also planning at times – and less 
favourable outcomes in areas like activation, adjustment, distress, and control over 
participation. Higher discharge activity limitation and participation restriction was 
also related to higher planning scores. Even when non-statistically significant 
correlations are examined for cognitive flexibility (and less frequently for planning), 
most correlations suggest a trend toward poorer outcomes for those with higher 
levels of cognitive flexibility functioning.  
It was thought cognitive functioning would have a relationship with 
activation via unimpaired ability to make healthcare-relevant decisions, and to self-
manage in terms of understanding, preventing, and treating healthcare problems, and 
knowing when to seek help with healthcare. In people with LLA, Coetzee et al. 
(2008) found that higher prospective memory – remembering to remember – was 
related to better adherence to medical treatment, which is a small component of 
patient activation. In terms of distress and adjustment, it was thought that persons 
with higher cognitive functioning would experience fewer distress-causing barriers, 
as they would be better-able to negotiate social and physical environments and to 
adopt practical, adaptive coping mechanisms. Higher levels of cognitive flexibility 
and planning – both executive functions – might have been expected to be associated 
with goal adjustment processes such as flexible goal adjustment via unimpaired 
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ability to select appropriate goals, modify goals with relation to emergent 
information and changing circumstances, and instigate new plans of action and 
behaviours. Indeed, adaptive self-regulation of goals has been observed to be related 
to positive and negative affective outcomes in people with lower limb amputations 
(Coffey, Gallagher, Desmond, & Ryall, 2014). Additionally, if worse cognitive 
functioning represents further progression of vascular pathology, participants with 
worse cognitive functioning may also be at risk of vascular depression. In a similar 
way, higher cognitive functioning was expected to relate to higher control over 
participation. With higher cognitive functioning (especially executive functions), it 
was thought participants would have and feel greater control over their participation. 
This would be by virtue of being able to draw on cognitive abilities and skills to 
make decisions and plan to “pursue dreams and desires, […] participate in activities 
that I choose” for example (Heinemann et al., 2013, p. 2161). Lastly, higher 
cognitive functioning was expected to have an association with fewer activity 
limitations and participation restrictions, again via the ability to draw on cognitive 
functions to negotiate environmental barriers. For example, it was thought absence 
of impairment would also make maintaining friendships easier (e.g. via ability to 
plan and remember and concentrate during events), and facilitate return to 
employment by not restricting employment opportunities. Thus, the findings from 
the current study were counterintuitive that higher executive function scores are 
associated with unfavourable rehabilitation outcomes.  
It may be that higher or preserved executive functioning facilitated different 
ways of evaluating outcomes. Higher functioning participants may have had 
different expectations for and following rehabilitation. Ostler, Ellis-Hill, and 
Donovan-Hall (2013), for example, found that while expectations were vague, 
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people expect a return to normality following rehabilitation. Persons with higher 
cognitive functioning may have engaged in more demanding activities pre-
amputation. They may have thus anticipated quicker return to employment or usual 
types and levels of participation. If expectations were not being met, this may have 
caused distress, feeling of maladjustment, feelings of lack of control over 
participation, and experiencing greater self-rated barriers to activity and 
participation. Alternatively, persons with intact or higher executive function may be 
more readily able to identify barriers to participation by being more able to evaluate 
circumstances, social programmes and supports, and opportunities. This too, may 
lead to distress and feelings of poorer adjustment. That significant relationships were 
not evident at 12 months suggests that this becomes less of a factor over time; this 
may reflect an eventual and gradual return to a lifestyle similar to that which existed 
premorbidly. Further research may help to discover potential mechanisms 
associating higher executive functioning with poorer short to medium term 
psychosocial functioning.  
Other cognitive functions had no significant relationships with psychosocial 
outcomes. Returning to familiar environments may mean that cognitive functioning 
does not have a major effect on psychosocial outcomes. Many of the impairments 
seen in this sample were relatively mild. With milder impairments equivalent to mild 
cognitive impairment, general functioning is said to remain largely unimpaired.  
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6.9.3.3 Impaired Cognitive Functioning Status and Rehabilitation Engagement, 
Prosthetic Outcomes, and Psychosocial Outcomes 
In a similar fashion to the absence of relationships between cognitive functioning 
and psychosocial outcomes described above, there were few significant relationships 
between impaired cognitive functioning status and rehabilitation engagement and 
prosthetic, mobility and psychosocial rehabilitation outcomes. There were however 
significant differences in rehabilitation engagement between people with and without 
impaired overall cognitive functioning, but not between participants with and 
without impairment in any other cognitive function. There were also significant 
differences between people with and without impaired delayed memory in terms of 
perceived social support. Participants in the impaired delayed memory group had 
lower levels of perceived social support longitudinally. Persons with delayed 
memory difficulties may forget arrangements, appointments, or conversation details, 
and this may negatively impact upon social support. Analyses of impairment status 
on both, one, or neither of overall cognitive functioning and cognitive flexibility 
found no differences between the groups. Considering the distribution of scores, 
differences between participants in terms of levels of cognitive functioning may not 
have been wide enough to uncover impairment.   
The low frequency of significant differences on follow-up measures between 
groups of participants who were impaired and non-impaired on cognitive variables 
may be attributable to factors relating to methodology and sampling. The small 
sample size and difference in the relative sizes of the groups meant that the statistical 
power of t-tests and ANOVAs was limited. Secondly, in cognitive impairment terms, 
the groups were not markedly different from each other. The non-impaired group 
had a distribution of scores skewed toward the impaired threshold; there are 
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relatively few scores in the overall sample in the normal range or higher. 
Furthermore, fewer of the participants ascribed to the impaired group took part in the 
follow-up stages of research. 79% of participants whose scores were in the ‘not 
impaired’ range on overall cognitive functioning completed follow-up at discharge,  
compared to 56% of participants who had impaired or borderline overall cognitive 
functioning scores.  
 
6.9.4 Limitations 
Aspects of sampling may have affected outcomes in this part of the research study. 
Sample size and rates of completion of the neuropsychological assessment battery 
limited the number and range of analyses that could be performed. Losing 
participants to follow-up and to mortality contributed similarly to these limitations. 
The number of predictor variables which could be entered into regression models 
was restricted by sample size. Structural equation modelling might have shown 
promise in terms of being able to reveal relationships between cognitive functions 
outcomes and potential moderators and mediators, but a larger number of cases 
would have been required to perform this analysis.  
Inferences regarding relationships with rehabilitation engagement or 
prosthetic, mobility or psychosocial rehabilitation outcomes cannot be made about 
those cognitive functions which were not examined as predictors, including 
psychomotor speed, a range of attention functions, immediate memory/learning, 
language functions, visuospatial perception, and other aspects of executive 
functioning, amongst others. Nonetheless, functions deemed the most pertinent in a 
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population with likely prevalent cerebrovascular disease were chosen, i.e. functions 
dependent upon the frontal lobes and white matter.  
Participants who completed follow-up questionnaires at each time point had 
significantly higher cognitive functioning. Thus, this sample may not reflect the 
difficulties experienced with psychosocial outcomes by service users with the 
greatest levels of impairment. This may limit the generalizability of these findings of 
lack of relationships between cognitive functioning and psychosocial outcomes to 
that group. Cognitive functioning was assessed solely during inpatient/day-patient 
rehabilitation, and not re-assessed in the post-rehabilitation period. Cerebral small 
vessel disease is progressive, so persons with VCI, or issues with cognitive 
functioning related to dysvascularity, may experience deterioration in cognitive 
functioning over time. Such deteriorations might have a differential course in 
different participants in their expression in terms of additional cognitive impairment 
– in terms of degree or nature. If such deteriorations might have influenced cognitive 
functioning and outcomes they might have done so differently for different 
participants.  
Service users experiencing cognitive difficulties may have received 
psychological and/or cognitive rehabilitation supports that helped to offset the 
impact of any cognitive impairment upon activities and participation. Additional 
family education may have prepared service users’ social network to provide 
additional support to help compensate for cognitive impairments. Most participants 
in this research reported high levels of social support. These additional supports may 
have reduced any differences in prosthetic and psychosocial outcomes between those 
with and without difficulties in cognitive functioning.  
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6.9.5 Conclusion 
Despite evident limitations, this study provides important information on the changes 
– or lack thereof – over time in prosthetic, mobility and psychosocial rehabilitation 
outcomes, and rehabilitation engagement. It also provides important new information 
on the relationships between cognitive functioning and both prosthetic, mobility, and 
psychosocial rehabilitation outcomes, and rehabilitation engagement. Strong 
relationships between cognitive functions and rehabilitation outcomes were found. A 
relationship was found between higher overall cognitive functioning, as well as 
delayed memory and visuospatial construction, and higher prosthetic and mobility 
outcomes. A counterintuitive relationship between higher executive functioning and 
less favourable prosthesis satisfaction and psychosocial outcomes was also 
uncovered.  
For these reasons, comprehensive neuropsychological assessment may reveal 
important information about whether service users are at risk of poor prosthetic and 
mobility outcomes. Additionally, those with high or intact cognitive functioning – 
especially executive functioning – may face additional challenges in adjusting to 
amputation, and with distress, activation, activity limitation and participation 
restriction, and feelings of control over participation. In combination, these findings 
warrant a programme of continued monitoring of outcomes, and opportunities for 
people with amputations to engage readily with rehabilitation supports and services, 
even after discharge from inpatient services.  
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7.1 Summary of the Rationale for the Present Study 
Lower limb amputation presents a myriad of challenges for individuals in terms of 
impairment, activity and participation. Recent estimates number persons living with 
a major lower limb amputation in the USA alone at 623,000 (Ziegler-Graham et al., 
2008). In economically developed countries, peripheral vascular disease (PVD) and 
complications related to diabetes are the most frequent precipitator of lower limb 
amputation (Kurichi et al., 2010). Almost three quarters of lower limb amputation 
referrals to prosthetic centres in Great Britain in the 2006/7 period were related to 
dysvascularity (National Amputee Statistical Database, 2009). Utilization of 
revascularization procedures and improved disease management are likely 
contributors to what appears to be gradually falling incidence of lower limb 
amputation in people with peripheral vascular disease and diabetes (Jones et al., 
2012; Varma et al., 2014). Yet incidence in the general population of peripheral 
vascular disease and diabetes is rising (Alzamora et al., 2016; Velescu et al., 2016). 
Countries with developing economies are also witnessing rising incidence of 
cardiovascular disease, diabetes, and PVD (e.g. Shaw, Sicree, and Zimmet (2010)). 
Moreover, populations in almost every country are ageing, with the number of 
persons aged 60+ projected to more than double by 2050 (United Nations 
Department of Economic and Social Affairs Population Division, 2013). Increased 
age is linked to increased incidence of lower limb amputation, especially of 
dysvascular aetiology, but also non-dysvascular (Amputee Coalition of America, 
2008; Dillingham et al., 2002). Ultimately, it is likely that large numbers of people 
with lower limb amputations are likely to continue to present to rehabilitation 
programmes well into the future. Most of these people are likely to have dysvascular 
aetiology, which is linked to impairments in cognitive functioning.  
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A review of the literature found that cognitive impairment and dementia 
seem to be more prevalent amongst people with lower limb amputations than in the 
general population. Yet, it also found that most investigations used merely 
categorical definitions of cognitive functioning, including undetermined dementia 
diagnoses. It also found that even more comprehensive studies have suffered from 
very or relatively narrow batteries, insufficient reporting of demographic, clinical, or 
results data to make determinations about profile. Only one of these more 
comprehensive studies included people with lower limb amputations of non-vascular 
aetiology for comparison and sometimes aetiology was not reported at all. Often, 
studies also suffered from sample sizes that were small or biased by selection, such 
that generalisation to general populations of people with lower limb amputations on 
rehabilitation programmes was precluded. With this limited number of studies, and a 
too-narrow focus in terms of battery use and samples, it has not been possible to 
reach precise conclusions about the profile of cognitive functioning in people with 
lower limb amputations. However, where the relationship between cognitive 
functioning and outcomes has been studied, a number of assessments have focused 
on blunt outcomes like mortality or rehabilitative success. In such cases, 
rehabilitation success was defined solely in prosthetic and mobility terms. Indeed, 
prosthesis use and mobility are the rehabilitation outcomes that have most frequently 
been assessed in relation to cognitive functioning. Psychosocial outcomes have 
largely been neglected. Studies have often not covered a full range of cognitive 
functions. Again, this makes it difficult to draw clear conclusions about the 
relationship between cognitive functions and outcomes. There is some evidence that 
lower levels of cognitive functioning are related to lower levels of prosthesis use, 
mobility, and social integration, with conflicting information about activities/activity 
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restriction. Examination of a wider range of prosthetic, mobility and psychosocial 
outcomes was warranted, as was use of a spectrum of cognitive functions for this.  
 
7.2 Summary of the Present Study and Its Findings 
7.2.1 Summary of the Present Study  
There were two overarching aims in this research study of people with lower limb 
amputations in a rehabilitation programme. The first aim was to assess the following 
aspects of cognitive functioning: estimated premorbid intellectual functioning, a 
brief cognitive screen and overall cognitive functioning, reasoning, psychomotor 
speed, information processing, attention, memory, visuospatial perception and 
construction, language, and executive function. The second aim was to assess the 
relationships between cognitive functions, rehabilitation engagement, and prosthetic, 
mobility, and psychosocial outcomes. The study undertaken to meet these aims was 
a prospective cohort longitudinal study, which incorporated a cross-sectional profile 
of neuropsychological functioning. A range of neuropsychological variables were 
collected during inpatient rehabilitation (T1). A clinician-rated measure of 
rehabilitation engagement was collected at discharge (T2). Prosthetic, mobility, and 
psychosocial outcomes were collected at discharge, 6 months post-discharge (T3), 
and 12-months post-discharge (T4).  
 
7.2.2 Summary of Findings  
Cognitive functioning, across a range of domains, was impaired in this sample of 
individuals with lower limb amputations. Impairment was evident both in terms of 
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significantly lower mean scores and significantly higher proportions of scores in the 
borderline and impaired ranges compared to normative values. Half of participants 
had scores below the cut-off for cognitive impairment on the brief cognitive screen. 
Considerations of sensitivity and specificity of the screen suggest that up to a quarter 
of the sample may thus have mild cognitive impairment. Impaired aspects of 
cognition included overall cognitive functioning and functions such as fluid 
reasoning, psychomotor speed, information processing, focused attention, sustained 
attention, immediate recall, delayed recall, delayed recognition memory, visuospatial 
construction, and executive functions including inhibition, cognitive flexibility, 
verbal fluency (executive-mediated memory retrieval/self-monitoring), planning, and 
self-rated everyday executive functioning. Impairment is also suggested on more 
complex confrontational naming, and spatial perception. Working memory (an 
executive function), divided attention and one element of simple information 
processing (word reading) did not differ significantly from normative populations 
either in terms of mean scores or sample proportions impaired. The working memory 
assessment, similar to those commonly employed in other studies (Phillips et al., 
1993; Williams et al., 2014, 2015), may not have been sensitive enough to 
impairment, and may tap into attention span or short-term memory instead. Results 
also indicated that there were no significant differences between the vascular and 
non-vascular groups on neuropsychological assessments. Ostensibly, this was due to 
the non-vascular group performing just as poorly as the vascular group. Presence of 
vascular comorbidities or traumatic brain injury in a number of participants with 
non-vascular amputation aetiologies may help to explain the lack of differences in 
cognitive functions.  
NEUROPSYCHOLOGICAL FUNCTIONING AND LOWER LIMB LOSS 
 
277 
 
With the exception of increased daily hours of prosthesis use, most 
rehabilitation outcomes remained stable over time within this sample of individuals 
with lower limb amputations. Compared to normative populations, there were 
elevated levels of depression caseness and activity limitation and participation 
restriction in this sample. Regarding participation engagement, activities that were 
both important to people and that were most frequently performed enough included: 
family/friend interaction and communication, household activities, and religious or 
spiritual activities. As well as active/sports recreation, the activities that were both 
important to people and least frequently performed enough were often those that 
required participation outside the home and/or with persons other than close 
relatives. Higher levels of rehabilitation engagement were mostly related to better 
longer term outcomes including better general adjustment, adjustment to limitation, 
lower distress, and higher perceived social support, as well as greater levels of 
community participation (engagement, importance, and control), and less limitation 
and restriction. Rehabilitation engagement was also related to better discharge 
mobility. 
Higher levels of overall cognitive functioning, better delayed memory and 
better visuospatial construction were related to better mobility. Higher overall 
cognitive functioning, and lower cognitive flexibility, were related to longer hours of 
prosthesis use in the short and longer term respectively. Higher overall cognitive 
functioning and cognitive flexibility were linked to lower aesthetic and functional 
satisfaction respectively. Overall cognitive functioning, combined processing speed 
and attention, delayed memory, and visuospatial construction were not significantly 
associated with psychosocial outcomes at any time point. Higher executive 
functioning (cognitive flexibility or planning) was related to a range of unfavourable 
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short to medium-term outcomes including lower activation, lower general 
adjustment, higher distress, lower control over participation and higher activity 
limitation & participation restriction. Controlling for rehabilitation engagement, 
cognitive functioning generally did not predict six month prosthetic, mobility, or 
psychosocial outcomes. However, higher cognitive functioning predicted higher 
levels of distress. No significant differences existed between groups with and 
without impaired overall cognitive functioning, processing speed and attention, 
delayed memory, visuospatial construction, or cognitive flexibility scores. The 
exception was that persons with impaired/borderline delayed memory scores had 
poorer perceived social support. Results indicated no differences between people 
who were impaired on neither, one or both of overall cognitive functioning and 
cognitive impairment categories across the range of prosthetic and psychosocial 
outcomes, or for rehabilitation engagement at discharge. 
 
7.3 Recommendations for Rehabilitation Practice 
Impaired and borderline-impaired cognitive functioning was found to be widespread 
amongst this sample of people admitted to limb loss rehabilitation. Persons with 
vascular aetiology comprise the majority of amputations and admissions to 
rehabilitation and are likely to exhibit impairments across a wide range of cognitive 
functions. Persons with non-vascular aetiology of amputation may also have 
impairments in cognitive functioning similar to those with vascular aetiologies. This 
may or may not result from presence of vascular risk factors. Increased susceptibility 
of people with dysvascularity to amputation for non-vascular aetiologies may be 
another contributory factor. Lastly, with traumatic amputation in particular, 
comorbid acquired brain injury may be present. Therefore, a brief cognitive screen is 
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at least warranted for all participants in lower limb amputation rehabilitation 
programmes. It is suggested that the Montreal Cognitive Assessment (MoCA; 
Nasreddine et al., 2005) be employed in this capacity. The MoCA has been validated 
for use with samples with a range of vascular pathologies (Koski, 2013; A. J. Larner, 
2013). McLennan, Mathias, Brennan, and Stewart (2011) suggested a cut-off score 
of <24 for the detection of mild cognitive impairment in people with cardiovascular 
disease. This cut-off score had 100% sensitivity, and 50 – 52% specificity. In this 
study, 30 of 59 participants (52%) who completed the MoCA had scores <24, 
suggesting that it is capable of identifying cognitive dysfunction in this sample. A 
suitable alternative to the MoCA would be a similar screening instrument which is 
considered sensitive to executive functioning deficits. Two alternatives worth 
considering might be the Addenbrooke's Cognitive Examination Revised (ACE-R; 
Mioshi, Dawson, Mitchell, Arnold, & Hodges, 2006), and the Brief Memory and 
Executive Test (BMET; Brookes, Hannesdottir, Lawrence, Morris, & Markus, 
2012), which was developed recently for the detection of subcortical ischaemic 
vascular disease. Based upon previous research, the MMSE (Folstein et al., 1975) is 
unlikely to be suitably sensitive for these purposes as it is not sufficiently sensitive to 
the profile of deficits in vascular cognitive impairment, nor is it sensitive to milder 
forms of cognitive impairment (Pendlebury et al., 2010, 2012). One caveat is that 
both the MoCA and the ACE-R may be insufficiently sensitive to the presence of 
impairment in a single cognitive domain other than memory (Pendlebury et al., 
2012). Cognitive screening can also help to direct limited resources in terms of 
neuropsychological assessment and psychological or rehabilitative supports to 
rehabilitation service users based on greatest need and with increased efficiency. 
Beyond initial screening, should comprehensive neuropsychological assessment not 
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be feasible, administration of the RBANS (Randolph et al., 1998) allows for 
assessment of a range of cognitive functions with a relatively low administrative 
burden. Availability of alternative RBANS formats allows for the monitoring of 
cognitive functioning over time. It is important to supplement the RBANS with 
measures of executive functioning, for example the trail making test (cognitive 
flexibility) or the BADS zoo map subtest (planning).  
Comprehensive neuropsychological assessment is indicated in this 
population, with a battery sensitive to vascular cognitive impairment. Half of the 
present sample scored below the cut-off on the cognitive screening measure, and a 
third had impaired or borderline scores on a measure of overall cognitive 
functioning. There were frequent difficulties with executive functions. For example, 
almost half had impaired or borderline scores on cognitive flexibility, while almost 
nine out of every ten participants who completed the planning measure had impaired 
or borderline scores. Every participant, irrespective of the nature or extent of their 
cognitive functioning or impairments had a different profile. Identification of 
participants’ relative or actual cognitive functioning strengths and weaknesses is 
greatly facilitated by neuropsychological assessment that covers a wide range of 
cognitive functioning. The need for a broadly based, flexible battery assessment is 
underlined by the fact that participants experienced difficulties in almost every 
aspect of cognitive functioning examined: reasoning, psychomotor speed, 
information processing, attention, immediate and delayed memory, visuospatial 
cognition, naming, and executive functions. Interpretation of neuropsychological 
assessment can help to determine whether, for example incorrect sequencing of steps 
in donning and doffing a prosthesis might be due to difficulties with learning the 
correct steps, recalling the correct steps, sustained attention to the task, visual 
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perception, or executive management of the task and problem solving. It can also 
help to determine what cognitive strengths a person might be able to draw on to 
overcome these difficulties.  
It is important that the possibility of the presence of cerebral pathologies 
other than subcortical ischaemic vascular disease not be discounted. The majority of 
admissions to lower limb rehabilitation are middle aged or older. Older age carries 
increased risk of age-related cognitive impairments. This raises the possibility that 
stroke, mild cognitive impairment of Alzheimer’s pathology, Alzheimer’s dementia, 
or indeed any of a range of dementia syndromes may be present in a proportion of 
admissions to limb loss rehabilitation. This further supports the utilization of 
cognitive screening measures that assess multiple cognitive domains (e.g. MoCA) as 
standard practice to identify persons who may need further neuropsychological 
assessment and support.  
Within this study, from an anecdotal perspective, many research participants 
did not show obvious signs of difficulties with everyday cognitive functioning. 
During recruitment, and assessment, many (though certainly not all) participants 
seemed alert, chatty, and to be functioning well. For some, their neuropsychological 
assessments told a different story, and they may have had impaired or borderline 
scores in more than one area. This again underlines the importance of cognitive 
screening, referral for comprehensive neuropsychological assessment when 
appropriate, and the recording of a detailed clinical history by experienced clinicians.   
Cognitive rehabilitation interventions are many and varied and there is 
evidence that they are efficacious (Heugten, Wolters Gregório, & Wade, 2012). 
Errorless learning is one form of cognitive rehabilitation which has already been 
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trialled in people with dysvascular lower limb amputations as an intervention to 
improve prosthesis use by Donaghey, McMillan, and O’Neill (2010). It seems to 
have been successful; participants in the intervention remembered more correct steps 
and made fewer errors than controls. They also reported that the technique required 
“no additional clinical resources” (p. 200). O’Neill, Moran, and Gillespie (2010) also 
investigated the use of voice–mediated assistive technologies to ‘scaffold’ 
behaviours in a small group of participants with difficulties fitting limbs. The 
intervention reduced the number of omitted steps in limb fitting and reduced the 
number of ‘safety-critical’ errors. Although further research is warranted, access to 
similar programmes could enhance prosthetic and mobility outcomes for persons 
who may otherwise struggle with learning to use a prosthesis. Metacognitive training 
to improve awareness of one’s own thinking patterns has been declared a ‘practice 
standard’ intervention for executive functions in traumatic brain injury and stroke 
(Cicerone et al., 2011). It may also show utility in the lower limb amputation 
population. Metacognitive training along with direct attention training has similarly 
been recommended for attentional functioning. Memory strategy training has been 
recommended for memory deficits in traumatic brain injury. This includes both the 
use of internal mnemonic strategies and assistive devices. Information processing 
training is another intervention which may help participants. In a review of six 
studies, Ball, Edwards, and Ross (2007) found that, in older adults, speed of 
processing training can improve IADL performance, with gains being maintained for 
up to two years. This was particularly the case when training was tailored to the 
abilities of participants, rather than standardised. Speed of information processing is 
compromised in people with vascular pathologies, was compromised in this sample, 
and was related to rehabilitation engagement. Improved ADL performance has the 
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potential to contribute also to improved participation. Should faster processing speed 
have a beneficial effect upon rehabilitation engagement, there is potential for 
improved long term rehabilitation outcomes. It is important overall that evidence-
based cognitive rehabilitation be made available to service users as appropriate. 
Additionally, clear presentation of instructions in rehabilitation settings, with 
repetition as appropriate, and with additional visual aids or cues if possible, may 
assist service users with cognitive impairment to maximize benefit from 
rehabilitation programs.  
Higher executive functioning was associated with a range of unfavourable 
prosthetic satisfaction and psychosocial outcomes. It may be the case that people 
with higher function have more difficulty in adapting to post-amputation or post-
rehabilitation changes. There are a number of potential contributors to this. They 
might have different expectations from rehabilitation than peers with lower levels of 
functioning. They may have had different lifestyles prior to amputation. Returning to 
this lifestyle may not be possible post-rehabilitation. The one variable consistently 
associated with higher levels of cognitive functioning was longer time spent in 
education. This may have been associated with different career types or lifestyles. In 
contrast, persons with lower levels of cognitive functioning may have transitioned 
out of employment or have already retired (for example) prior to amputation due to 
difficulties performing employment activities. While these associations were not 
present by 12 months post-discharge, it suggests that monitoring the outcomes of 
persons with high levels of cognitive functioning is just as important as those with 
low levels of functioning. Provision of psychological supports around adjustment to 
amputation and prosthesis use may be indicated to support the transition from 
rehabilitation to the community and further to the return to normal living. Universal 
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availability of such supports is important, while results from the present research 
indicate that persons with higher executive/cognitive functioning ability may warrant 
particular attention. Considering resource implications of extending psychological 
support services beyond inpatient/day-patient rehabilitation programmes and service 
user mobility impairment, telehealth service provision is worth considering.  
Prevention of impairment in the first instance is preferable to management. 
Slightly elevated proportions of people with lower levels of, or impaired, estimated 
premorbid cognitive function were evident in the present research. There is potential 
for impaired cognitive functioning to contribute to acquired lower limb amputation 
via difficulties with health self-management or general self-care. Widespread 
cognitive screening has significant resource implications, but implementation of 
brief cognitive screening for at-risk persons – for example persons with diabetic 
neuropathy – in primary or acute healthcare settings may contribute to reduction in 
amputation incidence.  
The potential for people with a range of cognitive impairments to achieve 
favourable outcomes is a strong argument against streamed rehabilitation
.
 Rather, 
rehabilitation services should be tailored to individual needs, with reviewable 
rehabilitation goals set as appropriate. Neuropsychological assessment, including use 
of cognitive screening tools and comprehensive assessment, may inform 
rehabilitation goal formation, adaptation, or modification. In revealing cognitive 
impairments and strengths, such assessment can help to support rehabilitation service 
users in the achievement of their goals. This is already standard practice in limb loss 
rehabilitation at the National Rehabilitation Hospital. Further research that explores 
supporting those with a range of cognitive functioning difficulties to manage 
NEUROPSYCHOLOGICAL FUNCTIONING AND LOWER LIMB LOSS 
 
285 
 
involvement in multifaceted rehabilitation programmes and return to the community 
is warranted.  
 
7.4 Recommendations for Research 
Certainty of pathological mechanisms is not possible with neuropsychological 
assessment alone; the present research cannot answer whether participants with 
impaired cognitive functioning actually had cerebrovascular pathology. For this 
purpose, future research incorporating both neuropsychological assessment and brain 
imaging might prove fruitful. Future research should explore the possibility of 
multicentre recruitment to ensure sample representativeness. Dichotomous 
classifications of cognitive functioning (i.e. classification as impaired or not 
impaired) were not helpful in determining likely rehabilitation outcomes. Categorical 
classification based on both overall cognitive functioning and cognitive flexibility 
did not relate to discharge outcomes either. This information is useful in encouraging 
measurement of cognitive functioning with continuous variables. It is also an 
argument against using dichotomous classifications such as presence or absence of 
dementia. Dementia is an umbrella term, and the cognitive profile of dementia can 
vary greatly. Use of comprehensive neuropsychological assessments and scalar 
scores should be the starting point for future research endeavours in order to capture 
the full range of cognitive functioning.  
Further research examining working memory in people with lower limb 
amputations is warranted. The preponderance of subcortical ischemic vascular 
disease and its effects upon the frontal lobes suggest that a significant degree of 
working memory impairment should have been found in this sample. Findings across 
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the VCI spectrum of impairment are in accordance with this. However, examinations 
of working memory in people with amputations, including this study, have employed 
digit span measures which have incorporated digit forward conditions insensitive to 
working memory (Phillips et al., 1993; Williams et al., 2014, 2015). Digit backward 
conditions also potentially do not measure working memory in adults, but rather 
short term memory (St Clair-Thompson, 2010). Digit ordered conditions alone, or an 
n-back task are potential alternatives for the examination of working memory in this 
population (Lezak et al., 2012).  
In this sample, most participants achieved outdoor mobility, and the majority 
of the remainder achieved indoor mobility. Many participants were satisfied with 
their prosthesis and used it often. Many also attained good levels of adjustment, and 
were satisfied with many aspects of participation. While some cognitive functions 
related to prosthesis use or mobility, in the main, cognitive functioning was not 
related to psychosocial rehabilitation outcomes. Executive functioning had 
unexpected relationships with a range of outcomes in this sample, with higher 
executive functioning being related to a range of unfavourable outcomes. It is 
unclear precisely what mechanisms underlay these relationships. Qualitative research 
paradigms may also help to explore potential issues around premorbid lifestyle and 
expectations following rehabilitation. Prospective research examining a full 
complement of executive functions in relation to rehabilitation outcomes may then 
be worth consideration. Another potential contributor to the unexpected relationship 
between executive functions and outcomes is relative or actual absence of apathy 
concomitant with frontal-executive impairment in those persons who are higher 
functioning – or least impaired – in terms of executive functioning.  
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Multicentre recruitment would also increase the likelihood of obtaining a 
sample of sufficient size to perform multiple regression analyses with a large number 
of predictors. This would make it possible to both examine the relationships between 
other cognitive functions and rehabilitation outcomes, and to control for a wider 
range of sociodemographic and clinical variables. Similarly, larger samples would 
facilitate the use of structural equation modelling to understand causal relationships 
between predictors, moderators/mediators, and outcomes. If possible, research 
should also record whether service users received cognitive rehabilitation, family 
education, or other psychological supports which might offset the impact of any 
cognitive impairment on rehabilitation outcomes. Provision of such supports is worth 
controlling in analyses of cognitive functioning and outcomes or rehabilitation 
engagement.  
Cognitive interventions (similar to those outlined above in Section 7.3 
Recommendations for Rehabilitation Practice) to improve prosthetic and mobility 
rehabilitation outcomes need to be explored. While the results of  research 
examining errorless learning interventions in prosthetic rehabilitation (Donaghey et 
al., 2010; O’Neill et al., 2010) have been promising, both of the relevant studies 
relied on small samples. No intervention has yet examined the impact of a specific 
cognitive rehabilitation programme on mobility in people with lower limb 
amputations. With overall cognitive functioning, delayed memory, and visuospatial 
construction all having a relationship with mobility in this sample, future research 
exploring this might provide useful information on improving mobility outcomes. It 
is potentially worth examining the impact of speed of processing training on 
rehabilitation engagement and outcomes, considering its reported efficacy in 
improving older adults’ IADL performance (Ball et al., 2007). Evidence in similar 
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populations for the efficacy of a range of cognitive training and rehabilitation 
techniques is limited, and hampered by study design and quality. This includes areas 
such as rehabilitation of memory and attention in people with stroke (das Nair, 
Cogger, Worthington, & Lincoln, 2016; Loetscher & Lincoln, 2013), and the effect 
of various programmes on ADLs in mild to moderate Alzheimer’s disease and 
vascular dementia (Bahar-Fuchs, Clare, & Woods, 2013), though in the latter case 
for example while cognitive training appears ineffective, cognitive rehabilitation has 
shown promise. Drawing firm conclusions from research on cognitive rehabilitation 
in mild cognitive impairment has been similarly hampered by study design and 
quality, but results have been described as promising (Huckans et al., 2013). 
Controlled-trial research is currently underway investigating a wide range of 
interventions. For example, a trial is underway to improve attentional functioning in 
subcortical ischaemic vascular disease (Salvadori et al., 2016). It is worth monitoring 
the outcomes of such research for potential application in the lower limb amputation 
population. RCTs are warranted to investigate the potential efficacy of cognitive 
rehabilitation in lower limb amputation and similar/related populations. Information 
processing training, and metacognitive training might be two particular types of 
intervention worth exploring. Single-case design pilot studies may help to reveal 
cognitive rehabilitation interventions which are potentially efficacious in this 
population.   
Findings from this study indicate that cognitive functioning has a relationship 
with rehabilitation engagement. This adds to recent developments in the literature 
linking psychological facilitators and barriers to rehabilitation engagement 
(Ramanathan-Elion, McWhorter, Wegener, & Bechtold, 2016). Further investigation 
of this relationship may be warranted, especially in light of both the current and 
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previous (Kortte et al., 2007) findings of relationships between rehabilitation 
engagement and rehabilitation outcomes. The relationship between rehabilitation 
engagement and a broader range of cognitive functioning variables is one avenue of 
exploration. Working memory and inhibition are perhaps two candidates worth 
special consideration. They are two of the core executive functions
28
 (Diamond, 
2013; Miyake et al., 2000), and functions that are possibly important in rehabilitation 
therapeutic sessions. Working memory and inhibition are the abilities respectively to 
manipulate information while holding it ‘online’, and to inhibit irrelevant or 
distracting information in one’s surroundings. Though the executive functions 
investigated did not have a significant relationship with rehabilitation engagement, 
this does not negate the examination of other executive functions. Attentional 
variables like sustained attention may also be worth investigating further. 
Therapeutic sessions often last for an hour or longer, and the ability to concentrate 
for such prolonged periods of time may be important to the rehabilitation process.  
Rehabilitation engagement further has a relationship with rehabilitation outcomes, as 
seen in this and other research (Kortte et al., 2007). Potential exists to modify 
rehabilitation engagement levels among participants in limb loss rehabilitation. 
Amelioration of, or compensation for, the effects of cognitive impairments via 
cognitive rehabilitation may ultimately improve rehabilitation engagement.  
 
7.5 Strengths and Limitations 
This study was the first to assess cognitive functioning in lower limb amputation 
with such a broad battery of standardised neuropsychological assessments. It was 
                                                 
28 ‘Executive functions’ is an umbrella term. Although unified in ways, executive functions 
are also separable (Miyake et al., 2000). 
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also the first study to employ a battery that is also sensitive to the most prominent 
cognitive sequelae of cerebrovascular disease – impaired information processing, 
attention, and executive functions, as well as a broad range of other functions. This is 
also the only study to provide an estimation of premorbid cognitive functioning for 
this population. The study also incorporated a brief cognitive screen which is 
sensitive to vascular cognitive impairment – the MoCA (Nasreddine et al., 2005) – 
which had not yet been reported previously with this population. This research is one 
of the few studies to prospectively examine cognitive functioning contributors to 
rehabilitation outcomes. An exploration of the relationships between cognitive 
functioning and rehabilitation engagement is presented for the first time in lower 
limb amputation, as are explorations between both of these and adjustment, patient 
activation, and a number of aspects of participation.  
The present study did not employ a control group. It was thought that the 
vascular and non-vascular aetiology groups would serve as comparison groups for 
each other when analysing rehabilitation outcomes. This was complicated by 
recruitment of fewer participants than initially expected and the stark difference in 
group sizes. Comparison of participants from each group at the cognitive functioning 
level revealed no differences between groups, with the non-vascular group 
performing poorly (and poorer than expected) on measures of cognitive functioning. 
These findings, and practical considerations regarding maximization of available 
data points for statistical analyses, led to the decision to pool the data of the two 
groups to examine rehabilitation outcomes. This study sampled consecutive 
admissions to rehabilitation. Recruitment of age matched participants across vascular 
and non-vascular LLA groups would be problematic, given the socio-demographic 
differences between typical patients in these groups.  Future research should 
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consider the recruitment of age-matched controls; perhaps sampled from a 
population with musculoskeletal/mobility impairments but without elevated risk of 
cognitive impairment.  
Differing completion rates for each of the neuropsychological assessments 
are a limitation of the present study. Lower completion rates were largely related to 
restrictions in scheduling and availability of participants for research, early discharge 
from rehabilitation back to acute hospital settings, declining to continue (often 
reported to be due to fatigue), and the length of time required to complete the 
assessment battery. Fractionation of testing sessions due to test-fatigue and 
scheduling difficulties in researching a population with dysvascular lower limb 
amputations was previously reported by Phillips et al. (1993). Phillips et al.'s  (1993) 
study was the only other study to employ a comparably comprehensive 
neuropsychological assessment. Additionally, the assessment battery was 
administered with a set structure, resulting in tests earlier in the order of 
administration being completed more frequently. During the course of data 
collection, the order of administration was adapted to allow for earlier administration 
of prioritised assessments. Low completion rates for neuropsychological tests mean 
that potential for bias exists; smaller sample sizes reduce generalizability. 
Furthermore, it reduces ability to examine bivariate relationships with rehabilitation 
outcomes, and curtails the utility of the neuropsychological assessment in predicting 
rehabilitation outcomes. Nevertheless, by comparison to Phillips et al.'s  (1993) 
study, this study had more than double the number of data points for even the least 
frequently completed assessment, and more than 5.5 times the data points for the 
most-frequently completed measures. As outlined briefly above, the WAIS-IV digit 
span test may not have been sensitive enough to assess working memory. More 
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sensitive measures of working memory such as an n-Back task could potentially 
have revealed difficulties in this area. Use of such a measure is worthy of 
consideration in future research.  
The neuropsychological assessment profile sample included two groups of 
participants. One was a fully prospectively recruited and assessed group. The other 
(Group B) included a) thirteen participants who did not want to complete additional 
assessment, but were happy to consent for extant data to be included in research, and 
b) two fully retrospectively recruited participants. Group B participants were older 
and had more comorbidities. Including Group B in the cognitive functioning profile 
was justified in part because it increased the sample size. More importantly, it 
ensured inclusion of a number of older, less medically-well persons who would not 
otherwise have participated. These participants are likely to be representative of the 
typical inpatient in rehabilitation. If these participants had not participated, this 
would have been a source of bias in itself. It would have reduced the generalizability 
of the findings to the general population engaged in limb loss rehabilitation. 
Separately, there was also large difference in aetiology group sizes. This difference 
in group sizes is to be expected in rehabilitation programmes in industrialized 
countries, but made statistical comparison between aetiology groups difficult. 
The follow up samples were a potential source of sampling bias. Firstly, 
participants who completed follow-up at any of the time points had higher levels of 
overall cognitive functioning, or cognitive flexibility, or both, depending on the time 
point. Insofar as these were significantly better-functioning subsets of participants, 
conclusions drawn about the absence of relationships between cognitive functions 
and rehabilitation outcomes may be limited by this. Participants who completed 
follow-up assessments may also have represented a sub-group with higher 
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motivation. This could be as a result of differing personalities or attitudes to 
assessment and research. Alternatively, the subset with better cognitive functioning 
may also have had lower levels of dysvascular-related apathy relative to other 
participants. Participants in this study reported higher levels of self-rated everyday 
executive dysfunction. Assessment of this included measurement of apathy. 
Examination of scores on that subscale revealed elevated levels of self-reported 
apathy.  
Small sample sizes in terms of follow-ups completed were also an issue. 
Sample sizes restricted the type of analyses that could be performed; they precluded 
structural equation modelling for example. Sample size also restricted statistical 
analyses that were actually performed. It limited the number of predictors that could 
be entered into the regression models. The subsequent approach taken was to 
prioritise two cognitive variables – overall cognitive functioning and cognitive 
flexibility on the basis of extant literature and hypothesised importance for 
predicting outcomes. The distribution of obtained planning scores precluded its use 
as a predictive measure in the place of the other prioritised executive functioning 
measure, cognitive flexibility. Rehabilitation engagement was prioritised for use as a 
controlling variable instead of socio-demographic and clinical variables, as it was 
thought to represent how well participants engaged in rehabilitation regardless of 
other factors. This was deemed to be the best approach to maximise the use of data 
and the amount of useful information from analyses.  
 This study did not measure cognitive functioning longitudinally. Cognitive 
functioning for many participants may have changed in the period between 
admission assessment and 12 month follow-up. Williams et al. (2014) reported 
improvements in cognitive functioning from pre-amputation to six months post 
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amputation in immediate and delayed memory. This may have reflected greater post-
operation physical/cardiovascular health, change in medication usage, or lower 
levels of distress, or the large differences in sample sizes between some of the time 
points. Cerebral small vessel disease is slowly progressive in nature. Hence, a 
decline in cognitive functioning might have been expected for a number of 
participants with vascular pathology in this study. Similarly, the older age of 
participants means they are susceptible to cognitive impairment resulting from 
various pathologies, which might manifest in the time between admission and 12 
months post-discharge.  
 
7.6 Conclusion 
The first aim of this research study was to create a profile of cognitive functioning in 
lower limb amputation. Evidence was presented for a profile of cognitive 
functioning largely consistent with vascular cognitive impairment. This includes 
frequently impaired overall cognitive functioning, fluid reasoning (visuospatial and 
verbal), information processing (especially complex/time-pressured processing), 
attention (including sustained and focused), memory (including immediate and 
delayed recall and delayed recognition), spatial perception and visuospatial 
construction, naming of low frequency objects, and executive functions (including 
inhibition, cognitive flexibility, planning, and verbal fluency).  
This study provides evidence that even persons admitted to lower limb 
amputation rehabilitation for non-vascular aetiologies may have difficulties with 
cognitive functions – potentially resulting from comorbid vascular risk factors or 
acquired brain injury. The use of an appropriately sensitive cognitive screening tool 
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as standard on admission to rehabilitation is strongly recommended. This cognitive 
screen should be sensitive to the sequelae of cerebrovascular disease. Referral for 
comprehensive and wide-ranging neuropsychological assessment should be made as 
appropriate to identify relative or actual cognitive functioning strengths and 
weaknesses.  
The second aim of this research study was to examine relationships between 
cognitive functioning and rehabilitation engagement and rehabilitation outcomes. 
Rehabilitation engagement was associated with a range of longer term prosthetic and 
psychosocial rehabilitation outcomes. Its assessment and monitoring may provide 
useful information in the prediction of outcomes. Further research clarifying the 
cognitive functions related to rehabilitation engagement could open up opportunities 
for interventions to improve rehabilitation engagement.  
Higher cognitive functioning was related to higher prosthetic and mobility 
rehabilitation outcomes. Future research efforts could be focused on examining 
interventions to reduce the impact of cognitive impairment on prosthetic and 
mobility outcomes. Appropriate, evidence-based cognitive rehabilitation should be 
considered in order to assist persons to achieve optimal rehabilitation outcomes. 
Higher executive function abilities showed relationships with some unfavourable 
psychosocial outcomes. Research efforts could be focused on clarifying these 
relationships, and understanding the mechanisms underlying same. Monitoring of, 
and developing psychological interventions to support all those with unfavourable 
psychosocial outcomes is also recommended. Dichotomising cognitive functioning 
does not appear to provide particularly useful information on its relationship to 
rehabilitation outcomes. This approach should be avoided in favour of scalar 
measurement with standardised neuropsychological assessments. Lastly, an attempt 
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was made to quantify the impact of impairment on more than one domain on 
rehabilitation outcomes. Only two measures were used in this assessment, so 
drawing final conclusions is premature. For now, this categorical combination of 
impairment or otherwise on both overall cognitive functioning and cognitive 
flexibility did not have relationships with rehabilitation outcomes.  
People with lower limb amputations face many and varied challenges during 
the rehabilitation process, and in returning to life in the community. Understanding 
whether, and how, aspects of cognitive functioning contribute to these processes will 
aid the development of supports and interventions to help service users achieve 
optimal outcomes. There is still much to discover about relationships between 
cognitive functioning and prosthetic and mobility rehabilitation outcomes – 
especially regarding prosthesis satisfaction, and interventions. However, concordant 
with the development of bio-psycho-social approaches to health and well-being, 
contemporary lower limb amputation rehabilitation has progressed beyond focusing 
solely on prosthetic and mobility issues. Post-rehabilitation activities and 
participation, and broader issues of adjustment, and holistic approaches to quality of 
life after amputation are now of keen interest. Relationships between cognitive 
functioning and these latter aspects of rehabilitation have heretofore been neglected. 
Research on cognitive functioning and lower limb amputation is a vital step toward 
that ultimate goal of optimal health-related quality of life. 
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Section 1: Standard Cover Letter 
 
         
[Date] 
 
Dear _________________________, 
 
You are invited to participate in a study entitled Neuropsychological functioning and 
prosthetic rehabilitation outcomes in lower limb amputees during your time at the 
National Rehabilitation Hospital. This study is being carried out by Richard 
Lombard-Vance, a research psychologist, liaising with Dr Fiadhnait O’Keeffe, 
senior clinical psychologist on the POLAR programme. This study is supported by 
Dr Nicola Ryall, consultant in rehabilitation medicine at the NRH. 
 
The overall aim of this study is to gain a better understanding of which areas of 
thinking best predict levels of prosthetic, physical, and life-participation outcomes 
up to a year after rehabilitation, in those who have lost a limb. Such areas of thinking 
would include memory, attention, and planning.  
 
These areas of thinking and memory will be assessed by administering a number of 
neuropsychological tests. These tests will take about 2 
1
/2 hours to complete and may 
be split over two sessions. All of these assessments are used regularly in routine 
clinical practise. Follow-up questionnaires will also be completed as part of this 
study, to be completed six weeks after being discharged from the NRH and again six 
months and twelve months after discharge.  The questionnaires will take 
approximately 30-40 minutes to fill in.  
 
Your participation would provide valuable information which, we hope will guide us 
in improving patient care in the future.  
 
Please note that your participation in this study is entirely voluntary, and all 
information provided will be kept strictly confidential. It will not affect the standard 
or quality of care you receive if you decline to take part. Information from research 
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assessments will be shared with the clinical psychologist on the POLAR programme, 
Dr Fiadhnait O’Keeffe. 
 
Please read the information attached for further details about the study. 
 
Richard Lombard-Vance, research psychologist, will be in contact over the next two 
days to answer any further questions you may have. 
 
 
Yours sincerely, 
 
__________________________ 
 
Dr Nicola Ryall  
Consultant in Rehabilitation Medicine 
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Section 2: Cover Letter for Retrospective Participation 
 
 
[Date] 
[Address] 
[Address] 
[Address] 
 
 
Dear _________________________ 
 
 
I hope you are keeping well.  You may recall that during your admission to the 
National Rehabilitation Hospital last year, you were referred to the Department of 
Psychology for routine clinical assessment.  Since you left NRH, my psychology 
colleagues in collaboration with Dublin City University, have commenced a study 
investigating the neuropsychological functioning in patients who have had a limb 
loss.  The study is titled ‘Neuropsychological Functioning and Prosthetic 
Rehabilitation Outcomes in Lower Limb Amputees’ and is being undertaken by 
Richard Lombard-Vance, PhD student supervised by Dr Fiadhnait O’Keeffe, Senior 
Clinical Psychologist.  
 
It would be very helpful if the results from your psychological assessment 
undertaken when you were a patient here could be included in this study in order to 
strengthen the overall results and recommendations from the study. 
 
From your perspective all that is involved is that you consent that your test results 
can be included in the data analysis.  It does not involve any further testing or 
assessment.  All the data is coded and anonymous, this is an essential requirement 
for patient protection and for the study as determined by best clinical and ethical 
practice. 
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Your decision include your test results in the study is entirely voluntary and will not 
influence any current or prospective treatment at NRH.    
 
To provide your consent, please sign and return the enclosed consent form in the 
stamped- addressed envelope provided.  If we do not hear from you we will assume 
that you do not agree to give consent.  
 
If you have any questions about this request, please contact Dr Fiadhnait O’Keeffe, 
Senior Clinical Psychologist, POLAR programme on 01 2355326.  If you have any 
further queries, we will follow-up this letter with a phone call in approximately one 
week’s time. 
 
 
Yours sincerely 
 
__________________________ 
Dr Nicola Ryall, 
Consultant in Rehabilitation Medicine 
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PATIENT/PARTICIPANT INFORMATION LEAFLET 
Neuropsychological Functioning and Prosthetic Rehabilitation Outcomes in 
Lower Limb Amputees 
 
Principal Investigator:  
Dr Nicola Ryall, Consultant Physician, National Rehabilitation Hospital (NRH) 
 
Co-Investigators:  
Dr Robert Coen, Senior Neuropsychologist, St. James’s Hospital 
Dr Deirdre Desmond, Lecturer, National University of Ireland, Maynooth 
Dr Pamela Gallagher, Senior Lecturer, Dublin City University 
Dr Fiadhnait O’Keeffe, Senior Clinical Psychologist, NRH  
 
Researcher: 
Mr Richard Lombard-Vance, Research Psychologist, Dublin City University 
 
 
Introduction 
You are being invited to take part in a research study.  Before you decide whether or 
not to take part, it is important that you understand why the study is being done and 
what it will involve.  Please take time to read the following information carefully and 
feel free to discuss it with others. If you have any questions or would like more 
information, please let us know. 
 
 
 
What is the purpose of the study? 
The overall aim of this study is to gain a better understanding of which brain 
functions best predict levels of prosthetic, physical, prosthetic and life-participation 
outcomes up to a year after rehabilitation, in those who have lost a limb. Such brain 
functions would include memory, attention and concentration. 
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Why have I been invited? 
You have been chosen to take part in this study as you have experienced the loss of a 
limb. 
 
Do I have to take part? 
No. It is completely up to you whether you take part or not.  If you do decide to take 
part, you are free to withdraw from the study at any time, without giving a reason.  
Your decision will not affect the standard of care you receive. 
 
What will happen to me if I take part? 
You are being asked to take part in a study about neuropsychological functioning 
and prosthetic rehabilitation outcomes. If you are interested in taking part, you will 
meet with a researcher, who will tell you more about the study and answer any 
questions you may have. If you decide to take part, you will be asked to sign a 
consent form, which indicates that you agree to participate in the study. Once you 
have signed the consent form, the researcher will arrange to meet with you again 
within the next few days. At this meeting, the researcher will administer a number of 
neuropsychological assessments, to test cognitive functions like memory, attention, 
concentration and planning. These tests will take about 2 
1
/2 hours to complete and 
may be split over two sessions. You will also be asked to fill out a questionnaire on 
three other occasions: 
 Six weeks after you have finished your rehabilitation programme  
 Six months after you have finished 
 One year after you have finished  
These questionnaires will take about half an hour to complete. 
The questionnaires will be posted to where you live along with a stamped, addressed 
envelope in which to return it. Please note that if you would like some help in 
completing the questionnaire, the researcher can telephone you, or visit you at your 
home to assist you in filling it out. 
 
 
 
What are the possible risks of taking part? 
You may feel fatigued completing neuropsychological tests. Breaks will be arranged 
if you feel tired or fatigued. . If you feel uncomfortable or upset at any stage, you can 
withdraw without any consequences and without affecting your medical care or 
treatment.  Additionally, the research team will help you in accessing suitable 
support systems if required. 
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What are the possible benefits of taking part? 
You will receive feedback from a Senior Clinical Psychologist about the results of 
the neuropsychological assessment. There are no other direct benefits from taking 
part in the study. However, it is expected that the research will improve our 
understanding of the cognitive factors that contribute to successful rehabilitation and 
adjustment to amputation. Having this knowledge may lead to the development of 
interventions to aid future patient rehabilitation. 
 
What information will be held about me? 
Data collected that will be relevant for your clinical care, such as results of 
neuropsychological assessments will be held in your health care records. All other 
information collected will be kept strictly confidential within the limitations of the 
law. All other information will have your name and address removed so as to 
preserve confidentiality. Any information on non-clinically relevant information that 
will identify you in any way will be removed. The researcher, Mr Richard Lombard-
Vance, will be responsible for the safety and security of the data. The procedures for 
handling, processing, storage and destruction of your data will be compliant with the 
Data Protection Act (1998). 
 
What will happen to the results of the study?  
The results of the neuropsychological assessment will be given to the Senior Clinical 
Psychologist. This will be fed-back as appropriate to the clinical rehabilitation team 
and to the participant. All of the anonymised group results of this study will form the 
basis for preparation of reports, academic publications, conference papers and other 
scientific publications.  
 
 
 
What will happen if I don’t want to continue participating in the study? 
Your participation in this study is entirely voluntary. You are free to refuse to take 
part, or to withdraw from the study any time without having to give a reason. If you 
choose not to participate in the study, or to withdraw once entered, you will not be 
penalised. It will NOT affect your medical care or rehabilitation programme at the 
NRH and you will not give up any benefits you had before entering the study. Any 
participation you had in the study previous to your departure from the study will be 
stricken from the record and destroyed if you so wish. Participation in this study will 
in no way affect your legal rights. 
 
Who is organising and funding the research? 
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This research is being organised by a research team from the National Rehabilitation 
Hospital and Dublin City University. The research is funded by the Faculty of 
Science and Health, Dublin City University.  
 
 
Complaints 
If you have any concerns about this study, please contact a member of the research 
team who will do their best to answer your questions: 
Dr Nicola Ryall (principal investigator): e-mail [investigator email] 
Dr Robert Coen (co-investigator): e-mail [investigator email] 
Dr Deirdre Desmond (co-investigator): e-mail [investigator email] 
Dr Pamela Gallagher (co-investigator): e-mail [investigator email] 
Dr Fiadhnait O’Keeffe (co-investigator): e-mail [investigator email] 
Mr Richard Lombard-Vance (researcher): e-mail 
richard.lombardvance3@mail.dcu.ie 
 
 
 
 
 
If you wish to discuss any concerns you may have with an independent source, 
please contact:  
The Secretary  
Ethics Committee,  
National Rehabilitation Hospital,  
Rochestown Avenue,  
Dún Laoghaire, Co. Dublin 
 
Phone: (01) 2355000 
 
This research has been reviewed by the National Rehabilitation Hospital Research 
Ethics Committee. 
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You will be given a copy of the information sheet and a signed consent form to 
keep. 
 
If you have any queries regarding this study, please contact the researcher at 
the following: 
 
Richard Lombard-Vance   
School of Nursing & Human Sciences, 
Dublin City University, 
Dublin 9, 
Ireland  
Phone:  (01) 7007933 
Email:  richard.lombardvance3@mail.dcu.ie 
 
Thank you for taking time to read this sheet.  
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Consent Forms  
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Section 1: Standard Consent Form 
PATIENT/PARTICIPANT CONSENT FORM 
Neuropsychological Functioning and Prosthetic Rehabilitation Outcomes  
 
Please tick the appropriate answer. 
 
I confirm that I have read and understand the Patient/Participant Information Leaflet 
attached, and that I have had ample opportunity to ask questions all of which have 
been satisfactorily answered.   
Yes    □ No   □ 
 
I understand that my participation in this study is entirely voluntary and that I may 
withdraw at any time, without giving reason and without this decision affecting my 
future treatment or medical care.  
Yes    □ No   □ 
 
I understand that my records will be viewed by Dr Ryall and Dr O’Keeffe.  
Yes    □ No   □ 
 
I understand that my name and address will be given to Richard Lombard-Vance, 
Researcher at Dublin City University. I understand the purpose of this is so that the 
researcher can post out follow-up questionnaires 6 months and 1 year after discharge 
from the NRH.  
Yes    □ No   □  
 
I understand that scores from psychological assessments that I have completed at the 
Department of Psychology NRH, will be provided to Dr O’Keeffe.  This is in order 
to avoid repeating tests unnecessarily. Dr O’Keeffe will also provide feedback of the 
assessment results, if appropriate.  
Yes    □ No   □ 
 
I understand that if any of the assessments have been carried out in the psychology 
department, that the scores will be passed on to the researcher to avoid duplication. 
Yes    □ No   □ 
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I understand that my identity will remain confidential at all times.   
Yes    □ No   □ 
 
I understand that the researcher will have access to my healthcare records to access 
background information. 
Yes    □ No   □ 
 
I understand that the researcher may seek consent to contact my Rehabilitation 
Consultant or GP if risks are identified at follow-up.  
Yes    □ No   □ 
 
I have been given a copy of this Consent Form for my records.   
Yes    □ No   □ 
 
I agree that I will not restrict the use to which this study may be put.  (This would be 
subject to approval by an independent body, the National Rehabilitation Hospital 
Ethics Committee).   
Yes □ No   □ 
 
 
Patient Name (print): _______________________________ 
Patient Signature: ___________________________________ 
Date:  ____________________ 
 
Researcher Name (print): ____________________________ 
Researcher Signature: _______________________________ 
Date:  ____________________ 
 
Please complete this section (as required): 
 
Participant’s Nominated Representative Name (print):  
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_________________________________ 
 
 
Nominated Co-signatory Signature: _____________________  
 
Date: ___________________ 
 
Phone Number: _________________________ 
 
 
 
 
 
 
Continued overleaf  ► 
COMMENTS OR CONCERNS DURING/ABOUT THE STUDY 
 
If you have any concerns about this study that you wish to discuss with an 
independent source, please contact: 
The Secretary  
Ethics Committee,  
National Rehabilitation Hospital,  
Rochestown Avenue,  
Dún Laoghaire,  
Co. Dublin 
Phone: (01) 235 5237  
 
………………………………………………………………… 
THE SECTION BELOW IS TO BE COMPLETED BY A CONSULTANT 
PHYSICIAN OR NOMINEE 
 
I the undersigned have taken the time to fully explain to the above patient the nature 
and purpose of this study in a manner that he/she could understand.  I have explained 
the risks involved, as well as the possible benefits and have invited him/her to ask 
questions on any aspect of the study that concerned them. 
 
Investigator Name/Initials (print): _____________________ 
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Investigator Signature:  ______________________________ 
Date:  _____________ 
 
Continued overleaf  ► 
In accordance with Good Clinical Practice if there is a dependent relationship 
between the Physician and the participant then another physician should obtain 
consent.  Likewise the person obtaining consent should be fully conversant with the 
study and be suitably trained and qualified. 
 
 
3 copies to be made; 1 for patient, 1 for Principal Investigator and 1 for hospital 
records 
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Section 2: Consent form for Retrospective Participation 
 PATIENT/PARTICIPANT CONSENT FORM 
Neuropsychological Functioning and Prosthetic Rehabilitation Outcomes  
Please tick the appropriate answer. 
 
I confirm that I have read and understand the Patient/Participant Information Leaflet 
attached, and that I have had ample opportunity to ask questions all of which have 
been satisfactorily answered.   
Yes    □ No   □ 
 
I understand that my participation in this study is entirely voluntary and that I may 
withdraw at any time, without giving reason and without this decision affecting my 
future treatment or medical care.  
Yes    □ No   □ 
 
I understand that my records will be viewed by Dr Ryall and Dr O’Keeffe Richard 
Lombard-Vance, Researcher at Dublin City University. 
Yes    □ No   □ 
 
I understand that scores from psychological assessments that I have completed at the 
Department of Psychology NRH, will be provided to Richard Lombard-Vance.   
Yes    □ No   □ 
 
I understand that my identity will remain confidential at all times.   
Yes    □ No   □ 
I understand that the researcher will have access to my healthcare records to access 
background information. 
Yes    □ No   □ 
 
I understand that a copy of this Consent Form will be posted to me for my records.   
Yes    □ No   □ 
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I agree that I will not restrict the use to which this study may be put, e.g. publication 
in a scientific journal.  (This would be subject to approval by an independent body, 
the National Rehabilitation Hospital Ethics Committee).   
Yes □ No   □ 
 
 
Patient Name (print): ____________________________________ 
 
Patient Signature: _______________________________________  
 
Date:  _________________ 
 
 
Researcher Name (print):__________________________________ 
 
Researcher Signature: ____________________________________  
 
Date:  _________________ 
 
 
COMMENTS OR CONCERNS DURING/ABOUT THE STUDY 
If you have any concerns about this study that you wish to discuss with an 
independent source, please contact: 
The Secretary  
Ethics Committee,  
National Rehabilitation Hospital,  
Rochestown Avenue,  
Dún Laoghaire,  
Co. Dublin 
Phone: (01) 235 5237 
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………………………………………………………………………………………… 
THE SECTION BELOW IS TO BE COMPLETED BY A CONSULTANT 
PHYSICIAN OR NOMINEE 
I the undersigned have taken the time to fully explain to the above patient the nature 
and purpose of this study in a manner that he/she could understand.  I have explained 
the risks involved, as well as the possible benefits and have invited him/her to ask 
questions on any aspect of the study that concerned them. 
 
Investigator Name/Initials (print): ___________________________ 
Investigator Signature:  ___________________ Date:  ____________ 
In accordance with Good Clinical Practice if there is a dependent relationship 
between the Physician and the participant then another physician should obtain 
consent.  Likewise the person obtaining consent should be fully conversant with the 
study and be suitably trained and qualified. 
3 copies to be made; 1 for patient, 1 for Principal Investigator and 1 for hospital 
records 
 
NEUROPSYCHOLOGICAL FUNCTIONING AND LOWER LIMB LOSS 
355 
 
Appendix E:  
Follow-up Questionnaire Pack 
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School of Nursing and Human Sciences, 
Dublin City University, 
Glasnevin, 
Dublin 9 
[Date] 
 
Dear __________________________, 
 
Many thanks for participating in the study ‘Cognitive Functioning, Social 
Participation, Well-Being, and Prosthetic Rehabilitation Outcomes of People with a 
Lower Limb Amputation’ during your time at the National Rehabilitation Hospital. 
Your participation provided valuable information. This study is being carried out by 
me and Dr. Nicola Ryall. 
 
As you may recall, follow-up questionnaires are to be completed as part of this 
study. Please find enclosed the second follow-up questionnaire. The questionnaire 
will take approximately 30 - 40 minutes to fill in. 
 
We would be very grateful if you would take the time to complete the questionnaire 
and return it in the enclosed postage-paid envelope as soon as possible. As we want 
to look at how people’s experiences might change over time, getting completed 
questionnaires back from people at each time point is very important.  
 
Please note that your continued participation in this study is entirely voluntary, and 
all information provided will be kept strictly confidential. 
 
If you have been experiencing emotional distress since your discharge from the 
NRH, we recommend that you consult your general practitioner or local mental 
health services. 
 
If you have any questions about the questionnaire, or any other aspect of the study, 
or if you would like help filling in the questionnaire, please do not hesitate to contact 
me at 01 700 7933 or 087 2147264, email richard.lombardvance3@mail.dcu.ie or 
write to me at the above address. We wish to thank you again for your continued 
participation. 
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Yours sincerely, 
 
__________________________ 
 
Richard Lombard Vance 
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Cognitive Functioning, Social Participation, Well-Being, and Prosthetic 
Rehabilitation Outcomes of People with a Lower Limb Amputation 
Follow-up Questionnaire 
 
 
 
For each question, please tick () clearly inside one box () using a black, or 
blue pen. If you make a mistake, don’t worry; cross out the mistake (X) and tick 
the correct box. 
 
Please answer every item as honestly as you can. There are no right or wrong 
answers. 
 
All responses are confidential. Completion of this questionnaire is voluntary. 
 
 
 
 
 
 
 
 
ID:  _____ 
T:  _____ 
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This section of the questionnaire asks about how you’re feeling. Answer each 
question with regard to how you feel at the present time. Try not to think about 
your answers too much. 
 
1. I feel tense or “wound up”
  
 Not at all 
 Occasionally 
 A lot of the time 
 Most of the time 
2. I still enjoy the things I used 
to enjoy  
 
 Hardly at all 
 Only a little 
 Not quite so much 
 Definitely as much 
3. I get a sort of frightened 
feeling as if something awful 
is about to happen 
 
 Not at all 
 A little, but it doesn't worry me 
 Yes, but not too badly 
 Very definitely and quite badly 
4. I can laugh and see the funny 
side of things 
 Not at all 
 Definitely not so much now 
 Not quite so much now 
 As much as I always could 
5. Worrying thoughts go 
through my mind 
  Very little 
  Not too often 
  A lot of the time 
  A great deal of the time 
6. I feel cheerful  Never 
 Not often 
 Sometimes 
 Most of the time 
7. I can sit at ease and feel 
relaxed 
 Not at all 
 Not often 
 Usually 
 Definitely 
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8. I feel as if I am slowed down  Not at all 
 Sometimes 
 Very often 
 Nearly all the time 
9. I get a sort of frightened 
feeling like “butterflies” in 
my stomach  
 Not at all 
 Occasionally 
 Quite often 
 Very often 
10. I have lost interest in my 
appearance 
 I take just as much care as ever 
 I may not take quite as much 
care 
 I don't take as much care as I 
should 
 I definitely don't take as much 
care 
11. I feel restless as if I have to 
be on the move 
 Not at all 
 Not very much 
 Quite a lot 
 Very much indeed 
12. I look forward with 
enjoyment to things 
 Hardly at all 
 Definitely less than I used to 
 Somewhat less than I used to 
 As much as I ever did 
13. I get sudden feelings of 
panic 
 Not at all 
 Not very often 
  Quite often 
 Very often indeed 
14. I can enjoy a good book, or 
radio or TV program 
 Very seldom 
 Not often 
 Sometimes 
 Often 
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Please read the following statements that describe a person’s relationships with 
family and friends.  
 
As you read each statement, please mark the appropriate answer FOR YOU, to 
indicate that you strongly disagree, disagree, slightly disagree, neither agree nor 
disagree, slightly agree, agree, or strongly agree with the statement. 
 
Please tick () the number corresponding to each response: 
Strongly disagree = 1, 
Disagree = 2, 
Slightly disagree = 3, 
Neither agree nor disagree = 4, 
Slightly agree = 5, 
Agree = 6, 
Strongly agree = 7 
 
There is a special person who is around when I am in need 
1   2   3   4  5  6  7  
 
There is a special person with whom I can share my joys and sorrows. 
1   2   3   4  5  6  7  
My family really tries to help me. 
1   2   3   4  5  6  7  
I get the emotional help and support I need from my family. 
1   2   3   4  5  6  7  
I have a special person who is a real source of comfort to me. 
1   2   3   4  5  6  7  
My friends really try to help me. 
1   2   3   4  5  6  7  
I can count on my friends when things go wrong. 
1   2   3   4  5  6  7  
I can talk about my problems with my family. 
1   2   3   4  5  6  7  
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Please tick () the number corresponding to each response: 
Strongly disagree = 1, 
Disagree = 2, 
Slightly disagree = 3, 
Neither agree nor disagree = 4, 
Slightly agree = 5, 
Agree = 6, 
Strongly agree = 7 
 
I have friends with whom I can share my joys and sorrows. 
1   2   3   4  5  6  7  
There is a special person in my life who cares about my feelings. 
1   2   3   4  5  6  7  
My family is willing to help me make decisions. 
1   2   3   4  5  6  7  
I can talk about my problems with my friends. 
1   2   3   4  5  6  7  
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For each statement, please mark one of the responses below. 
 
When all is said and done, I am the person who is responsible for managing my 
health condition. 
Strongly Agree  Agree  Disagree  Strongly Disagree   
Not Applicable  
Taking an active role in my own healthcare is the most important factor in 
determining my health and ability to function. 
Strongly Agree  Agree  Disagree  Strongly Disagree   
Not Applicable  
I am confident that I can take actions that will help prevent or minimize some 
symptoms or problems associated with my health condition. 
Strongly Agree  Agree  Disagree  Strongly Disagree   
Not Applicable  
I know what each of my prescribed medications does. 
Strongly Agree  Agree  Disagree  Strongly Disagree   
Not Applicable  
I am confident that I can tell when I need to get medical care and when I can handle 
a health problem myself. 
Strongly Agree  Agree  Disagree  Strongly Disagree   
Not Applicable  
I am confident I can tell my health care provider concerns I have even when he or 
she does not ask. 
Strongly Agree  Agree  Disagree  Strongly Disagree   
Not Applicable  
I am confident that I can follow through on medical treatments I need to do at home. 
Strongly Agree  Agree  Disagree  Strongly Disagree   
Not Applicable  
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For each statement, please mark one of the responses below. 
 
I understand the nature and causes of my health condition(s). 
Strongly Agree  Agree  Disagree  Strongly Disagree   
Not Applicable  
I know the different medical treatment options available for my health condition. 
Strongly Agree  Agree  Disagree  Strongly Disagree   
Not Applicable  
I have been able to maintain the lifestyle changes for my health that I have made. 
Strongly Agree  Agree  Disagree  Strongly Disagree   
Not Applicable  
I know how to prevent further problems with my health condition. 
Strongly Agree  Agree  Disagree  Strongly Disagree   
Not Applicable  
I am confident I can figure out solutions when new situations or problems arise with 
my health condition. 
Strongly Agree  Agree  Disagree  Strongly Disagree   
Not Applicable  
I am confident that I can maintain lifestyle changes like diet and exercise even 
during times of stress. 
Strongly Agree  Agree  Disagree  Strongly Disagree   
Not Applicable  
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This section asks about difficulties due to health conditions. Health conditions 
include diseases or illnesses, other health problems that may be short or long 
lasting, injuries, mental or emotional problems, and problems with alcohol or 
drugs. 
Think back over the past 30 days and answer these questions, thinking about 
how much difficulty you had doing the following activities. For each question, 
please tick only one response. 
 
In the past 30 days, how much difficulty did you have in: 
Standing for long periods such 
as 30 minutes? 
None  
 
Mild  
 
Moderate  
 
Severe  
 
Extreme,  
or cannot 
do  
 
Taking care of your household 
responsibilities? 
None  
 
Mild  
 
Moderate  
 
Severe  
 
Extreme,  
or cannot 
do  
 
Learning a new task, for 
example, learning how to get to 
a new place? 
None  
 
Mild  
 
Moderate  
 
Severe  
 
Extreme,  
or cannot 
do  
 
How much of a problem did you 
have joining in community 
activities (for example, 
festivities, religious or other 
activities) in the same way as 
anyone else can? 
None  
 
Mild  
 
Moderate  
 
Severe  
 
Extreme,  
or cannot 
do  
 
How much have you been 
emotionally affected by your 
health problems? 
None  
 
Mild  
 
Moderate  
 
Severe  
 
Extreme,  
or cannot 
do  
 
Concentrating on doing 
something for ten minutes? 
None  
 
Mild  
 
Moderate  
 
Severe  
 
Extreme,  
or cannot 
do  
 
Walking a long distance such as 
a kilometre [or equivalent]? 
None  
 
Mild  
 
Moderate  
 
Severe  
 
Extreme,  
or cannot 
do  
 
Washing your whole body? None  
 
Mild  
 
Moderate  
 
Severe  
 
Extreme,  
or cannot 
do  
 
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In the past 30 days, how much difficulty did you have in: 
 
Getting dressed? None  
 
Mild  
 
Moderate  
 
Severe  
 
Extreme,  
or cannot 
do  
 
Dealing with people you 
do not know? 
None  
 
Mild  
 
Moderate  
 
Severe  
 
Extreme,  
or cannot 
do  
 
Maintaining a friendship? None  
 
Mild  
 
Moderate  
 
Severe  
 
Extreme,  
or cannot 
do  
 
Your day-to-day work? None  
 
Mild  
 
Moderate  
 
Severe  
 
Extreme,  
or cannot 
do  
 
 
 
 Overall, in the past 30 days, how many days were these  
difficulties present?       _____  
 
 In the past 30 days, for how many days were you totally unable  
to carry out your usual activities or work because of any health  
condition?        _____  
 
 In the past 30 days, not counting the days that you were totally  
unable, for how many days did you cut back or reduce your  
usual activities or work because of any health condition?   
         _____  
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The statements below describe many of the ways that people participate 
in society. For each item, tell us: 
 
1) How often you do the activity, 
2) If the activity is important to you, and 
3) If you feel you are doing the activity enough, too much, or not enough. 
   
 
How often? 
>>> 
Important? 
>>> 
Doing enough? 
>>> 
In a typical 
week, how 
many days 
do you: 
N
o
n
e 
1
 -
 2
 D
ay
s 
3
 -
 4
 D
ay
s 
5
 -
 6
 D
ay
s 
7
 D
ay
s 
Is this 
activity 
important to 
you? 
Are you doing this activity: 
No Yes Enough? 
Not 
enough? 
Too 
much? 
Get out and 
about? 
          
Spend time 
with family? 
          
Keep in 
touch with 
family by 
phone or 
internet? 
          
Spend time 
with 
friends? 
          
Keep in 
touch with 
friends by 
phone or 
internet? 
          
Go to 
parties, out 
to dinner, or 
other social 
activities? 
          
Is having an intimate relationship 
important to you? 
     
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For each item, tell us: 
1) How often you do the activity, 
2) If the activity is important to you, and 
3) If you feel you are doing the activity enough, too much, or not enough. 
 
How often? >>>  Important? >>> Doing enough? 
In a 
typical 
week, how 
many 
hours do 
you: 
N
o
n
e 
1
 -
 4
 h
o
u
rs
 
5
 -
 9
 h
o
u
rs
 
1
0
 -
 1
9
 h
o
u
rs
 
2
0
 -
 3
4
 h
o
u
rs
  
3
5
 o
r 
m
o
re
 h
o
u
rs
 Is this 
activity 
importan
t to you? 
Are you doing this activity: 
No Yes 
Enough
? 
Not 
enough
? 
Too 
much
? 
Work for 
money? 
           
Cook, 
clean, and 
look after 
your 
home? 
           
Manage 
household 
bills, and 
expenses? 
           
Look after 
children, 
or provide 
care for a 
loved one? 
           
Go to 
classes, or 
participate 
in learning 
activities? 
           
Volunteer
? 
           
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For each item, tell us: 
1) How often you do the activity, 
2) If the activity is important to you, and 
3) If you feel you are doing the activity enough, too much, or not enough. 
 How often? >>> 
Important
> > > 
Doing enough? >>>  
In a typical 
month, how 
many times 
do you: 
N
o
n
e 
O
n
ce
 
2
 t
im
es
 
3
 t
im
es
 
4
 t
im
es
 
5
 o
r 
m
o
re
 t
im
es
 
Is this 
activity 
important to 
you? 
Are you doing this activity: 
No Yes 
Enough
? 
Not 
enough
? 
Too 
much
? 
Participate in 
religious or 
spiritual 
activities? 
           
Go to support 
groups, or 
self-help 
meetings? 
           
Engage in 
hobbies, or 
leisure 
activities? 
           
Go to movies, 
sporting 
events, or 
entertainment 
events? 
           
Exercise, 
participate in 
sports, or 
active 
recreation? 
           
Participate in 
community 
clubs, or 
organisations
? 
           
Participate in 
civic or 
political 
activities? 
           
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Please mark the choice that most closely reflects your opinion 
  All 
the 
Time 
Frequently Sometimes Seldom Almost 
Never 
1 I live my life the way 
that I want 
 
     
2 People try to put limits 
on me 
 
     
3 I participate in a 
variety of activities 
     
4 I am uncomfortable 
participating in 
community activities 
     
5 I spend time doing 
things that improve 
my community 
     
6 I participate in 
activities that I choose 
     
7 I spend time helping 
others 
 
     
8 I count as a person in 
society 
 
     
9 I have the freedom to 
make my own 
decisions 
     
10 I live my life fully 
 
     
11 I regularly seek out 
new challenges 
     
12 I have reliable access 
to a telephone 
     
13 I have a say on 
decisions in my 
community 
     
14 I have choices about 
the activities I do 
     
15 I actively pursue my 
dreams and desires 
     
16 I do things that are 
important to me 
     
17 People have high 
expectations of me 
     
18 I am able to go out      
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  All 
the 
Time 
Frequently Sometimes Seldom Almost 
Never 
and have fun 
 
19 I contribute to society 
 
     
20 I have opportunities to 
make new friends 
     
21 I speak up for myself 
 
     
22 People speak to me 
disrespectfully 
     
23 I take responsibility 
for my own life 
     
24 I have good job 
opportunities 
 
     
25 People underestimate 
me 
 
     
26 I assume leadership 
roles in organisations 
     
27 I am welcome in my 
community 
     
28 I am treated equally 
 
     
29 I have reliable access 
to community services 
     
30 I do important things 
with my life 
     
31 My community 
respects me the way 
that I am 
     
32 I have influence in my 
community 
     
33 I am in control of my 
own life  
 
     
34 I am ignored 
 
     
35 I feel safe 
participating in 
community activities 
     
36 I am treated as a 
valued member of 
society 
     
37 People see my 
potential 
     
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  All 
the 
Time 
Frequently Sometimes Seldom Almost 
Never 
 
38 I have access to 
reliable transportation 
     
39 I have reliable access 
to the internet 
     
40 I have control over 
how I spend my time 
     
41 People listen to what I 
say 
 
     
42 I participate in 
activities when I want 
     
43 I am uncomfortable 
participating in public 
meetings 
     
44 I am treated like a 
human being 
 
     
45 People count on me 
 
     
46 I contribute to the 
well-being of my 
community 
     
47 I am actively involved 
in my community 
     
48 It is hard for me to get 
information about 
community 
services 
     
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This section of the questionnaire asks you about how you usually get around, 
using any walking aid if needed. 
Please tick () YES or NO after each question, as is most true for you. 
 
 Yes No 
1. 
Do you wear a prosthesis? 
 
  
If ‘NO’, skip to page 18. 
 
2. 
Do you wear your prosthesis for cosmetic appearances only? i.e. you 
do not walk on it / them. 
  
3. 
Do you wear your prosthesis to help you move very short distances? 
(e.g. move from bed to chair or chair to toilet) 
  
4a. Are you receiving any nursing care at present?   
If ‘YES’ to 4a, please read on, 
if ‘NO’, skip to question 5a. 
4b. 
Do you wear your prosthesis to help you with any nursing care you 
may be receiving? 
  
5a. 
Are you receiving any physiotherapy or occupational therapy at 
present? 
  
If ‘YES’ to 5b, please read on, 
if ‘NO’, skip to question 6. 
5b. 
Do you wear your prosthesis to help you with any therapy you may be 
receiving? 
  
6. Do you usually walk indoors at all, wearing your prosthesis?   
7. 
Do you usually need the physical help of another person to help you 
walk indoors, if you wear your prosthesis? 
  
8. 
Indoors, wearing your prosthesis, do you usually need the help of a 
walking frame to walk? 
  
9. 
Indoors, wearing your prosthesis, do you usually need the help of 2 
crutches to walk? 
  
10. 
Indoors, wearing your prosthesis, do you usually need the help of 2 
sticks to walk? 
  
11. 
Indoors, wearing your prosthesis, do you usually need the help of 1 
crutch or 1 stick to help you walk? 
  
12. Indoors, do you usually use any walking aid at all?   
13. 
Do you usually manage to walk more than 50 metres 
(55 yards) at a time? 
  
14. Do you usually walk outdoors at all, wearing your prosthesis?   
15. Do you usually walk on level ground only?   
16. Outdoors, do you usually need the help of a frame to walk?   
17. Outdoors, do you usually need the help of 2 crutches to walk?   
18. Outdoors, do you usually need the help of 2 sticks to walk?   
19. Outdoors, do you usually need the help of 1 crutch or 1 stick to walk?   
20. 
Outdoors, do you just occasionally use a walking aid, such to increase 
your confidence in adverse weather conditions or on uneven ground? 
  
21. 
Outdoors, wearing your prosthesis, do you walk anywhere, in any 
weather conditions, without using any walking aid at all? 
  
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Below are written a series of statements concerning the wearing of a prosthesis. 
Please read through each statement carefully. Then tick the box beside each 
statement, which shows how strongly you agree or disagree with it. 
  
  
Strongly 
disagree Disagree Agree 
Strongly 
agree 
Not 
applicable 
1 
I have adjusted to having 
a prosthesis       
2 
As time goes by, I accept 
my prosthesis more      
3 
I feel that I have dealt 
successfully with this 
trauma in my life      
4 
Although I have a 
prosthesis, my life is full      
5 
I have gotten used to 
wearing a prosthesis      
6 
I don’t care if somebody 
looks at my prosthesis      
7 
I find it easy to talk about 
my prosthesis      
8 
I don’t mind people 
asking about my 
prosthesis      
9 
I find it easy to talk about 
my limb loss in 
conversation      
10 
I don’t care if somebody 
notices that I am limping      
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Strongly 
disagree Disagree Agree 
Strongly 
agree 
Not 
applicable 
11 
A prosthesis interferes 
with the ability to do 
my work      
12 
Having a prosthesis 
makes me more 
dependent on others 
than I would like to be      
13 
Having a prosthesis 
limits the kind of work 
that I can do      
14 
Having an amputation 
means that I can’t do 
what I want to do      
15 
Having a prosthesis 
limits the amount of 
work that I can do      
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Please tick the box that represents the extent to which you are satisfied or 
dissatisfied with each of the different aspects of your prosthesis mentioned 
below: 
 
Not 
satisfied 
Satisfied 
Very 
Satisfied 
i) Colour . . . . . . . . . . . . . . . .     
ii) Shape . . . . . . . . . . . . . . . .     
iii) Appearance . . . . . . . . . . .     
iv) Weight . . . . . . . . . . . . . . .     
v) Usefulness . . . . . . . . . . . .     
vi) Reliability . . . . . . . . . . . . .     
vii) Fit . . . . . . . . . . . . . . . . . .     
viii) Comfort . . . . . . . . . . . . .     
 
Please circle the number (0-10) that best describes how satisfied you are with 
your prosthesis? 
 
0 1 2 3 4 5 6 7 8 9 10 
Not at all satisfied         
 Very Satisfied 
 
 
How many hours per day, on average, do you wear your prosthesis? 
 
_____________ hours 
 
 
 
 
You have reached the end of the questionnaire. 
 
 
Please return this questionnaire in the stamped, addressed enveloped provided. 
 
 
Thank you very much for your time and help. 
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Appendix F:  
Holm Method Significance Calculations 
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Table 36 
Comparisons to Normative Samples: Proportions Borderline/Impaired – 
According to the Holm Method 
Measure p Holm-corrected p Rank Sig. 
RBANS total  0.001 0.033 1 Yes 
WTAR  0.001 0.033 2 Yes 
RBANS list learning 0.001 0.033 3 Yes 
RBANS immediate story 0.001 0.033 4 Yes 
WMS logical memory I  0.001 0.033 5 Yes 
CVLT free recall T-score 0.001 0.033 6 Yes 
CVLT short delay list 
recall 
0.001 0.033 7 Yes 
RBANS long delay: free 
recall, list 
0.001 0.033 8 Yes 
RBANS long delay: free 
recall, story 
0.001 0.033 9 Yes 
WMS logical memory II 0.001 0.033 10 Yes 
RBANS long delay: free 
recall, visual 
0.001 0.033 11 Yes 
CVLT long delay 0.001 0.033 12 Yes 
RBANS list recognition 0.001 0.033 13 Yes 
CVLT cued recall 0.001 0.033 14 Yes 
WAIS symbol search  0.001 0.033 15 Yes 
RBANS coding 0.001 0.033 16 Yes 
RBANS digit span  0.001 0.033 17 Yes 
DKEFS TMT visual 
scanning 
0.001 0.033 18 Yes 
DKEFS letter sequencing 0.001 0.033 19 Yes 
DKEFS number 
sequencing 
0.001 0.033 20 Yes 
Telephone search 0.001 0.033 21 Yes 
DKEFS category fluency 0.001 0.033 22 Yes 
DKEFS letter fluency 0.001 0.033 23 Yes 
RBANS semantic fluency 0.001 0.033 24 Yes 
DKEFS TMT number-
letter switching  
0.001 0.033 25 Yes 
DKEFS colour-word 
inhibition 
0.001 0.033 26 Yes 
RBANS picture naming 0.001 0.033 27 Yes 
RBANS figure copy  0.001 0.033 28 Yes 
RBANS line orientation  0.001 0.033 29 Yes 
DKEFS motor speed 0.001 0.033 30 Yes 
WAIS matrix reasoning  0.003 0.033 31 Yes 
WAIS block design  0.017 0.119 32 No 
WAIS similarities  0.021 0.126 33 No 
WAIS digit span  0.265 1 34 No 
Telephone search with 
counting  
0.393 1 35 No 
DKEFS colour naming  0.438 1 36 No 
DKEFS word reading  0.676 1 37 No 
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Table 37 
Differences Between Mean Sample Scores and Mean Normative Scores 
– According to the Holm Method 
Measure p 
Holm-
corrected p 
Rank Sig. 
RBANS overall cognitive 
functioning 
0.001 0.041 1 Yes 
RBANS list learning 0.001 0.041 2 Yes 
WMS logical memory I 0.001 0.041 3 Yes 
RBANS delayed list recall 0.001 0.041 4 Yes 
RBANS delayed story recall 0.001 0.041 5 Yes 
WMS logical memory II 0.001 0.041 6 Yes 
CVLT long delay recall 0.001 0.041 7 Yes 
RBANS figure recall 0.001 0.041 8 Yes 
RBANS list recognition 0.001 0.041 9 Yes 
CVLT cued recall 0.001 0.041 10 Yes 
RBANS coding 0.001 0.041 11 Yes 
WAIS symbol search 0.001 0.041 12 Yes 
DKEFS visual scanning 0.001 0.041 13 Yes 
DKEFS number sequencing 0.001 0.041 14 Yes 
DKEFS letter sequencing 0.001 0.041 15 Yes 
DKEFS number-letter switching 0.001 0.041 16 Yes 
DKEFS motor speed 0.001 0.041 17 Yes 
DKEFS colour naming 0.001 0.041 18 Yes 
TEA telephone search 0.001 0.041 19 Yes 
DKEFS number-letter switching 0.001 0.041 20 Yes 
DKEFS letter fluency 0.001 0.041 21 Yes 
RBANS semantic fluency 0.001 0.041 22 Yes 
DKEFS colour-word switching 0.001 0.041 23 Yes 
FrSBe total 0.001 0.041 24 Yes 
WAIS block design 0.001 0.041 25 Yes 
WAIS similarities 0.001 0.041 26 Yes 
WAIS matrix reasoning 0.001 0.041 27 Yes 
RBANS figure copy 0.001 0.041 28 Yes 
DKEFS psychomotor speed 0.001 0.041 29 Yes 
DKEFS category fluency 0.002 0.041 30 Yes 
CVLT free recall T-score 0.003 0.041 31 Yes 
TEA telephone search with 
counting 
0.034 0.340 32 No 
CVLT short delay recall 0.036 0.340 33 No 
RBANS immediate story memory 0.042 0.340 34 No 
RBANS picture naming 0.044 0.340 35 No 
DKEFS word reading 0.045 0.340 36 No 
RBANS line orientation 0.149 0.745 37 No 
WTAR 0.171 0.745 38 No 
WAIS digit span 0.238 0.745 39 No 
RBANS digit span 0.314 0.745 41 No 
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Table 38 
Differences Between Vascular and Other Groups’ Proportion of Scores in 
Borderline & Impaired Ranges  
Assessment χ2 (df = 1) p 
Holm-
corrected p Rank Sig. 
RBANS coding 5.858 0.016 0.656 1 No 
MoCA 5.545 0.019 0.76 2 No 
RBANS figure copy 5.218 0.022 0.858 3 No 
RBANS line orientation 4.217 0.04 1.000 4 No 
DKEFS number sequencing 4.169 0.041 1.000 5 No 
DKEFS colour-word inhibition 3.553 0.059 1.000 6 No 
RBANS delayed story recall 2.296 0.13 1.000 7 No 
DKEFS visual scanning 1.614 0.204 1.000 8 No 
RBANS total index 0.999 0.318 1.000 9 No 
CVLT trials 1-4 free recall T-
score 
0.723 0.395 1.000 10 No 
CVLT form cued recall 0.711 0.399 1.000 11 No 
WAIS symbol search 0.682 0.409 1.000 12 No 
BADS zoo map 0.672 0.412 1.000 13 No 
VOSP position discrimination 0.699 0.414 1.000 14 No 
RBANS digit span 0.559 0.454 1.000 15 No 
TEA telephone search 0.506 0.477 1.000 16 No 
RBANS List Recognition 0.345 0.557 1.000 17 No 
WAIS block design 0.341 0.559 1.000 18 No 
RBANS figure recall 0.317 0.573 1.000 19 No 
RBANS semantic fluency 0.311 0.577 1.000 20 No 
WMS logical memory II 0.297 0.586 1.000 21 No 
DKEFS category fluency 0.236 0.627 1.000 22 No 
DKEFS number-letter 
switching 
0.218 0.64 1.000 23 No 
FrSBe self-rated total 0.215 0.643 1.000 24 No 
RBANS immediate story 
memory 
0.206 0.65 1.000 25 No 
WAIS similarities 0.188 0.665 1.000 26 No 
RBANS delayed list recall 0.112 0.738 1.000 27 No 
DKEFS letter sequencing 0.098 0.754 1.000 28 No 
CVLT short delay free recall 0.097 0.755 1.000 29 No 
DKEFS letter fluency 0.023 0.879 1.000 30 No 
WTAR standard score 0.013 0.911 1.000 31 No 
WAIS matrix reasoning 0.003 0.995 1.000 32 No 
DKEFS motor speed 0 1 1.000 33 No 
DKEFS colour naming 0 1 1.000 34 No 
DKEFS word reading 0 1 1.000 35 No 
TEA telephone search while 
counting 
0 1 1.000 36 No 
RBANS list learning 0 1 1.000 37 No 
WMS logical memory I 0 1 1.000 38 No 
CVLT long delay free recall 0 1 1.000 39 No 
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Differences Between Vascular and Other Groups’ Proportion of Scores in 
Borderline & Impaired Ranges  
Assessment χ2 (df = 1) p 
Holm-
corrected p Rank Sig. 
RBANS picture naming 0 1 1.000 40 No 
WAIS digit span 0 1 1 41 No 
Graded Naming Test n/a n/a n/a n/a n/a 
Note. Holm Method Corrected Significance of Chi Square Tests 
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Appendix G:  
 
Descriptive and Inferential Statistics for 
Objective 7 
 
  
NEUROPSYCHOLOGICAL FUNCTIONING AND LOWER LIMB LOSS 
383 
 
Table 39 
Overall Cognitive Functioning (RBANS) Impairment Status and Rehabilitation 
Outcomes: Descriptive Statistics 
Variable Impaired Discharge Six months 12 months 
 
 N M SD N M SD N M SD 
Rehab. 
engagement 
Y 25 26.84 2.84             
  N 48 28.71 2.11             
Prosthesis 
use 
Y 13 7.27 3.96 8 6.63 3.56 7 8.57 4.76 
  N 37 7.36 3.71 26 8.14 4.21 19 8.63 4.97 
Functional 
satisfaction 
Y 14 10.29 2.3 8 10.5 2.98 7 10.86 3.24 
  N 37 9.32 2.51 25 10.36 2.78 19 10.37 2.59 
Aesthetic 
satisfaction 
Y 14 6.71 1.59 8 6.38 1.77 7 6.57 2.37 
  N 37 5.86 1.78 25 6.12 2.09 19 6.16 2.01 
General 
adjustment 
Y 14 2.89 0.78 8 2.93 0.7 7 3.06 0.89 
  N 37 3.02 0.67 26 3.06 0.67 20 3.29 0.76 
Social 
adjustment 
Y 14 3.11 0.72 8 3.1 0.26 7 3.49 0.54 
  N 37 3.21 0.74 26 3.2 0.63 20 3.26 0.74 
Adjustment 
to limitation 
Y 14 1.79 0.58 8 1.63 0.56 7 1.46 0.77 
  N 37 2.04 0.69 26 2.2 0.74 20 2.05 0.86 
Distress Y 14 9.14 8.35 8 8.5 9.4 7 17.14 10.78 
  N 38 10.08 5.98 28 9.75 6.17 20 8.6 6.25 
Social 
support 
Y 14 5.63 1.52 8 5.88 1.03 7 5.35 1.17 
  N 38 6 1.21 28 6.29 0.98 20 6.08 1.16 
Limitation & 
restriction 
Y 14 24.71 8.7 8 25.88 9.91 7 34 13.98 
  N 38 24.74 5.73 28 22.96 8.04 20 26.05 7.54 
Participation 
engagement 
Y       8 57.31 26.14 7 52.28 33.19 
  N       28 56.37 26.99 20 66.65 23.51 
Importance & 
meaning of 
participation 
Y       8 44.44 10.47 7 39.31 21.34 
  N       28 45.58 9.67 20 47.1 13.81 
Control over 
participation 
Y       8 54.08 7.15 7 58.39 24.81 
  N       28 61.24 14.54 20 61.41 13.64 
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Table 40 
Overall Cognitive Functioning (RBANS) Impairment Status and Longitudinal Change of Rehabilitation Outcomes  
Variable ANOVA
 a
  t-test 
b
 
 F(df) ANOVA p ηp
2
  t (df) t-test p gs 
Rehab. Engagement     -3.178 (71)* .002 .776 
Prosthesis use .044 (1, 18) .836 .002  -.079 (48) .938 .023 
Functional satisfaction .005 (1, 20) .943 .000  1.249 (49) .248 .389 
Aesthetic satisfaction .132 (1, 20) .720 .006  1.562 (49) .125 .483 
General adjustment .342 (1, 20) .565 .017  -.594 (49) .555 .183 
Social adjustment .078 (1, 20) .783 .004  -.419 (49) .677 .134 
Adjustment to limitation 3.692 (1, 20) .069 .156  -1.215 (49) .230 .371 
Distress 1.056 (1, 22) .315 .046  -.448 (50) .656 .139 
Social support 1.233 (1, 22) .279 .053  -.911 (50) .367 .281 
Limitation & restriction 2.189 (1, 22) .153 .090  -.009 (17.33) .993 .004 
Participation engagement .184 (1, 22) .672 .008  -1.115 (34) .273 .034 
Importance & meaning of participation 1.028 (1, 22) .322 .045  .148 (34) .854 .113 
Control over participation 1.817 (1, 22) .191 .076  -.431 (34) .669 .524 
Note. ANOVA ηp
2
 and t-test Hedges’s g effect sizes: .01 ≤ ηp ≥ .059 is small, .60 ≤ ηp ≥ .79 is medium, and ηp ≥ .138 is large.  
a
 Mixed between-within ANOVA: between groups result; 
b 
Discharge (six months  for participation variables)  
*Significant after Holm correction
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Table 41 
Overall Cognitive Functioning (RBANS) Impairment Status and Mobility and Activation  
Status Variable Discharge Six Months 12 Months Between Groups (Discharge) 
 Mobility n % n % n % χ2(df) Exact p Cramer’s V 
Impaired Dependent 6 24 1 12.5 1 14.3 5.697 (2) .067 .279 
 Ind. indoors 8 32 0 0 0 0    
 Ind. outdoors 11 44 7 87.5 6 85.7    
Not Impaired Dependent 4 8.3 3 10.7 3 15    
 Ind. indoors 10 20.8 2 7.1 3 15    
 Ind. outdoors 34 70.8 23 82.1 14 70    
           
 Activation n % n % n % χ2(df) Exact p phi 
Impaired Level 1 or 2 2 14.3 0 0 2 28.6 .000 (1) 1.00 .015 
 Level 3 or 4 12 85.7 8 100 5 71.4    
Not Impaired Level 1 or 2 5 13.2 7 25 5 25    
 Level 3 or 4 33 86.8 21 75 15 75    
Note. Effect sizes: .1 ≤ ηp ≥ .29 is small, .3 ≤ ηp ≥ .49 is medium, and ηp ≥ .5 is large. 
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Table 42 
Processing Speed & Attention Impairment Status and Rehabilitation Outcomes 
 Variable  Impaired Discharge Six Months 12 Months 
  
 
N M SD N M SD N M SD 
Rehabilitation 
engagement 
Y 19 26.89 3.2       
N 40 28.53 2.15       
Prosthesis use  Y 11 6.55 3.62 7 8 3.35 5 9.1 2.3 
  N 26 8.35 3.15 18 8.75 3.7 12 11.13 4.36 
Functional 
satisfaction 
Y 11 10.18 2.6 7 10.43 2.37 6 10.17 3.66 
N 26 9.85 2.6 17 10.35 3.06 12 11.33 2.23 
Aesthetic 
satisfaction 
Y 11 5.73 1.74 7 5.57 2.07 6 5.83 2.71 
N 26 6.58 1.58 17 6.47 2.03 12 6.83 1.95 
General 
adjustment 
Y 11 2.89 0.87 7 2.83 0.82 6 2.97 0.99 
N 26 3.14 0.6 18 3.18 0.63 13 3.55 0.61 
Social 
adjustment 
Y 11 2.96 0.85 7 2.8 0.86 6 2.8 1.1 
N 26 3.31 0.73 18 3.39 0.49 13 3.63 0.44 
Adjustment to 
limitation 
Y 11 2.13 0.65 7 1.91 0.55 6 1.9 0.73 
N 26 2.03 0.73 18 2.24 0.82 13 1.97 1.03 
Distress Y 11 6.45 5.41 7 7.57 3.31 6 12.83 12.64 
  N 27 10.74 5.72 19 9.95 7.37 13 8.23 6.35 
Social support Y 11 6.34 0.72 7 6.43 0.456 6 5.58 1.49 
  N 27 6 1.42 19 6.29 1.01 13 6.51 0.67 
Limitation & 
restriction 
Y 11 21.45 3.8 7 22.14 4.56 6 31 12.15 
N 28 24.61 6.43 19 21.74 7.79 13 24.85 9.57 
Participation 
engagement 
Y    7 64.65 15.71 6 59.32 21.39 
N    19 54.22 30.25 13 69.1 26.79 
Participation 
importance & 
meaning 
Y    7 45.29 7.23 6 37.83 19.82 
N    19 37.21 12.28 13 42.77 11.59 
Control over 
participation 
Y    7 51.43 7.89 6 42 19.59 
N    19 49 11 13 54.54 8.84 
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Table 43 
Processing Speed & Attention Impairment Status and Longitudinal Changes in Prosthetic/Physical and Psychosocial 
Functioning 
Variable  ANOVA
 a
   t-test
 b
  
 F(df) p ηp
2
 t(df) p gs 
Rehab. engagement - - - -2.018 (26.01) .054 .641 
Prosthesis use 1.016 (1, 12) .333 .078 -1.521 (35) .137 .535 
Functional satisfaction .234 (1, 13) .636 .018 .359 (35) .722 .124 
Aesthetic satisfaction .421 (1, 13) .528 .031 -1.453 (35) .155 .511 
General adjustment 2.786 (1, 13) .119 .177 -.995 (35) .326 .355 
Social adjustment 3.794 (1, 13) .073 .226 -1.248 (35) .220 .447 
Adjustment to limitation .658 (1, 13) .432 .048 .377 (35) .709 .138 
Distress .055 (1, 14) .818 .004 -2.128 (36) .040 .745 
Social support .457 (1, 14) .510 .032 .763 (36) .451 .263 
Limitation & restriction .084 (1, 14) .777 .006 -1.585 (36) .122 .530 
Participation engagement .020 (1, 14) .888 .001 1.143 (20.71) .266 .369 
Participation importance & 
meaning 
.371 (1, 14) .552 .026 1.615 (24) .119 .697 
Control over participation .480 (1, 14) .500 .033 .520 (24) .608 .228 
Note. ANOVA ηp
2
 and t-test Hedges’s g effect sizes: .01 ≤ ηp ≥ .059 is small, .60 ≤ ηp ≥ .79 is medium, and ηp ≥ .138 is large.  
a Mixed between-within ANOVA: between groups result; b Discharge (six months  for participation variables) 
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Table 44 
 
  
Processing Speed & Attention Impairment Status and Mobility and Activation 
Status Variable Discharge Six Months 12 Months Between-Groups Difference (Discharge) 
 Mobility n % n % n % χ2(df) Exact p Cramer’s V 
Impaired Dependent 5 25.0 0 0 1 16.7 .891 (2) .688 .122 
 Ind. indoors 4 20.0 0 0 0 0    
 Ind. outdoors 11 55.0 7 100 5 83.3    
Not Impaired Dependent 6 15.0 2 10.5 2 15.4    
 Ind. indoors 9 22.5 1 5.3 3 23.1    
 Ind. outdoors 25 62.5 16 84.2 8 61.5    
           
 Activation n % n % n % χ2 Exact p Phi 
Impaired Level 1 or 2 1 9.1 1 14.3 2 33.3 .455 (1) 1.000 .109 
 Level 3 or 4 10 90.9 6 85.7 4 66.7    
Not Impaired Level 1 or 2 1 3.7 5 26.3 2 15.4    
 Level 3 or 4 26 96.3 14 73.7 11 84.6    
Note. Effect sizes: .1 ≤ ηp ≥ .29 is small, .3 ≤ ηp ≥ .49 is medium, and ηp ≥ .5 is large. 
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Table 45 
Delayed Memory Impairment Status and Prosthetic and Psychosocial 
Functioning 
Variable    Discharge Six Months 12 Months 
  Impaired N Mean SD N Mean SD N Mean SD 
Rehabilitation 
engagement 
Y 19 26.37 3.1       
 
N 39 28.31 2.28       
Prosthesis use  Y 8 5.06 3.76 6 5.25 5.51 4 6.75 8.02 
 
N 25 6.9 3.2 21 8.6 3.72 14 9.5 4.28 
Functional 
satisfaction 
Y 9 9.44 2.4 6 9.33 2.94 4 8.25 1.5 
 
N 25 9.4 2.61 20 10.1 2.86 15 10.07 3.17 
Aesthetic 
satisfaction 
Y 9 5.67 1.66 6 5.17 2.32 4 4.75 1.5 
  N 25 6.08 1.85 20 6.05 1.85 15 6.13 2.13 
General 
adjustment 
Y 9 2.58 0.98 6 2.63 0.7 4 2.5 0.66 
 
N 25 2.97 0.75 21 2.99 0.72 16 3.26 0.86 
Social 
adjustment 
Y 9 2.82 1.09 6 3.4 0.51 4 3.4 0.52 
 
N 25 3.26 0.7 21 3.18 0.66 16 3.35 0.84 
Adjustment to 
limitation 
Y 9 1.96 0.58 6 1.68 0.61 4 1.25 0.94 
 
N 25 2.02 0.72 21 2.11 0.78 16 1.85 0.91 
Distress Y 9 10.11 6.47 6 10 7.67 4 11 2.58 
 
N 26 11.54 7.63 22 10.14 7.49 16 10.63 9.66 
Social support Y 9 5.31 1.54 6 5.15 1.28 4 4.65 1.14 
  N 26 5.88 1.45 22 6.2 1.04 16 5.95 1.26 
Limitation & 
Restriction 
Y 9 24.22 5.65 6 28.33 14.05 4 31.75 14.31 
 
N 27 24.52 7.21 22 23.45 9.18 16 28.44 11.68 
Participation 
engagement 
Y    6 36.26 22.25 4 36.1 16.98 
 
N    22 49.8 25.62 16 54.94 24.29 
Participation 
importance & 
meaning 
Y    6 31.67 14.49 4 31.25 11 
 
N    22 37.05 11.14 16 38.88 14.75 
Control over 
participation 
Y    6 43.33 12.72 4 43.5 12.07 
  N    22 48.27 10.65 16 47.38 14.06 
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Table 46 
 
Delayed Memory Impairment Status and Longitudinal Changes in Prosthetic and Psychosocial Functioning  
Variable 
 ANOVA
 a
   t-test
 b
  
 F(df) p ηp
2
 t(df) p gs 
Rehabilitation engagement    -2.428 (27.89) .022 .744 
Prosthesis use  3.500 (1, 12) .086 .226 -1.355 (31) .185 .538 
Functional satisfaction 1.737 (1, 14) .209 .110 .045 (32) .965 .015 
Aesthetic satisfaction 3.270 (1, 14) .092 .189 -.590 (32) .559 .222 
General adjustment 1.737 (1, 14) .209 .110 -1.235 (32) .226 .468 
Social adjustment .183 (1, 14) .676 .013 -1.396 (32) .172 .527 
Adjustment to limitation .446 (1, 14) .515 .031 -.226 (32) .832 .085 
Distress .037 (1, 15) .851 .002 -.501 (33) .620 .189 
Social support 18.054 (1, 15)* .001 .546 -1.011 (33) .319 .378 
Limitation & Restriction .036 (1, 15) .853 .002 -.175 (33) .862 .043 
Participation engagement 2.553 (1, 16) .130 .138 -1.176 (26) .250 .526 
Participation importance & meaning 2.903 (1, 16) .108 .154 -.985 (26) .334 .440 
Control over participation 1.617 (1, 16) .222 .092 -.968 (26) .342 .433 
Note. ANOVA ηp
2
 and t-test Hedges’s g effect sizes: .01 ≤ ηp ≥ .059 is small, .60 ≤ ηp ≥ .79 is medium, and ηp ≥ .138 is large. 
 
a
 Mixed between-within ANOVA: between groups result; 
b
 Discharge (six months  for participation variables)   
* Significant after Holm method correction 
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Table 47 
Delayed Memory Impairment Status and Mobility and Activation 
Impaired Variable Discharge Six Months 12 Months Between-Groups Difference 
 Mobility N % N % N % χ2(df) Exact p Cramer’s V 
Impaired Dependent 8 40.0 1 16.7 1 25.0 5.977 (2) .046 .318 
 Ind. indoors 5 45.0 0 0 0 0    
 Ind. outdoors 7 35.0 5 83.3 3 75.0    
Not Impaired Dependent 5 12.8 3 13.6 4 25.0    
 Ind. indoors 11 28.2 1 4.5 3 18.8    
 Ind. outdoors 23 59.0 18 81.8 9 56.3    
           
 Activation N % N % N % χ2(df) Exact p Phi 
Impaired Level 1 or 2 0 0 1 16.7 3 75.0 1.563 (1) .330 -.211 
 Level 3 or 4 9 100 5 83.3 1 25.0    
Not Impaired Level 1 or 2 4 15.4 7 31.8 5 31.3    
 Level 3 or 4 22 84.6 15 68.2 11 68.8    
Note. Effect sizes: .1 ≤ ηp ≥ .29 is small, .3 ≤ ηp ≥ .49 is medium, and ηp ≥ .5 is large. 
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Table 48 
Visuospatial Construction Impairment Status and Rehabilitation Outcomes  
Variables Impairment Discharge 
 
Six Months 
 
12 Months 
 
  
 
N M SD N M SD N M SD 
Rehab. 
engagement 
Y 33 28 2.64       
N 44 30 2.42       
Prosthesis use  
Y 21 6 3.84 12 6.25 3.88 9 4.43 6 
N 30 8 3.76 24 8.5 4.35 18 4.84 11.25 
Functional 
satisfaction 
Y 22 10 2.59 12 10 2.88 9 2.77 9 
N 30 9 2.42 23 10 3.07 19 2.89 10 
Aesthetic 
satisfaction 
Y 22 6.55 1.71 12 6.5 1.98 9 5.89 2.15 
N 30 5.76 1.72 23 6.13 2.03 19 6.42 1.95 
General 
adjustment 
Y 21 3 0.76 12 3.1 0.64 9 0.73 3 
N 31 3 0.67 24 3 0.71 20 0.83 3.5 
Social 
adjustment 
Y 21 3 0.83 12 3 0.35 9 0.61 3.4 
N 31 3.2 0.65 24 3 0.66 20 0.73 3.4 
Adjustment to 
limitation 
Y 21 2 0.69 12 2 0.77 9 0.7 1.6 
N 31 2 0.67 24 2 0.76 20 0.92 1.8 
Distress Y 22 7 8.22 13 7 7.46 9 8.64 13 
  N 31 9 5.27 25 9 6.36 20 7.52 8.5 
Social support 
Y 22 5.96 1.53 13 6.5 0.92 9 1.42 5.42 
N 31 6.5 1.11 25 6.43 1.14 20 1.11 6.29 
Limitation & 
restriction 
Y 22 22 7.99 13 24 10.4 9 10.7 30 
N 31 24 6.24 25 23 9.48 20 10.79 27 
Participation 
engagement 
Y    13 60.26 27.34 9 56 32.6 
N    25 51.04 27.02 20 60.52 25.47 
Participation: 
importance & 
meaning 
Y    13 39.69 13.76 9 37 17.07 
N    25 36.24 10.34 20 41.2 12.3 
Control over 
participation 
Y    13 49.85 9.02 9 46.78 14.82 
N    25 47.72 11.1 20 49.35 12.52 
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Table 49 
Visuospatial Construction Impairment Status and Longitudinal Changes in Prosthetic and Psychosocial Functioning 
Variable  ANOVA
 a
   t-test
 b
  
 F(df) p ηp
2
 t(df) p gs 
Rehabilitation engagement - - - -1.556 (75) .124 .339 
Prosthesis use  .003 (1, 19) .960 .000 -.424 (49) .674 .519 
Functional satisfaction .104 (1, 21) .750 .005 .469 (50) .641 .395 
Aesthetic satisfaction .316 (1, 21) .580 .015 1.619 (50) .112 .453 
General adjustment .032 (1, 21) .859 .002 -.922 (50) .361 .0 
Social adjustment .043 (1, 21) .837 .002 -.555 (50) .582 .271 
Adjustment to limitation 1.265 (1, 21) .273 .057 .553 (50) .583 .0 
Distress .127 (1, 23) .725 .005 -.332 (51) .741 .297 
Social support .101 (1, 23) .754 .004 -1.138 (51) .260 .409 
Limitation & restriction .646 (1, 23) .430 .027 -.582 (51) .563 .281 
Participation engagement .058 (1,24) .812 .002 .995 (36) .327 .333 
Participation: importance & meaning .000 (1, 24) .997 .000 .871 (36) .390 .291 
Control over participation .025 (1, 24) .875 .001 .595 (36) .326 .199 
Note. ANOVA ηp
2
 and t-test Hedges’s g effect sizes: .01 ≤ ηp ≥ .059 is small, .60 ≤ ηp ≥ .79 is medium, and ηp ≥ .138 is large. 
 
a
 Mixed between-within ANOVA: between groups result; 
b
 Discharge (six months  for participation variables)   
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Table 50 
Visuospatial Construction Impairment Status and Mobility and Activation  
Status Variable Discharge 6 M 12 M Between-Groups Difference (Discharge) 
 Mobility N % N % N % χ2(df) Exact p Cramer’s V 
Impaired Dependent 6 18.2 3 23.1 2 22.2 8.219 (2) .015 .327 
 Ind. indoors 13 39.4 1 7.7 0 0    
 Ind. outdoors 14 42.2 9 69.2 7 77.8    
Not Impaired Dependent 6 13.6 2 8.0 3 15.0    
 Ind. indoors 6 13.6 2 8.0 4 20.0    
 Ind. outdoors 32 72.7 21 84.0 13 65.0    
           
 Activation N % N % N % χ2(df) Exact p Phi 
Impaired Level 1 or 2 3 13.6 1 7.7 2 22.2 .000 (1) 1.00 -.034 
 Level 3 or 4 19 86.4 12 92.3 7 77.8    
Not Impaired Level 1 or 2 5 16.1 8 32.0 7 35.0    
 Level 3 or 4 26 83.9 17 68.0 13 65.0    
Note. Effect sizes: .1 ≤ ηp ≥ .29 is small, .3 ≤ ηp ≥ .49 is medium, and ηp ≥ .5 is large. 
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Table 51 
Cognitive Flexibility Impairment Status and Rehabilitation Outcomes  
Function Impaired Discharge Six Months 12 Months 
  N M SD N M SD N M SD 
Rehab. 
engagement 
Y 25 28.44 1.73 
      
N 28 28.39 2.35 
      
Prosthesis use 
Y 17 7.47 3.4 10 9.15 4.53 8 11.38 4.66 
N 21 7 4 17 7.09 4 13 6.92 4.69 
Functional 
satisfaction 
Y 17 10.47 2.4 10 11.9 2.85 8 11.38 2.77 
N 22 8.86 2.62 16 9.06 2.62 14 9.57 2.41 
Aesthetic 
satisfaction 
Y 17 6.71 1.79 10 6.1 2.38 8 6.88 2.47 
N 22 5.77 1.77 16 6 1.83 14 6 1.62 
General 
adjustment 
  
Y 17 3.07 0.7 10 3.28 0.48 8 3.25 0.64 
N 21 2.81 0.78 19 2.71 0.79 15 2.87 0.85 
Social 
adjustment 
Y 17 3.01 0.89 10 3.44 0.52 8 3.45 0.69 
N 21 3.24 0.66 17 3.08 0.66 15 3.12 0.7 
Adjustment to 
limitation 
Y 17 2.08 0.75 10 2.08 0.78 8 1.75 1.04 
N 21 1.82 0.61 17 1.89 0.79 15 1.63 0.79 
Distress Y 17 8.24 4.78 10 6.8 3.74 8 13.5 11.38 
  N 23 9.74 5.21 19 11.68 6.63 15 10.27 4.37 
Social support 
Y 17 6.14 1.27 10 6.53 0.51 8 5.83 1.37 
N 23 5.77 1.31 19 5.79 1.29 15 5.63 1.24 
Limitation & 
restriction 
Y 17 25.59 9.08 10 25 13.45 8 36.88 13.18 
  N 22 25.5 6.02 19 26 6.98 15 27.2 6.1 
Participation 
engagement 
Y 
   
10 58.61 26.81 8 60.15 25.48 
N 
   
19 50.12 28.84 15 54.34 25.91 
Participation 
importance & 
meaning 
Y 
   
10 42.77 11.73 8 30.45 20.94 
N 
   
19 44.39 9.47 15 47.26 8.83 
Control over 
participation 
Y 
   
10 59.05 10.86 8 50.42 19.79 
N 
   
19 54.78 10.96 15 57.73 9.68 
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Table 52 
Cognitive Flexibility Impairment Status and Longitudinal Change in Rehabilitation Outcomes 
Variable ANOVA
 a
 t-test
 b
 
 F(df)
 
 p ηp
2
 t(df)
 
 p gs 
Rehab. engagement    .082 (51) .935 .024 
Prosthesis use 1.178 (1, 14) .296 .078 .385 (36) .702 .123 
Functional satisfaction 6.488 (1, 16) .022 .289 1.967 (37) .057 .624 
Aesthetic satisfaction 2.573 (1, 16) .128 .139 1.622 (37) .113 .518 
General adjustment 3.518 (1,16) .079 .180 1.079 (36) .288 .341 
Social adjustment 1.502 (1, 16) .238 .086 -.899 (36) .375 .292 
Adjustment to limitation .411 (1, 16) .531 .025 1.206 (36) .235 .377 
Distress .980 (1, 18) .335 .052 -.935 (39) .356 .292 
Social support 1.074 (1, 18) .314 .056 .895 (38) .376 .280 
Limitation & restriction .131 (1, 18) .722 .007 .137 (38) .891 .012 
Participation engagement .069 (1, 19) .796 .004 .772 (27) .447 .293 
Participation importance & meaning 1.992 (1, 19) .174 .095 -.267 (27) .792 .153 
Control over participation .016 (1, 19) .900 .001 1.096 (27) .283 .380 
Note. ANOVA ηp
2
 and t-test Hedges’s g effect sizes: .01 ≤ ηp ≥ .059 is small, .60 ≤ ηp ≥ .79 is medium, and ηp ≥ .138 is large. 
 
a
 Mixed between-within ANOVA: between groups result; 
b
 Discharge (six months  for participation variables) 
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Table 53 
 Cognitive Flexibility Impairment Status and Mobility and Activation  
Status Variable Discharge 6 M 12 M Between-Groups Difference (Discharge) 
 Mobility n % n % n % χ2(df) Exact p Cramer’s V 
Impaired Dependent 4 16.0 1 10.0 1 12.5 .053 (2) 1.000 .031 
 Ind. indoors 4 16.0 0 0 0 0    
 Ind. outdoors 17 68.0 9 90.0 7 87.5    
Not Impaired Dependent 4 14.3 3 15.8 3 20.0    
 Ind. indoors 5 17.9 2 10.5 4 26.7    
 Ind. outdoors 19 67.9 14 73.7 8 53.3    
           
 Activation n % n % n % χ2(df) Exact p phi 
Impaired Level 1 or 2 0 0 1 10 4 50 1.637 (1) .123 -.287 
 Level 3 or 4 17 100 9 90 4 50    
Not Impaired Level 1 or 2 4 17.4 8 42.1 5 33.3    
 Level 3 or 4 19 82.6 11 57.9 10 66.7    
Note. Effect sizes: .1 ≤ ηp ≥ .29 is small, .3 ≤ ηp ≥ .49 is medium, and ηp ≥ .5 is large. 
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Appendix H:  
 
Descriptive and Inferential Statistics for 
Objective 8  
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Table 54 
Outcomes According to Whether Participants Were Impaired on Neither, One, 
or Both of Overall Cognitive Functioning and Cognitive Flexibility 
Variable Group Discharge Six Months 12 Months 
    N M SD N M SD N M SD 
Rehabilitation 
engagement 
Neither 23 28.78 1.97       
One 17 28 2.6       
Both 10 28.4 0.84       
Prosthesis use Neither 18 7.31 4.15 14 7.82 3.94 10 7.9 4.82 
 One 12 7.33 2.68 8 7.5 4.95 6 8.83 5.19 
 Both 6 7.67 4.68 2 9.25 0.35 2 12 0 
Functional 
satisfaction 
Neither 18 8.94 2.82 13 9.46 2.57 11 10.09 2.15 
One 13 9.77 2.28 8 10.75 3.01 6 10.5 3.21 
Both 6 11.33 2.5 2 12.5 3.54 2 13.5 0.71 
Aesthetic 
satisfaction 
Neither 18 5.83 1.92 13 6.15 1.95 11 6.27 1.71 
One 13 5.92 1.66 8 5.13 2.1 6 5.17 2.14 
Both 6 7.5 1.64 2 7.5 2.12 2 9 0 
General 
adjustment 
Neither 17 2.96 0.68 14 2.81 0.75 12 2.97 0.82 
One 13 2.97 0.82 8 3.1 0.81 6 3.4 0.91 
Both 6 3 0.82 2 3.5 0.42 2 2.6 0.28 
Social 
adjustment 
Neither 17 3.34 0.65 14 3.04 0.7 12 3.05 0.75 
One 13 2.98 0.87 8 3.38 0.55 6 3.4 0.68 
Both 6 3.07 0.95 2 3.3 0.42 2 3.4 0.85 
Adjustment to 
limitation 
Neither 17 1.91 0.6 14 2.05 0.78 12 1.78 0.66 
One 13 2.03 0.83 8 2.06 0.91 6 1.83 0.104 
Both 6 1.93 0.65 2 1.7 0.42 2 1.3 0.42 
Distress Neither 19 9.63 5.38 16 12.69 6.47 12 10.42 4.17 
One 13 9.38 5.17 8 5.38 4.14 6 8.83 8.66 
Both 6 6 3.29 2 6 1.41 2 27.5 6.36 
Social support Neither 19 6.04 1.13 16 6.05 1.2 12 5.99 1.07 
One 13 5.87 1.38 8 6.14 0.98 6 5.42 1.63 
Both 6 5.93 1.78 2 6.88 0.18 2 5.75 1.41 
Limitation & 
restriction 
Neither 18 24.72 4.88 16 25.31 7.14 12 27 6.52 
One 13 23.38 5.2 8 20 6.44 6 26.67 9.14 
Both 6 26.33 10.48 2 24 8.19 2 45 8.19 
Participation 
engagement
 a
 
Neither    16 50.6 30.09 12 59.9 26.1 
One    8 57.77 24.71 6 54.08 22.02 
Both    2 81.81 25.71 2 70 42.43 
Participation: 
importance & 
meaning
 a
 
Neither    16 36.63 11.84 12 41.75 10.3 
One    8 39.13 12.21 6 30 10.95 
Both    2 36.5 0.71 2 33 26.87 
Control over 
participation
 a
 
Neither    16 45.88 10.75 12 51 8.34 
One    8 51.5 7.03 6 42.33 14.28 
Both    2 50.5 6.36 2 39.5 31.82 
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Table 55 
One-Way ANOVAs for Impaired on Neither, One, or Both of Overall Cognitive Functioning and Cognitive Flexibility 
Status 
Variable One-Way ANOVA 
 F(df) p ηp
2
 
Rehabilitation engagement .705 (2, 47) .499 .029 
Prosthesis use .021 (2, 33) .979 .001 
Functional satisfaction 1.942 (2, 34) .159 .103 
Aesthetic satisfaction 2.092 (2, 34) .139 .110 
General adjustment .005 (2, 33) .995 .000 
Social adjustment .819 (2, 33) .450 .047 
Adjustment to limitation .107 (2, 33) .899 .006 
Distress 1.240 (2, 35) .302 .066 
Social support .072 (2, 35) .930 .004 
Activity limitation & participation restriction .483 (2, 35) .621 .027 
Participation engagement 
a
 1.123 (2, 23)
a
 .342 .089 
Participation: importance & meaning
 a
 .128 (2, 23)
a
 .880 .011 
Control over participation
 a
 .991 (2, 23)
a
 .387 .079 
Note. Effect sizes: .01 ≤ ηp ≥ .059 is small, .60 ≤ ηp ≥ .79 is medium, and ηp ≥ .138 is large
 
a
 six month variable tested.  
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Table 56 
 
  
Impairment Status on Both  Overall Cognitive Functioning & Cognitive Flexibility and Categorical Variables  
Impairment Status Variable Discharge 6 M 12 M Between-Groups Difference (Discharge) 
 Mobility N % N % N % χ2(df) Exact p Cramer’s V 
Neither Dependent 3 13.0 3 18.8 3 25.0 1.942 (4) .794 .139 
 
Independent 
indoors 
4 17.4 1 6.3 3 25.0    
 
Independent 
outdoors 
16 69.6 13 75.0 6 50.0    
One Depend. 2 11.8 0 0 0 0    
 Ind. in. 3 17.6 0 0 0 0    
 Ind. out. 12 70.6 8 100 6 100    
Both Depend. 3 30.0 0 0 0 0    
 Ind. in. 1 10.0 0 0 0 0    
 Ind. out. 6 60.0 2 100 2 100    
           
 Activation N % N % N % χ2(df) Exact p Cramer’s V 
Neither Level 1 2  3 15.8 7 43.8 3 25.0 3.257 (2) .264 .293 
 Level 3/4  16 84.2 9 56.3 9 75.0    
One Level 1/2  0 0 0 0 3 50.0    
 Level 3/4  13 100 8 100 3 50.0    
Both Level 1/2  0 0 0 0 1 50.0    
 Level 3/4  6 100 2 100 1 50.0    
Note. Effect sizes: .1 ≤ ηp ≥ .29 is small, .3 ≤ ηp ≥ .49 is medium, and ηp ≥ .5 is large.  
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